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Despite  that  ultrasound  has  been  in  existence  for  more  than  100  years  and  is 
considered a mature technology by many, the field is constantly evolving. The history 





materials. His  specific  application was  the  use  of  ultrasound  to  detect  submarines 
during World War I. Industrial uses of ultrasound began in 1928 with the suggestion 
of Soviet Physicist Dr.Sokolov that it could be used to detect hidden flaws in materials. 
Medical  uses  of  ultrasound  through  the  1930s  were  confined  to  therapeutic 
applications such as cancer treatments and physical therapy for various ailments. The 
potential of ultrasound as an imaging modality was realized as early as in late 1940ʹs 
when  several  groups  of  investigators  around  the  world  utilizing  sonar  and  radar 
technology developed during World War II started exploring diagnostic capabilities of 
ultrasound.    he  publication  by  Dr.  Dussik  (Austria)  in  1942  on  their  work  on 








Ultrasonic  imaging  is  one  of  the most  important  tools  in  diagnostic medicine  and 
nondestructive  testing  today.  The  objective  of  this  book  is  to  provide  graduate 
students,  researchers,  engineers  and  physicists  involved  in Ultrasound  Imaging  the 
latest  information  on  state‐of‐the‐art  work  in  the  development  and  application  of 
Ultrasound Imaging. 




This  book  provides  an  overview  of  ultrafast  ultrasound  imaging,  3D  high‐quality 
ultrasonic imaging, correction of phase aberrations in medical ultrasound images,  etc.  
Several interesting medical and clinical applications area are also discusses in the book 
like  use  of  three  dimensional  ultrasound  imaging  in  evaluation  of  Asherman’s 
syndrome, the role of 3D ultrasound  in  assessment  of  endometrial  receptivity and  
follicular  vascularity  to  predict    the  quality  oocyte,  ultrasound  imaging  in  vascular 
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Ultrafast Ultrasound Imaging 
Jeremy Bercoff 
SuperSonic Imagine    
France 
1. Introduction  
Ultrasound can be considered as a disruptive technology in the medical device arena 
(Christensen, 2003). A disruptive technology has the potential to break the rules of 
existing markets. Thanks to its real time capabilities, its non ionizing properties and its 
cost - much lower than any other medical modality - ultrasound has significantly 
impacted clinical segments within radiology, obstetrics, vascular or cardiology and 
created new markets of emergency medicine and intervention. It could, in the future, 
change the rules for screening (where whole breast ultrasound devices are entering the 
market of breast imaging), diagnosis (with  the standardization of elastography 
techniques in the prostate) and surgery (with HIFU – High Intensity Focused Ultrasound –, 
histotripsy devices and therapy monitoring tools). 
In this context, innovations in the ultrasound field always have enormous potential. In the 
history of ultrasound, many innovations have been developed since its  establishment as a 
medical imaging device in the 1960s, roughly one or two per decade (Szabo, 2004). The 
key innovation that launched the modality in the 1960s, is the real time imaging capability 
through mechanical scanning. Multichannel systems with electronic control of transducer 
arrays were developed in the 1970s. In the 1980s, flow analysis tools came to maturity 
through color flow imaging and quantitative Doppler modes (Pulse Wave Doppler - 
PWD). In the 1990's significant improvements in image quality were made possible with 
the introduction of real time compounding techniques and harmonic imaging. Although 
many of these concepts were studied in research laboratories years before the commercial 
dates cited above, it is systematically the maturity of a new technology that trigger the 
introduction of the innovations on commercially available platforms: for example, real 
time imaging was triggered by microprocessors development, Doppler modes were 
prompted by digital signal processing chips with enough dynamics to detect, at the same 
time, very weak blood signal and strong tissue echoes. The introduction of low cost 
Analog to Digital (A/D) converters has led to fully digital systems, significantly 
increasing the quality of the information delivered. Harmonic imaging was triggered  
by large bandwidth transducers, allowing reception of the signal at twice the transmit 
frequency.   
In the first decade of the 21st century, technology moved towards extensive miniaturization 
leading to the introduction of high performances portable devices. Portable devices have 
created new markets for ultrasound - the emergency market for example, underlying again 
the disruptive potential of the modality. Today portable devices are the primary sources of 
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market growth in the industry and miniaturization can be considered as a global trend of 
the ultrasound industry: available technologies and innovations are progressively integrated 
in portable systems.   





Fig. 1. A few important innovations in ultrasound imaging and their corresponding 
technology enablers. 
Today a new technological breakthrough is ongoing with the advent of massive parallel 
computing capabilities. This results from the incredible demand in processing and display 
performances needed in the videogame industry. In addition to multicore architecure 
CPU's, new graphical processing units (GPU) allow parallel processing on thousands of 
channels simultaneously. This technology is available for the ultrasound industry and is the 
enabler to full software-based architecture systems. In 2009, SuperSonic Imagine introduced 
the first full software-based ultrasound system (Aixplorer®):  instead of increasing 
integrated hardware processing channels,  all the processing is performed by the software 
unit (CPU and GPUs). The concept of processing channels disappears - the system is able to 
compute in parallel as many channels as required by the acquisition. 
This architecture paves a new way to perform ultrasound imaging: ultrafast ultrasound 
imaging. This is the focus of this chapter: what is ultrafast imaging (section 2),  what new 
information can be assessed using it (section 3), how can we revisit standard ultrasound 
modes using ultrafast capabilities and enhance performances of current ultrasound devices 
(sections 4) and what innovations could it bring in the future (section 5) ? 
2. Ultrafast ultrasound imaging: definition and example 
2.1 Conventional ultrasound imaging 
Ultrasound imaging is usually performed by sequential insonification of the medium using 
focused beams. Each focused beam allows the reconstruction of one image line. A typical 2D 
image is made of a few tens of lines (64 to 512). The overall sequence is illustrated on Fig. 2. 
The frame rate of the imaging mode is set by the time required to transmit a beam, receive 
and process the backscattered echoes from the medium and repeat that for all the lines of 
the image.  
For a conventional 2D image, the time to build an image is: 
 * 2 *linesimage
N ZT
c
  (1) 
 




Fig. 2. Conventional imaging acquisition process 
Where Z is the image depth, c the speed of ultrasound waves assumed constant (1540 m/s) 
and Nlines the number of lines in the image. 






  (2) 
For example, an image of 5cm in depth and 256 lines in width would have the following 
frame rate: 
 max 60FR Hz  (3) 
Ultrasound system architectures were designed to process one image line at a time. 
2.2 Increasing ultrasound imaging frame rate 
Limitations of the conventional approach appears as soon as higher frame rates are 
required, typically in echocardiography for the heart motion analysis, as well as in 3D/4D 
imaging where the number of lines become significant (~ a few thousands).  
Parallelization schemes have been considered to overcome these limitations. In the academic 
area this has been reported as soon as the late 70's (Delannoy, 1979; Shattuck, 1984; Von 
Ramm, 1991). Most current systems have multiline capabilities: for each transmit beam, 
several lines (typically from 2 to 16) are computed. Multiline processing can be used either 
to increase the frame rate (for echocardiography for example) either to increase the number 
of lines computed per image (for 3D imaging).   
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2.3 Ultrafast imaging 
With or without multiline capabilities, current ultrasound systems are built on a serialized 
architecture and images are reconstructed sequentially from several equivalent transmits. 
Ultrafast imaging breaks this paradigm. An ultrafast imaging system is able to compute in 
parallel as many lines as requested and is therefore capable of computing a full image from 
one single transmit whatever the size and the characteristics of the image. In such a system 
the image frame rate is no longer limited by the number of lines reconstructed but by the 
time of flight of a single pulse to propagate in the medium and get back to the transducer. 
Table 1 gives typical frame rates for different ultrasound clinical applications using  
conventional and ultrafast architectures. 
 
Application Typical imaging depth 
Conventional 
architecture Ultrafast architecture 
Abdominal imaging 20 cm 20 Hz 3800Hz 
Cardiac Imaging 15 cm 150 Hz 5000Hz 
Breast imaging 5 cm 60 Hz 15000 Hz 
Table 1. Example of typical frame rates in different clinical applications for conventional and 
ultrafast architectures. 
New applications of ultrafast systems have been reported in the literature. Fink 
demonstrated for the first time that transient shear waves, never visualized before on an 
ultrasound scanner, can be imaged (Sandrin, 2000). Jensen used an ultrafast device to 
implement synthetic imaging techniques and derive vectorial estimation of flow motion 
(Jensen 2005). Ultrafast prototypes reported in those works allowed the storage of 
acquisitions in a digital memory stack and then the transfer to a PC. Processing was then 
performed offline on the stored data.   
Although the concept of ultrafast imaging has been explored in academics during the last 
decade, it is only recently that this technology has entered the commercial realm due to 
major technological barriers that had to be overcome. 
For example, to achieve ultrafast imaging, the image computation must be performed on a 
fully parallelized platform, typically a software-based platform. 
There are two technologically challenging aspects to building a fully software-based platform: 
- the data transfer rate from the acquisition module to the processing unit. As raw (non 
beamformed) Radio Frequency (RF) signals are directly transferred to the PC, the data 
rate required to perform real time imaging is huge: several GigaBytes/s.  
- the processing unit needs to be powerful enough to ensure real time imaging. As an 
example, conventional gray scale imaging requires 1 to 2 Gigaflops (multiplication + 
addition) per second.  
New powerful processing units (GPUs) have reached a satisfactory level of performance at 
the end of the 2000s. Consequently, GPU's are more and more used in the medical field to 
speed up processing algorithms (Schiwietz, 2006; Xu, 2007; Rosenzweig, 2011). The ultrafast 
architecture leverages this processing power by combining it with fast numerical links (PCI 
express technology) capable of transferring huge volume of data to these units. This 
combination allows the shift of the beamforming process - the most demanding processing 
step of an ultrasound system - from hardware to software, enabling full parallelization of 
ultrasound image computation.  
Fig. 3 represents the architecture of an ultrafast system compared to a conventional one.  
 




Fig. 3. As beamforming is performed in software, full parallelization of image formation can 
be performed. Each insonification can therefore lead to a full image. (TX refers to Transmit 
and RX to Receive).  
2.4 Ultrafast imaging using coherent plane wave compound 
There are many ways to leverage an Ultrafast imaging architecture (Lu, 1998; Jensen 2005). 
SuperSonic Imagine's approach is based on the use of plane wave insonifications. A plane 
wave is generated by applying flat delays on the transmit elements of the ultrasound probe 
as illustrated on Fig. 4. The generated wave will insonify the whole area of interest.    
 
 
Fig. 4. A plane wave is sent by a linear transducer and insonifies the whole region of 
interest. An ultrasound image is computed from this single insonification. 
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Fig. 3. As beamforming is performed in software, full parallelization of image formation can 
be performed. Each insonification can therefore lead to a full image. (TX refers to Transmit 
and RX to Receive).  
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as illustrated on Fig. 4. The generated wave will insonify the whole area of interest.    
 
 
Fig. 4. A plane wave is sent by a linear transducer and insonifies the whole region of 
interest. An ultrasound image is computed from this single insonification. 
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The backscattered echoes are then recorded and processed by the ultrafast scanner to 
compute an image of the insonified area. 
Plane wave imaging allows the computation of one full ultrasound image per transmit at the 
expense of the image quality. As the transmit focalization step is removed, the image 
contrast and resolution are reduced, as illustrated in the figure below: 
 
Fig. 5. Image of a phantom with anechoic inclusion of different sizes with plane wave 
insonification (left) and standard focused method (right). The images were acquired with  
a 5 MHz linear probe. 
 
 
Fig. 6. Ultrasound image obtained using ultrafast coherent plane wave compound  
To overcome this limitation, several tilted plane waves are sent into the medium (Montaldo, 
2009) and coherently summed to compute a full image. Using this method the transmit 
focalization step is retrospectively done by this summation (Fig. 6). The quality of the final 
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image is therefore dependent on the number of angles used to reconstruct it as illustrated  
on Fig. 7.  
There is a trade off between the maximum ultrafast frame rate achievable by the mode and 
the image quality: the higher the number of angles, the better the image quality. 
 
 
Fig. 7. Image quality as a function of the number of angles used to compute the final 
ultrasound image for a 40mm depth image. 
The ultrafast compounded acquisition sequence presents several advantages: 
- Firstly, the retrospective transmit focalization can be done dynamically for each pixel of 
the image increasing the homogeneity of the final image compared to physical 
insonification. 
- Secondly, the number of firings required to obtain an image of a quality equivalent to a 
focused mode (in terms of contrast and resolution) is around 5 to 10 times lower 
(Montaldo, 2009). As a consequence, frame rates of ultrasound imaging can be 
increased by the same factor using coherent plane wave strategies on an ultrafast 
system. Fig. 8 shows an example of equivalent quality ultrasound images using the 
coherent plane wave approach and the focused one. Maximum reachable frame rates 
increase from 30 Hz to more than 300 Hz. 
- Finally by cleverly trading off the compromises in the image quality, imaging frame 
rates of a few thousands of Hz can be reached and allow a full new range of 
applications and innovations. 
This chapter presents two innovations that leverage ultrafast imaging on an ultrasound 
system: the first one is a new imaging mode called Shear Wave Elastography that provides 
quantitative visco-elastic analysis of tissues. The second one is a new way to perform 
Doppler flow analysis changing the performances and workflow paradigms of current 
available Color and PW modes.  
3. Shear wave elastography 
3.1 Transient shear waves for tissue mechanical investigation 
Ultrasound imaging provides both morphological (gray scale images) and functional 
imaging (flow imaging) of soft tissue. Using ultrafast capabilities, a third dimension can be 
added to ultrasound: physio-pathological information through the assessment of tissue  
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Fig. 8. 2 images of equivalent quality using focused (left) and ultrafast (right) techniques. 
Maximum achievable frame rates are respectively 30 and 325 Hz. 
viscoelasticity. Ultrafast imaging can be used to capture phenomena that have never been 
imaged on commercial ultrasound devices: transient shear waves propagating in soft tissue. 
Shear wave imaging leads to quantification of tissue mechanical properties.  
3.1.1 Shear waves in soft tissues 
Two types of mechanical waves propagate in soft tissue: compressional waves (ultrasound 
waves are compressional waves in a given frequency range) and shear waves. 
Compressional waves travel much faster than shear waves in soft tissue: typically 1 to 
1500m/s  compared to 10m/s for shear waves. In other words, the bulk modulus (K) of soft 
tissue is much larger than the shear modulus (µ) (a factor 106 higher).  
 K>>µ (4) 
This has two important consequences: 
- Tissue viscoelasticity is only dependent on the shear modulus. The Young's modulus, 
that quantifies tissue viscoelasticity, can be written : 







- The difference in propagation speed is so large that shear wave motion can be 
considered as negligible during the propagation time of a compressional wave. Imaging 
methods relying on compressional waves such as ultrasound can therefore be used to 
record propagation of shear waves. Note that this is not true in other solids such as 
metals or rocks (in seismology for example, bulk waves cannot image shear waves) 
In summary, shear waves reflect tissue viscoelasticity properties and they can be imaged 
using ultrasound.  
3.1.2 Imaging shear waves: need for ultrafast imaging 
If compressional waves can propagate within tissue on a very large frequency range [up to 
the GHz), shear waves suffer from much stronger viscous/attenuation effects. Maximum 
shear wave frequencies propagating in human tissue are organ-dependent and typically 
vary between 500 Hz and 2000 Hz. As a consequence the minimum frame rate required to 
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correctly sample transient waves are of a few thousands Hertz (from 1000 Hz to 4000Hz 
taking the Nyquist limit).  
Those frame rates are only achievable using ultrafast imaging. 
In order to image shear waves, the system must be tuned to maximize the imaging frame 
rate. Typically a single flat wave is sent to compute a full image (Fig. 4), allowing to reach 
the required frame rates (a few thousands Hz), the maximum value only depending on the 
considered image depth (time of flight of the wave back and forth from the maximum depth 
imaged).  
3.1.3 Generating transient shear waves 
There are three different types of source of transient shear waves in the body.  
The first type is natural body vibrations: heart beating, arterial pulses or voice are examples 
of vibrating sources that induce shear waves. It is a free source of information but the 
assessment of reliable information is challenging outside of the vicinity of the vibrating 
organ.  
To better control the generation of the vibration, external vibrators that create controlled 
transient pulses have been proposed. The first report of externally generated transient shear 
wave analysis was published in the 1990s (Catheline, 1999). A that time, ultrafast imaging 
was not used and shear wave propagation was analyzed along a single ultrasound line. The 
work was extended to 2D shear wave imaging using the first ultrafast imaging prototype 
(Sandrin, 2000) and the first quantitative elasticity image was shown. 
Also in the late 1990s, Sarvazyan proposed a third way to generate transient shear waves in 
the body (Sarvazyan, 1998): the acoustic radiation force induced by ultrasound beams. If 
sufficient energy if applied at the focus of an ultrasound beam, tissue can be remotely 
pushed in the direction of the ultrasound wave propagation. A transient shear wave that 
propagates transversally is generated as illustrated on Fig. 9.  
 
Fig. 9. Radiation force from an ultrasound focused beam generates a transverse bipolar 
shear wave. 
In Sarvazyan's setup, the shear wave was induced with a specific transducer and the motion 
was recorded using a separate conventional scanner and iterative methods. 
In 2004, a new imaging mode has been introduced coupling radiation force induced 
transient shear waves and ultrafast imaging called Supersonic Shear Imaging (Bercoff, 2004). 
In this approach, the shear wave is generated and imaged with the same ultrasound probe. 
The generation method was based on the induction of a shear wave source that moves into 
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the body at a supersonic speed, allowing, through the equivalent of a sonic boom, the 
creation of high amplitude shear waves in human organs.  
3.1.4 Measuring tissue viscoelasticity 
Once properly generated and imaged, a transient shear wave can provide many insights on 
the mechanical properties of the imaged tissue. Fig. 10 illustrates the propagation of a shear 
wave in a tissue-mimicking phantom using Supersonic Shear Imaging. The wave is captured 
on a 2D imaging plane thanks to ultrafast imaging. 
 
 
Fig. 10. 3 snapshots of a shear wavefront propagating in a phantom. The gray level indicates 
amplitude of the displacements generated by the shear in the tissue. The wavefront is 
distorted when passing through a harder inclusion (right image) as the shear wave 
propagates faster in the inclusion.  
The phase velocity as a function of the frequency as well as the group velocity can be 
calculated locally.  




Fig. 11. Shear wave velocity map superimposed on the ultrasound image of the phantom. 
The harder spherical inclusion appears on the velocity map in red while it is barely visible 
on the ultrasound image. This enhances the fact that the contrast given by both imaging 
modes are uncorrelated. 
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Because the shear wave is imaged inside the medium, all wave components can be assessed 
and used for velocity estimation including evanescent waves. The resolution of the shear 
wave velocity image is therefore not limited by the shear wavelength but by the wavelength 
of the imaging method, i.e. ultrasound. In the above example, the resolution of the image is 
1mm while the shear wavelength is around 15 mm. 
Depending on the organ, different rheological models can be used to derive tissue 
mechanical characteristics from the shear wave propagation map. 
- In a purely elastic medium, phase velocity does not vary as a function of frequency 
(Royer, 2000) and is equal to the group velocity. The velocity is directly linked to tissue 
Young's modulus E through the formula where c is the shear wave speed and ρ the 
tissue density. 
 23E c   (6) 
- In a viscoelastic medium such as breast or liver, the phase velocity increases as a 
function of frequency. Many rheological models can be considered such as the Voigt or 
the thermoviscous models. Most of them appear to be consistent only in a limited 
frequency range (Orescanin, 2010). A well-established model for compressional waves 
is the time causal model (Szabo, 2004) which shows a power law dependence of the 
attenuation and phase velocity as a function of frequency and works on the full 




( ) ( ) 2
y yy f f
c f c f
            
 (7) 
f and fo represents frequencies of analysis,  α and y the two parameters modelizing the 
power law dependence of the attenuation. Analysis of the shear wave propagation 
allows deduction of c(fo), α and y enabling full rheological characterization  of the 
tissue.  In such cases, the estimation of group velocity values gives a representation of 
medium viscoelasticity at the central frequency of the wave spectral content.  
- In a thin medium that has geometrical characteristics much smaller than the shear 
wavelength, such as arteries, guidance of the shear waves through medium leads to 
geometrical dispersion effects. Depending on the medium external environment and its 
geometrical characteristics, shear wave velocity propagation can be modeled and 
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Where c is the shear wave speed in an infinite medium, ω the frequency, h the height of the 
artery and K a correction factor. Young's modulus can then be deduced using the formula (6). 
3.2 A new imaging mode in ultrasound imaging 
3.2.1 Presentation 
Basic concepts introduced in the Supersonic Shear Imaging technique (Bercoff, 2004) have been 
used to create a real time imaging mode, called ShearWave Elastography (SWE), on a 
commercially available system. Two key aspects have made this innovation transfer possible: 
- An new technology (multicore CPU, GPUs, as explained above) for the building of a 
ultrafast imaging system able to image transient shear waves. 
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- A user workflow enabler: using this approach, the generation and imaging of the shear 
wave is performed with the same ultrasound probe as the one conventionally used for 
other imaging modes. No additional material is necessary to perform elasticity imaging. 
Acceptance of the mode in the clinical workflow is easier and the learning curve for the 
new mode is minimized.   
The SWE mode is an additional real-time imaging mode that provides tissue elasticity 
estimation in kiloPascal (Fig. 12). 
In its primary implementation, the mode estimates the shear wave group velocity locally 
and deduces the value in kPa assuming the medium is purely elastic (eq 6). This is done in 
real time on a 2D image plane as illustrated on figure below. 
 
Fig. 12. ShearWave Elastography mode: Elasticity Information is displayed in real time in a 
box with color coded values. 
Recently, the mode has been implemented on a specific probe providing volumetric 
imaging. In addition to axial view, transverse and coronal views of lesions elasticity 
distribution can be assessed as illustrated on figure below: 
 
Fig. 13. 3D ShearWave Elastography. 3 planes can be viewed. By navigating within the 
volume the displayed imaging plane can be chosen. 
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Volume assessment can be performed allowing more accurate visualization and 
quantification of elastic distribution. 3D SWE may be extremely useful in the framework of 
therapy monitoring.   
Indeed complementary information of tissue stiffness changes can increase information on 
response to therapy compared to simple tumor volume size. Additional modules for specific 
applications requiring more complex rheological modelizations can be envisioned. In the 
example below, it is possible to measure and display the phase velocity as a function of the 
wave frequency in a region of interest of the liver. In addition to the group velocity, the 
slope of the phase velocity variation can be assessed. This full assessment of the liver 
viscoelasticity could be of great interest for diffuse liver disease diagnostics and staging. 
 
Fig. 14. Dispersion of shear waves in liver assessed by ShearWave Elastography. The white 
curve represents the shear wave phase velocity as a function of the frequency calculated in the 
square box displayed on the gray scale image. The yellow one is the spectrum amplitude of the 
transient wave. The group velocity, the central frequency of the shear wave and the relaxation 
time (in ms) corresponding to the slope of the curve are displayed to the left of the image.  
The same principle can be applied to reconstruct the arterial Young's modulus by combining 
the group velocity measurement and the thickness of the artery as described in (8). 
3.2.2 Clinical value 
The ShearWave Elastography (SWE) mode has recently been implemented for different 
organs. Fig. 15 shows elasticity images in the breast, tendons, liver and prostate.  
Multicentric studies to assess the clinical value of the mode are currently ongoing: 
- Breast: SWE could potentially help improve the diagnosis of breast lesions by increasing 
the overall accuracy of the BI-RADS® (Mendelson, 2001) classification. Recent studies have 
shown promising results for breast cancer diagnostic (Evans, 2010). SWE could help 
correctly reclassify malignant lesions that would have been missed with ultrasound alone 
and declassify benign lesions that would have been biopsied. From a global perspective 
this could lead to a reduction of the number of unnecessary biopsies and an increase in 
positive biopsy rate reducing healthcare cost and patient’s stressful experience.  
A multicentric study on 1800 patients and 17 clinical sites is ongoing to confirm these 
preliminary results. 
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Fig. 15. SWE images in a) breast , b) MSK, c) liver, d) prostate 
- Liver: SWE is currently being evaluated in the framework of diffuse liver disease staging 
and on its ability to improve the diagnosis of focal lesions. A preliminary study on  
113 patients (Bavu, 2011) demonstrated high accuracy of fibrosis staging using  
SWE. 
- Thyroid: As for breast, SWE could increase the diagnosis accuracy . The number of 
benign nodules that are undergoing Fine Needle Aspiration is currently extremely high. 
A preliminary study (Sebag, 2010) demonstrated very promising results on the 
pertinence of elasticity images for nodule characterization. More importantly, the 
specific case of follicular neoplasm raises an important issue as 85% of surgeries of this 
type of lesions are done for benign lesions. 
- Prostate: SWE could be of great interest for improved detection rate of prostate cancer, 
through localization of prostate lesions, monitor localized treatments. Ongoing studies 
intend to demonstrate the value of SWE for increased positive biopsy rate in the 
prostate diagnostic workflow. 
3.2.3 Perspectives for SWE 
Today, SWE is mainly positioned in the disease diagnosis of specific static organs (cited 
above).  However, given its specificities, other domains could benefit from the mode: 
- Its resolution (up to 1mm in superficial organs) and sensitivity (elastic contrasts of 20 % 
can be detected) could improve screening for specific organs.   
- Its quantitative aspect, implemented on a 3D imaging system, can target the emerging 
field of localized and minimally (or non) invasive therapy monitoring (RF, 
Cryoablation, HIFU).  
- Its ability to acquire the elasticity information on a wide region of interest in a few tens 
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4. Changing the paradigm in blood flow analysis using ultrafast imaging 
We demonstrated how ultrafast imaging could bring new information to the medical 
community by imaging fast transient phenomena such as shear waves. Ultrafast imaging 
can also be used to re-think conventional ultrasound modes. We will investigate in this 
section the potential of ultrafast imaging for flow analysis.  
Doppler analysis is one of the most demanding features in ultrasound from a technical 
standpoint - the number and complexity of firings to acquire the information is huge - and 
from a performance standpoint - quantitative measurements are expected, raising the 
requirements of the mode in term of accuracy and reproducibility. Due to this complexity, 
Doppler tools suffer from technical limitations that impact the user in a significant way. It is 
shown here how ultrafast imaging can overcome those limitations and open new 
perspectives in Doppler analysis both in terms of performance and user workflow. 
4.1 Ultrafast sequence for Doppler imaging 
The same type of ultrafast sequences as the ones described above for B-mode (2.4) are used 
in Doppler imaging. Several tilted plane waves are sent into the medium and backscattered 
echoes are coherently summed to reconstruct ultrasound images. Then Doppler processing 
can be performed as on conventional images.  
 
 
Fig. 16. Ultrafast compound imaging for Doppler analysis of flow. 
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Fig. 15. SWE images in a) breast , b) MSK, c) liver, d) prostate 
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The maximum number of angles that can be used to compute an image is limited by the 
acquisition Pulse Repetition Frequency (PRFdoppler) needed to measure the desired Doppler 





  (9) 
Where PRFmax is the maximal PRF reachable given the imaging depth considered.  
Interestingly, it has been shown, in Color flow imaging, that resolution and sensitivity 
equivalent to classical schemes can be obtained using only 9 different angles (Bercoff, 2011). 
This indicates that Doppler images can be acquired 10 to 15 times faster than with 
conventional approaches (For a typical 20 to 30 mm color box, around 100 lines are 
acquired). Such a huge gain in acquisition time can be used in several ways:  
- Increase Doppler imaging modes performance: we demonstrate below increases in 
temporal resolution and sensitivity (4.2). 
- Improve user workflow: this gain in time can be used to perform other acquisition types 
such as PW, potentially increasing performances of highly demanding modes such as 
triple mode (Bmode, Color flow imaging and PW simultaneously). 
- Change Doppler mode paradigm by merging Color flow imaging and PW Doppler 
modes in a single acquisition and with this, increase the accuracy of the examination 
and reduce its overall time (4.3).   
The use of several tilted plane compounded waves as described above is essential for the 
performance of the mode in terms of sensitivity and accuracy (Udesen, 2008).   
4.2 Improving color flow imaging (CFI) 
Conventional schemes offer limited frame rates for color flow imaging (typically 20 Hz) and 
suffer from severe trade-offs between image size and frame rate (that can go down to a  
few Hertz for boxes covering the whole image area). Ultrafast compound based Doppler 
imaging provides flow images with a temporal resolution never reached before on ultrasound 
systems whatever the box size. Complex and fast flows can be visualized in a much finer  
way potentially leading to a more reliable diagnosis of cardiovascular diseases such as 
stenoses.   
The figure below shows images of a color flow clip acquired at 200 Hz (around 10 times 
faster than the conventional mode). A histogram of the velocities in one sample volume is 
provided as a function of time. It demonstrates the ability to quantify flow with very high 
temporal resolution.  
With such high frame rates as demonstrated above (100- 200Hz), the visualization of the 
color clip can be done after acquisition through a slow motion movie.  
For slower flow imaging, high frame rates are not necessary. Ultrafast sequences can therefore 
be tuned to increase spatial resolution and sensitivity. In a sensitive ultrafast acquisition, as the 
PRF required to measure slow flows is lower, the number of angles to compute a color image 
is increased to calculate the Doppler frequency shift. Sensitive color images acquired on the 
thyroid of a healthy volunteer is shown below and compared to classical color flow imaging. 
Deep small vessels are detected only on the ultrafast compounded image.  
Increasing the ensemble length can even further optimize sensitivity. The number of 
samples used to calculate the flow per pixel can be increased up to a factor 15. Ultrasensitive 
images can be obtained like the ones reported by Institut Langevin on the rat brain (Macé, 
2010) and may be of great interest in many applications: functional imaging of the brain, 
imaging of tumor vascularization, obstetrics....  
 




Fig. 17. Ultrafast color flow imaging provides very fine temporal resolution. The plot is 
computed by displaying a histogram of the velocity on the small ROI indicated as a function 
of time. 
 
Fig. 18. Sensitive flow images based on ultrafast plane wave acquisition on the thyroid. 
Images have been acquired using 16 angles to compute ultrasound images and an ensemble 
length of 16 to deduce flow images.  
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From a general perspective, ultrafast imaging breaks usual limitations and compromises of 
color flow imaging: 
- Clips of color data can be generated with higher sensitivity and frame rate than on 
conventional systems. 
- The increase quality is maintained whatever the box size. Usual schemes suffer from 
trade-offs between frame rate and color box size. Using plane waves, the whole area 
of interest can be filled with color Doppler information without any drop in frame 
rate. 
The information is consistent and synchronous all over the imaged area. Doppler pixels 
have been assessed at the same time on the contrary of focused strategies where lines  
are sequentially acquired. In a classical approach, the Doppler signals on the sides of the 
box are therefore acquired with a time lag that can reach several hundreds of 
milliseconds. 
4.3 Quantitative ultrafast Doppler imaging   
Conventional Doppler analysis is usually performed using in two ultrasound modes: 
- the color flow imaging mode to spatially locate a region of interest 
- the Pulsed Wave mode to perform quantitative measurements at the region of interest 
depicted by color flow imaging. PW mode is a local assessment of quantitative 
information - information is assessed at one single location at a time. 
In clinical exams, the user constantly goes back and forth between those two modes and 
successively analyzes with the PW the locations pointed out by the color flow imaging 
mode. Triple mode (simultaneous color and PW) has been introduced to improve the user 
workflow. Despite some compromises on the PW spectrum quality, it facilitates the 
acquisition of information in many cases.  
Using an ultrafast architecture, Doppler can be envisioned in a completely different manner: 
quantitative information is acquired at the same time in all pixels of the color box breaking 
the incompatibility between imaging and quantitative measurements. In a typical 
implementation, a one shot acquisition can be launched from the conventional color flow 
imaging mode. A full clip of Doppler data is acquired (typically 2 to 6 s) and the system is 
frozen. The user can then review the color flow imaging clip, locate the frame of interest that 
better depicts flow properties and perform PW measurements at several locations, allowing 
for the first time a comparison of spectra from different regions of interest from the same 
cardiac cycle. 
The quantitative ultrafast Doppler acquisition workflow is illustrated on the figure 19. 
Using the retrospective review of ultrafast data, many automatic tools can be added to help 
physician diagnosis: 
- Comparison of flow data from several locations (as described above) 
- Automatic localization of peak velocities within the image for accurate flow 
quantification 
- Calculation and display of the mean and peak velocities all over the image 
- Automatic calculation and compensation of the Doppler angle. 
Ultrafast imaging opens perspectives to Doppler imaging by enhancing its performances, 
allowing visualization of very fast flow characteristics, perform accurate quantification and 
comparison of flow velocities through the whole image area and provide new types of 
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visualization and automation tools. It will probably allow a significant reduction of the 
vascular exam duration as all data necessary for the diagnosis of a given area is acquired in a 
few seconds.. In the future, ultrafast Doppler could be used to derive new information such as 
the shear stress on the arterial wall, perform accurate vortex analysis and quantification 
5. Conclusion 
ShearWave Elastography and Ultrafast Doppler are two important innovations that are 
made possible thanks to ultrafast imaging.  They are the first demonstrations of many other 
benefits that an ultrafast architecture can bring to the clinical world. Cardiovascular is one of 
the fields that could tremendously benefit from this technology. Ultrafast imaging can change 
the way moving organs are imaged. Recent works demonstrated, for example, the ability to 
locally measure Pulse Wave Velocity in the artery in less than one second (Couade 2010). 
Other publications reported dynamic analysis of heart mechanics using SWE for higher 
performance and more accurate detection of cardiovascular diseases. Elasticity of myocardium 
has been assessed locally as a function of time through a whole heart cycle (Couade 2011). 
Ultrafast imaging can also provide analysis of other transient phenomena that have not been 
extensively explored such as the dissolution of ultrasound contrast agents (Couture 2009) or 
the monitoring of brain activity (Macé 2010) through ultrasensitive flow images - positioning 
for the first time ultrasound in the field of functional brain imaging. 
 
 
Fig. 19. Doppler analysis workflow.   
There is no doubt that  such ultrafast imaging based academic works will create new 
standards in ultrasound imaging in the next coming years - in 2D, as well as, on a longer 
perspective, in 4D.  
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1. Introduction 
Methods of direct quasioptical vision and holography can be used in systems of ultrasonic 
vision to form high-quality images of objects (V. A. Zvereva, I. N. Stepanova, 1979). The 
formation of images in the ultrasonic wavelength bands has certain specific features, 
namely: the sizes of the image-forming systems and of the objects of observation are 
comparable with wavelength, so that the diffraction nature of the image must be taken into 
account in calculating the structure of the image. 
Both in the ultrasonic and optical wave bands, dielectric lenses and mirror antennas are 
used to format images of objects (Zelkin E. T., Petrova R. A., 1974). The application of these 
focusing elements does not solve the problem completely since objective lenses with very 
large apertures – on the order of several meters – are needed to obtain high-quality 
ultrasonic images. Fabrication of such lenses involves considerable technological problems 
because the more practical ones are lenses with a small refractive coefficient and focal length 
equal to the aperture (Minin I.V., Minin O.V., 1992).  
The thickness of the lens is several tens of percent of aperture size. Therefore the mass of 
such a ultrasonic objective is considerable. Energy losses connected with absorption of the 
transmitted radiation in the lens material are high. Using mirrors to generate ultrasound 
images is constrained by the fact that the object and the image area on the same side of the 
focusing system.  
Promising analogues of lenses in the ultrasonic band are objectives based on diffractive 
elements (Minin I.V., Minin O.V., 1992. Minin I. V., Minin O. V. , 1988. Minin I. V., Minin 
O. V., 1989). 
When building a real system for generating ultrasonic images of objects with the 
resolution depth greater than given by a conventional image, one must scan the object in 
three coordinates. For instance, using a mechanical scanning into the depth of the object 
makes it difficult, and sometimes impossible, to obtain the entire radio image of the object 
in real time.  
A realistic system of visualization of three-dimensional objects in the ultrasound wave band 
must provide scanning of a volume of space of at least (105 - 108)3, and it is required that 
objects whose characteristic sizes come to several wavelength must be reliably identified in 
this volume. Therefore, the system of visualization must provide resolving power in the 
object space of about 5-6 mm. In classical systems of image generation, that is, in systems 
that use lenses and mirrors as image formatting elements, high transversal resolution 
(relative to the optical axis of the objective lens) is achieved at high values of numerical 
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aperture. However, as the resolution on the object increases, the resolution depth of the lens 
(and therefore, the longitudinal resolution) decreases, and if we take into account that  
longit~2(F/D) 2         and      transv~1.22(F/D), 
it is not difficult to arrive at the following estimate: 
longit ~ 1.32transv/ . 
A contradiction thus arises: trying to increase resolution on the object in the transverse 
direction, the resolution depth of the image-formatting systems decreases following square 
law, that is, the problem of generating a ultrasonic image of a three-dimensional object 
whose extension in the longitudinal direction is several tens of wavelengths, becomes 
practically unresolvable in this approach because of the high spatial resolution.  
Generation of quasioptical ultrasonic images of objects 
We shall consider now how to obtain images of objects with resolution depth greater than 
that provided by the quasioptical system. 
The problem may be solved in this case by applying the so-called layer-by-layer scanning of 
the object. The essence of this technique is that at each given moment of time a flat two-
dimensional radio image is constructed of one layer of the object or of an individual point 
within the resolution depth of the transmitting lens with high transversal resolution. The 
total image of a three-dimensional object is then reconstructed by summing up individual 
layer images with assigned weight coefficients. A layer-by-layer scanning of a three-
dimensional object can be implemented, for instance, using the method pointed to in (Pat. 
FRG 1762, 406, 2301800, 26555257).  
For instance, three-dimensional information is reconstructed in several spatial zones 
arranged stepwise into 3D space. The zones are then displayed sequentially one after 
another for a short interval on the controlling video device. Therefore, the observer is 
offered not only the general view of an object observed in a single plane of image – as we 
have in cinema or television – but also information on spatial depth which is used as 
additional information by quantizing over depth. It is expedient to choose the time sequence 
of the displayed two-dimensional flat images in such a way that the observer (owing to the 
inertia of eye vision) perceives the sequence as one total image.  
In a continuous process of creating a large number of images with various positions of 
layers, an object is created and poorly defined details are suppressed by filtering through a 
filter with predominantly high-frequency characteristics. By adding up these filtered signals, 
the total image of a three-dimensional object is created and the corresponding non-filtered 
image is added to the filtered one. Filtration here can be implemented with a filter with a 
linearly growing frequency curve – because it is assumed that in continuous focusing and 
summation (integration). For instance, if a distribution of intensity of light dots over black 
background is processed and then this image is integrated, a pointlike image with a wide 
halo appears. 
A change in the focal distance of the quasi-optical system that uses diffractive elements is 
implemented by changing the frequency of radiation emitted by the irradiator. To 
implement spatial selection of the signal reflection by the object and the signal sent by the 
irradiator, and for automatic “tracing” of the region of focusing along one of the 
coordinates, for instance, along the optical axis, it is advisable to use either off-axis 
diffractive elements or diffractive elements with off-axis position of the focusing region. The 
former option is preferable for the radio vision because diffractive elements then retain their 
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focusing ability in a wider frequency band than elements with off-axis position of the focal 
point.  
Formation of images using partially coherent radiation 
We will consider the problem of suppressing interference fringes in the optical system for 
formatting the image, with the irradiator being a small-size thermal source of quasi-
monochromatic radiation / << 1, where  and  are the effective frequency and the 
irradiator’s frequency band, respectively. 
According to (Perina J., 1972. Tarlykov V. A., Magurin V. G., 2002) we can observe here 
interference fringes, provided 
a <  , 
where  = c/   is the effective wavelength, с is the velocity of light and a is the size of the 
source (Kaliteevskii N. I., 1971). 
If a thermal source of quasi-harmonic radiation is used as irradiator, the interference fringes 
on the image is removed if the ratio of numerical apertures of the source and the receiver 
s/0 >> 1 and the resulting resolution corresponds to the diffraction limit of receiver optics 
with non-coherent illumination.  
When an object with specularly reflecting surface is observed, its image contains sparkling 
that suppresses the fine structure of the image. At the same time sparkling from external 
sources are superimposed onto the original images. 
It is possible to remove this distorting noise without changes in illuminating sources, for 
instance, by placing in front of a flat object a nonuniform transparent scattering (refracting) 
plate. The possibility of removing the sparkling is determined by the scattering diagram of 
the plate and by the optical power of noise.  
The illumination of the object in systems of direct vision in the ultrasound band is done with 
coherent radiation. The image of the object is constructed in reflected radiation using special 
high-aperture objectives (lenses). An interference image is formed when layer images are 
added up. Furthermore, most objects have specular surface in this wavelength band. This 
occurs because the wavelength 0 at which vision systems work is much longer than the 
visible light wavelength c used to visualize an object 0/c  104. Therefore the surface 
structure of visualized objects is smoother (more specular) with respect to ultrasonic than it 
is for light by a factor of (0/c); hence, an interpretation of the resulting image becomes 
ambiguous. For instance, the image of a sphere is a point. 
Method of isotropic construction of images of three-dimensional objects (Minin I. V., Minin 
O. V., 1998) 
As it well known reflection coefficients of objects for ultrasound waves are generally 
random complex value. Hence the conventional coherent imaging systems have suffered to 
some extent from speckle noise. Speckle occurs when scattered radiation from objects or 
rough surfaces randomly destructively interferes and degrades image smoothness. So 
speckle noise and weak edges make the image difficult to identify the object in the 
ultrasound image. And the analysis of ultrasound image is more challenging one. But if we 
can generate at each point on the object sufficient large number of sample wave fields with 
the same magnitude and random phases and the image of the average intensity of the field 
can be derived, then a desired imaging which is free from speckle noises must be realized 
(Takayoshi Yokota, Takuso Sato, and Makoto Hirama, 1985).  
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The “spaced-apart reception” techniques can be used to suppress interference noise in 
ultrasonic images. 
Let us consider an object model consisting of two pointlike reflectors. With two-frequency 
illumination, the best suppression of interference noise is achieved if 
/  1/2m, 
where m = d/ and d is the distance between the reflectors. 
In the case where there is only one wavelength and we have two receivers whose signals are 
added up, the following condition can be obtained for the angular separation  between 
two receivers: 
  = arctan[(4m - 1)1/2/(2m - 1)] . (1) 
Similarly, we can derive for n-frequencies illumination and a string of n receivers the 
formulas 
/ = (n - 1)/mn, 
к = arctan[(2mnк - к2)/(mn - к)],    n = 2, ... , 
  к = 0, ... , (n - 1). 
The interval  corresponds to the difference between the maximum and the minimum of 
wavelengths of n-frequencies irradiation and к corresponds to the angular separation 
between the first and the Kth receiver of the linear string.  
Consider the placement of several receivers optimized for suppressing interference noise in 
a finite field of view. 
To suppress interference noise in a finite field of view we distribute n receivers in such a 
way that for each point there would be two receivers whose signals are in antiphase. We 
define the number of receivers as the ratio of the solid angle covering the system of receivers 
to the solid angle of a single receiver.  
In order to maximally suppress interference effects at a point A on the axis (fig. 1) it is 
necessary to place the second receiver 2 at a distance given by formula (1). To suppress 
interference effects at the edge of the field of view at points BB’ it is necessary to install 
receivers 3 and 4 at such a distance from receiver 1 that the difference between the optical 
path lengths between receivers 3 and 4 and the point B equal 1/2 of the wavelength of the 
radiation used.  
 
 
Fig. 1. Locations of radiation receivers for suppressing interference noise in a finite field of view. 
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Consequently, in a string of four receivers, two pairs of them are strictly in antiphase (at the 
centre and at the edge of the field of view). For n receivers, the number of such locations is n-1. 
We were looking so far at a one-dimensional case. To consider a two-dimensional case, the 
string of receivers has to be rotated K times around the X axis by an angle , so that (К)=. 
The required number of receivers can be found as 
N = / = {2(1 – cos /2)}/{(/4)(D/4)2}. 
Let us find the optimum location of two receivers for an arbitrary location of the object in 
the field of view. Let the object lie on the axis of the first receiver. The signals of the two 
receivers will be at opposite phases if 
0 0
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We conclude that for optimum suppression of interference noise the distance between the 
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Therefore, this method of forming radio images on the basis of an “isotropic” receiver 
(source) essentially consists in implementing the principle of spatial averaging. For instance, 
the object may be scanned by a focused beam of electromagnetic waves, the radiation 
scattered by the object being received by a systems of receivers located in space on the side 
of the irradiator, while the signals from them are added up non-coherently and are sent to 
the common system of reconstruction. The receivers are placed on the surface of a 
hemisphere whose centre lies on the object. As a result, it becomes possible to visualize 
objects using the difference between their reflection coefficient and the reflection coefficient 
for the background signal, that is, to visualize an image of a three-dimensional object. 
Non-coherent adding suppresses interference effects. When integrating narrow directed 
signals reflected from obstacles (the background signal), the received interference signal is 
proportional to the coefficient of reflection from the obstacle, and this is typically much 
lower than the coefficient of reflection from the object. On the whole, a system of N receivers 
proves to be more sensitive than a single receiver by a factor of N1/2. Furthermore, 
averaging considerably reduces the dynamic range of signals recorded, which makes the 
requirements to systems reconstructing radio images less stringent.  
Another important factor must be mentioned. In systems of direct vision, a receiving device 
is as a rule large and heavy which makes using this technique very difficult (for instance, the 
diameter of the objective is at least 200-300, so that even with a speed of 1 frame per second 
and the number of added layers n  30, the objective that does mechanical scanning of the 
object over its depth must periodically move at a typical speed of about 350 m/s). 
Attempts to use the conventional “optical” approach to constructing ultrasonic images of 
three-dimensional objects result in extremely unwieldy formulas. The resulting dimensions, 
weight and parameters of objective lenses fail to satisfy today’s requirements. 
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Fig. 1. Locations of radiation receivers for suppressing interference noise in a finite field of view. 
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Consequently, in a string of four receivers, two pairs of them are strictly in antiphase (at the 
centre and at the edge of the field of view). For n receivers, the number of such locations is n-1. 
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Therefore, this method of forming radio images on the basis of an “isotropic” receiver 
(source) essentially consists in implementing the principle of spatial averaging. For instance, 
the object may be scanned by a focused beam of electromagnetic waves, the radiation 
scattered by the object being received by a systems of receivers located in space on the side 
of the irradiator, while the signals from them are added up non-coherently and are sent to 
the common system of reconstruction. The receivers are placed on the surface of a 
hemisphere whose centre lies on the object. As a result, it becomes possible to visualize 
objects using the difference between their reflection coefficient and the reflection coefficient 
for the background signal, that is, to visualize an image of a three-dimensional object. 
Non-coherent adding suppresses interference effects. When integrating narrow directed 
signals reflected from obstacles (the background signal), the received interference signal is 
proportional to the coefficient of reflection from the obstacle, and this is typically much 
lower than the coefficient of reflection from the object. On the whole, a system of N receivers 
proves to be more sensitive than a single receiver by a factor of N1/2. Furthermore, 
averaging considerably reduces the dynamic range of signals recorded, which makes the 
requirements to systems reconstructing radio images less stringent.  
Another important factor must be mentioned. In systems of direct vision, a receiving device 
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diameter of the objective is at least 200-300, so that even with a speed of 1 frame per second 
and the number of added layers n  30, the objective that does mechanical scanning of the 
object over its depth must periodically move at a typical speed of about 350 m/s). 
Attempts to use the conventional “optical” approach to constructing ultrasonic images of 
three-dimensional objects result in extremely unwieldy formulas. The resulting dimensions, 
weight and parameters of objective lenses fail to satisfy today’s requirements. 
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Layer-by-layer construction of the image of a three-dimensional object without mechanical 
scanning over depth can be implemented by using the frequency characteristics of DOE in 
which the position of focusing area depends on the wavelength of the irradiating field. In 
this case the speed of the vision system improves considerably. It becomes possible to start 
with locating an object by scanning over the depth of the scene and then to carefully 
“scrutinize it” in detail. 
Listed below are the main specifics of designing the ultrasonic vision system. 
1. Row-by-row scanning for building the image of an object in real time is carried out by 
electronic scanning of the string of receivers. 
2. Frame-by-frame scanning (column-by-column scanning) is implemented by mechanically 
moving the object controlled. 
3. Mirror flashes in the image are removed and the images of the object in different 
orientations are obtained using quasi-isotropic illumination by a system of irradiators 
distributed in space.  
4. Scanning of the controlled space is done by the electronically shifting the plane of 
focusing of the vision device (its focal length) by varying the irradiators’ wavelength 
and using diffractive optics. The use of elements of diffractive optics on a non-flat 
surface makes it possible to extend the field of view of the vision device and improve 
the signal-to-noise ratio in the ultrasonic image. 
5. Access to the object scanned is provided on one side only. 
The vision set supports scrutinizing an object with a single frequency (scanning of a plane) 
or with a number of frequencies (scanning over the depth of the scene) in single-pass or 
continuous modes of recording the frames of image with an external coupling (to the motion 
sensor) or internal coupling to the motion of the object, and can also operate in adjustment 
mode to fine-tune individual components of the vision set. 
The main component of any vision system of quasioptical type is an objective that must 
satisfy a number of requirements (Minin I. V., Minin O. V.,1986. Edward O.Belcher et al., 
1999. Yuji Sato at al., 2009): 
 to be multicomponent (to satisfy the requirements to field of view (2  600) and the 
number of resolved pixels on it (N2~100100)); 
 to possess frequency characteristics adequate for inspecting three-dimensional scenes in 
real time; 
 to have aperture ratio of at least 0.5 and lens aperture (D/) of at least 200 to provide 
high spatial resolution constrained by the diffraction limit over the entire field of view; 
 to be fabricated of a material possessing low absorption of ultrasonic power, and be of 
minimal thickness. 
In the active vision mode, when monochromatic radiation is used to illuminate the target 
object, it is possible to reshape the focusing surface by controlling the frequency of the 
illuminating radiation and scan the space over the depth of the scene by this surface (Minin 
I. V., Minin O. V., et al.1985). Therefore, frequency characteristics of diffractive objectives 
make it possible to remove limitations stemming from the small depth of definition of 
classical lenses. Such systems of image generation are capable of scanning space over depths 
exceeding the depth of definition by a factor of 10 to 20 without mechanical scanners (Minin 
I. V., Minin O. V. 1986.  Baibulatov F. H., Minin I. V., Minin O. V. 1985.). Small thickness of 
diffractive objectives (on the order of radiation wavelength) allows designers to achieve 
high efficiency of using ultrasonic power.  
 




Fig. 2. The pilot version (1988) of 40 KHz real-time ultrasonic imaging system for concealed 
weapon detection, based on points 1,2,5 and developed under the scientific leadership of 
Professor V. F. Minin (Minin I.V., Minin O.V., 2003).  
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2. Fresnel lenses design by acoustic network 
Fresnel zone plate (amplitude binary type) was designed by Shu Zhang (Shu Zhang., 2010) 
to pass only the odd (even) zones and obstructs the even (odd) zones. Fig.3 (left) shows the 
configuration of planar 1D Fresnel lens we designed. The lens is composed of an array of 
Helmholtz resonators. The resonators which resonate at 50 KHz in pass even zone are filled 
with water. The cells in odd zone are filled with air to induce large impedance mismatch, 
resulting large reflection to obstruct vibration.  
Finite-element method was employed to study the focusing of the designed Fresnel plate 
lens. A collimated acoustic wave is incident on the plate, which is put inside water medium. 
More than 50dB pressure level difference is found between pass and obstruct zones in 
Fresnel zone plate based on acoustic network at 50 KHz. Compared with conventional 
Fresnel lens with the same thickness, the focus effect is more efficient through those based 
on acoustic network design .The focal length of the lens can be tuned at different frequency 
as well.  
 
 
Fig. 3. Configuration of acoustic Fresnel lens (left) and the unit of Helmholtz resonator 
(right) (Shu Zhang., 2010) 
3. Elementary principles of diffractive optics design in acoustics  
Acoustic zone plates are used to demonstrate various physical processes (Kirilov V. A., 
Tverdohlebov V. I., Homenko V. I., 1964). Considerable difficulties are encountered, 
however, in creating acoustic zone plates that invert the phase of oscillations of one half of 
the zones. The reason is that the acoustic resistance u of any material is so high compared 
to the resistance of air that acoustic waves are nearly completely reflected. A phase zone 
plate can be produced using the method suggested by Kock (Kock W. 1965) for fabrication 
of microwave lenses. The method consists in forcing waves to move between tilted plates; 
the path length then increases by a factor of 1/cosQ which corresponds to the effective index 
of reflection n = 1/cosQ for the propagation of waves in free space. 
The strip width l is found from the conventional relation d(n - 1) = /2 or d(n - 1) = , which 
in this particular case of n = 1/cosQ and strip width l = d/cosQ takes the simplest and 
physically transparent form: 
l – d = /2 . 
Also the circular Fresnel zone transducers may be made, for example, of sandwiched 
structure with C-axis oriented ZnO piezoelectric film between two Au electrodes (QIAO 
DongHai, LI ShunZhou, WANG ChengHao. 2007). 
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3. Ultrasonic piezoelectric transducer based on diffractive optics 
For active focusing systems the surface of a rigid plate makes bending oscillations, and 
allocation of their amplitudes of particle displacements along radius of a plate looks like 
standing waves. Each point oscillations surfaces radiate an ultrasonic wave in an air 
medium. As is well know, in condition of central exciting of thin flat disk, which radius is 
multiple to half of flexural waves (in disk material), distribution of oscillating displacement 
on the disk surface will look like stationary waves. The radial boundaries on the plate from 
centre of a plate calculating according to the formula from microwaves (Minin O.V., Minin 
I.V. 2003). In this case the waves radiated of each exact plate will come to a focal point in one 
phase. The Noise level in a focal point in that case reaches values 200-220 decibel and above, 
and around of focal point surfaces of equal phases where the noise level reaches values 140-
170 decibel is formed. The vibration amplitude of a radiating surface is about 200 micron. 
 
   
Fig. 4. The active ultrasonic diffractive transducers of half-wave (left) and four-level (right) 
types.    
It could be noted that the advantages of diffractive plate-type emitters are: the possibility of 
forming ultrasonic vibrations of high power and provide frequency tuning of the radiation 
due to transition from one harmonic to another. The same diffractive plate-type emitter can 
create vibrations of different frequencies, operating at different harmonics. 
For example, for the circular membrane in an common case we can use polar co-ordinates 
(r,θ). The spatial part of the wave function will be of the form R(r)Θ(θ). The boundary 
conditions will act specifically on R(r) which will be a Bessel function Jm(kr) with zeros at 
well known (tabulated) values xmn (m for the function and n for the nth zero). This leads to 
the relation kmna=xmn to force a zero at r=a, the radius of the membrane. These results in the 




   
where v is the velocity of the wave in the membrane. The solution of our problem for the 
mode (m,n) is, basically, of the form: 
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where v is the velocity of the wave in the membrane. The solution of our problem for the 
mode (m,n) is, basically, of the form: 
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( , , ) ( )cos( )cos( )m mn mnS r t J k r m t    . 
A dependence with sin(mθ) is also possible, giving rise to the existence of 2 degenerate modes 
for each m (except for m=0). In general, a linear combination of both modes will be excited. 
For the case of a transducer we need only the modes with m=0. The distribution of 
oscillations amplitude on the first three oscillation modes of disk radiator is shown in Fig 5.  
 
 
Fig. 5. The distribution of oscillation amplitude of diffractive radiator on the different 
oscillation modes: n=1, 2, 3.  
4. Some other diffractive optical elements applications in acoustics 
Fresnel zone plates can be used in audiovision (Greguss P. 1980) and nondestructive 
ultrasound testing (Stamnes J. J., Cravelsxter J., Bentsen O., 1982.  Ermolaev I. N., Kanevskii 
I. N., Kofolev V. D. et al. 1980.  Chernoverskii M. P. 1988), both in reception and emission 
modes. In reception mode, the zone plate consists of a sequence of alternating transparent 
and opaque zones. This zone plate behaves as a conventional acoustic lens. 
If used as focusing emitter, the acoustic converter is fabricated as a zone plate. For instance, 
a binary zone plate with 10 zones made as a sequence of gold electrodes on the surface of a 
ceramic converter was described in (Stamnes J. J., Cravelsxter J., 1982). The other side of the 
converter has a common metal coating. When used to transform electric fields, only 
transparent zones emit. This means that the same zone plate can be used to generate both an 
“audio” picture and an image of an object. 
Acoustically emitted diffractive focusing elements possess another very interesting and very 
promising property (Kock W., 1965.  Greguss P., 1980). If zones made of gold electrodes are 
replaced with photoconducting layers and placed between a converter and an optically 
transparent electrode, this device can be controlled by light. If an optical image of a 
diffractive element is projected onto such a converter and is moved transversally, the point 
of acoustical focus will also move. Therefore, two-dimensional scanning can be realized. 
The design and development of a low cost, electro-mechanical ultrasonic scanner for 
obtaining high resolution C-scan images of the friction skin ridge structure found on the 
digits of the hands or feet in order to create imagery of sufficient quality for use in 
automated personal identification systems were discussed in (J.K. Schneider, S.M. Gojevic. 
2001). It has been shown the optical scanner is unable to image through the contamination, 
while the ultrasonic scanner is unaffected. 
A breadboard ultrasound sensor has been developed for remotely detecting and imaging 
concealed weapons (Applied Technologies - Jaycor http://www.jaycor.com/eme_sens_ 
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ultra.htm). The breadboard sensor can detect metallic and non-metallic weapons concealed on 
a human body under heavy clothing at ranges up to 8 m and can image concealed weapons at 
ranges up to 5 m.  
This breadboard sensor has produced the only remote ultrasound images of concealed 
weapons, including lexan (plastic) knives and a handgun concealed under a heavy 
sweatshirt at 15 feet. The sensor includes a highly efficient source of high-power, tunable 
ultrasound radiation suitable for remote imaging in air. Together with millimeter-sized, highly 
sensitive ultrasound detectors and high-gain transceivers, these advances make possible the 
centimeter-resolution imaging of concealed weapons at ranges between 1 m and 5 m.  
Ultrasound is also a “technology that uses high-pitched sound waves to create images of 
hidden internal anatomy” to detect a land-mine (C. P. Gooneratne, S. C. Mukhopahyay, G. 
Sen Gupta. 2004). Conventional ultrasound detection involves the emission of a sound wave 
with a frequency higher than 20 kHz into a medium. This sound wave reflects on 
boundaries between materials with different acoustical properties. A strong enough 
ultrasound signal could penetrate the ground and detect otherwise unobtainable signatures 
of buried mines. It is also capable of operating in wet ground. Ultrasound systems encounter 
problems at the interface of air and ground. 
One of the classical applications of the ultrasonic imaging system is a nondestructive 
method of inspection. For example (SERDP PP-1134, Final Report, November 2001), the 
inspection of very thin metallic sheets (0.06 inches up to 0.125 inches thick) was shown to be 
difficult for the reflection method of ultrasound imaging to undertake; this was due to the 
extremely short time delay between the front and back surfaces of the thin sheets. By 
injecting the sound beam into the metallic sheet at an appreciable angle it was found to 
cause multiple reflections progressing along the sheet with the end result of illuminating a 
large region of the sample with sound energy. A prototype angle beam ultrasound camera 
was fabricated at the Becker Labs of the Naval Air Warfare Center Aircraft Division (Figure 
6) and has proven that rapid ultrasound imaging of thin sheet is practicable and is 
unaffected by painted coatings. 
 
 
Fig. 6. Schematic of oblique angle reflection camera for real-time ultrasound imaging 
(SERDP PP-1134, Final Report, November 2001). 
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The Acoustocam system (Development of Innovative Nondestructive Evaluation 
Technologies for the Inspection of Cracking & Corrosion Under Coatings SERDP PP-1134, 
Final Report, November 2001) was shown to be able to respond to the dynamic range of the 
multiple bounces with an image very similar to that of a through transmission image with 
the exception that recurring images of a defect are observed in the oblique angle reflection 
mode owing to the fact that the sound beam continues to reflect (See Figure 7). The concept, 
however, has proven to be viable for the inspection of corrosion under painted coatings at 
high speed and with high sensitivity. Application has been made for the issuance of a patent 
based on the oblique angle beam system. 
 
 
Fig. 7. Angle beam image of a flat bottom hole showing the multiple images that occur (C. P. 
Gooneratne, S. C. Mukhopahyay, G. Sen Gupta. 2004). 
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Use of Three Dimensional Ultrasound Imaging 
in Evaluation of Asherman’s Syndrome 
Catha Fischer and Alan Copperman 
Mount Sinai School of Medicine in New York  
USA 
1. Introduction 
Asherman’s syndrome is defined as the presence of intrauterine adhesions or fibrosis 
within the uterine cavity that either partially or completely obliterate the cavity. It was 
initially described by Heinrich Fritsch in 1894 and then further characterized by Joseph 
Asherman in 1948. (1) The most common etiology of the disease is dilation and cutterage 
due to pregnancy complications such as incomplete abortion, postpartum hemorrhage, or 
retained placenta. (2, 3) While the disease is rare within the general population, it is 
commonly cited as a factor in pregnancy complications in the infertile population. (4)  
Clinical manifestations of the disease include recurrent pregnancy loss, infertility, 
menstrual abnormalities, and cyclic pelvic pain. (5)  The extent of intrauterine adhesions 
is graded and the severity of disease classified by extent of cavity obliterated, location of 
adhesions within the cavity, and character of the adhesions. (6) The American Society of 
Reproductive Medicine recommends classification of disease based on extent of cavity 
obliterated (<1/3, 1/32/3, >2/3), quality of adhesions seen of hysteroscopy (filmy, filmy 
and dense, dense), and patient’s menstrual pattern (normal, hypomenorrhea, 
amenorrhea).(7)  At present, there are several modalities useful in the screening and 
diagnosis of Asherman’s syndrome. In this chapter, we will discuss these modalities in 
detail, explaining the benefits and drawbacks of each.  We also suggest that three 
dimensional sonography appears to enhance the physician’s ability to provide an accurate 
diagnosis and prognosis to patients with Asherman’s syndrome. 
Traditionally, the diagnosis of Asherman’s syndrome was made by history and physical 
examination. (1) Over time, direct visualization via hysteroscopy, hysterosalpingography, 
and sonography have all led to improved diagnostic accuracy.  The hysterosalpingogram 
(HSG) is a procedure that provides an indirect means of evaluating the uterine cavity, 
since by injecting radio opaque dye transcervically, information can be gathered on the 
location and extent of adhesions. (8) Unfortunately, several studies have shown that 
hysterosalpingogram produces a large number of false positives, specifically in those 
whose cavities contain lesions other than intrauterine adhesions such as cervical stenosis, 
endometrial polyps, and myomas. (8, 9) Another drawback of this procedure is its 
inability to characterize the uterine cavity beyond where the radioopaque dye perfused, 
and thus potentially not identifying lower uterine segment outflow obstructions.  
Therefore, patients with normal cavities except for the presence of adhesions in the lower 
uterine segment will have hysterosalpingograms that appear similar to patients with 
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severe disease, thus having their disease severity incorrectly classified and potentially 
leading to treatment errors. (10)  Furthermore, even in patients who did not have lower 
tract obstruction, HSG over-estimated disease severity compared to three dimensional 
ultrasound due to decreased clarity. (10) 
Sonohysterography is another modality used to survey the uterine cavity for adhesions.  It is a 
simple procedure that involves injecting sterile saline into the uterus to distend the cavity.  The 
saline outlines the cavity aiding the operator in identifying structural abnormalities on the two 
dimensional ultrasound. Unlike hysterosalpingography, sonohysterography does not use 
radiation and can be done in an office setting.  Initially, in small studies and case reports 
sonohysterography was thought to have diagnostic superiority to hysterosalpingography. 
(11,12, 13) However, when a larger study was conducted, it showed that two dimensional 
sonohysterography and hysterosalpingography have similar sensitivities both with high false 
positive rates. (9)  At this point, it was suggested by these authors that the use of three 
dimensional ultrasound may in fact improve sonohysterographic accuracy. (9) 
The use of two dimensional transvaginal ultrasound to identify intrauterine adhesions is  
controversial. In two dimensional ultrasound, sound waves are sent straight and reflected 
back in a linear vector, allowing for an image to be constructed only from the x and y 
planes.  This modality is very operator dependent making its efficacy at diagnosing and 
prognosticating Asherman’s syndrome difficult to accurately assess.  In small  studies, 
sensitivities of 80 to 90 percent for diagnosing intrauterine adhesions have been reported, 
however these numbers have not been reproduced. (14, 15) Rather, in another small series, 
two dimensional transvaginal ultrasound failed to diagnose intrauterine adhesions in any 
of the 4 cases in the study and gave 3 false positive diagnoses. (11)  In a larger study that 
included 209 patients, two dimensional transvaginal ultrasound had a 97% sensitivity and 
11% specificity at identifying intrauterine adhesions.(9) Again suggesting that two 
dimensional transvaginal ultrasound has a high false positive rate but may be useful as a 
screening modality. However, it has been showed that hysterosalpingography is a more 
accurate screening test. (8) 
In three dimensional ultrasound, sound waves are emitted across a sector. The intensity of 
these sounds waves is the same as two dimensional ultrasound.  The returning echoes are 
processed by a sophisticated algorithm resulting in a reconstructed three dimensional 
volume image with x, y, and z planes. This process is very similar to a CT scan.  Three 
dimensional ultrasound allows clinicians to see width, height, and depth of images. A 
Voluson Endocavity transducer S-VDW 5-8 (Kretztechnik AG, Austria) with a center 
frequency of 6.5 MHz connected to a Voluson 530D (Medison, USA) 3D ultrasound 
machine is applied for scanning.   Every examination starts with a 2D evaluation of the 
endometrial cavity. After switching into 3D-mode, the region of interest is selected with 
the volume box and the volume is acquired. When possible, information regarding the 
scan is stored on a 540-MB removable hard disk for further evaluation and calculations 
One of the advantages of three dimensional ultrasound is the real time assessment of the 
uterine cavity.  Unlike hysterosalpingography, three dimensional ultrasound uses no 
radiation and can be done during an office visit.  In a study done by Knopman et al, 54 
infertile patients with suspected Asherman’s syndrome underwent both three 
dimensional ultrasound and hysterosalpingography prior to hysteroscopy.  In this study, 
intrauterine adhesions were demonstrated on three dimensional ultrasound and 
hysterosalpingography in all cases.  However, three dimensional ultrasound had a 
sensitivity of 100% and hysterosalpingography  had a sensitivity of 66.7%. Furthermore, 
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in 61.1% of cases in which hysterosalpingography results were inconsistent with 
hysteroscopy, lower uterine segment outflow tract obstruction was present and the 
hysterosalpingogram misclassified findings as severe disease with complete cavity 
obstruction. (10)  Therefore, as prognosis in patients with Asherman’s syndrome is based 
on severity of disease, it appears from this data that three dimensional ultrasound more 
accurately assesses prognosis, which has strong clinical applications. 
Clinically, many women presenting with fertility problems are found to have Asherman’s 
syndrome during routine infertility work-up.  Knopman et al suggest that because the 
data obtained from three dimensional ultrasound correlates more closely with the 
character and extent of Asherman’s disease, it could be a helpful tool in predicting fertility 
outcome postoperatively.  Furthermore, the high pregnancy rates achieved in their clinic 
may in part be due to the excellent pre-operative information obtained from the three 
dimensional ultrasound, ensuring a well informed surgical procedure.  Three dimensional 
ultrasound has many other uses in obstetrics, gynecology, and reproductive medicine. 
Three dimensional volumetry of the gestational sac in the first trimester has been 
suggested as a sensitive predictor of pregnancy outcome. (16) Additionally, three 
dimensional sonography has been suggested in case reports to be an accurate tool to 
identify multiple gestations in the first trimester. (17) Due to the high risk nature of 
multiple gestation pregnancies, an early assessment of amnionicity and chorionicity is an 
essential part of perinatal management.  In summary, three dimensional ultrasound has 
many promising uses in infertility(18, 19, 20, 21),  early pregnancy (22, 23, 24), and fetal 
malformations (25, 26).  As the technology matures and treating physicians obtain more 
training, skills, and comfort with this technology, we anticipate more widespread 
acceptance and patient benefit to ensue. 
 
 
Fig. 1. Frontal plane demonstratinf a caviy with <10% scarring. Normal cavity with ouflow 
obstruction. 
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Fig. 2. Frontal plane demonstrating about 50% of cavity scarred. Abnoramal cavity without 
ouflow obstruction. 
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1. Introduction  
The pulse-echo technique has been widely used in medical ultrasound imaging. This 
technique uses an array of transducer elements to transmit a focused beam into the body, 
and each element then becomes a receiver to collect the echoes. The received echoes from 
each element are dynamically focused to form an image. Focusing on transmission and 
reception is performed assuming that the wave propagation speed inside the body is the 
same everywhere. Unfortunately, the speed inside the body is not constant; it varies from 
1470 m/s to greater than 1600 m/s. This speed variation will result in increased side lobes 
and degraded lateral resolution. Aberration phenomena and their extent in tissue have been 
evaluated in many works (O'Donnell & Flax 1988; Zhu & Steinberg, 1992; Shmulewitz et al., 
1993; Robinson et al., 1994; Hinkelman et al., 1998). The degradation might be tolerable if the 
frequency is not very high and the aperture size of the array is not very large. However, 
higher frequencies and larger apertures have been used to improve lateral resolution of 
ultrasound images. But the resolution improvement cannot be achieved beyond a certain 
limit, because both larger aperture and higher frequency make the system more sensitive to 
propagation velocity variations in the body. For example, the four transverse abdominal 
scan images shown in the first row of Fig.1 were formed with a 64-element linear array 
using four different aperture sizes (9 mm, 12 mm, 18 mm, and 27 mm) to form each single 
beam in the image. The array pitch was 1.0 mm and the pulse had a 3.5 MHz centre 
frequency and 2 MHz bandwidth. The Superior-Mesenteric-Artery (SMA) and the Aorta (A) 
are the main objects in these images. Because of the shape of the rectus muscles (speed ~ 
1580 m/s) and the fat layers (speed ~ 1450 m/s) at this position, the distortions caused by 
phase aberration in these images can be easily seen. In the 9-mm aperture image, the 
superior-mesenteric-artery is almost doubled but the artery wall can still be recognized. 
When the aperture size becomes larger, the distortion becomes worse.  
Phase aberration is one of the most important factors that limit improvement to lateral 
resolution of ultrasound imaging systems. Successful correction of phase aberrations will 
make it possible to improve the lateral resolution of images. Phase aberration corrected 
images using the near-field-signal-redundancy algorithm (Li, 1997) are shown in the second 
row of Fig.1 and the lateral resolution is improved when the aperture size becomes larger. In 
this chapter, the near-field-signal-redundancy algorithm is described in details. But first, a 
review of some related methods developed for phase-aberration correction is given. The 
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phase aberration problem is not unique to medical ultrasound imaging. It exists in almost all 
imaging areas, such as atmospheric effects in astronomical imaging (Jennison, 1958; 
Goodman et al., 1966; Ishiguro, 1974; Muller & Buffington, 1974; Buffington et al., 1977; 
Hamaker et al., 1977; Hogg, 1981; Tyson, 2010), antenna-position errors in radar and 
microwave imaging (Steinberg, 1991) and weathered-layer-effect in seismic imaging (Yilmaz 
& Doherty, 1987).    
 
Aperture = 9 mm 12 mm 18 mm 27 mm 
 
SMA                 A (a) original  
 
 (b) corrected  
Fig. 1. The resolution of images is only improved with increased aperture size after phase- 
aberration correction. (a) without phase-aberration correction. (b) with phase-aberration 
correction. 
In astronomical imaging, phase and amplitude aberrations caused by the atmosphere make 
it difficult to achieve diffraction-limited resolution on the ground. One widely used 
aberration-correction method is the direct-wave-front-measurement method. This is used 
when there is a dominant bright star either present or artificially created using laser (Tyson, 
2010). A plane wavefront at the aperture should be observed since the dominant point target 
is in the far field of the imaging aperture. Any departure from a plane wavefront is caused 
by phase aberration. After measuring the wavefront, the next step is to separate the phase-
aberration profile across the aperture from the non-aberrated wavefront. This is not a simple 
task because the angle of the star is generally unknown. Fortunately, for a target in the far 
field, such separation is unnecessary since the error of the assumed angle of the star causes a 
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shift of the image position only and has no effect on focusing. Methods using signals 
received from arbitrary target distributions have also been developed in astronomical 
imaging. These include maximum-sharpness (Muller & Buffington, 1974; Buffington et al., 
1977) and redundant-spacing interferometer methods. (Jennison, 1958; Ishiguro, 1974)  
Hamaker et al. (Hamaker et al., 1977) pointed out that these methods are all based on the 
same fundamental principle: signal redundancy. When the target distribution is complex, 
there is no prior knowledge about the wavefront shape without phase aberrations. 
Therefore, the aberration profile cannot be separated directly from the unaberrated 
wavefront in the measured wavefront. In this case, the signal-redundancy principle makes 
the separation unnecessary. The redundant-spacing interferometer method does not 
measure the wavefront but the phase difference between redundant signals, and then 
directly derives the phase-aberration profile across the array. The result also contains an 
arbitrary steering angle which has no effect on focusing. The maximum-sharpness method 
uses a trial-and-error method to adjust each antenna’s phase. When an indicator is 
maximized, the system is in focus. This method is also based on the signal-redundancy 
principle. When the system is in focus, redundant signals are added in phase and the 
indicators will be maximized.  
Phase-aberration correction methods have also been developed for active (pulse-echo) and 
near-field imaging systems, such as radar, microwave, ultrasonic and seismic imaging 
systems. Since the number of references is large, they are not listed here and can be found in 
the references list in (Li, 1997; Li & Robinson, 2008). When there is a dominant point target 
in the near field, the first step is again to measure the arrival wavefront from the target. 
Nearest-neighbor-cross-correlation and indicator (maximum sharpness) methods have been 
used. The next step is to separate the aberration profile from the unaberrated wavefront, 
which should be spherical. Without knowing the position of the dominant point target, the 
phase-aberration profile can be obtained only by estimating the target location. The error in 
the estimated aberration profile because of the wrongly assumed target position will cause 
de-focusing in the near field case. The image at the dominant point target will still be well 
focused (at the wrong position) if this inaccurate aberration profile is used to do the 
correction, since the two errors cancel each other at that position. But, the correction will 
become increasingly inaccurate away from that point. This correction is therefore only valid 
in a region around the dominant target. The size of the region depends on the distance from 
the target to the aperture, the size of the aperture, and the accuracy of the estimated target 
position. It can be much smaller than the isoplanatic patch, defined as the region where the 
phase-aberration value is a constant, if the focusing quality is too poor before phase-
aberration correction to estimate the dominant point target position with adequate accuracy. 
Therefore, aberration correction in the near field may have problems even when a dominant 
point target is available. In some situations, such as forming an image around the dominant 
target only, estimating the dominant target position accurately is not so important. On the 
other hand, it is unusual to have a dominant point target in every isoplanatic patch, or even 
in the entire image, in medical ultrasonic imaging. Techniques have also been developed 
which use signals from randomly distributed scatterers that generate speckle in an image to 
measure the wavefront. In the nearest-neighbor-cross-correlation method, a focused beam is 
transmitted (try to generate an artificial dominant point target) and the phase aberration 
profile is derived from the cross-correlation measurements between neighboring elements. 
An iterative method is used to improve the measurement accuracy. The indicator method 
has also been used in a speckle-generating region. It is an iterative phase-correction 
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procedure in which the timing of acoustic signals transmitted and received from individual 
elements is adjusted to optimize the quality indicator. In a lens and mirror astronomical 
imaging system it is the intensity-sensitive recorder that generates the necessary cross-
correlation process between signals coming from different locations on the lens aperture to 
produce redundant signals. Phases of redundant signals are difficult to directly compare at 
optical frequencies. A trial-and-error method has to be used with a deformable mirror to 
focus the image by maximizing an indicator; this is time consuming and it may not converge 
to the right position. On the other hand, in a very large baseline, radio astronomy imaging 
system, phases of redundant signals can be compared directly. In ultrasonic imaging, radio-
frequency (RF) signals can be acquired and their phases can be compared directly. 
Therefore, direct phase-difference measurement between redundant signals can be used. A 
comparison of the nearest-neighbor-cross-correlation algorithm, the indicator method, and 
the near-field-signal-redundancy algorithm discussed in this chapter can be found in (Li & 
Gill, 1998).  In seismic imaging, a phase-aberration correction (surface-consistent residual 
static correction) method using signals coming from a specular reflecting plane has been 
developed to correct the phase aberration caused by weathered layers near the ground 
surface. The specular reflecting plane is a special kind of target. It is similar to a dominant 
point target in that every receiver element receives a dominant echo from it. The difference 
is that the position of the reflecting point is different for different transmitter or receiver 
positions. The non-aberrated arrival wavefront from a specular reflecting plane depends on 
the angle of the plane and the propagation speed between the plane and the array. Common 
receiver, common transmitter, and common midpoint signals can be used for the 
measurement. Common midpoint signals are generally preferred because of several 
advantages, such as insensitivity to the angle of the reflecting plane. It should be noted that 
common midpoint signals are not redundant when there is a specular reflecting plane in the 
near field, because the position of the reflecting point is different for different transmitter or 
receiver positions. Therefore, the seismic method is not a signal-redundancy method.  
A least-mean-squares error-fitting method has been developed in ultrasonic imaging 
(Hirama & Sato, 1984) to form an image of targets on a plane parallel to the transducer array 
surface through an inhomogeneous layer. The method uses the complete signal set to build 
an over-determined equation group which has sufficient equations to estimate the spatial 
frequency components of the target plane and the aberration profiles across the array. The 
technique requires the area of the target to be small; when the system is in the Fresnel zone, 
only an approximated image can be obtained. The method will not apply to targets that 
extend in range. A least-mean-squares error-fitting method using the far-field signal-
redundancy principle to measure the phase aberration profile directly has also been 
developed (Rachlin, 1990). In this method, first, common midpoint signals are cross  
correlated directly (without compensating for the near field effect, as shown in (11) in 
Rachlin, 1990) to find the relative time-shift between them, then an over-determined matrix 
is used to derive the phase-aberration value for each element. When there is no phase 
aberration, the relative time-shift between common midpoint signals is zero according to (9) 
and (10) in (Rachlin, 1990), which is true only in the far field. Therefore, this technique is a 
far-field signal redundancy technique. The analysis in this chapter shows that for targets in 
the near field, there is a near-field term in the relative time-shift between common midpoint 
signals. A dynamic near-field-delay correction is proposed to reduce its effect on the 
measurement. This is the major difference between the near-field signal-redundancy 
technique described in this chapter and the technique described in (Rachlin, 1990). In 
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medical ultrasound imaging, dominant point targets, specular reflecting planes, and large 
areas of uniformly distributed speckle-generating target distributions are unlikely to be 
found in every isoplanatic patch. The signal redundancy method, which relies very little on 
target distributions, seems attractive. But, before it can be used in medical ultrasound 
imaging systems, the near-field effect has to be considered. First, however, the signal 
redundancy principle for targets in the far field will be reviewed in the next section.  
 
 
Fig. 2. The signal-redundancy principle for targets in the far field. 
2. Signal-redundancy principle in the far field  
For an active imaging system, when an array with many small aperture sensors is used to 
synthesize a larger aperture, it is possible to acquire identical signals using different sensors 
from arbitrary target distributions in the far field. These signals are termed redundant 
signals. Common midpoint signals (the middle point position of the transmitter and the 
receiver is the same) are redundant as shown in Fig. 2. Signal SAC is acquired by transmitting 
from Element A and receiving at Element C; signal SBB is acquired by transmitting and 
receiving at Element B.  The midpoint of Elements A and C is the center of Element B.  
Therefore, SAC and SBB are common midpoint signals.  When targets are in the far field, e.g.,  
targets a, b and c, SAC and SBB are exactly the same (redundant), because the length of the line 
segment on the right hand side of Element C and the line segment on the left hand side of 
Element A in Fig. 2 is the same for targets in all directions. When phase aberrations A, B 
and C exist at Elements A, B and C, respectively, SAC and SBB will still have the same shape 
but will have a relative arrival-time difference 2B-(A+C), and this information can be used 
to derive the phase-aberration profile across the array. 
These results are valid for short as well as long pulsed signals. They are valid generally for 
arbitrary target distributions provided that targets are in the far field and the propagation  
speed is homogenous. The effective aperture concept, defined as the convolution of the 
transmission aperture T(z) and the reception aperture R(z) for an active imaging system, is 
based on the assumption that common midpoint signals are identical; the integration of 
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procedure in which the timing of acoustic signals transmitted and received from individual 
elements is adjusted to optimize the quality indicator. In a lens and mirror astronomical 
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and (10) in (Rachlin, 1990), which is true only in the far field. Therefore, this technique is a 
far-field signal redundancy technique. The analysis in this chapter shows that for targets in 
the near field, there is a near-field term in the relative time-shift between common midpoint 
signals. A dynamic near-field-delay correction is proposed to reduce its effect on the 
measurement. This is the major difference between the near-field signal-redundancy 
technique described in this chapter and the technique described in (Rachlin, 1990). In 
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R(z')T(z - z') over all z' values adds common midpoint signals (midpoint z/2) together with 
the complex weighting of multiplied sensitivities and added phases of T(z - z') and R(z').  
 
 
Fig. 3. An active imaging system with targets in the near field and the received and 
corrected signals when a delta-shaped pulse is transmitted and received.  
3. Signal redundancy principle in the near field  
For near-field targets, the signal redundancy principle described above is no longer valid. 
However, although common midpoint signals are not exactly redundant for active near-
field imaging, their differences for echoes coming from certain regions can be significantly 
reduced by a dynamic near-field-delay correction (Li, 1997). Consider a three-element array 
on the x-axis in Fig. 3. The center element c is located at the origin x = 0, and the upper 
element u and lower element d are located at xu and xd respectively. It is assumed that  
xu = - xd = h. Let yi,j(t) denotes the received signal at element j when element i is the 
transmitter; yu,d(t), yd,u(t) and yc,c(t) are common midpoint signals; yu,d(t) and yd,u(t) are 
reciprocal signals, which are identical even for targets in the near field and 
inhomogeneous media. Assume that transmitted and received signals are delta-shaped 
pulses. The received signal yc,c(t) is shown in Fig. 3. Echoes coming from targets A, B, D 
and E arrive at the same time. The received signal yu,d(t) is also shown in Fig. 3. Even 
though yu,d(t) and yc,c(t) are common midpoint signals, the difference between them is 
obvious. The echo from target E, which is located on the x-axis, is the only one at the same 
location in signals yc,c(t) and yu,d(t).  
The echo-location difference is larger for targets at angles nearer to the z-axis and at 
distances closer to the transducer elements. When the distance between the target and the 
aperture increases, the echo-location difference in yc,c(t) and yu,d(t) decreases, eventually 
becoming zero at infinite for the far-field situation. The echo-location difference in yc,c(t) and 
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yu,d(t) reaches its maximum value 2h/c0 , where c0 is the wave-propagation speed in the 
medium, when the target is at the position of Element c. A dynamic near-field-delay 
correction can be used to improve the similarity between yc,c(t) and yu,d(t) for echoes from the 
region around the z-axis of importance for imaging. This correction shifts signals so that 
envelope peaks of echoes coming from targets in a particular direction line up in the two 
common midpoint signals. It is the same as the delay process in the "delay-and-sum" 
dynamic focus image forming algorithm. The signal y'u,d (t, B), which is the corrected 
version of yu,d(t), with the correction angle in the direction of targets B and C is shown in Fig. 
3. The positions of echoes coming from targets B and C in y'u,d (t, B) are the same as those in 
yc,c(t). That is, for echoes coming from these two targets, y'u,d (t, B) and yc,c(t) are redundant. 
But the positions of echoes from targets A, D and E in y'u,d (t, B) are different from that in 
yc,c(t), since these targets are not at the correction angle. The corrected signal y'u,d (t, A) at 
angle of target A is also shown in Fig. 3. 
A pulse with non-zero length will cause problems even for echoes coming from targets at 
the correction angle. For example, to make the echo from target B identical in yc,c(t) and 
yu,d(t), the whole pulse has to be moved with the same correction as that for the peak of the 
pulse envelope. But, since these echoes are overlapping, it is impossible to separate pulses 
from different depths (and angles) and move them separately. One can only do a dynamic 
delay correction as for a delta-shaped pulse. This will stretch the echo since the leading part 
of an echo is always shifted forwards more than its trailing part. Therefore, for a pulse of 
finite length, the dynamically corrected common midpoint signals are not strictly identical 
even for echoes coming from targets at the correction angle; the longer the pulse, the larger 
the difference. Fig. 5 in (Li. 1997) compares echoes coming from targets A, B, and D 
separately in y'u,d (t, B) and yc,c(t). The echo from target B in y'u,d (t, B) is stretched 
compared to that in yc,c(t) but their envelope peaks are coincident (Fig. 5(b)). The echo from 
target A in y'u,d (t, B) is stretched compared with that in yc,c(t), and its envelope peak is 
shifted forward because of overcorrection. The echo from target D in y'u,d (t, B) is stretched 
and shifted backward because of undercorrection. 
After a dynamic near-field-delay correction, common midpoint signals will not become 
exactly redundant in the near field. But, they will be more similar for echoes coming from 
the region of interest. Within a specified error, the echoes coming from the region of interest 
can be regarded as redundant. The question is, given a pulse length L and an acceptable 
phase error limit 0, in what angular range should targets be for their echoes to become 
redundant in common midpoint signals after a dynamic near-field-delay correction? This 
question has been answered in (Li, 1997). Before the dynamic near-field-delay correction, the 
region of redundancy is around the x-axis (Fig. 3), which is not a region of interest. After the 
dynamic near-field-delay correction, the region of redundancy is around the correction 
angle. If transducer elements have some degree of directivity, so that their angular response 
is limited to the region of redundancy around the correction angle, the dynamic near-field-
delay correction can increase the similarity between common midpoint signals in the near 
field. It has been shown in (Li, 1997) that common-midpoint signals are still a special group 
of signals in the near field because, after the dynamic near-field-delay correction, they are 
much more similar to one another compared with corrected signals in other signal groups. 
This is termed the near-field signal-redundancy principle. 
For linear arrays, the element size is usually considerably larger than the wavelength. 
Therefore the beam width of each element is small and most signal energy is from the region 
of redundancy when the correction angle is around 90º. As a result, common-midpoint 
signals can be considered as redundant after the dynamic near-field-delay correction.  
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obvious. The echo from target E, which is located on the x-axis, is the only one at the same 
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The echo-location difference is larger for targets at angles nearer to the z-axis and at 
distances closer to the transducer elements. When the distance between the target and the 
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yu,d(t) reaches its maximum value 2h/c0 , where c0 is the wave-propagation speed in the 
medium, when the target is at the position of Element c. A dynamic near-field-delay 
correction can be used to improve the similarity between yc,c(t) and yu,d(t) for echoes from the 
region around the z-axis of importance for imaging. This correction shifts signals so that 
envelope peaks of echoes coming from targets in a particular direction line up in the two 
common midpoint signals. It is the same as the delay process in the "delay-and-sum" 
dynamic focus image forming algorithm. The signal y'u,d (t, B), which is the corrected 
version of yu,d(t), with the correction angle in the direction of targets B and C is shown in Fig. 
3. The positions of echoes coming from targets B and C in y'u,d (t, B) are the same as those in 
yc,c(t). That is, for echoes coming from these two targets, y'u,d (t, B) and yc,c(t) are redundant. 
But the positions of echoes from targets A, D and E in y'u,d (t, B) are different from that in 
yc,c(t), since these targets are not at the correction angle. The corrected signal y'u,d (t, A) at 
angle of target A is also shown in Fig. 3. 
A pulse with non-zero length will cause problems even for echoes coming from targets at 
the correction angle. For example, to make the echo from target B identical in yc,c(t) and 
yu,d(t), the whole pulse has to be moved with the same correction as that for the peak of the 
pulse envelope. But, since these echoes are overlapping, it is impossible to separate pulses 
from different depths (and angles) and move them separately. One can only do a dynamic 
delay correction as for a delta-shaped pulse. This will stretch the echo since the leading part 
of an echo is always shifted forwards more than its trailing part. Therefore, for a pulse of 
finite length, the dynamically corrected common midpoint signals are not strictly identical 
even for echoes coming from targets at the correction angle; the longer the pulse, the larger 
the difference. Fig. 5 in (Li. 1997) compares echoes coming from targets A, B, and D 
separately in y'u,d (t, B) and yc,c(t). The echo from target B in y'u,d (t, B) is stretched 
compared to that in yc,c(t) but their envelope peaks are coincident (Fig. 5(b)). The echo from 
target A in y'u,d (t, B) is stretched compared with that in yc,c(t), and its envelope peak is 
shifted forward because of overcorrection. The echo from target D in y'u,d (t, B) is stretched 
and shifted backward because of undercorrection. 
After a dynamic near-field-delay correction, common midpoint signals will not become 
exactly redundant in the near field. But, they will be more similar for echoes coming from 
the region of interest. Within a specified error, the echoes coming from the region of interest 
can be regarded as redundant. The question is, given a pulse length L and an acceptable 
phase error limit 0, in what angular range should targets be for their echoes to become 
redundant in common midpoint signals after a dynamic near-field-delay correction? This 
question has been answered in (Li, 1997). Before the dynamic near-field-delay correction, the 
region of redundancy is around the x-axis (Fig. 3), which is not a region of interest. After the 
dynamic near-field-delay correction, the region of redundancy is around the correction 
angle. If transducer elements have some degree of directivity, so that their angular response 
is limited to the region of redundancy around the correction angle, the dynamic near-field-
delay correction can increase the similarity between common midpoint signals in the near 
field. It has been shown in (Li, 1997) that common-midpoint signals are still a special group 
of signals in the near field because, after the dynamic near-field-delay correction, they are 
much more similar to one another compared with corrected signals in other signal groups. 
This is termed the near-field signal-redundancy principle. 
For linear arrays, the element size is usually considerably larger than the wavelength. 
Therefore the beam width of each element is small and most signal energy is from the region 
of redundancy when the correction angle is around 90º. As a result, common-midpoint 
signals can be considered as redundant after the dynamic near-field-delay correction.  
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For phased arrays, the element size is usually smaller than a wave length and the beam of 
each element is wide. This causes two major problems. One problem is that the similarity 
between common-midpoint signals is not improved by the dynamic near-field-delay 
correction. It only shifts the region of redundancy to the area around the correction angle. 
Another problem is that echoes coming from different angles may experience different 
aberration values, which makes it impossible to measure the phase aberration profiles using 
the linear array algorithm. The sub-array method proposed in (Li, 2000a, 2000b; Li & 
Robinson, 2000b) can be used to solve both problems, if the phase-aberration value for 
elements in the same sub-array can be considered as the same in all directions. This 
requirement may limit the maximum size of sub-arrays, and therefore limit the narrowest 
achievable beamwidth and the maximum spatial frequency of the aberrator that can be 
successfully measured. In this method, sub-arrays are formed of adjacent groups of 
elements to narrow the beams used to acquire common-midpoint signals and steer the 
beam direction, so that the similarity between common-midpoint signals is increased and 
angle-dependent, phase-aberration profiles can be measured. There are several methods 
can be used to implement the dynamic near-field-delay correction on common-midpoint 
signals collected with sub-arrays. These methods have different computation loads and 
the degree of similarity between common-midpoint signals collected in these methods is 
also different. The performance of these methods has been analyzed and compared 
theoretically in (Li, 2000b). 
For two-dimensional arrays, besides using elements along a straight line, there is another 
element configuration that can be used to acquired common-midpoint signals, which does not 
exist for one-dimensional arrays. Consider four adjacent, point-like transducer elements (Fig. 
4) in a two-dimensional array. They are labeled as Element 1, 2, 3 and 4 and located in the x-y 
plane at (px/2, py/2),  (-px/2, py/2), (-px/2, -py/2) and (px/2, -py/2), respectively, where px and py 
are array pitches in the x and y directions respectively. y2,4(t) and y1,3(t) are common midpoint 
signals, because the midpoints between their transmitters and receivers are located at the same 
point (the origin in Fig. 4). It has been shown (Li & Robinson, 2008) that without the dynamic 
near-field-delay correction, the region of redundancy is between two rectangular hyperbolas 
(Fig. 5), which is in the direction of interest for imaging. This is different from the case of one-
dimensional arrays, where, without the dynamic near-field-delay correction, the region of 
redundancy is in the direction of the axis that goes through the three consecutive transducer 
elements used to acquire common-midpoint signals (Fig. 3), which is not in the direction of 
 
 
Fig. 4. A four-element sub-aperture in a two-
dimensional array. 
Fig. 5. The region of redundancy (not to scale). 
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interest for imaging. The region of redundancy is narrowest in the direction of T = ±45º  
(Fig. 5). The region of redundancy can be approximately defined as inside the circle within 
those hyperbolas as shown in Fig. 5. Many properties of the region of redundancy have been 
theoretically derived in (Li & Robinson, 2008). 
As in the case of one-dimensional arrays, the region of redundancy for common-midpoint 
signals acquired with four adjacent transducer elements can also be shifted to other 
directions with the dynamic near-field-delay correction. This is a useful property for 
measuring angle-dependent phase-aberration profiles using sub-arrays and it has been 
theoretically analyzed in (Li & Robinson, 2008).  
In this section, the near-field signal redundancy principles have been discussed for linear, 
phased and two-dimensional arrays. In the next section, phase-aberration correction 
algorithms based on these principles are introduced and experimental results are presented. 
4. Aberration correction using near field signal redundancy  
4.1 Algorithm for linear arrays 
Since the array pitch of linear arrays are much larger than the center-frequency wave length 
of the transmitted pulse, each element has a relatively narrow beam in the z-axis direction. 
However, the beam cannot be steered. A sub-aperture of the array is used to form an image 
line and the whole image is formed by sliding the sub-aperture across the array. The linear 
array algorithm for phase-aberration correction based on the near-field signal-redundancy 
principle was proposed in (Li, 1997). A few important considerations relating to this 
algorithm are discussed here. 
For each midpoint position, many common midpoint signals can be acquired using a linear 
array. However, only the closest common midpoint signal pairs (acquired using three 
adjacent elements) should be used because the near-field effect is smallest for these signals. 
The received signals are dynamically corrected at the 90º angle. The normalized cross-
correlation functions are calculated at a selected depth with a selected window length. The 
region chosen for correlation should be the region in which one wants to improve the lateral 
resolution. The length of the correlation window should be chosen so that the signal 
experiences the same aberration effect, i.e. in the same isoplanatic patch. On the other hand, 
it should be as long as possible to improve the signal-to-noise ratio of cross-correlation 
functions. The dynamic near-field-delay correction can also be applied at a few angles and 
the peak position of the cross-correlation function with the maximum cross-correlation 
coefficient is chosen for deriving the phase-aberration profile. 
For an N element array, there are N-2 pairs of common-midpoint signals and measured 
peak positions. They are related to the phase error at each element by equation (26) in (Li, 
1997). The phase aberration profile can be derived assuming that the phase-aberration 
values for the two elements at the ends of the array are zero. This assumption causes a 
linear-component error (the ambiguity profile) between the derived phase-aberration profile 
and the real phase-aberration profile. If the ambiguity profile is small, its effect is 
approximately a global rotation and range shift of the image. If it is large, it will influence 
the focusing quality. A detailed analysis of the influence of ambiguity profiles on focusing in 
the very near field can be found in (Li, 2002a, 2002b).   
Errors in peak position measurements of cross-correlation functions will be magnified in the 
process of deriving the phase aberration profile. Results of theoretical analysis in (Li, 2007) 
indicate that the accuracy requirement on the peak position measurement is very high for an 
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For phased arrays, the element size is usually smaller than a wave length and the beam of 
each element is wide. This causes two major problems. One problem is that the similarity 
between common-midpoint signals is not improved by the dynamic near-field-delay 
correction. It only shifts the region of redundancy to the area around the correction angle. 
Another problem is that echoes coming from different angles may experience different 
aberration values, which makes it impossible to measure the phase aberration profiles using 
the linear array algorithm. The sub-array method proposed in (Li, 2000a, 2000b; Li & 
Robinson, 2000b) can be used to solve both problems, if the phase-aberration value for 
elements in the same sub-array can be considered as the same in all directions. This 
requirement may limit the maximum size of sub-arrays, and therefore limit the narrowest 
achievable beamwidth and the maximum spatial frequency of the aberrator that can be 
successfully measured. In this method, sub-arrays are formed of adjacent groups of 
elements to narrow the beams used to acquire common-midpoint signals and steer the 
beam direction, so that the similarity between common-midpoint signals is increased and 
angle-dependent, phase-aberration profiles can be measured. There are several methods 
can be used to implement the dynamic near-field-delay correction on common-midpoint 
signals collected with sub-arrays. These methods have different computation loads and 
the degree of similarity between common-midpoint signals collected in these methods is 
also different. The performance of these methods has been analyzed and compared 
theoretically in (Li, 2000b). 
For two-dimensional arrays, besides using elements along a straight line, there is another 
element configuration that can be used to acquired common-midpoint signals, which does not 
exist for one-dimensional arrays. Consider four adjacent, point-like transducer elements (Fig. 
4) in a two-dimensional array. They are labeled as Element 1, 2, 3 and 4 and located in the x-y 
plane at (px/2, py/2),  (-px/2, py/2), (-px/2, -py/2) and (px/2, -py/2), respectively, where px and py 
are array pitches in the x and y directions respectively. y2,4(t) and y1,3(t) are common midpoint 
signals, because the midpoints between their transmitters and receivers are located at the same 
point (the origin in Fig. 4). It has been shown (Li & Robinson, 2008) that without the dynamic 
near-field-delay correction, the region of redundancy is between two rectangular hyperbolas 
(Fig. 5), which is in the direction of interest for imaging. This is different from the case of one-
dimensional arrays, where, without the dynamic near-field-delay correction, the region of 
redundancy is in the direction of the axis that goes through the three consecutive transducer 
elements used to acquire common-midpoint signals (Fig. 3), which is not in the direction of 
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interest for imaging. The region of redundancy is narrowest in the direction of T = ±45º  
(Fig. 5). The region of redundancy can be approximately defined as inside the circle within 
those hyperbolas as shown in Fig. 5. Many properties of the region of redundancy have been 
theoretically derived in (Li & Robinson, 2008). 
As in the case of one-dimensional arrays, the region of redundancy for common-midpoint 
signals acquired with four adjacent transducer elements can also be shifted to other 
directions with the dynamic near-field-delay correction. This is a useful property for 
measuring angle-dependent phase-aberration profiles using sub-arrays and it has been 
theoretically analyzed in (Li & Robinson, 2008).  
In this section, the near-field signal redundancy principles have been discussed for linear, 
phased and two-dimensional arrays. In the next section, phase-aberration correction 
algorithms based on these principles are introduced and experimental results are presented. 
4. Aberration correction using near field signal redundancy  
4.1 Algorithm for linear arrays 
Since the array pitch of linear arrays are much larger than the center-frequency wave length 
of the transmitted pulse, each element has a relatively narrow beam in the z-axis direction. 
However, the beam cannot be steered. A sub-aperture of the array is used to form an image 
line and the whole image is formed by sliding the sub-aperture across the array. The linear 
array algorithm for phase-aberration correction based on the near-field signal-redundancy 
principle was proposed in (Li, 1997). A few important considerations relating to this 
algorithm are discussed here. 
For each midpoint position, many common midpoint signals can be acquired using a linear 
array. However, only the closest common midpoint signal pairs (acquired using three 
adjacent elements) should be used because the near-field effect is smallest for these signals. 
The received signals are dynamically corrected at the 90º angle. The normalized cross-
correlation functions are calculated at a selected depth with a selected window length. The 
region chosen for correlation should be the region in which one wants to improve the lateral 
resolution. The length of the correlation window should be chosen so that the signal 
experiences the same aberration effect, i.e. in the same isoplanatic patch. On the other hand, 
it should be as long as possible to improve the signal-to-noise ratio of cross-correlation 
functions. The dynamic near-field-delay correction can also be applied at a few angles and 
the peak position of the cross-correlation function with the maximum cross-correlation 
coefficient is chosen for deriving the phase-aberration profile. 
For an N element array, there are N-2 pairs of common-midpoint signals and measured 
peak positions. They are related to the phase error at each element by equation (26) in (Li, 
1997). The phase aberration profile can be derived assuming that the phase-aberration 
values for the two elements at the ends of the array are zero. This assumption causes a 
linear-component error (the ambiguity profile) between the derived phase-aberration profile 
and the real phase-aberration profile. If the ambiguity profile is small, its effect is 
approximately a global rotation and range shift of the image. If it is large, it will influence 
the focusing quality. A detailed analysis of the influence of ambiguity profiles on focusing in 
the very near field can be found in (Li, 2002a, 2002b).   
Errors in peak position measurements of cross-correlation functions will be magnified in the 
process of deriving the phase aberration profile. Results of theoretical analysis in (Li, 2007) 
indicate that the accuracy requirement on the peak position measurement is very high for an 
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array with a large number of elements. For a 64-element array, the bias in the peak-position 
measurement is magnified by a factor up to 496. Assume that the acceptable largest bias of 
the derived phase-aberration value is one radian, then the measurement bias needs to be less 
than 1/496 radians, which is a very strict requirement. Assuming that a constant or linear 
profile does not influence focusing, the requirement is relaxed to 1/325 radians, and the 
maximum bias value in the derived phase aberration profile occurs at the ends of the array. 
The standard deviations of peak position measurements also have to be small in order to 
measure the phase-aberration profiles accurately. For a 64-element array, the maximum 
standard deviation in the derived phase-aberration profile is about 72 times the standard 
deviation of the measured peak position; the rms is 52 times, or 25 times if the constant and 
linear profiles are considered as harmless. 
The strict accuracy requirement on peak position measurements creates a new problem. The 
timing of electronic channels (receiver and transmitter) has to be calibrated accurately. The 
requirement for channels to be considered as identical is much stricter for phase-aberration 
measurement than for image formation. Therefore, the system calibration on a commercial 
machine usually is not accurate enough. The timing errors of channels are part of the phase 
aberration profile and they make phase aberration profiles for transmission and reception 
different. When the timing error difference between transmission and reception channels 
connected to the same element is small enough for the purpose of image formation, the 
method proposed in (Li, 1997) can be used to solve this problem. The two reciprocal signals 
y u, d(t) and y d, u(t) (Fig. 3) are dynamically corrected and cross-correlated with y c, c(t) 
separately. The two peak positions are then averaged and used to derive the phase 
aberration profile, which can be used for both transmission and reception phase-aberration 
corrections. There is no need to measure the transmission and reception phase aberration 
profiles separately. That is, when the difference between transmission and reception phase-
aberration profiles is small for image-formation purpose but large for phase-aberration 
measurement, they have to be treated as different when performing the phase-aberration 
measurement, but they can be treated as the same in the image-formation process after the 
measurement. If the difference is large for imaging purpose, they need to be measured 
separately. In this case, the reciprocal-signal method proposed in (Li, 2008) can be used.  
To perform the dynamic near-field-delay correction, the array pitch and the average 
propagation speed in the medium need to be known. How accurately these parameters need 
to be known for the near-field signal-redundancy algorithm to perform properly? This has 
been analyzed in (Li et al., 1996). If the array pitch and propagation speed are not known 
accurately, the formed image (image formation also uses the two parameters) will also be 
distorted even if the medium is homogeneous. That is, phase aberrations are introduced by 
incorrect pitch and speed values and the phase aberration profile across the array is 
different at different points in the image. It has been shown in (Li et al., 1996) that the near-
field signal-redundancy algorithm is capable of correcting phase aberrations generated by 
pitch and speed errors. Therefore, the array pitch and average propagation speed need not 
to be known very accurately. However, large errors will reduce the size of the isoplanatic 
patch and therefore require more phase-aberration profiles to be measured to correct the 
whole image (Li et al., 1996).  
The near-field signal-redundancy algorithm for linear arrays typically includes the 
following steps: 
1. Common midpoint signals are acquired. 
2. Dynamic near-field-delay corrections are applied at a proper angle.  
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3. The dynamically corrected common midpoint signals are cross-correlated at a selected 
depth with a selected window length. 
4. The relative time-shift between common midpoint signals are measured from the peak 
position of the cross-correlation functions. 
5. The relative time-shifts between y u, d(t) and y c, c(t) and between y d, u(t) and y c, c(t) are 
averaged. 
6. The phase-aberration profile across the array is derived. 
7. If necessary, the undetermined linear term (ambiguity profile) is adjusted to optimize 
the performance of the system.  
This algorithm has been experimentally tested (Li et al., 1997). The system used to test this 
algorithm was based on a Toshiba model SAL-32B 8-channel Scanner. This system has 64 
transmission channels, 8 reception channels multiplexed across the array. This system is 
capable of separately transmitting on each individual element, and receiving on eight 
channels at a time. It can be switched between the normal real-time scan mode and the 
single-element-transmit/multiple-element-receive data collecting mode. A 64-element linear 
array was used with a pitch of 1.0 mm and an element width of about 1.0 mm. The element 
height is 10 mm, and the focus of the lens in the elevation direction is at about 60 mm. The 
received pulse has a 3.5 MHz centre frequency and 2 MHz bandwidth. 
 
original Correction I Correction II 
Fig. 6. Correction results of images from a tissue mimicking phantom with an aberrator. 
4.1.1 Experimental results from a tissue-mimicking phantom 
The data were acquired from a tissue-mimicking phantom overlaid by an aberrator. The 
aberrator has a speed of 1420 ms-1 and an attenuation coefficient 1.2 dB cm-1MHz-1. The 
shape of the aberrator is shown in Fig. 1 in (Li et al., 1997). Two aberrating structures were 
cut out and put above the two cysts in the phantom. The speed of the aberrator is close to 
that of fat. Since the array is one-dimensional, the structure of the aberrator is also one-
dimensional. The tissue mimicking phantom was RMI-413, but is an earlier version and the 
cysts are 6 mm, not 7.5 mm, in diameter. 
The original aberrated image and two corrected images are shown in Fig. 6. The first 
correction used signals coming from a depth near the upper cyst (indicated by arrows). The 
second correction used signals from a depth near the lower cyst. The two cysts are distorted 
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array with a large number of elements. For a 64-element array, the bias in the peak-position 
measurement is magnified by a factor up to 496. Assume that the acceptable largest bias of 
the derived phase-aberration value is one radian, then the measurement bias needs to be less 
than 1/496 radians, which is a very strict requirement. Assuming that a constant or linear 
profile does not influence focusing, the requirement is relaxed to 1/325 radians, and the 
maximum bias value in the derived phase aberration profile occurs at the ends of the array. 
The standard deviations of peak position measurements also have to be small in order to 
measure the phase-aberration profiles accurately. For a 64-element array, the maximum 
standard deviation in the derived phase-aberration profile is about 72 times the standard 
deviation of the measured peak position; the rms is 52 times, or 25 times if the constant and 
linear profiles are considered as harmless. 
The strict accuracy requirement on peak position measurements creates a new problem. The 
timing of electronic channels (receiver and transmitter) has to be calibrated accurately. The 
requirement for channels to be considered as identical is much stricter for phase-aberration 
measurement than for image formation. Therefore, the system calibration on a commercial 
machine usually is not accurate enough. The timing errors of channels are part of the phase 
aberration profile and they make phase aberration profiles for transmission and reception 
different. When the timing error difference between transmission and reception channels 
connected to the same element is small enough for the purpose of image formation, the 
method proposed in (Li, 1997) can be used to solve this problem. The two reciprocal signals 
y u, d(t) and y d, u(t) (Fig. 3) are dynamically corrected and cross-correlated with y c, c(t) 
separately. The two peak positions are then averaged and used to derive the phase 
aberration profile, which can be used for both transmission and reception phase-aberration 
corrections. There is no need to measure the transmission and reception phase aberration 
profiles separately. That is, when the difference between transmission and reception phase-
aberration profiles is small for image-formation purpose but large for phase-aberration 
measurement, they have to be treated as different when performing the phase-aberration 
measurement, but they can be treated as the same in the image-formation process after the 
measurement. If the difference is large for imaging purpose, they need to be measured 
separately. In this case, the reciprocal-signal method proposed in (Li, 2008) can be used.  
To perform the dynamic near-field-delay correction, the array pitch and the average 
propagation speed in the medium need to be known. How accurately these parameters need 
to be known for the near-field signal-redundancy algorithm to perform properly? This has 
been analyzed in (Li et al., 1996). If the array pitch and propagation speed are not known 
accurately, the formed image (image formation also uses the two parameters) will also be 
distorted even if the medium is homogeneous. That is, phase aberrations are introduced by 
incorrect pitch and speed values and the phase aberration profile across the array is 
different at different points in the image. It has been shown in (Li et al., 1996) that the near-
field signal-redundancy algorithm is capable of correcting phase aberrations generated by 
pitch and speed errors. Therefore, the array pitch and average propagation speed need not 
to be known very accurately. However, large errors will reduce the size of the isoplanatic 
patch and therefore require more phase-aberration profiles to be measured to correct the 
whole image (Li et al., 1996).  
The near-field signal-redundancy algorithm for linear arrays typically includes the 
following steps: 
1. Common midpoint signals are acquired. 
2. Dynamic near-field-delay corrections are applied at a proper angle.  
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3. The dynamically corrected common midpoint signals are cross-correlated at a selected 
depth with a selected window length. 
4. The relative time-shift between common midpoint signals are measured from the peak 
position of the cross-correlation functions. 
5. The relative time-shifts between y u, d(t) and y c, c(t) and between y d, u(t) and y c, c(t) are 
averaged. 
6. The phase-aberration profile across the array is derived. 
7. If necessary, the undetermined linear term (ambiguity profile) is adjusted to optimize 
the performance of the system.  
This algorithm has been experimentally tested (Li et al., 1997). The system used to test this 
algorithm was based on a Toshiba model SAL-32B 8-channel Scanner. This system has 64 
transmission channels, 8 reception channels multiplexed across the array. This system is 
capable of separately transmitting on each individual element, and receiving on eight 
channels at a time. It can be switched between the normal real-time scan mode and the 
single-element-transmit/multiple-element-receive data collecting mode. A 64-element linear 
array was used with a pitch of 1.0 mm and an element width of about 1.0 mm. The element 
height is 10 mm, and the focus of the lens in the elevation direction is at about 60 mm. The 
received pulse has a 3.5 MHz centre frequency and 2 MHz bandwidth. 
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Fig. 6. Correction results of images from a tissue mimicking phantom with an aberrator. 
4.1.1 Experimental results from a tissue-mimicking phantom 
The data were acquired from a tissue-mimicking phantom overlaid by an aberrator. The 
aberrator has a speed of 1420 ms-1 and an attenuation coefficient 1.2 dB cm-1MHz-1. The 
shape of the aberrator is shown in Fig. 1 in (Li et al., 1997). Two aberrating structures were 
cut out and put above the two cysts in the phantom. The speed of the aberrator is close to 
that of fat. Since the array is one-dimensional, the structure of the aberrator is also one-
dimensional. The tissue mimicking phantom was RMI-413, but is an earlier version and the 
cysts are 6 mm, not 7.5 mm, in diameter. 
The original aberrated image and two corrected images are shown in Fig. 6. The first 
correction used signals coming from a depth near the upper cyst (indicated by arrows). The 
second correction used signals from a depth near the lower cyst. The two cysts are distorted 
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in the original image, and the distortions in the original image are partially corrected in the 
two corrected images.  
For comparison, the results from the same phantom without the aberrator are shown in Fig. 
7. The difference between the original and corrected is very small because the measured 
phase-aberration profile has very small values (Li et al., 1997), which indicates that the noise 







Fig. 7. Correction results of images from a tissue mimicking phantom without the aberrator. 
4.1.2 Experimental results from volunteers  
Data were acquired from a group of volunteer subjects. Since the height of elements in the 
linear array was large (10 mm) and the algorithm requires that phase aberration values for 
echoes received at an element can be considered as the same, transverse abdomen scan was 
used because of the structure of muscles and fat layers in that position.  The system was 
operated in the normal real-time scanning mode to scan for an aberrated image, and then 
switched to the synthetic-aperture mode to acquire data.  
Fig. 8 shows the original and two corrected images from Volunteer 1. The superior-
mesenteric-artery (SMA) and the aorta are used as the main objects to evaluate the quality of 
the images. In the original image the SMA and the aorta are distorted. In the corrected 
images, their boundaries are much better defined and their shape is more circular. Fig. 9 
shows the results from Volunteer 2. The boundaries of the SMA and the aorta are better 
defined in the corrected image than they are in the original image. Fig. 10 shows the results 
from Volunteer 3 using data from three different depths. The boundaries of the SMA and 
the aorta are better defined in the corrected images; the Splenic Vein (SV) is also much 
clearer in the corrected image. This data set is the same as that used to form images in Fig. 1. 
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Fig. 9. Correction results of images from Volunteer 2. 
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in the original image, and the distortions in the original image are partially corrected in the 
two corrected images.  
For comparison, the results from the same phantom without the aberrator are shown in Fig. 
7. The difference between the original and corrected is very small because the measured 
phase-aberration profile has very small values (Li et al., 1997), which indicates that the noise 
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mesenteric-artery (SMA) and the aorta are used as the main objects to evaluate the quality of 
the images. In the original image the SMA and the aorta are distorted. In the corrected 
images, their boundaries are much better defined and their shape is more circular. Fig. 9 
shows the results from Volunteer 2. The boundaries of the SMA and the aorta are better 
defined in the corrected image than they are in the original image. Fig. 10 shows the results 
from Volunteer 3 using data from three different depths. The boundaries of the SMA and 
the aorta are better defined in the corrected images; the Splenic Vein (SV) is also much 
clearer in the corrected image. This data set is the same as that used to form images in Fig. 1. 
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Fig. 9. Correction results of images from Volunteer 2. 
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Fig. 10. Correction results of images from Volunteer 3. 
 
 






Fig. 11. Results of correcting phase aberrations generated by incorrect pitch values. 
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Fig. 12. Results of correcting phase aberrations generated by incorrect speed values. 
4.1.3 Experimental results of correcting phase aberrations generated by incorrect 
pitch and speed values 
Data acquired from a tissue-mimicking phantom without any aberrator were used to test the 
performance of the linear array algorithm on correcting phase aberrations generated by 
incorrect array pitch and propagation speed values. The phantom had a propagation speed 
of 1420 m/s. The true array pitch was 1.00 mm. The synthetic aperture image formed using 
five pitch values and five speed values are shown in Figs. 11(a) and 12(a), respectively, and 
the image in the middle was formed with the correct value. The size of the images is 45 mm 
x 55 mm. Images formed with incorrect values are significantly distorted. Phase aberration 
profiles were measured using the linear array algorithm with the incorrect pitch and speed 
values. The signal range used in the measurements was around the fourth row of small 
cysts. The corrected images are shown in Figs. 11(b) and 12(b), respectively. The correction 
has restored the focus, especially in the region around the fourth row of small cysts. By 
measuring several phase aberration profiles using signals from different depths, the whole 
image can be improved, as it is demonstrated later in the chapter with images formed using 
phased arrays. These corrected images also show distortions (expansion or compression) in 
both lateral and axial directions caused by ambiguity profiles (Li et al., 1996). 
4.2 Algorithm for phased arrays 
The sub-array algorithm for small-element arrays has been proposed in (Li & Robinson, 
1997; Li, 2000b). It can be used to overcome problems caused by the wide beam and  
angle-dependent aberration profiles. This sub-array algorithm typically includes the 
following steps: 
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Fig. 10. Correction results of images from Volunteer 3. 
 
 






Fig. 11. Results of correcting phase aberrations generated by incorrect pitch values. 
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Fig. 12. Results of correcting phase aberrations generated by incorrect speed values. 
4.1.3 Experimental results of correcting phase aberrations generated by incorrect 
pitch and speed values 
Data acquired from a tissue-mimicking phantom without any aberrator were used to test the 
performance of the linear array algorithm on correcting phase aberrations generated by 
incorrect array pitch and propagation speed values. The phantom had a propagation speed 
of 1420 m/s. The true array pitch was 1.00 mm. The synthetic aperture image formed using 
five pitch values and five speed values are shown in Figs. 11(a) and 12(a), respectively, and 
the image in the middle was formed with the correct value. The size of the images is 45 mm 
x 55 mm. Images formed with incorrect values are significantly distorted. Phase aberration 
profiles were measured using the linear array algorithm with the incorrect pitch and speed 
values. The signal range used in the measurements was around the fourth row of small 
cysts. The corrected images are shown in Figs. 11(b) and 12(b), respectively. The correction 
has restored the focus, especially in the region around the fourth row of small cysts. By 
measuring several phase aberration profiles using signals from different depths, the whole 
image can be improved, as it is demonstrated later in the chapter with images formed using 
phased arrays. These corrected images also show distortions (expansion or compression) in 
both lateral and axial directions caused by ambiguity profiles (Li et al., 1996). 
4.2 Algorithm for phased arrays 
The sub-array algorithm for small-element arrays has been proposed in (Li & Robinson, 
1997; Li, 2000b). It can be used to overcome problems caused by the wide beam and  
angle-dependent aberration profiles. This sub-array algorithm typically includes the 
following steps: 
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1. Choose a sub-array size. The optimal sub-array size depends on the aberrator 
properties; therefore, it is difficult to determine in advance. A trial-and-error method 
may have to be used. 
2. Acquire individual signals (transmit at one element and receive at one element) by 
transmitting at one element at a time and receiving at several elements. The number of 
receiving elements depends on the size of sub-arrays.  
3. Form common-midpoint signals acquired with sub-arrays at several steering directions 
or imaging lines at selected angle intervals. 
4. Calculate the normalized cross-correlation function between these common-midpoint 
signals at a selected depth with a selected window length. 
5. Measure relative time-shift between common-midpoint signals from the peak position 
of these cross-correlation functions. 
6. Derive the phase-aberration profiles across the array for each steering angle or image 
line. 
7. Assign the derived phase-aberration value for each sub-array to each element in that 
sub-array. 
4.2.1 Experimental results from a tissue-mimicking phantom 
This algorithm has been successfully tested on data acquired from a tissue mimicking 
phantom with an aberrator (Li & Robinson, 2000b). The imaging system was a modified 
ATL Ultramark 8. The transducer used was an ATL 48-element phased-array with 0.28 
mm pitch and 3.0 MHz center frequency. The azimuthal cross-section from the center of the 
transducer is shown in Fig. 13. The aberrator was made from cast RTV, which had a sound  
 
 
Fig. 13. The azimuthal center cross-section of the ATL transducer with the aberrator 
attached to its front surface. 
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velocity of 1020 ms-1, and an attenuation coefficient 1.5 dB mm-1 at 3 MHz. The aberrator 
had a sinusoidal surface, the peak-to-peak range of the sinusoidal wave was 0.51 mm and 
the period was 4.42 mm. The total active aperture of the array was about 3.03 wavelengths 
of the sinusoidal wave. The total thickness of the aberrator was about 0.76 mm. The 
aberrator was cast so that its inner surface conformed to the surface of the elevational focus 
lens of the array. The potential space between the lens and the aberrator was filled with 
ultrasound coupling gel, which had a sound speed of 1540 ms-1. Coupling gel also filled the 
space between the sinusoidal surface of the aberrator and the phantom.  
The aberrator introduces a (one-way) phase-error of almost exactly -radians at 3 MHz. The 
unaberrated image of the RMI 413 phantom is shown in Fig. 14(a), which was obtained with 
the same transducer without the aberrator at approximately the same location on the 
phantom. The image of the phantom from the data set collected with the aberrator attached 
to the transducer is shown in Fig. 14(b). It is severely aberrated; each point target is tripled 
with reduced resolution, and the contrast ratio of the anechoic cystic structures is 
significantly reduced. 
To demonstrate the problem related to the wide beam of small elements, we first use the 
linear-array algorithm to correct the phase aberration.  The correction angle for the 
dynamic near-field-delay correction was at 90 (perpendicular to the array) and the 
measured profile was used to correct phase aberrations for all image lines (Fig.14(c)). The 
image quality near the 90 direction has been improved, revealing a column of point 
targets. The image quality at other directions has not been improved as much. There are 
no means to measure angle-dependent, phase-aberration profiles without forming sub-
arrays. Note that by performing the dynamic near-field-delay correction at different 
angles in a single-element measurement one does not measure the aberration profiles at 
different directions. To demonstrate this, phase-aberration profiles were measured with 
19 different correction angles, from 45 to 135 at 5 intervals. The measured aberration 
profiles were very similar for these correction angles (Li & Robinson, 2000b) and the 
corrected image (Fig. 14(d)) is very similar to that in Fig. 14(c). To measure angle-
dependent phase-aberration profiles, sub-arrays need to be formed to narrow and steer 
the beams. In the sub-array algorithm, each sub-array was formed with three elements (16 
sub-arrays in total). The beams of sub-arrays were formed with the synthetic aperture 
approach and were dynamically focused both on transmission and reception at a 
correction angle (the beam steering direction). The formed beam had a theoretical -6 dB 
(two-way) beamwidth of about 20.5 (Li & Robinson, 2000b). It subtended about 0.17 
wavelengths of the sinusoidal aberrator. Beams were steered at 19 different angles, from 
45 to 135 at 5 intervals, and 19 phase-aberration profiles were derived. The corrected 
image using the measured phase-aberration profile at the 90 beam steering angle for all 
images lines is shown in Fig. 15(a) and the focusing quality is only improved around the  
90 direction.  Similarly, using the phase aberration profile measured at the 105 beam 
steering angle to correct all images lines only improved the focusing quality around the 
105 direction (Fig. 15(b)). The corrected image using all 19 measured profiles is shown in 
Fig. 15(c) and resolution is improved in all directions. However, the image quality in 
regions near the left and right boundaries of the image has not improved as much. This is 
because the strong refraction effect (between RTV and coupling gel) at those angles makes 
it difficult to measure the aberration profiles accurately in those directions. The aberration 
values for the two sub-arrays at the two ends of the array are different, and the difference 
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1. Choose a sub-array size. The optimal sub-array size depends on the aberrator 
properties; therefore, it is difficult to determine in advance. A trial-and-error method 
may have to be used. 
2. Acquire individual signals (transmit at one element and receive at one element) by 
transmitting at one element at a time and receiving at several elements. The number of 
receiving elements depends on the size of sub-arrays.  
3. Form common-midpoint signals acquired with sub-arrays at several steering directions 
or imaging lines at selected angle intervals. 
4. Calculate the normalized cross-correlation function between these common-midpoint 
signals at a selected depth with a selected window length. 
5. Measure relative time-shift between common-midpoint signals from the peak position 
of these cross-correlation functions. 
6. Derive the phase-aberration profiles across the array for each steering angle or image 
line. 
7. Assign the derived phase-aberration value for each sub-array to each element in that 
sub-array. 
4.2.1 Experimental results from a tissue-mimicking phantom 
This algorithm has been successfully tested on data acquired from a tissue mimicking 
phantom with an aberrator (Li & Robinson, 2000b). The imaging system was a modified 
ATL Ultramark 8. The transducer used was an ATL 48-element phased-array with 0.28 
mm pitch and 3.0 MHz center frequency. The azimuthal cross-section from the center of the 
transducer is shown in Fig. 13. The aberrator was made from cast RTV, which had a sound  
 
 
Fig. 13. The azimuthal center cross-section of the ATL transducer with the aberrator 
attached to its front surface. 
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velocity of 1020 ms-1, and an attenuation coefficient 1.5 dB mm-1 at 3 MHz. The aberrator 
had a sinusoidal surface, the peak-to-peak range of the sinusoidal wave was 0.51 mm and 
the period was 4.42 mm. The total active aperture of the array was about 3.03 wavelengths 
of the sinusoidal wave. The total thickness of the aberrator was about 0.76 mm. The 
aberrator was cast so that its inner surface conformed to the surface of the elevational focus 
lens of the array. The potential space between the lens and the aberrator was filled with 
ultrasound coupling gel, which had a sound speed of 1540 ms-1. Coupling gel also filled the 
space between the sinusoidal surface of the aberrator and the phantom.  
The aberrator introduces a (one-way) phase-error of almost exactly -radians at 3 MHz. The 
unaberrated image of the RMI 413 phantom is shown in Fig. 14(a), which was obtained with 
the same transducer without the aberrator at approximately the same location on the 
phantom. The image of the phantom from the data set collected with the aberrator attached 
to the transducer is shown in Fig. 14(b). It is severely aberrated; each point target is tripled 
with reduced resolution, and the contrast ratio of the anechoic cystic structures is 
significantly reduced. 
To demonstrate the problem related to the wide beam of small elements, we first use the 
linear-array algorithm to correct the phase aberration.  The correction angle for the 
dynamic near-field-delay correction was at 90 (perpendicular to the array) and the 
measured profile was used to correct phase aberrations for all image lines (Fig.14(c)). The 
image quality near the 90 direction has been improved, revealing a column of point 
targets. The image quality at other directions has not been improved as much. There are 
no means to measure angle-dependent, phase-aberration profiles without forming sub-
arrays. Note that by performing the dynamic near-field-delay correction at different 
angles in a single-element measurement one does not measure the aberration profiles at 
different directions. To demonstrate this, phase-aberration profiles were measured with 
19 different correction angles, from 45 to 135 at 5 intervals. The measured aberration 
profiles were very similar for these correction angles (Li & Robinson, 2000b) and the 
corrected image (Fig. 14(d)) is very similar to that in Fig. 14(c). To measure angle-
dependent phase-aberration profiles, sub-arrays need to be formed to narrow and steer 
the beams. In the sub-array algorithm, each sub-array was formed with three elements (16 
sub-arrays in total). The beams of sub-arrays were formed with the synthetic aperture 
approach and were dynamically focused both on transmission and reception at a 
correction angle (the beam steering direction). The formed beam had a theoretical -6 dB 
(two-way) beamwidth of about 20.5 (Li & Robinson, 2000b). It subtended about 0.17 
wavelengths of the sinusoidal aberrator. Beams were steered at 19 different angles, from 
45 to 135 at 5 intervals, and 19 phase-aberration profiles were derived. The corrected 
image using the measured phase-aberration profile at the 90 beam steering angle for all 
images lines is shown in Fig. 15(a) and the focusing quality is only improved around the  
90 direction.  Similarly, using the phase aberration profile measured at the 105 beam 
steering angle to correct all images lines only improved the focusing quality around the 
105 direction (Fig. 15(b)). The corrected image using all 19 measured profiles is shown in 
Fig. 15(c) and resolution is improved in all directions. However, the image quality in 
regions near the left and right boundaries of the image has not improved as much. This is 
because the strong refraction effect (between RTV and coupling gel) at those angles makes 
it difficult to measure the aberration profiles accurately in those directions. The aberration 
values for the two sub-arrays at the two ends of the array are different, and the difference 
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depends on the steering angle. By assuming that they are zeros in the process of deriving 
the aberration profile, different ambiguity profiles are introduced in the derived 
aberration profiles at different steering angles. For targets far from the transducer, where 
the angle from an image pixel to all elements is approximately the same, the changing 
ambiguity profile will not influence the focusing of the system at each pixel; however, the 
image may become distorted (change of target shape). For targets near the transducer, 
where the angle from an image pixel to each element varies, the focusing quality is 
reduced at that pixel because of the different ambiguity profiles for the derived aberration 
profiles from different steering angles. The derived aberration profiles were adjusted by 
adding a proper ambiguity profile and the corrected image is shown in Fig. 15(d). The 
image quality is further improved.  
 
 
(a) without the aberrator (b) original with the aberrator 
 
(c) The corrected image using the phase-
aberration profile derived without 
forming sub-arrays at correction angle 90º. 
 
(d) The corrected image using 19 phase-
aberration profiles derived without forming 
sub-arrays and at 19 correction angles 
between 45º and 135º at 5º intervals. 
Fig. 14. (a) Original image without the aberrator. (b) Original image with the aberrator. (c) 
The corrected image using the phase-aberration profile derived without forming sub-arrays 
at correction angle 90º. (d) The corrected image using 19 phase-aberration profiles derived 
without forming sub-arrays and at 19 correction angles between 45º and 135º at 5º  
intervals. 
 




(a) The corrected image using the 
measured phase-aberration profile at the 
90 beam steering angle for all images 
lines. 
(b) The corrected image using the 
measured phase-aberration profile at the 
105 beam steering angle for all images 
lines. 
 
(c) The corrected image using the phase-
aberration profile derived with the steering 
angle-based sub-array method. 
 
(d) The corrected image using the phase-
aberration profiles derived using the 
steering angle-based sub-array method after 
manually adjusting ambiguity profiles. 
 
(e) The corrected image using the phase-
aberration profiles derived using the image 
line-based sub-array method without 
adjusting ambiguity profiles 
 
Fig. 15. Correction results using sub-arrays. (a) The corrected image using the measured 
phase-aberration profile at the 90 beam steering angle for all images lines. (b) The corrected 
image using the measured phase-aberration profile at the 105 beam steering angle for all 
images lines. (c) The corrected image using all 19 measured phase-aberration profiles (d) 
The corrected image using all 19 measured phase-aberration profiles with manually 
adjusted ambiguity profiles. (e) The corrected image using 19 measured phase-aberration 
profiles derived along image lines.  
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Fig. 15. Correction results using sub-arrays. (a) The corrected image using the measured 
phase-aberration profile at the 90 beam steering angle for all images lines. (b) The corrected 
image using the measured phase-aberration profile at the 105 beam steering angle for all 
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The corrected image using all 19 measured phase-aberration profiles with manually 
adjusted ambiguity profiles. (e) The corrected image using 19 measured phase-aberration 
profiles derived along image lines.  
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However, this process requires knowledge of the ambiguity profile for all directions, 
which is usually not available. A better way to measure the phase-aberration profile is to 
form common-midpoint beams along an image line (Li, 2000b), instead of at a steering 
angle. The advantage is that the focusing quality of each image pixel will not be 
influenced by the undetermined linear ambiguity profile; however, the image may still be 
distorted if the undetermined linear terms are very different for different image lines. The 
corrected image using this method is shown in Fig. 15(e). Compared with Fig. 15(c), the 
image quality for pixels near the transducer surface is improved in Fig. 15(e). Note that 
the derived aberration profiles are not adjusted for the undetermined different steering 
terms in this case.  
4.2.2 Experimental results of correcting phase aberrations generated by incorrect 
pitch and speed values 
The data set acquired from the phantom without the aberrator (Fig. 15(a)) was also used to 
demonstrate the capability of the sub-array method to correct phase aberrations generated 
by incorrect array pitch or propagation speed errors (Li et al., 2002). The synthetic aperture 
image formed using four incorrect  pitch values and four incorrect speed values are shown 
in Figs. 16(a) and 17(a), respectively. The distortions are obvious.  
 
p = 0.18 mm p = 0.22 mm p = 0.34 mm p = 0.38 mm 
 
(a) original 
    
(b) corrected 
Fig. 16. Correction of phase aberrations generated by incorrect pitch values. (a) original 
images. (b) corrected images. 
Phase aberration profiles were measured using the assumed pitch and speed values. The 
profile was again derived at 19 steering angles (45º ≤ θi ≤ 135º with 5º interval) and signals 
around the nearest (to the transducer) point target, the cyst, and the farthest point target 
vertically below the nearest point target were used to derive three profiles for each 
direction, resulting in a total of 57 profiles. Figs. 16(b) and 17(b) show images after 
corrections. These results demonstrated that, after correction, the focusing quality in all the 
investigated cases is significantly improved in the whole image. These results also show 
distortions caused by the ambiguity profile (expansion and compression in both lateral and 
axial directions). The image is compressed (expanded) in the axial direction because the 
echo from a point target is treated as if it were from a target at a closer (farther) distance 
from the transducer when the speed is underestimated (overestimated). Different scales 
were used in Figs. 16 and 17 so that targets of interest occupy a similar image size as that in 
the un-aberrated image.  
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v = 1000 m/s v = 1200 m/s v = 1900 m/s v = 1000 m/s 
 
(a) original 
    
(b) corrected 
Fig. 17. Correction of phase aberrations generated by incorrect speed values. (a) original 
images. (b) corrected images. 
4.2.3 Experimental results of system-error-difference calibration  
The data set acquired using this phased-array system was also used to experimentally test 
the reciprocal signal algorithm for system-error-difference calibration (Li, 2008). The system 
has 48 transmission channels and 48 reception channels. Therefore each element has its own 
transmission and reception channels. Reciprocal signals acquired using each element (the 
reference element) in the transducer and all other elements were cross correlated. The cross-
correlation coefficients between these reciprocal signals are shown in Fig. 18(a). All 
coefficients are very close to unity, except those that involve Element 12, which indicates 
that Element 12 was abnormal. Note that the cross-correlation coefficient between reciprocal 
signals acquired using the reference element and itself is also shown in Fig. 18(a), which is 
unity because the two reciprocal signals were the same signal. The peak positions of the 
cross-correlation functions are shown in Fig. 18(b) in grayscale.  Each row in Fig. 18(b) is the 
derived system-error-difference profile using a different reference element. As a 
consequence, all rows should have identical shape but may have different offsets, if there 
was no noise (Li, 2008). This can be clearly seen in Fig. 18 (c), where the row profiles are 
plotted on top of one another. All the rows can be treated as the measurement result using a 
different element as the reference element. Its advantage is that only a small number of 
cross-correlation functions needs to be calculated. To improve the measurement accuracy, 
all row profiles can be averaged and it is shown in Fig. 18(d) together with the one standard 
deviation (each direction) lines. The profile should have a bias that is the average value of all 
system-error-difference values (Li, 2008). The peak-to-peak range of system-error-difference 
values of this system is less than 0.03 microseconds. The period of the transmitted signal at 
the center frequency (3.5 MHz) is about 0.29 microseconds. Therefore the difference between 
timing errors in the transmission and reception channels is less than one tenth of a period. 
Consequently, the transmission and reception phase-aberration profiles can be considered 
as the same for image formation. There is no need to separately measure transmission and 
reception channel-timing errors.   
4.3 Algorithm for two-dimensional arrays  
A few methods have been proposed to implement the near-field signal redundancy 
algorithm on a two-dimensional array. The all-row-plus-two-column algorithm (Li & 
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However, this process requires knowledge of the ambiguity profile for all directions, 
which is usually not available. A better way to measure the phase-aberration profile is to 
form common-midpoint beams along an image line (Li, 2000b), instead of at a steering 
angle. The advantage is that the focusing quality of each image pixel will not be 
influenced by the undetermined linear ambiguity profile; however, the image may still be 
distorted if the undetermined linear terms are very different for different image lines. The 
corrected image using this method is shown in Fig. 15(e). Compared with Fig. 15(c), the 
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terms in this case.  
4.2.2 Experimental results of correcting phase aberrations generated by incorrect 
pitch and speed values 
The data set acquired from the phantom without the aberrator (Fig. 15(a)) was also used to 
demonstrate the capability of the sub-array method to correct phase aberrations generated 
by incorrect array pitch or propagation speed errors (Li et al., 2002). The synthetic aperture 
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in Figs. 16(a) and 17(a), respectively. The distortions are obvious.  
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Fig. 16. Correction of phase aberrations generated by incorrect pitch values. (a) original 
images. (b) corrected images. 
Phase aberration profiles were measured using the assumed pitch and speed values. The 
profile was again derived at 19 steering angles (45º ≤ θi ≤ 135º with 5º interval) and signals 
around the nearest (to the transducer) point target, the cyst, and the farthest point target 
vertically below the nearest point target were used to derive three profiles for each 
direction, resulting in a total of 57 profiles. Figs. 16(b) and 17(b) show images after 
corrections. These results demonstrated that, after correction, the focusing quality in all the 
investigated cases is significantly improved in the whole image. These results also show 
distortions caused by the ambiguity profile (expansion and compression in both lateral and 
axial directions). The image is compressed (expanded) in the axial direction because the 
echo from a point target is treated as if it were from a target at a closer (farther) distance 
from the transducer when the speed is underestimated (overestimated). Different scales 
were used in Figs. 16 and 17 so that targets of interest occupy a similar image size as that in 
the un-aberrated image.  
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Fig. 17. Correction of phase aberrations generated by incorrect speed values. (a) original 
images. (b) corrected images. 
4.2.3 Experimental results of system-error-difference calibration  
The data set acquired using this phased-array system was also used to experimentally test 
the reciprocal signal algorithm for system-error-difference calibration (Li, 2008). The system 
has 48 transmission channels and 48 reception channels. Therefore each element has its own 
transmission and reception channels. Reciprocal signals acquired using each element (the 
reference element) in the transducer and all other elements were cross correlated. The cross-
correlation coefficients between these reciprocal signals are shown in Fig. 18(a). All 
coefficients are very close to unity, except those that involve Element 12, which indicates 
that Element 12 was abnormal. Note that the cross-correlation coefficient between reciprocal 
signals acquired using the reference element and itself is also shown in Fig. 18(a), which is 
unity because the two reciprocal signals were the same signal. The peak positions of the 
cross-correlation functions are shown in Fig. 18(b) in grayscale.  Each row in Fig. 18(b) is the 
derived system-error-difference profile using a different reference element. As a 
consequence, all rows should have identical shape but may have different offsets, if there 
was no noise (Li, 2008). This can be clearly seen in Fig. 18 (c), where the row profiles are 
plotted on top of one another. All the rows can be treated as the measurement result using a 
different element as the reference element. Its advantage is that only a small number of 
cross-correlation functions needs to be calculated. To improve the measurement accuracy, 
all row profiles can be averaged and it is shown in Fig. 18(d) together with the one standard 
deviation (each direction) lines. The profile should have a bias that is the average value of all 
system-error-difference values (Li, 2008). The peak-to-peak range of system-error-difference 
values of this system is less than 0.03 microseconds. The period of the transmitted signal at 
the center frequency (3.5 MHz) is about 0.29 microseconds. Therefore the difference between 
timing errors in the transmission and reception channels is less than one tenth of a period. 
Consequently, the transmission and reception phase-aberration profiles can be considered 
as the same for image formation. There is no need to separately measure transmission and 
reception channel-timing errors.   
4.3 Algorithm for two-dimensional arrays  
A few methods have been proposed to implement the near-field signal redundancy 
algorithm on a two-dimensional array. The all-row-plus-two-column algorithm (Li & 
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Robinson, 2000a) applies the one-dimensional near-field signal redundancy algorithm on all 
rows as well as the first and last columns of the transducer array, and then these results are 
combined to form a two-dimensional phase-aberration profile. However, the ambiguity 
profile of this method is not linear and a time-consuming iterative method has to be used to 
linearize the ambiguity profile. To solve this problem, an all-row-plus-two-column-and-a-
diagonal algorithm has been proposed (Li & Robinson, 2007). In this algorithm, the  
one-dimensional algorithm is also applied to elements along a tilted line (the diagonal line if 
the array is square). The ambiguity profile of this algorithm is linear but it is very sensitive 
to noise. Another method, the cross algorithm (Li & Robinson, 2008), is based on the two-







Fig. 18. (a) The cross-correlation coefficient distributions. (b) The peak positions distribution. 
(c) The peak positions profiles with all reference elements plotted on top of one another. (d) 
The derived system-error-difference profile by averaging profiles derived with all reference 
elements. The boundaries of one standard deviation are also plotted. 
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this algorithm, most common-midpoint signals are acquired using four adjacent transducer 
elements, which is not available in one-dimensional arrays. An initial two dimensional 
phase-aberration profile is derived from the peak positions of cross-correlation functions 
between these common midpoint signals. The boundary conditions needed to drive the final 
phase-aberration profile are derived by applying the one-dimensional-array algorithm to the 
first row and the first column of the array. The cross algorithm has a linear ambiguity profile 
and high signal-to-noise ratio. Due to the lack of experimental data from two-dimensional 
arrays (still hard to build), the discussed algorithms for two-dimensional arrays have only 
been tested using simulated data (Li, & Robinson, 2000a, 2007, 2008).  
5. Conclusion  
Compared with astromical imaging, phase-aberration correction in medical ultrasound 
imaging is more challenging in the sense that targets are in the near field and aberrators can 
exist anywhere between the interested targets and the array. Many successful algorithms used 
in astromical imaging are based on the signal-redundancy principle. However, this principle is 
invalid in the near field. To use the signal redundancy principle for phase-aberration 
correction in medical ultrasound images, the near-field effects have to be managed. In this 
chapter, the near-field signal-redundancy principle has been discussed in depth. Common-
midpoint signals are still a special group of signals in the near field because they can be 
considered as redundant after a dynamic near-field-delay correction. Based on the near-field 
signal-redundancy principle, phase-aberration-correction algorithms have been developed for 
linear arrays, phased arrays, and two-dimensional arrays. There are three basic requirements 
for these algorithms to work properly. One of the requirements is that the phase-aberration 
effects of aberrators between targets in a region of interest and the transducer array can be 
approximately modelled as the effects of a phase screen on the transducer surface. The second 
requirement is that the element size is small enough so that the phase aberration value of the 
phase screen under each element can be considered as the same. The third requirement is that 
multi-path echoes are ignorable in common-midpoint signals, because they are not redundant.  
The linear array algorithm has been successfully tested on transverse scan of abdomen of 
volunteers. At this body position, the aberrators are mainly muscle and fat layers under the 
skin (close to the transducer surface), which makes it easier to model their effect as that of a 
phase screen on the transducer surface. Another property of the body structure at this 
location and the transducer orientation is that the thickness of the fat and muscle layers 
changes very slowly in the direction of element height (10 mm). This property makes it 
easier to satisfy the second requirement. The high cross-correlation coefficient between 
common-midpoint signals (Li et al., 1997) also indicated that multi-path echoes were weak 
in common-midpoint signals and the third requirement was satisfied. Experimental results 
also show that the measured phase aberration profiles were different for targets from 
different depths. This could be because the aberration effect of fat and muscle layers near 
the transducer surface is different for targets at different depths, which is similar to the 
effect of the aberrator attached to the phased-array transducer surface in phased-array 
experiments (Section 4.2.1), where the phase screen was different for echoes from targets in 
different directions. Another possible reason is that the effect of other aberrators between 
the targets and the transducer surface was included.   
For other imaging positions on the body, small element size in both dimensions is usually 
required to sample the phase screen properly (the second requirement). That is, a two-
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this algorithm, most common-midpoint signals are acquired using four adjacent transducer 
elements, which is not available in one-dimensional arrays. An initial two dimensional 
phase-aberration profile is derived from the peak positions of cross-correlation functions 
between these common midpoint signals. The boundary conditions needed to drive the final 
phase-aberration profile are derived by applying the one-dimensional-array algorithm to the 
first row and the first column of the array. The cross algorithm has a linear ambiguity profile 
and high signal-to-noise ratio. Due to the lack of experimental data from two-dimensional 
arrays (still hard to build), the discussed algorithms for two-dimensional arrays have only 
been tested using simulated data (Li, & Robinson, 2000a, 2007, 2008).  
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Compared with astromical imaging, phase-aberration correction in medical ultrasound 
imaging is more challenging in the sense that targets are in the near field and aberrators can 
exist anywhere between the interested targets and the array. Many successful algorithms used 
in astromical imaging are based on the signal-redundancy principle. However, this principle is 
invalid in the near field. To use the signal redundancy principle for phase-aberration 
correction in medical ultrasound images, the near-field effects have to be managed. In this 
chapter, the near-field signal-redundancy principle has been discussed in depth. Common-
midpoint signals are still a special group of signals in the near field because they can be 
considered as redundant after a dynamic near-field-delay correction. Based on the near-field 
signal-redundancy principle, phase-aberration-correction algorithms have been developed for 
linear arrays, phased arrays, and two-dimensional arrays. There are three basic requirements 
for these algorithms to work properly. One of the requirements is that the phase-aberration 
effects of aberrators between targets in a region of interest and the transducer array can be 
approximately modelled as the effects of a phase screen on the transducer surface. The second 
requirement is that the element size is small enough so that the phase aberration value of the 
phase screen under each element can be considered as the same. The third requirement is that 
multi-path echoes are ignorable in common-midpoint signals, because they are not redundant.  
The linear array algorithm has been successfully tested on transverse scan of abdomen of 
volunteers. At this body position, the aberrators are mainly muscle and fat layers under the 
skin (close to the transducer surface), which makes it easier to model their effect as that of a 
phase screen on the transducer surface. Another property of the body structure at this 
location and the transducer orientation is that the thickness of the fat and muscle layers 
changes very slowly in the direction of element height (10 mm). This property makes it 
easier to satisfy the second requirement. The high cross-correlation coefficient between 
common-midpoint signals (Li et al., 1997) also indicated that multi-path echoes were weak 
in common-midpoint signals and the third requirement was satisfied. Experimental results 
also show that the measured phase aberration profiles were different for targets from 
different depths. This could be because the aberration effect of fat and muscle layers near 
the transducer surface is different for targets at different depths, which is similar to the 
effect of the aberrator attached to the phased-array transducer surface in phased-array 
experiments (Section 4.2.1), where the phase screen was different for echoes from targets in 
different directions. Another possible reason is that the effect of other aberrators between 
the targets and the transducer surface was included.   
For other imaging positions on the body, small element size in both dimensions is usually 
required to sample the phase screen properly (the second requirement). That is, a two-
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dimensional array is needed, but it is still difficult and expensive to build a two-dimensional 
array. When two-dimensional arrays become available, the near-field signal redundancy 
algorithm should work at more imaging positions. However, there will be imaging positions 
where the structure is so complex that the three basic requirements are not satisfied. In this 
case, the cross-correlation coefficient between common midpoint signals will be low and it 
can be used as the trigger to abandon the correction.   
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dimensional array is needed, but it is still difficult and expensive to build a two-dimensional 
array. When two-dimensional arrays become available, the near-field signal redundancy 
algorithm should work at more imaging positions. However, there will be imaging positions 
where the structure is so complex that the three basic requirements are not satisfied. In this 
case, the cross-correlation coefficient between common midpoint signals will be low and it 
can be used as the trigger to abandon the correction.   
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The success of human and embryo implantation depends on maternal and embryonic factors 
and their interactions. To asses uterine receptivity one must take various factors into account. 
Current advances in transvaginal 3D ultrasonography have allowed us to examine in detail 
and visualize pelvic organ structures to analyse their volumes with great accuracy (Alcazar et 
al., 2006 ),(Raga et al., 1999 ). It is reasonable to believe that an analysis of power Doppler 
signals in a volume better reflects the overall vascularization in an organ than analysis of a 
two-dimensional (2D) ultrasound image or measurement of blood flow velocity in a single or a 
few vessels. Using 3D Power Doppler Angiography we can assess both arterial and venous 
circulation also the whole architecture of the vascular net into a volumetric image with the 
posibility of an overall evaluation of blood flows , and computer analysis makes this 
assessment objective (Jokubkiene et al., 2006). The VOCAL (Virtual Organ Computer – aided 
Analysis) and volume calculation is semi-authomatic type of calculating volumes starting from 
the rotation of the organ target of study. Allows to calculate partial volumes and at the same 
time the of vascular system and flows into the region of interest. Two dimensional Doppler 
sonography provides a subjective estimation of uterine and ovarian vascularity. Is it limited, 
however, by providing flow depiction in a single plane as opposed to the sample volume as 
obtained by free dimensional imaging. Therefore, three dimensional ultrasound and power 
Doppler angiography (3D US-PDA) have advantage of assessing simultaneously both the 
endometrial blood flow and endometrial volume (EV) (Merce et al., 2008 ) and improves better 
traditional ultrasound scanning imaging with the posibility of storing information for further 
analysis or share datasets through telemedicine. 
The follicular blood flow seems to play a major role during the growth and development of 
the follicle containing the oocyte (Chui et al. ,1997 ),(Coulam et al.,1999). The surge in 
perifolicullar angiogenesis during selection of dominant follicles and following the LH 
surge or HCG can be detected by measurment of perifolicular flow/velocities. This allows 
identification of those follicles likely to produce high quality eggs and embryos. 3D surface 
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circulation also the whole architecture of the vascular net into a volumetric image with the 
posibility of an overall evaluation of blood flows , and computer analysis makes this 
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Analysis) and volume calculation is semi-authomatic type of calculating volumes starting from 
the rotation of the organ target of study. Allows to calculate partial volumes and at the same 
time the of vascular system and flows into the region of interest. Two dimensional Doppler 
sonography provides a subjective estimation of uterine and ovarian vascularity. Is it limited, 
however, by providing flow depiction in a single plane as opposed to the sample volume as 
obtained by free dimensional imaging. Therefore, three dimensional ultrasound and power 
Doppler angiography (3D US-PDA) have advantage of assessing simultaneously both the 
endometrial blood flow and endometrial volume (EV) (Merce et al., 2008 ) and improves better 
traditional ultrasound scanning imaging with the posibility of storing information for further 
analysis or share datasets through telemedicine. 
The follicular blood flow seems to play a major role during the growth and development of 
the follicle containing the oocyte (Chui et al. ,1997 ),(Coulam et al.,1999). The surge in 
perifolicullar angiogenesis during selection of dominant follicles and following the LH 
surge or HCG can be detected by measurment of perifolicular flow/velocities. This allows 
identification of those follicles likely to produce high quality eggs and embryos. 3D surface 
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rendering at 4xmagnification can show the blood vessels in the follicular wall and can 
identify features incompatible with successfull oocyte retrieval (Cambell,2010). 
2. Evaluation of endometrial receptivity  
Failure of implantation remains the main reason why most IVF treatment fails to result in 
pregnancy. Angiogenesis plays a critical role in various female  reproductive processes such as 
development of dominant follicle, formation of a corpus luteum, growth of endometrium and 
implantation. A good blood supply towards the endometrium is usually considered as an 
essentials requirement for implantation. The ability to identify a receptive uterus prospectively 
by a noninvasive method would have an invaluable clinical impact on treatment efficiency and 
succes rates. This chapter explores the role of transvaginal three dimensional ultrasound (3d 
US) and 3D power –Doppler ultrasound (3D-PDA) in evaluation of endometrial receptivity.  
2.1 Technical aspects and three dimensional data analysis 
3D US images can be obtained by two methods: freehand and automated. The freehand 
method requires manual movement of the transducer through the ROI. The automated 
method acquires the images using dedicated 3D transducers. When these probes are activated, 
the transducer elements automatically sweep through the ROI selected by the operator (the so-
called "volume box") while the probe is held stationary. This provides more accuracy to this 
method as compared with the freehand systems, in which speed of sweep is more difficult to 
maintain constant manually by the operator. The digitally stored volume data can be 
manipulated and presented in various displays: multiplanar display, "niche" mode or surface 
rendering mode. Probably, the most used and useful display is multiplanar display, which 
simultaneously shows three perpendicular planes (axial, sagital and coronal), allowing 
navigation through these three planes with the possibility of switch over any desired plane 
(Alcazar et al, 2006). There are two basic methods employed to calculate volume from a three 
dimensional dataset :the convencional ,,full planar,, or ,,contour,, method and the more 
recently introduced ,rotational,, method possible through the VOCAL –imaging program 
(Virtuala Organ Computer aided analysis).This rotational method based on rotations in given 
steps (6°, 9°, 15°, 30°) on a given orthogonal plane (A, B or C).Vascularization of tissues within 
the ROI can be also assessed using 3D Power –Doppler ultrasound (3D PDA) and the VOCAL 
program. Three Indices of vascularity are calculated: the Vascularization Index (VI) reflects the 
ratio of power Dopler information within the total dataset relative to both colour and grey 
information, the Flow Index (FI) represents the mean power Doppler signal intensity and the 
Vascularisation Flow index represents a combination of the two (Pairleitner et al., 1999). Using 
the ,,shell,, function it is possible to calculate a volume at different thickness around the 
predetermined endometrium and estimate the vascularization in this ,,shell,,.This allows the 
assessment of the so-called ,,subendometrial region,, (Alcazar et al, 2006). 
2.2 Results and authors studies  
The pregnancy outcome of frozen embryo transfer is known to be dependent on multiple 
clinical and embryological factors, including the age of the woman at IVF/ICSI treatment; 
(Salumets et.al, 2006 ),(Wang et. al, 2001), the method of oocyte fertilization used (Van 
Steirteghem et. Al , 1994 ),(Salumets et al., 2006 ), the developmental stage of embryos at 
freezing (Salumets et al., 2003 ), the embryo quality before freezing (Schalkoff et al., 1993 ), the 
extent of embryo damage after thawing (Edgar et al., 2000 ) and the resumption of post-thaw 
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blastomere divisions (Van der Elst et al., 1997 ). On the other hand the risk of pregnancy loss is 
similar after cryopreservation and fresh IVF or ICSI (Aytoz et al., 1999) and embryo 
morphology is not related to the miscarriage rates in any of the treatment modalities studied 
(Veleva et al., 2008 ). Several ultrasound parameters of the endometrium and the evaluation of 
uterine and endometrial blood flow have been proposed for assessing endometrial receptivity, 
including endometrial thickness, endometrial pattern and endometrial and subendometrial 
blood floow and considered as implantation markers in vitro fertilization (IVF) and embryo 
transfer cycles. These parameters may identify patients with low implantation potential. 
However, their positive predictive value is low. No differences were find in endometrial 
thickness, endometrial volume, endometrial pattern, uterine PI, uterine RI, endometrial and 
subendometrial 3D power Doppler flow indeces between the nonpregnant and pregnant 
groups on LH+1(1 day after the LH surge) during frozen –thawed embryo transfer cycles (Ng 
et al., 2006 ). Nevertheless another studies suggested  any corelations between the thickness of 
endometrium and pregnancy rate during the treatment with assisted reproductive technology. 
There was the endometrial thickness decreases as function of the patients age on the day of 
HCG administration during an IVF cycle. (Amir et.al., 2007 ). In our study at the time of 
embryo transfer only the structure of endometrium seems to be of significance and 3D power 
Doppler ultrasound and steroids levels does not provide us any additional information at this 
point . The 3D transvaginal ultrasound measurements (Voluson Expert 730, Kretz, Zipf, 
Austria) were performed on the day of the FET and repeated about one week later, at the time 
of the expected implantation. The 3D ultrasound technique enabled the determination of 
endometrial, subendometrial, and ovarian volume, including possible changes in the vascular 
network. Identical preinstalled instrument settings (frequency, mid; dynamic set, 2; balance, 
G>170; smooth, 5/5; ensemble, 16; line density, 7; power Doppler map, 5; and the setting 
conditions for the power Doppler mode were gain, -5.6; quality, normal; wall motion filter, 
low 1; peak repetitive frequency PRF, 0.9 kHz) were applied for all patients. At the second 
visit, the power Doppler mode was not used to examine the uterus. During the ultrasound 
examination, the uterus was first visualized in two-dimensional (2D) B-mode after the patient 
had emptied her bladder. The power Doppler mode was switched on, and the power Doppler 
box was positioned to cover the whole uterus. The 3D facility was engaged by switching to 
'volume mode. The volume sector angle was preset to 80°, and the fast volume acquisition 
(low-resolution) setting was selected to avoid artifacts. Thereafter, the ovaries were examined 
similarly. The ultrasonographic volume data were saved on the hard drive and analyzed later 
using the built-in virtual organ computer-aided analysis imaging program (VOCAL, GE 
Healthcare, Zipf, Austria) for 3D power Doppler histogram analysis. The manual mode of the 
VOCAL Contour Editor was used to cover the whole 3D volume of the region of interest 
(ROI), with 15° rotation steps. Hence, 12 contour planes were analyzed for each ROI to cover 
360°. After obtaining the total volume of the ROI, the program calculated the ratio of color 
voxels to all the voxels; this ratio (%) was expressed as the vascularization index (VI). The 
vascularized volume (unit mL) in the endometrium or in the ovary was calculated by 
multiplying the total volume of the ROI by its VI. The VOCAL program automatically 
calculated the index for mean grayness (MG) in the ROI, which presents the average grayness 
in the gray-scale voxels. We have reported only vascularization index and vascularized 
volume(VI x volume),since only the last one has been shown to reflex corpus luteal function in 
several studies(Järvelä et al., 2007; Järvelä et al.,2008; Niinimäki et al 2009).We have not 
analysed any data concerning VI or VFI , neither do we have any intention to analyse 
them,because we are unaware what kind of physiological phenomena they reflect (Zackova et 
al., 2009).  
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called "volume box") while the probe is held stationary. This provides more accuracy to this 
method as compared with the freehand systems, in which speed of sweep is more difficult to 
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ratio of power Dopler information within the total dataset relative to both colour and grey 
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2.2 Results and authors studies  
The pregnancy outcome of frozen embryo transfer is known to be dependent on multiple 
clinical and embryological factors, including the age of the woman at IVF/ICSI treatment; 
(Salumets et.al, 2006 ),(Wang et. al, 2001), the method of oocyte fertilization used (Van 
Steirteghem et. Al , 1994 ),(Salumets et al., 2006 ), the developmental stage of embryos at 
freezing (Salumets et al., 2003 ), the embryo quality before freezing (Schalkoff et al., 1993 ), the 
extent of embryo damage after thawing (Edgar et al., 2000 ) and the resumption of post-thaw 
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blastomere divisions (Van der Elst et al., 1997 ). On the other hand the risk of pregnancy loss is 
similar after cryopreservation and fresh IVF or ICSI (Aytoz et al., 1999) and embryo 
morphology is not related to the miscarriage rates in any of the treatment modalities studied 
(Veleva et al., 2008 ). Several ultrasound parameters of the endometrium and the evaluation of 
uterine and endometrial blood flow have been proposed for assessing endometrial receptivity, 
including endometrial thickness, endometrial pattern and endometrial and subendometrial 
blood floow and considered as implantation markers in vitro fertilization (IVF) and embryo 
transfer cycles. These parameters may identify patients with low implantation potential. 
However, their positive predictive value is low. No differences were find in endometrial 
thickness, endometrial volume, endometrial pattern, uterine PI, uterine RI, endometrial and 
subendometrial 3D power Doppler flow indeces between the nonpregnant and pregnant 
groups on LH+1(1 day after the LH surge) during frozen –thawed embryo transfer cycles (Ng 
et al., 2006 ). Nevertheless another studies suggested  any corelations between the thickness of 
endometrium and pregnancy rate during the treatment with assisted reproductive technology. 
There was the endometrial thickness decreases as function of the patients age on the day of 
HCG administration during an IVF cycle. (Amir et.al., 2007 ). In our study at the time of 
embryo transfer only the structure of endometrium seems to be of significance and 3D power 
Doppler ultrasound and steroids levels does not provide us any additional information at this 
point . The 3D transvaginal ultrasound measurements (Voluson Expert 730, Kretz, Zipf, 
Austria) were performed on the day of the FET and repeated about one week later, at the time 
of the expected implantation. The 3D ultrasound technique enabled the determination of 
endometrial, subendometrial, and ovarian volume, including possible changes in the vascular 
network. Identical preinstalled instrument settings (frequency, mid; dynamic set, 2; balance, 
G>170; smooth, 5/5; ensemble, 16; line density, 7; power Doppler map, 5; and the setting 
conditions for the power Doppler mode were gain, -5.6; quality, normal; wall motion filter, 
low 1; peak repetitive frequency PRF, 0.9 kHz) were applied for all patients. At the second 
visit, the power Doppler mode was not used to examine the uterus. During the ultrasound 
examination, the uterus was first visualized in two-dimensional (2D) B-mode after the patient 
had emptied her bladder. The power Doppler mode was switched on, and the power Doppler 
box was positioned to cover the whole uterus. The 3D facility was engaged by switching to 
'volume mode. The volume sector angle was preset to 80°, and the fast volume acquisition 
(low-resolution) setting was selected to avoid artifacts. Thereafter, the ovaries were examined 
similarly. The ultrasonographic volume data were saved on the hard drive and analyzed later 
using the built-in virtual organ computer-aided analysis imaging program (VOCAL, GE 
Healthcare, Zipf, Austria) for 3D power Doppler histogram analysis. The manual mode of the 
VOCAL Contour Editor was used to cover the whole 3D volume of the region of interest 
(ROI), with 15° rotation steps. Hence, 12 contour planes were analyzed for each ROI to cover 
360°. After obtaining the total volume of the ROI, the program calculated the ratio of color 
voxels to all the voxels; this ratio (%) was expressed as the vascularization index (VI). The 
vascularized volume (unit mL) in the endometrium or in the ovary was calculated by 
multiplying the total volume of the ROI by its VI. The VOCAL program automatically 
calculated the index for mean grayness (MG) in the ROI, which presents the average grayness 
in the gray-scale voxels. We have reported only vascularization index and vascularized 
volume(VI x volume),since only the last one has been shown to reflex corpus luteal function in 
several studies(Järvelä et al., 2007; Järvelä et al.,2008; Niinimäki et al 2009).We have not 
analysed any data concerning VI or VFI , neither do we have any intention to analyse 
them,because we are unaware what kind of physiological phenomena they reflect (Zackova et 
al., 2009).  
 
Ultrasound Imaging – Medical Applications 76
 
Fig. 1. Three dimensional multiplanar depicting multiplanar display of the uterus. All three 
ortogonal planes can be displayed using this technique. Endometrium thickness meassurment.  
 
 
Fig. 2. Endometrial volume calculation by using VOCAL software after three dimensional 
ultrasound . Determination of the subendometrial area volume by using the ,,shell ,, facility. 
In this case 5 mm has been chosen.  
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Fig. 3. The endometrial echo patterns  in the pregnant group (93.3% vs. 40.0%, 95% CI 25.5-
81.2%) on the day of FET and one week after (91.7% vs. 42.9%, 95% CI 18.5-79.1%) .No 
differences were observed in the dominant ovarian vasculature. 
 
 
Fig. 4. Vascularization of the subendometrial area by 3D –Power Doppler . 3D power doppler 
indexes VI,FI, and VFI refers to the shell area- subendometrium. Determination of the 
subendometrial area volume by using the ,,shell ,, facility. I n this case 5 mm has been chosen 
 
Ultrasound Imaging – Medical Applications 76
 
Fig. 1. Three dimensional multiplanar depicting multiplanar display of the uterus. All three 
ortogonal planes can be displayed using this technique. Endometrium thickness meassurment.  
 
 
Fig. 2. Endometrial volume calculation by using VOCAL software after three dimensional 
ultrasound . Determination of the subendometrial area volume by using the ,,shell ,, facility. 
In this case 5 mm has been chosen.  
The Role of 3D Ultrasound in Assessment of Endometrial  
Receptivity and Follicular Vascularity to Predict the Quality Oocyte 77 
 
Fig. 3. The endometrial echo patterns  in the pregnant group (93.3% vs. 40.0%, 95% CI 25.5-
81.2%) on the day of FET and one week after (91.7% vs. 42.9%, 95% CI 18.5-79.1%) .No 
differences were observed in the dominant ovarian vasculature. 
 
 
Fig. 4. Vascularization of the subendometrial area by 3D –Power Doppler . 3D power doppler 
indexes VI,FI, and VFI refers to the shell area- subendometrium. Determination of the 
subendometrial area volume by using the ,,shell ,, facility. I n this case 5 mm has been chosen 
 
Ultrasound Imaging – Medical Applications 78
2.3 Assessment of endometrial echogenicity 
In the recent literature there has been interest in the possible relationship between the 
degree of endometrial echogenicity an IVF-ET outcome and the cycles sorted into six groups 
according to the extent of the upward hyperechogenic transformation of the endometrium. 
In contrast to the similiraty in individual , control ovarian hyperstimulation /COH / and 
embryology data among groups, they observed a dramatic decrease in clinical and ongoing 





Fig. 5. The endometrial pattern ,which was assessed in the longitudinal section and 
described as triple –line or homoechogenic. 
The Role of 3D Ultrasound in Assessment of Endometrial  
Receptivity and Follicular Vascularity to Predict the Quality Oocyte 79 
echogenicity groups. Conversely, no relationship between endometrial thickness on the day 
of hCG administration and IVF-ET outcome was observed (Fanchin et al., 2001). This 
ultrasonographic aspect may be reflection of glandular straightness, reduced glandular 
secretion, and reduced stromal edema that characterize the proliferative endometrium, with 
a decreased number of interfaces to ultrasound. Since the echogenity of the secretory 
endometrium is usually higher than in the surrounding myometrium, we assessed the 
echogenity in these two areas subjectively and used software to provide the MG values. A 
strong correlation between these two methods was observed. Future studies will show 
whether this index has clinical value (Zackova et al., 2009). 
3. Color Doppler sonography for the the optimization of follicular vascularity 
The 2D color Doppler studies have show that perifolicular blood flow of individual follicles 
during IVF treatment correlates with oocyte recovery (Nargund et al., 1996) ,oocyte 
developmental potential (Van Blerkom et al., 1997), embryo quality (Nargund et al., 1996), 
(Chui et al., 1997 ) and pregnancy rate (Coulam et al.,1999). We analysed relationship between  
kind of stimulated protokol and cause of sterility to determine ovarian and dominant follicle 
blood flow characteristics using three dimensional power Doppler ultrasound , grading 
system of perifollicular vascularity (Chui et al, ,1997 ) and power doppler index PI and RI of 
dominant follicle artery in the prospective pilot study of 17 women in IVF/ICSI stimulation.  
Materials and methods. 17 the patients were stimulated in a long protocol (GnRh agonist-
Zoladex, Decapeptyl) on 22-th day of their period and subsequently with rekombinant FSH 
(puregon /gonal pen) 15 days after downregulation / no follicles more than 10 mm, 
endometrium thickness less than 5 mm and level of Estradiol /E2/ less than 50 pg/ml. We 
exluded the women, who didn ' t agree with the examination on the day of ovum pick up 
futher such as women , whose stimulation was stopped for the risk of OHSS, women with 
the operation of right or left ovary, women with ovarectomy , women with uterine 
malformation , women with FSH level more than 10 mIU/l in early follicular period or 
women with ovarian cysts. On the basis of male factor infertility exclusion we provided 
always ICSI Method. The 3D ultrasound examinations and power doppler sonography of 
the ovary and dominant follicle we provided on the day HCG (pregnyl) before ovum pick 
up. All the 3D ultrasound and PDA examinations were carried out by a single observer (T.Z) 
and all the patients were explored in a gynaecological position using Voluson Expert 760, 
Kretz, Zipf, Austria equipped with vaginal multifrequency ( from 3 to 9 mHz) volume 
transducer, which has a 146 ° field of view. The volume of the ovary and dominant follicle, 
vascularization index /VI/, flow index /FI/, vascularization flow index / VFI / , mean 
grayness , perifolicular vascularity and PI a RI of the dominant follicle was determined for 
each ovary separately. The dominant follicle is presented by maximal mean diameter (MD). 
Follicular volume (FV) was etermined for each follicle according to the sphere formula : FV 
(ml) = 4,1888 x (MD/2 (cm))3. The power dopler Windows was placed on the maximum 
longitudinal plane of both ovaries,including the whole ovarian surface. The following Doppler 
predetermined characteristics were applied in every patient (colour gain from -3 to -7 ,normal 
colour quality, wall motion filter,low 1, peak repetitive frequency PRF ,0.9 KHz). When an 
adequate power Doppler signal was achieved, we placed the 3D box to aquire the volume 
from the region of interest (ROI). The VOCAL imaging program was used tu calculate the 
ovarian volume and 3D power Dopler indices . Using the manual mode, the contour of the 
different ovarain slices was traced by taking 15° rotational steps by using the longitudinal 
plane as the work plane. 3D power Dopller indices were calculated using the histogram 
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facility. Vascularization Index (VI ) is the number of colour voxels in the volume studied, 
symbolizing in this way the number of vessels arriving to the organ, expressed as a 
percentage.The Flow Index (FI) is the metan colour value of the colour voxels,thus 
representing the average blood flow intensity, expressed as a whole number rating from 0 to 
100. VFI integrates both vascularization and blood flow (tisues perfusion). It si also expressed 
as a whole number rating from 0 to 100, and represents color value of grey and colour voxels 
in the studied ROI (Pairleitner et al., 1999). The Grading system (Chui, et al. 1997 ) was used to 
assess perifollicular vascularity. (a) shows 25% circumferential flow (Grade1); (b) 26–50% flow 
(Grade 2); (c) 51–75% flow (Grade 3) and (d)75% flow (Grade 4), where follicles of high grade 
follicular vascularity are associated with grade 3 and 4. The oocyte of the dominant follicle 
from both ovaries was fertilized by ICSI and observed his embryogeny. The embryos were 
classified into four morphological grades in accordance with our conventional criteria (Kondo 
et al., 1996) consisting of blastomere size and the amount of anucleate fragmentation 
(conventional method): grade 1 (g1), blastomere uniform in size and shape and little or no 
fragmentation; grade 2 (g2), blastomeres uneven in size and shape and/or fragmentation 
<10% of the embryonic surface; grade 3 (g3), fragmentation of 10–30% of the embryonic 
surface; and grade 4 (g4), fragments >30% of the embryonic surface. On the day of ovum pick 
up we have collected the samples of follicular fluid of dominanat follicle without of blood 
contamination. After the collecting of samples of follicular fluid of dominant follicle and serum 
we provided their centrifugate and stored at -40 C until their planned biochemical analysis 
after the completed collection of the samples at all intended 80 patients. 
Results .The IVF/ICSI cycle was evaluated in 17 women, among which 5 were pregnant 
(29.4 %) and 12 non-pregnant (70.6 %). The median age of the women was 32 (range 26-36). 
The causes of the infertility were male in 12 cases (70.6 %), tubal in 2 cases (11.8 %) and 
mixed in 3 cases (17.6 %). There were 11 cases (64.7 %) of primary and 6 cases (35.3 %) of 
secondary infertility.Statistical analysis of the data was performed with R programming 
language (http://cran.r-project.org), version 2.4.1. We have computed descriptive statistics 
and p-values of hypothesis tests for comparing the group of pregnant and non-pregnant 
patients. For continuous data the normality is not assumed because of small sample sizes 
and asymmetry of the data distribution. The following tables give the median and range 
(minimum and maximum) of each continuous variable together with the p-value of the two-
sample Wilcoxon test. For categorical data we list the tables of counts with percentages of 
cases. To compare the two groups, the p-value of Fisher’s exact test is computed (also for 
tables larger 2 by 2). Ultrasonography and Doppler angiography parameters measured on 
both ovaries are analyzed for each ovary separately.There is no significant difference 
between groups in the age of patients, type and causes of infertility and other general and 
clinical characteristics. In the group of pregnant women, there is a significantly larger 
number of grade 1 embryos on transfer day, a significantly larger flow index dx and there is 
a significant difference in the degree of morphological preimplantation quality of the 1. and 
2. transferred embryos and in the degree of perifollicular vascularity of the right follicle dx. 
Other variables yield a non-significant difference between the pregnant and non-pregnant 
group because of small sizes of the data samples; however the p-values are near the 5%-level 
for the vascularization index and vascularization flow index, for which the observed values 
have the tendency to be larger for pregnant women and a future research with a larger 
number of patients is intended to attain significant results. 
Implications. The follicular vascularity assesment with 3D ultrasonography and PDA of 
ovaries may represent a possible predictors of the the outcome of assisted conception 
therapy. Future research with a larger number of patients is intended to attain significant 
results ant to confirm these findings .  
The Role of 3D Ultrasound in Assessment of Endometrial  
Receptivity and Follicular Vascularity to Predict the Quality Oocyte 81 
 
Fig. 6. Assessment of the ovarian volume by the virtual organ computer-aided analysis 
(VOCAL). Using the manual mode, the contour of different ovarian slices was  traced by 
rotational steps every 15 ° taking the longitudinal plane as the work pattern. 
 
 
Fig. 7. Evaluation of the ovarian vascularity by three-dimensional power Doppler indices:  
vascualrization  index (VI), flow index (FI) and vascularization flow index (VFI).These 
indices were calculated using the histogram facility provided by the virtual organ computer 
– aided analysis (VOCAL) program. 
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Parametrs Pregnant (n=5) Non pregnant (n=12) P-value 
Age (years) 32 (26-34) 32 (29-36) 0.488 
Total dosage of FSH (IU) 2250 (1500-2825) 2250 (1 800-3 750) 0.560 
Days of FSH treatment 14 (10-15) 13 (10-19) 0.873 
Number of follicles > 16 mm 
on day of OPU 10 (6-28) 10 (5-17) 1.000 
Number of retrieved oocytes 6 (4-21) 7.5 (3-14) 0.792 
Number of fertilized oocytes 6 (3-16) 4.5 (3-10) 0.486 
Number of grade 1 embryos 
on transfer day 3 (2-4) 0 (0-2) 0.001 
Day of embryo transfer 3 (2-5) 3 (0-5) 0.914 
Type of infertility  0.600 
Primary 4 (36.3) 7 (63.6)  
Secondary 1 (16.7) 5 (83.3)  
Cause of infertility  0.547 
Male factor 4 (33.3) 8 (66.7)  
Tubal factor 1 (50.0) 1 (50.0)  
Mixed 0 (0.0) 3 (100.0)  
Number of transferred 
embryos  1.000 
1 0 (0.0) 1 (100.0)  




Table 1. General and clinical  parameters in relation to IVF/ICSI outcome 
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Degree of morphological  preimplantation 
quality of transferred embryos 1. 
  0.029 
1 5 (55.6) 4 (44.4)  
2 0 (0.0) 8 (100.0)  
3 0 0  
4 0 0  
Degree of morphological  preimplantation 
quality of transferred embryos 2. 
 0.020 
1 4 (80.0) 1 (20.0)  
2 1(14.3) 6 (85.7)  
3 0 (0.0) 4 (100.0)  
4 0 0  
Not obtained 0 (0.0) 1 (100.0)  
Grade of morphological reimplantationquality of 
selected oocytes from 3D measures dominant follicles dx 
  0.080 
1 2 (100.0) 0 (0.0)  
2 3 (33.3) 6 (66.7)  
3 0 (0.0) 4 (100.0)  
4 0 (0.0) 1 (100.0)  
Not obtained 0 (0.0) 1 (100.0)  
Grade of morphological preimplantation quality of 
selected oocytes from 3D measuresdominant follicles sin 
 0.755 
1 2 (66.7) 1 (33.3)  
2 1 (33.3) 2 (66.7)  
3 2 (28.6) 5 (71.4)  
4 0 0  
Not obtained 0 (0.0) 4 (100.0)  
 
Table 2. Embryological  parameters in relation to IVF/ICSI outcome  
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4 0 0  
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Not obtained 0 (0.0) 4 (100.0)  
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Parameters Pregnant(n=5) Nonpregnant (n=12) p-value 
Total ovarian volume OV 
(ml) dx  
43.96 (41.69-138.13)  42.55 (19.52-108.60)  0.279  
Total ovarian volume OV 
(ml) sin  
45.06 (43.86-116.96)  42.06 (11.32-102.38)  0.316  
Volume of the dominant 
follicle FV (ml) l.dx  
6.08 (5.28-6.43)  5.38 (2.36-7.05)  0.154  
Volume of the dominant 
follicle FV (ml) l.sin  
5.09 (4.08-5.65)  4.98 (3.26-9.63)  0.570  
Vascularization index VI 
l.dx  
12.47 (8.66-20.06)  8.22 (2.61-19.06)  0.066  
Vascularization index VI 
l.sin  
10.38 (5.02-25.43)  8.54 (6.20-11.72)  0.107  
Flow index FI l.dx  47.85 (42.78-52.25)  40.46 (32.31-57.66)  0.044  
Flow index FI l.sin  46.90 (35.23-48.90)  41.91 (28.83-51.47)  0.099  
Vascularization flow 
index VFI l.dx  
4.95 (2.85-8.46)  4.00 (0.90-10.05)  0.065  
Vascularization flow 
index VFI l.sin  
4.84 (2.30-10.05)  3.91 (2.82-4.62)  0.087  
Resistence index Doppler 
of the dominant follicle 
l.dx  
0.56 (0.55-0.62)  0.53 (0.42-0.67)  0.081  
Resistence index Doppler 
of the dominant follicle 
l.sin  
0.58 (0.50-0.62)  0.55 (0.38-0.71)  0.691  
Pulsatility index Doppler 
of the dominant follicle 
l.dx  
0.89 (0.83-1.00)  0.82 (0.65-1.24)  0.224  
 
 
Table 3. Three - dimensional ultrasonography ,  Power doppler angiography  parametrs   on 
the HCG day in relation  to IVF/ICSI outcome . Date are presented as mean +/- standart 
deviation. 
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Parameters Pregnant(n=5) Nonpregnant (n=12) p-value 
Degree of perifollicular vascularity of 
the dominant follicle l.dx  0.029 
1. 1 (11.1) 8 (88.9)  
2. 1 (20.0) 4 (80.0)  
3. 3 (100.0) 0 (0.0)  
Degree of perifollicular vascularity of 
the dominant follicle l.sin  0.093 
1. 1 (12.5) 7 (87.5)  
2. 2 (33.3) 4 (66.7)  
3. 2 (100.0) 0 (0.0)  
Table 4. Perifollicular vascularity grading score on the HCG day in relation  to IVF/ICSI 
outcome. Date are presented as mean +/- standart deviation. Grading system (Chui, et al. 
1997 ) used to assess perifollicular vascularity.  
 
 
Fig. 8. Dominant follicle volume calculation by using the VOCAL software after three-
dimensional ultrasound.  The  dominant follicle  is presented by maximal mean diameter  
(MD). Follicular volume (FV) was determined for each follicle according to the sphere 
formula : FV (ml)  = 4,1888 x ( MD/2 (cm))3. 
 
Ultrasound Imaging – Medical Applications 84
 
 
Parameters Pregnant(n=5) Nonpregnant (n=12) p-value 
Total ovarian volume OV 
(ml) dx  
43.96 (41.69-138.13)  42.55 (19.52-108.60)  0.279  
Total ovarian volume OV 
(ml) sin  
45.06 (43.86-116.96)  42.06 (11.32-102.38)  0.316  
Volume of the dominant 
follicle FV (ml) l.dx  
6.08 (5.28-6.43)  5.38 (2.36-7.05)  0.154  
Volume of the dominant 
follicle FV (ml) l.sin  
5.09 (4.08-5.65)  4.98 (3.26-9.63)  0.570  
Vascularization index VI 
l.dx  
12.47 (8.66-20.06)  8.22 (2.61-19.06)  0.066  
Vascularization index VI 
l.sin  
10.38 (5.02-25.43)  8.54 (6.20-11.72)  0.107  
Flow index FI l.dx  47.85 (42.78-52.25)  40.46 (32.31-57.66)  0.044  
Flow index FI l.sin  46.90 (35.23-48.90)  41.91 (28.83-51.47)  0.099  
Vascularization flow 
index VFI l.dx  
4.95 (2.85-8.46)  4.00 (0.90-10.05)  0.065  
Vascularization flow 
index VFI l.sin  
4.84 (2.30-10.05)  3.91 (2.82-4.62)  0.087  
Resistence index Doppler 
of the dominant follicle 
l.dx  
0.56 (0.55-0.62)  0.53 (0.42-0.67)  0.081  
Resistence index Doppler 
of the dominant follicle 
l.sin  
0.58 (0.50-0.62)  0.55 (0.38-0.71)  0.691  
Pulsatility index Doppler 
of the dominant follicle 
l.dx  
0.89 (0.83-1.00)  0.82 (0.65-1.24)  0.224  
 
 
Table 3. Three - dimensional ultrasonography ,  Power doppler angiography  parametrs   on 
the HCG day in relation  to IVF/ICSI outcome . Date are presented as mean +/- standart 
deviation. 
The Role of 3D Ultrasound in Assessment of Endometrial  
Receptivity and Follicular Vascularity to Predict the Quality Oocyte 85 
Parameters Pregnant(n=5) Nonpregnant (n=12) p-value 
Degree of perifollicular vascularity of 
the dominant follicle l.dx  0.029 
1. 1 (11.1) 8 (88.9)  
2. 1 (20.0) 4 (80.0)  
3. 3 (100.0) 0 (0.0)  
Degree of perifollicular vascularity of 
the dominant follicle l.sin  0.093 
1. 1 (12.5) 7 (87.5)  
2. 2 (33.3) 4 (66.7)  
3. 2 (100.0) 0 (0.0)  
Table 4. Perifollicular vascularity grading score on the HCG day in relation  to IVF/ICSI 
outcome. Date are presented as mean +/- standart deviation. Grading system (Chui, et al. 
1997 ) used to assess perifollicular vascularity.  
 
 
Fig. 8. Dominant follicle volume calculation by using the VOCAL software after three-
dimensional ultrasound.  The  dominant follicle  is presented by maximal mean diameter  
(MD). Follicular volume (FV) was determined for each follicle according to the sphere 
formula : FV (ml)  = 4,1888 x ( MD/2 (cm))3. 
 
Ultrasound Imaging – Medical Applications 86
4. Conclusions 
Developments in infertility treatment assisted reproduction methods are directed to transfer 
a single high quality embryo, while maintaining a high standard of treatment success. In 
this context, in recent years recede into the background, the standard ”stimulation protocols 
using higher doses of FSH, often with a higher number of oocytes. The importance of more 
and more become “soft stimulation protocols aimed at, although a smaller number of 
growing follicles, which are a source of high-quality oocytes. The Natural / Mild IVF 
managment / ISMAAR / requires greater understanding of medical physiology, follicular 
growth and endometrial receptivity, which can be investigated using high-quality 2D and 
3D ultrasound Dopler ultrasound and ultrasound, as evidenced by the results of our work. 
In this context, early identification of high-quality follicles might serve as one means of 
enabling a timely selection of oocytes and embryos with high developmental competence 
and the hope of a successful implantation. The follicular vascularity assessment with 3D 
ultrasonography and PDA of ovaries may represent a possible predictors of the the 
ooutcome of assisted conception therapy. Future research with a larger number of patients is 
intended to attain significant results and to confirm these findings . Definition of new 
applications of 3D ultrasound in the diagnosis of women enrolled in the program of assisted 
reproduction and the definition of predictive factors in the evaluation of the oocyte quality 
would have a significant contribution to our everyday clinical practice.  
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1. Introduction 
Atherosclerosis is a generalized process which begins early in childhood (first decade of 
life) and develops silently and more or less rapidly during adolescence and young 
adulthood (Stary et al., 1994). Recent investigation using whole body multislice computed 
tomography in 52 ancient Egyptians mummies (mean age 45.1 ± 9.2 years) from the 
Middle Kingdom to the Greco-Roman period, a time span of more than 2,000 years,  
Allam et al. (Allam et al., 2011) showed that  atherosclerosis (as in contemporary humans) 
was more evident and extensive with advancig age, and as common and devastating 
disease as at present time.  
Atherosclerotic cardiovascular (CV) disease, which includes coronary artery disease, stroke 
and peripheral arterial disease, is the most common cause of premature death in the 
industrialized world thereby constituting an immense public health problem. This disease 
was formerly considered an inevitable consequence of aging. The Framingham Heart Study, 
the most important and influential investigation in CV diseases which laid the foundation 
for preventive medicine and for CV disorders in particular (Greenberg, 2010), enrolled its 
first patient in 1948. In the following 40 years a large body of scientific evidence from the 
Framingham cohort and other major epidemiological studies definitely established that 
multiple CV risks were responsible of the growing CV disease burden, mainly in high-
income countries (Mendis 2010). The scientific Framingham Community gave foundation to 
the risk factor concept providing insights into their prevalence, incidence and prognostic 
value. Due to variation in prevalence of individual risk factors in different geographic 
regions specific approaches to CV disease prevention have been implemented in various 
countries. Accordingly, a WHO survey on CV risk factors in 2002 showed that more than 
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1. Introduction 
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Middle Kingdom to the Greco-Roman period, a time span of more than 2,000 years,  
Allam et al. (Allam et al., 2011) showed that  atherosclerosis (as in contemporary humans) 
was more evident and extensive with advancig age, and as common and devastating 
disease as at present time.  
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for preventive medicine and for CV disorders in particular (Greenberg, 2010), enrolled its 
first patient in 1948. In the following 40 years a large body of scientific evidence from the 
Framingham cohort and other major epidemiological studies definitely established that 
multiple CV risks were responsible of the growing CV disease burden, mainly in high-
income countries (Mendis 2010). The scientific Framingham Community gave foundation to 
the risk factor concept providing insights into their prevalence, incidence and prognostic 
value. Due to variation in prevalence of individual risk factors in different geographic 
regions specific approaches to CV disease prevention have been implemented in various 
countries. Accordingly, a WHO survey on CV risk factors in 2002 showed that more than 
three quarters of the global CV disease burden was attributable to the following 3: tobacco, 
blood pressure and cholesterol. And the INTERHART case-control study (Yusuf et al., 2004), 
involving 27,000 subjects from 52 countries representing all inhabited continents, provided 
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evidence that approximately 80% of the population attributable risk of acute myocardial 
infarction was predicted by smoking, lipids, hypertension, diabetes and obesity.  
As demonstrated in the Karelia Community (Puska, 2010), despite recent attempts to include 
new CV events predictors, it appears that targeting the already known major risk factors, 
identified 50 years ago in the Framingham community, remains a priority for the present 
time and the future. In addition to tobacco the most important modifiable risk factors are 
hypertension and hypercholesterolemia: due to distinct pathways of atherosclerosis in 
intracranial versus extracranial disease in patients with hypertension this risk factor has 
been thought to have major responsibility in the pathogenesis of cerebrovascular diseses  
whereas the second in coronary artery disese (Napoli et al., 2006). Increasing evidence 
suggests that atherosclerosis is a diffuse disease with first clinical manifestation in one 
territory often followed by symptoms coming from other vascular districts. Accordingly, a 
very high burden of preclinical (silent) coronary artery disease has been recently 
documented in patients with cerebral infarction (Amarenco, et al., 2010) In recent years, 
despite the wishful statement by the nobel prize winners Brown and Gldstein “heart attacks: 
gone with the century? (Brown & Godstein, 1996) CV diseases still remain the undisputed 
number one killer in most countries and will remain in the next future with an increasing 
contribution from eastern countries. The well known different gender susceptibility to 
advanced atherosclerotic lesions observed some 20 years before the occurence of clinical 
events, supports the pediatrician’s view that early preventive measures in young male 
people can significantly postpone the onset of clinical manifestations (Mc–Gill & McMahan, 
2006). Some optimism comes from the percentage decrease  (44% to 76%) in death due to 
coronary artery disease (CAD) during  1980 through 2000 attributed to risk-factor changes in 
10 studies in different populations across the globe (Ford et al., 2007). According to Jeremia 
Stamler (Stamler et al., 2006) an important goal is to increase the population at low risk until 
it will be the overwhelming majority. He also mentioned the importance of improving life 
style from the time of preconception to birth and through school age to young adult: a 
statement in line with studies pioneered by DJP Barker (Barker 1992) on the association 
between measures of fetal growth and increased risk of CV diseses later in life. Somehow in 
line with these observations, it has been reported that maternal hypercholesterolemia is 
associated with enhanced lipid deposition in human fetal arteries (Napoli et al., 2006).   
As far as the lipid story is concerned, after early pathological investigations demonstrating 
that younger hypercholesterolemic people manifest atheroscerotic plaques in their first or 
second decade of life, it became clear that serum cholesterol was responsible of the intimal 
atherosclerotic plaque formation laiding the foundation of the science of atherosclerosis as a 
major research target for the present time and years to come. It has been consistently shown 
in studies that on average each 1% raise in cholesterolemia is associated with an 
approximate 3% increase in risk for CV events, and that on the contrary, the HDL 
cholesterol level is inversely associated with CV diseases in both sexes at all ages ((Barker 
1992). At present a great number of experimental, genetic, and epidemiologic papers 
support the notion that LDL cholesterol is the most important risk factor for atherosclerosis 
and responsible for clinical events both in men and women (Freeman et al., 2006; Napoli et 
al.,2006). Moreover, as a relevant finding from the ARIC study it has been shown that a 
lifelong history of reduced LDL cholesterol levels (by a nonsense mutations in PCSK9)  over 
a 15-year period was associated with 47% reduction of  coronary artery disease risk even in 
presence of multiple risk factors (Cohen et al., 2006), a larger result compared to that 
predicted from other LDL-lowering trials. These findings strongly support the view that 
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benefits from cholesterol lowering treatments with statins are expected in relation with the 
effective duration of treatment along years.  According to William Robert (Roberts, 2002) 
substantial evidence exists that keeping serum total cholesterol <150 mg/dl, LDL-
cholesterol <100 mg/dl, and HDL cholesterol at least >20 mg/dl, the chances of forming 
atherosclerotic plaques are slim. Statins have been available since late-eighties and yet, more 
than 20 years later, most patients who have had atherosclerotic events or who are at high 
risk for atherosclerotic events unfortunately are not on statin therapy despite its proven 
benefit in decreasing first and repeated atherosclerotic events.   
2. The atherosclerotic plaque 
Atherosclerotic plaques develop over many years. Initiating event is focal subendothelial 
retention of apoB lipoproteins on extracellular matrix molecules particularly 
proteoglycans (Tabas et al., 2007). These retained molecules become aggregated and 
oxidized and induce a series of biological modifications producing a maladaptive 
inflammatory response by which monocytes enter the subendothelium and become 
cholesterol enriched foam cells after incorporating the modified lipoproteins. The fibrous 
cap of such a plaque may become thin and rupture as a result of the depletion of matrix 
components through the activation of proteolytic enzymes such as matrix-degrading 
proteinases. It has been shown that lipoprotein retention is amplified and retention 
continues to accelerate once lesions become established. This implies that lesions are more 
dangerous when formed early in life and suggests the great gain young subjects can have 
if don’t leave untreated their high blood cholesterol level and other risk factors. 
Endothelial dysfunction is the first step in atherosclerosis and the combined association of 
a decreased NO production with an increase of NO inactivation appears to be a marker of 
this condition. Major responsibility in the formation and progression of atherosclerotic is 
attributed to reduced adiponectin plasma levels. Adiponectin is thought to be also 
involved in the regulating of necrotic core development (see 3.4 section of this chapter). 
Of note, arterial wall reverse (outward) remodelling is usually associated with vulnerable 
plaques with higher risk of rupture. Their vulnerability is defined as a relatively large 
necrotic lipid core, intraplaque haemorrhage, abundant vasa vasorum and/or 
calcification. They are also covered by a thin, inflamed, fibrous cap that may fissure 
(Naghavi et al., 2003; Virmani et al., 2005).  Collagenous fibrous cap represents a form of 
scar-like response promoted by smooth muscle cells migration into the intima. Of note, 
plaque progression (Fig.1) is associated with dying macrophages giving rise to areas of 
necrosis with cholesterol crystals, extracellular debris, proteases and prothrombotic 
agents (Tabas et al., 2007). These advanced plaques (Fig. 2) are characterized by fibrous 
cap thinning, plaque erosion and rupture as a result of the depletion of matrix 
components through the activation of proteolytic enzymes such as matrix-degrading 
proteinases (MMPs) that are highly concentrated in atherosclerotic plaques by 
inflammatory cells (macrophages, foam cells), smooth muscle cells and endothelial cells, 
ultimately being responsible of clinical thrombotic events such as acute myocardial 
infarction or stroke. A number of research lines have been identified and a therapeutic 
window of opportunity appears to exist to selectively block proretentive subendothelial 
matrix-lipoprotein interaction with a potential for regression of advanced plaques  
Great advancement of the knowledge in coronary plaque structure has been obtained in 
recent years by intravascular imaging modalities which can characterize the plaque 
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according to the presence of thin fibrous cap and other findings such as active inflammation, 
lipid core disruption and severe stenosis, with high sensitivity specificity and predictive 
accuracy (Valgimigli et al., 2006; Hong et al., 2009). Much interest has been recently focused 
on the role of calcium which is incorporated into the plaque with an active process 
resembling bone formation preceded by apoptosis of smooth muscle cells and generation of 
apoptotic bodies acting as calcification sites with further steps ultimately leading to 




Fig. 1. Plaque formation and progression in the carotid artery. B-mode ultrasound imaging 
of the left carotid artery in a long-axis during a 10 years period follow-up (1998-2008)  in a 
healthy man from 45 to 55 years of age. Of note, this subject was normotensive and had 
surprisingly normal blood lipids level (total chol. 165 mg/dl, HDL chol. 71 mg/dl and 
tryglicerides 64 mg/dl). In 1998, at age 45 y.o., a small plaque was present (maximum short 
axis diameter: 1.3 mm). In the following ten years a progressive increase in plaque 
dimension occurred associated with a mild  expansive arterial wall remodelling [Glagov 
phenomenon (Glagov et al., 1987)] in the far field in the year 2003, with a marked step-up 
increase of the outward arterial remodelling in 2008. The large echo-lucent (black) area 
within the plaque in 2008 is associated with a thin fibrous cap indicating a high risk of 
plaque rupture in this subject. 
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Fig. 2. Vulnerable plaque of the carotid artery bifurcation referring to type VI lesion of the 
AHA plaque nomenclature. The asterisk indicates the area of the lipid necrotic core covered 
by a very thin fibrous cap (small arrow) with high risk of rupture. The plaque is associated 
with a marked outward vessel remodelling keeping intact the lumen of the artery.  
Moreover, a recent non invasive ultrasound study of femoral arteries in animals opened a 
door for clinical application of quantification of adventitial vasa vasorum proliferation, a 
feature of plaque progression (Moguillansky et al., 2011). But evidence exists that despite 
core in vivo imaging strategies are promising, their invasive nature and limited spatial 
resolution, as well as ionizing radiation and poor penetration, limit their possible 
application in human beings. A future however most exists for hybrid technologies and 
advanced reconstruction and post-processing techniques. 
Summarizing, atherosclerosis has top responsibility in total and CV mortality, either 
industrialized and in the developing countries, it is a cholesterol dependent disease, 
progressive in nature and characterized by a very long preclinical period. Total cholesterol 
plasma level > 130 mg/dl is the necessary causing factor. This process starts in the early 
decade of life and is accelerated by other major risk factors like hypertension, smoking, 
diabetes, obesity and male gender. It can be easily identified by B-Mode ultrasound of 
carotid and femoral arteries during the asymptomatic (preclinical) period long before 
clinical manifestations do occur, opening a window for early diagnosis and lipid-lowering 
interventions.  
2.1 Plaque regression and stabilization 
An ischemic event is usually associated with an advanced atherosclerotic lesion. Early 
studies in animals showed that removal of atherogenic factors reduced the prevalence of 
atherosclerotic lesions. As far as the regression studies of atherosclerosis in human beings is 
concerned, we must first acknowledge those studies pioneered at the University of 
California in 1978 by David Blankenhorn and his group (Blankenhorn et al., 1978; 
Blankenohorn 1978). These authors used advanced computer techniques for image 
processing derived from space-fly technology with a digital array depicting up to 256 
shades of gray. This group first demonstrated the regression by treatment of atherosclerotic 
lesions with serial femoral artery angiograms (two exams at 13 months interval) performed 
in 25 hyperlipidemic subjects. During the following 15 years nine arteriographic human 
studies have been conducted by different groups with a total of 2.101 patients and a mean 
follow-up of 3,3 (1 to 10) years. These studies have been reviewed by Brown et al. (Brown et 
al., 1993). Despite several diversities among these studies the analysis showed a benefit from 
treatment: whether by diet, diet plus life style changes, by hypolipidemic drugs niacin and 
lovastatin, or plus ileal by-pass associated with resins (cholestipol or cholestiramine). The 
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mean numbers of angiographic outcomes were the following: 53% progression and 8% 
regression in the control group, versus 26% progression and 26% regression in the treated 
groups. The authors concluded that this analysis has confirmed the hypothesis that lipid 
lowering therapy selectively depletes the atherosclerotic plaques lipid content and prevents 
plaque disruption and the associated clinical events. For what the plaque instability is 
concerned many factors concur to the phenomenon. The mechanical strength of the cap 
appears to be one of these and depends on the amount and structure of collagen and other 
tissue protein determinants of plaque rupture.  
Mechanisms by which lipid lowering may stabilize vulnerable plaques in humans have been 
extensively investigated in recent years. Specific cellular and molecular alterations 
consequent to lipid lowering have been identified: matrix metalloproteinase (MMP) activity 
reduction with associated increase of collagen content in plaques appears to have major 
importance. Smooth muscle cells have a central role in the formation and stabilisation of the 
fibrous cap because they produce connective tissue matrix proteins. It has been suggested 
that the combination of lipid lowering and antioxidant agents has a rationale for preserving 
fibrous cap stabilization (Davies, 1998). On this line it has been shown (Aikawa et al., 1998; 
Crisby et al., 2001) that pravastatin not only decreases lipid content, oxydized LDL and 
inflammation, but also MMPs-2 and cell death, whereas it increases collagen content 
providing the first strong evidence of plaque stabilizing effect by statins in humans.   
In 2001 Corti et al. (Corti et al., 2001) using serial black-blood MRI of the aorta and carotid 
arteries at baseline, 6 and 12 months after lipid-lowering therapy with simvastatin in 
hypercholesterolemic patients with aortic and/or carotid atherosclerotic plaques, 
demonstrated that persistent reduction in total and LDL cholesterol levels was associated 
with a significant inverse remodeling and lumen preservation of both aorta and carotid 
arteries at 12 months. In the REVERSAL study, published in 2004 by Nissen et al. (Nissen et 
al., 2005) intravascular ultrasound have been used in 502 patients divided into equal sized 
groups receiving either pravastatin 40 mg or atorvastatin 80 mg daily dose for 18 months: a 
complete halting of coronary disease progression was observed in the atorvastatin-treated 
patients but a continued disease progression occurred in the pravastatin-treated group, 
thereby suggesting that a very low levels of LDL cholesterol are needed to arrest and 
stabilize the ongoing atherosclerotic process and that 40 mg pravastatin is inadequate to this 
end. A step up progression of the results from lipid reducing drugs has been demonstrated 
by Corti et al. (Corti et al., 2005) in a further study in which a significant regression of 
atherosclerotic plaques has been obtained by effective and protracted lipid-lowering 
therapy: moreover and of major importance, the study suggested that the degree of LDL-
cholesterol reduction rather than the statin dose was associated with plaque regression. 
Differently from previous intravascular studies in which statins administration was 
accompanied only by slowing or halting of the atherosclerotic process, Nissen et al. (Nissen 
et al., 2006) first demonstrated in 2006 a significant regression of coronary atherosclerosis 
with serial intravascular ultrasound examinations in the ASTEROID trial: the study was 
conducted during 24 months period in 349 patients submitted to high-intensity statin 
therapy with rosuvastatin 40 mg. Of interest, a 10-12 months period appears to be the 
appropriate time interval for initial appreciation of plaque regression in carotid and femoral 
arteries during statin treatment also in our experience in the last ten years period (Rusconi 
C, 2008; Rusconi et al., 2011).  Thus, evidence exists allowing us to conclude that with 
appropriate statin use plaque regression and stabilization do occur. The phenomenon can be 
assessed non-invasively in patients using ultrasound imaging of carotid and femoral arteries 
and is further examined and described in details in the last part of this chapter.  
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3. The 4S trial and the statins story  
As far as the story of secondary CV events prevention is concerned, it is worthy to mention 
the pioneering Scandinavian Simvastatin Survival Study (4S) trial (The Lancet, 1994) and its 
promoter Prof. Terjie Pedersen who opened the door to evidence based secondary CAD 
prevention by statin use. In this study it has been shown for the first time that simvastatin 
reduced mortality in patients with a high cardiovascular risk. Many large outcome trials of 
statins have been performed during the following years confirming the results of the 4S trial. 
Further recent confirmation that statin use continues to be useful comes from a double-blind 
randomised trial (SEARCH Study, 2007)  comparing 80 versus 20 mg simvastatin 
administration in 12,064 men and women 18–80 years old with a history of myocardial 
infarction. In this study the higher simvastatin dosage has reduced from 25,7% to 24,5% 
(with 6% proportional reduction) the major vascular events. Consistent with previous trials, 
this result has been obtained by an average 0·35 mmol/L greater reduction in LDL 
cholesterol. In this study the risk of statin-related myopathy was low with the 20–40 mg 
simvastatin dosage (about one per 10,000 patients per year) but increased about ten times (to 
about one per 1000 patients per year) with 80 mg simvastatin daily. Of importance, the 
excess risk mainly occurred during the first year and has been largely confined to those 
people carrying SLCO1B1 genetic variants which can be otherwise detected before starting 
treatment and may be useful for tailoring the statin dose in the first year of treatment, 
especially when certain other drugs are simultaneously used (The Search Collaborative 
Group, 2008). In this study clear evidence has come out that lowering LDL cholesterol 
concentrations lowers the risk of major vascular events and that intensive LDL cholesterol 
lowering reduces the risk even more. Based on these results the authors suggested that “for 
patients deemed to be at sufficient risk of major cardiovascular events a more appropriate 
strategy - by contrast with current guidance - could be to consider regimens which involve 
newer, more potent, statins (80 mg atorvastatin or 20–40 mg rosuvastatin daily) or the 
combination of standard doses of generic statins (40 mg simvastatin daily) with other agents 
that can lower LDL cholesterol substantially, without producing such increases in the risk of 
myopathy”. On the subject of the recent statins introduction in the armamentarium of 
cardiovascular therapy Scott Grundy (Grundy, 2004) wrote the following statement: 
“lowering low-density lipoproteins by statin therapy to reduce the risk for major clinical 
events in patients with clinical atherosclerotic CV disease represents a therapeutic triumph 
of modern medicine”. After a seven years period from this statement a surprising sequence 
of successes has so far characterized the statins story, also extending the positive results to 
apparently healthy people with preclinical atherosclerosis. According to the extraordinary 
evidence on the issue and in agreement with the SHAPE Group strategy in USA-Texas State, 
(Naghavi, M., Libby, P., & Falk, E. 2003) we think that the time has come to go by far beyond 
such evidence by applying effective preventive measures also to the great group of 
individuals with preclinical atherosclerosis. 
There are now available multiple noninvasive imaging modalities that can identify 
subclinical atherosclerosis in different vascular beds. They include ultrasonography, 
coronary CCS assessment by CT, noninvasive CT angiography and MRI. All these methods 
have advantages and draw backs, but only CCS and ultrasonography have been mostly 
used. The CCS has provided powerful prognostic information in both sexes of multiple 
ethnic populations and a systematic review of both symptomatic and asymptomatic 
populations led investigators to conclude that who have a negative CCS are highly unlikely 
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mean numbers of angiographic outcomes were the following: 53% progression and 8% 
regression in the control group, versus 26% progression and 26% regression in the treated 
groups. The authors concluded that this analysis has confirmed the hypothesis that lipid 
lowering therapy selectively depletes the atherosclerotic plaques lipid content and prevents 
plaque disruption and the associated clinical events. For what the plaque instability is 
concerned many factors concur to the phenomenon. The mechanical strength of the cap 
appears to be one of these and depends on the amount and structure of collagen and other 
tissue protein determinants of plaque rupture.  
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therapy with rosuvastatin 40 mg. Of interest, a 10-12 months period appears to be the 
appropriate time interval for initial appreciation of plaque regression in carotid and femoral 
arteries during statin treatment also in our experience in the last ten years period (Rusconi 
C, 2008; Rusconi et al., 2011).  Thus, evidence exists allowing us to conclude that with 
appropriate statin use plaque regression and stabilization do occur. The phenomenon can be 
assessed non-invasively in patients using ultrasound imaging of carotid and femoral arteries 
and is further examined and described in details in the last part of this chapter.  
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to have CAD (Sewer et al. 2009). But discordant results have been also reported.  In our 
view, due to the associated radiation exposure and the need of repeated examination in the 
course of years also to establish the right moment for an interventional procedure, the 
coronary CCS should be used to this end only after careful evaluation of risk/benefit ratio. 
The issue will be later thoroughly treated in this chapter.  
3.1 Statins-induced event reduction in primary prevention setting 
Patients with established CHD or other clinical manifestation of atherosclerosis, or diabetes, 
have by definition a substantial risk for future cardiovascular events and premature death. 
These people should have intensive lipid-lowering therapy because the benefit from these 
drugs  is estimated to largely overweight the risk associated with such a treatment, even if 
low baseline LDL concentration is present (Cheung & Lam, 2010). On the other side, 
according to the results of several studies statin treatment appears appropriate in primary 
prevention setting only in presence of specific risk factors.  
The first clinical trial to study the effect of statins in primary prevention setting in patients 
with a relatively low risk was the WOSCOPS trial (Shepherd et al., 1995) performed in 6.595 
hypercholesterolemic patients using 40 mg pravastatin, obtaining a 32% risk reduction in 
major CV events during a 4.9 years period of follow-up. The following AFCAPS trial 
(Downs et al., 2001) studied the effects of lovastatin in healthy men and women and was 
associated with 39% reduction in major coronary events definitely confirming the benefits of 
statin treatment in healthy individuals. The results of the subsequent PROSPER trial 
(Shepherd et al., 2002) in 1,585 subjects taking pravastatin raised the question of the potential 
cancers risk and the problem of side effects with statins. The concern has been subsequently 
negated by the following studies: ASCOT (Sever et al., 2003)  in 5,168 hypertensive patients, 
HPS (Heart Protection Study Collaborative Group, 2002) in 20,536 patients, CARDS  (Colhoun 
et al. 2004.) in 1.428 diabetic patients, ASPEN (Knoop et al., 2006) in 959 diabetic patients. All 
the aforementioned studies have demonstrated mostly positive results on the incidence of 
coronary and cerebrovascular disease without increasing cancer risk.  
Recently, in primary prevention setting the MEGA trial (Nakamura et al., 2006) in 3.966 
hypercholesterolemic Japanese women during a mean follow-up of 5.3 years, randomly 
assigned to diet or diet plus 10-20 mg pravastatin, it has been shown that pravastatin 
reduced coronary events by 23% without any difference in the incidence of cancer or other 
adverse events between the two groups, suggesting that treatment with a low dose of 
pravastatin reduces the risk of coronary heart disease in Japan by much the same amount as 
higher doses have shown in Europe and the USA. In the year 2004 a meta-analysis (Grundy 
et al., 2004) from the National Cholesterol Education Program Adult Treatment Panel III 
Guidelines, including 26 randomized trial, 5 of them planned more vs less statins and 21 
planned statins vs control (also including the eight studies just mentioned in previous lines) 
with a total of 170.000 participants, the authors conclude that further reductions in LDL-
cholesterol safely produce definite further reductions in the incidence of heart attack, 
revascularisation and ischemic stroke, reducing the annual rate of these major vascular 
events by just over a fifth with each 1.0 mmol/L of LDL-cholesterol reduction. Furthermore, 
no evidence of any threshold within the cholesterol range studied was found suggesting 
that by 2-3 mmol/L plasma lowering of LDL-cholesterol would reduce risk by about 40-50% 
respectively. Of importance, further reduction of LDL-cholesterol did not produce any 
adverse effects even in those subjects with baseline LDL- cholesterol lower than 2.0 
mmol/L. A meta-analyses of more versus less intensive therapy, and of statins versus 
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control, did not discovered any adverse effects on cancer incidence (CTT Trialists, 2005). A 
number of other important conclusions for clinical practice have been drawn in this meta-
analysis: 1) the primary goal for patients at high CV risk should be to achieve the largest 
LDL-cholesterol reduction possible, without materially increasing myopathy risk, 2) 
lowering of LDL-cholesterol further below the limit established by NECP in 2004  (Grundy et 
al., 2004)  of 70 mg/dL (1.8 mmol/L) to achieve additional benefits, without an increased 
risk of cancer or non-vascular mortality, 3) to achieve these benefits, with newer more 
potent statins such as 80 mg atorvastatin or 20 mg rosuvastatin daily, 4) to use  combination 
of standard doses of generic statins  (40 mg simvastatin or pravastatin daily) with other 
LDL-cholesterol lowering therapies. 
In primary prevention setting (asymptomatic and apparently healthy subjects) statins  
are used in presence of risk factors and hypercholesterolemia in particular. Prototypic 
condition in which aggressive LDL-cholesterol reduction is mandatory is familial 
hypercholesterolemia. General agreement exists that in these patients should be used the 
highest tolerated statin dosage. In a study on this subset of patients it has been shown that 
atorvastatin 80 mg treatment was accompanied by regression of carotid intima media 
thickness whereas conventional LDL-cholesterol lowering was not (Smilde et al., 2001).  
Similarly, the great number of apparently healthy subjects with documented atherosclerosis, 
either by 2D-echo of carotid/femoral arteries or by CT scan of coronary calcium, in addition 
to life style modifications and other risk factors control, statin treatment appears appropriate 
according to the severity of the atherosclerotic process and the number and weight of risk 
factors. 
Of note, for what the dietary alcohol is concerned, it has been shown that comparing alcohol 
consumers and abstainers for a 3 years period follow-up after femoral or carotid artery 
surgery, alcohol consumers had less cardiovascular event rate as well as more stable plaque 
cores and less macrophage infiltration (Gisbertz et al., 2011) confirming that mild-to 
moderate alcohol consumption may help to reduce atherosclerosis progression.  
3.2 HDL-cholesterol and statins  
Clinical, experimental and epidemiological evidence consistently demonstrated the inverse 
association and causal relationship between low HDL levels and the risk of coronary artery 
disease (Gordon & Rifkind, 1989). Statin treatment of cardiovascular patients reduces clinical 
events by 25 to 45%. High-density lipoprotein (HDL) has been proposed as a therapeutic target 
to further reduce this residual cardiovascular risk. The primary role of HDL and reverse 
cholesterol transport in the reduction of CHD risk is supported by a considerable amount of 
experimental data. The mechanism by which HDL can mediate protection from atherosclerosis 
is complex and multifactorial and evolving concepts of the role of HDL in protection from 
atherosclerosis have been recently pointed out (Farmer &  Liao, 2011).   
The HDL particles exert a strong antiatherosclerotic action through several mechanisms. 
These include a facilitating cholesterol efflux from cholesterol-loaded foam cells, an 
antiinflammatory action, a positive effect on nitric oxide synthesis, serving as a plasma 
transport lipoprotein for biologically important proteins and as an antithrombotic agent by 
improving thrombolytic balance. In addition to their beneficial effects on the coagulation 
system the HDL molecules  have a favorable complex interaction with the protein C and 
protein S system and have a significant natural antioxidant effect which improves 
endothelial function and inhibits the oxidative step required for LDL uptake by the 
macrophage. These properties of HDL have been demonstrated to decreased apoptosis and 
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course of years also to establish the right moment for an interventional procedure, the 
coronary CCS should be used to this end only after careful evaluation of risk/benefit ratio. 
The issue will be later thoroughly treated in this chapter.  
3.1 Statins-induced event reduction in primary prevention setting 
Patients with established CHD or other clinical manifestation of atherosclerosis, or diabetes, 
have by definition a substantial risk for future cardiovascular events and premature death. 
These people should have intensive lipid-lowering therapy because the benefit from these 
drugs  is estimated to largely overweight the risk associated with such a treatment, even if 
low baseline LDL concentration is present (Cheung & Lam, 2010). On the other side, 
according to the results of several studies statin treatment appears appropriate in primary 
prevention setting only in presence of specific risk factors.  
The first clinical trial to study the effect of statins in primary prevention setting in patients 
with a relatively low risk was the WOSCOPS trial (Shepherd et al., 1995) performed in 6.595 
hypercholesterolemic patients using 40 mg pravastatin, obtaining a 32% risk reduction in 
major CV events during a 4.9 years period of follow-up. The following AFCAPS trial 
(Downs et al., 2001) studied the effects of lovastatin in healthy men and women and was 
associated with 39% reduction in major coronary events definitely confirming the benefits of 
statin treatment in healthy individuals. The results of the subsequent PROSPER trial 
(Shepherd et al., 2002) in 1,585 subjects taking pravastatin raised the question of the potential 
cancers risk and the problem of side effects with statins. The concern has been subsequently 
negated by the following studies: ASCOT (Sever et al., 2003)  in 5,168 hypertensive patients, 
HPS (Heart Protection Study Collaborative Group, 2002) in 20,536 patients, CARDS  (Colhoun 
et al. 2004.) in 1.428 diabetic patients, ASPEN (Knoop et al., 2006) in 959 diabetic patients. All 
the aforementioned studies have demonstrated mostly positive results on the incidence of 
coronary and cerebrovascular disease without increasing cancer risk.  
Recently, in primary prevention setting the MEGA trial (Nakamura et al., 2006) in 3.966 
hypercholesterolemic Japanese women during a mean follow-up of 5.3 years, randomly 
assigned to diet or diet plus 10-20 mg pravastatin, it has been shown that pravastatin 
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with a total of 170.000 participants, the authors conclude that further reductions in LDL-
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revascularisation and ischemic stroke, reducing the annual rate of these major vascular 
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promote endothelial repair. Clinical trials with new HDL-raising drugs are currently under 
way to provide definitive evidence that increasing HDL will reduce cardiovascular events 
(Brewer, 2011). 
Low HDL levels are present in about 10% of the general population and represent the most 
frequent form of dyslipidemia in patients with CAD. Reduced HDL concentrations seem to 
be unable to eliminate efficiently the cholesterol excess at vascular wall level, contributing to 
the onset of the inflammatory response that typically occurs in the pathogenesis of 
atherosclerosis from its earliest stages. In keeping with this evidence the results of numerous 
studies quite convincingly suggest that HDL is capable of exerting anti-inflammatory 
activity either directly or by modulating the expression of a number of acute phase 
reactants. Endothelial repair and reduced apoptosis are other mechanism by which HDLs 
preserve vascular function (Kera et al., 2011).   
In a recent careful examination of 20 randomized control trials (completed in the period 
from 1991 to 2009) in which statins have been used, for the first time clear evidence emerged 
that despite statin treatment a low HDL-cholesterol plasma level remains an independent 
predictor of higher cardiac events (Jafri et al., 2010) A post-hoc analysis of one of these 
studies, the TNT trial (Waters et al., 2004),  showed that low levels of HDL-cholesterol was 
predictive of high rate of major CV events even at very low level of LDL-cholesterol thus 
suggesting that low levels of HDL and high levels of LDL cholesterol are indipendently 
important predictors of cardiovascular disease. Similarly, in another meta-analysis of 23 
trials of various lipid-modifying drugs the sum of LDL-cholesterol percentage reduction 
and the HDL-cholesterol increase better predicted the benefit than the individual 
lipoprotein changes: it has been calculated that each 0.26 mmol/L (10 mg/dL) decrease in 
HDL-cholesterol level was associated with 7 additional myocardial infarction and 4 
additional CV events/1000 person-years (Brown et al., 2004). It has been also underlined 
that despite the aforementioned undisputable evidence of the benefit associated with higher 
HDL-lipoprotein plasma levels, certain drugs (fibrates) do not appear to be associated with 
clear benefit (Joy et al., 2008).  
In a recent and important study Kera et al. (Kera et al. 2011), measured the cholesterol efflux 
capacity from macrophages (a metric of HDL function) in 203 healthy volunteers who 
underwent carotid artery IMT assessment and in 442 angiographycally confirmed coronary 
patients, as well as in 351 patients without angiographic confirmed disease: in this study the 
authors demonstrated the followings: 1) HDL-cholesterol levels and apolipoprotein A-1 (the 
major protein component of HDL) were significant determinants of cholesterol efflux 
capacity accounting for less than 40% of the observed variation, 2) the efflux capacity was 
inversely related to IMT and was a strong inverse predictor of coronary artery disease 
status. The authors concluded that this capacity “is not explained simply by circulating 
levels of HDL-cholesterol or apoliprotein A-I and is independently related to both the 
presence and extent of atherosclerosis”.  
Therapeutic options for raising HDL-cholesterol plasma levels still appear inconsistent 
either in experimental or in preclinical setting and, up to now, in clinical studies the 
cholesterol efflux capacity has not been enhanced in statins treated patients. Due to inability 
of statins to further reduce the risk associated with low HDL-cholesterol, a treatment has 
been suggested (Cziraky et al., 2008) to promote optimal lipid values in several at risk 
patients-populations based on the association of a statin with extended-release niacin, the 
most effective agent for raising HDL-cholesterol levels. This approach appears most justified 
in type 2 diabetes which is characterized by two to three times higher prevalence of 
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hypertrigliceridemia usually associated with decreased HDL-cholesterol levels and 
increased small dense LDL-cholesterol particles, forming the powerful risk factor of the lipid 
triad (Temelkova- Kurktschiev & Hanefeld, 2004). As far as the antioxidant  potential of 
HDL particles is concerned it has been shown that distribution of HDL subpopulations 
according to their particle mean size has important implication for their antioxidant 
potential and that HDL3 particles  are more resistant to oxidation (Shuhei, 2010).  
3.3 Inflammation, C-reactive protein and lipoprotein (a) 
Inflammation and inflammatory pathways appear to have a fundamental role in the 
pathogenesis of atherosclerosis and coronary artery disease in particular (Hansson, 2005). 
Accelerated atherosclerosis has been described in patients with chronic inflammatory 
diseases such as rheumatoid arthritis, psoriasis and systemic lupus erythematosus. High 
sensitivity C-reactive protein (hsCRP), an acute phase reactant produced by the liver is the 
most studied, although nonspecific, marker of inflammation. In 1997 Ridker et al. (Ridker et 
al., 1997) gave first demonstration of hsCRP ability to predict future myocardial infarction 
and stroke in apparently healthy asymptomatic subjects, and several papers have been 
published in recent years on the subject supporting Ridker’s conclusions that hsCRP is a 
strong predictor of future major cardiovascular events. Moreover, evidence +has been 
published that the magnitude of this effect is similar to that of cholesterol and blood 
pressure and that also people with elevated hsCRP levels but without hyperlipidemia might 
benefit from statin treatment (Ridker et al., 2008).  
However, in a recent report of the Heart Protection Study (HPS Collaborative Group, 2002) 
with 20.536 high risk patients randomly assigned to simvastatin 40 mg versus placebo for 5 
years, it has been observed a 29% reduction of major vascular events without any significant 
difference between the four subgroup (defined by the combination of low or high baseline 
LDL-cholesterol and CRP)  with clear evidence of benefits mainly in those with both low 
LDL-cholesterol and low CRP. These findings suggested that LDL-cholesterol reduction is 
the necessary condition to reduce the risk of cardiovascular events, independently of CRP 
changes. According to the authors, this conclusion appears to be mainly supported by the 
finding that LDL-cholesterol reduction by simvastatin reduced the event risk to a similar 
extent irrespective of baseline CRP levels.  At present, it appears uncertain whether hsCRP 
should be considered only a clinically useful disease marker or whether it also may play a 
causal role in the atherothrombotic process. Of interest, in a recent study in the TNT study 
population (Arsenault et al., 2011) investigating the effects of atorvastatin 80 mg versus 10 
mg in patients with stable coronary artery disease, it has been shown that in contrast to the 
blood lipid levels almost none among several non-lipid biomarkers predicted recurrent CV 
events after 1 year of treatment. According to the authors’ suggestion the cardiovascular 
benefits were primarily due to the effects of statins on lipids biomarkers rather than on non-
lipid ones. According to 2009 Canadian Lipid Guidelines (Jenest et al., 2009) hsCRP should 
not performed on everyone but only in selected subjects and in patients with metabolic 
syndrome for better risk stratification. 
More recent data from Molenkampf et al. (Molenkampf et al., 2011) suggest that in primary 
prevention setting hsCRP may help selecting in the general population those people with 
highest risk of coronary events but with low coronary calcium score (CCS). In particular 
they demonstrated that CCS was superior to hsCRP in the discrimination and 
reclassification of coronary risk and that further improvement in coronary risk assessment 
was obtained when CCS was added to Framingham risk variables and hsCRP, whereas 
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hypertrigliceridemia usually associated with decreased HDL-cholesterol levels and 
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adding hsCRP to Framingham risk variables and CCS did not increase risk prediction. In 
any case, and in complete agreement with the authors, in asymptomatic subjects and for all 
individuals, the first-line recommendation remains a healthy lifestyle including quit 
smoking, regular physical activity, healthy diet, blood pressure and weight control. The 
efforts that are necessary to implement effective lifestyle modification in larger cohorts must 
be weighed against the costs of extended risk assessment and, for what CCS is concerned, 
the risk attributable to radiation exposure (see later). Being hsCRP a nonspecific marker of 
inflammation, it has been suggested that among the other inflammatory markers 
interleukine-6 may provide valuable additional prognostic information. In conclusion, at 
present time it appears that hsCRP should not be considered neither a major player in the 
atherosclerotic process nor a major predictor for future events, but may be thought to better 
stratify the risk and to support clinical decision in the individual patient.  
Finally, as far as the lipoprotein-(a) [Lp(a)] is concerned, the results from the recently 
published Young Finnish Study [a prospective population-based cohort study of 939 men 
and 1,141 women followed-up from the mean age of 17 and 38 years with repeated Lp(a) 
and both carotid IMT and flow-mediated dilation tests] do not provide any support for an 
early atherogenic effect of increased Lp (a) plasma levels (Kivimaki et al., 2010).   
3.4 Adiponectin  
Adiponectin is the most abundant adipokine released by adipocytes in response to 
extracellular stimuli and metabolic changes (Berseghian, 2011). It is predominately, but 
not exclusively, produced by adipose tissue and recent studies suggest that it is also 
synthesized and secreted by human cardiomyocytes (Pineiro et al., 2005). It is reduced in 
obesity and type 2 diabetes and low plasma concentration has been associated with an 
increased risk of CAD and acute coronary syndrome in several though not all studies. 
Low plasma levels of adiponectin are also associated with increased NO inactivation 
combined with decreased NO production, both of which contribute to endothelial 
dysfunction, the first step in atherosclerosis. Adiponectin is thought to be also involved in 
the regulation of necrotic core development. In patients with stable CAD and in acute 
coronary syndrome, a decrease in plasma adiponectin values has been found to be 
associated with an increase in necrotic core in both culprit and non-culprit lesions 
assessed by intravascular ultrasounds, suggesting that in this clinical setting lower 
adiponectin levels reflect plaque vulnerability (Otake et al., 2008). Accordingly, the 
association of decreased plasma adiponectin level and increased necrotic core ratio has 
not been demonstrated in patients with stable CAD (Sawada et al., 2010). Although 
produced by adipocytes, adiponectin exhibits plasma levels inversely proportional to 
body mass index and visceral adiposity (Bajaj & Ben-Yehuda, 2006). Adiponectin is 
thought to decrease atherosclerosis progression through inhibition of both neointimal 
thickening and SMC proliferation and migration into the intima. As recently suggested by 
Barseghian et al. (Barseghian et al., 2011) direct adiponectin administration in humans is 
premature and warrants further investigation but indirect methods such as lifestyle 
modifications and pharmacological interventions may be used to increase adiponectin 
plasma levels at present time (Hermann et al., 2006). On this line, a meta-analysis of 19 
studies confirmed an increase of endogenous adiponectin levels with thiazolidinediones 
use. Accordingly, pioglitazone exhibited the potential of coronary plaque stabilization in 
patients with type 2 diabetes by increasing adiponectin levels and reducing the necrotic-
core component (Ogasawara et al., 2009; Riera-Guardia & Rothenbacher, 2008). 
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3.5 Lipids and stroke prevention 
The stroke represents the second leading cause of death and is a major contributor to 
health-care cost. As recently reviewed by Endres et al (Endres et al., 2011) variations have 
been found between the main risk factors for haemorrhagic vs ischemic stroke and 
overwhelming evidence suggests that hypertension is a major cause of brain damage and 
that brain benefits more from high blood pressure treatment.  Moreover, it has been 
indicated (Pischon et al., 2007) that the main modifiable risk factors such as diabetes, 
smoking, hypertension, and hypercholesterolemia, explain only 55% of variance for stroke 
events compared to 88% variance for myocardial infarction. In that review (Endres et al., 
2011) it has been underlined that actually no randomized clinical trial exists providing a 
blood pressure target for effective prevention of first strokes. In several studies a close 
relationship between cholesterol plasma levels and stroke has not been found and 
hypercholesterolemia is thought to have major responsibility in atherothrombotic stroke 
only Endres et al., 2011). Although it is still unsettled whether statin use is useful in 
primary prevention of atherothrombotic stroke in subjects with mild 
hypercholesterolemia, evidence exists on the other side (Naghavi et al,. 2003) that even 
mild carotid atherosclerosis in apparently healthy subjects, and independently of lipid 
plasma values, identifies those subjects with more or less generalized subclinical disease 
which should be appropriately treated with statins.    
3.6 LDL-cholesterol and cancer 
Several cancer subtypes (gastrointestinal, hematological, female-specific, urologic and lung 
cancer) have been observed to be associated with low LDL-cholesterol levels and the 
mechanisms by which preclinical cancer might induce low LDL-cholesterol plasma levels 
are largely unknown. The issue of a potential increased risk of cancer in patients treated 
with hypolipidemic drugs has been already faced in previous pages (see section 3.1) where 
substantial evidence has been provided on the safety of statin use. The problem of an 
increased risk of cancer by hypolipidemic drugs has been raised since the late seventhies by 
the Clofibrate trial, a WHO Cooperative Trial on primary prevention of ischemic heart 
disease using clofibrate (Oliver et al., 1978). In this study a 47% excess mortality occurred in 
the treated group during the study period but it has not continued in the follow-up period 
with only 5% excess mortality after treatment has ended. Recent meta-analyses (Benn et al., 
2011) from more than 90,000 patients have lessened the concern, raised in the previous three 
decades, on risk of cancer using LDL-cholesterol lowering drugs (Rose et al. 1974). However, 
the pendulum of the potential damage from cholesterol lowering thearpy has been again a 
little bit forced forward by the results from two studies in Denmark – the Copenhagen City 
Heart Study (CCHS) and the Copenhagen General Population Study (CGPS) on 59,566 and 
6,816 subjects respectively– which have shown that, indipendently of statin use, participants 
with low plasma cholesterol level (<87 mg/dL) were associated with a 47% increased risk of 
cancer, a finding not observed in those patients with innate low plasma LDL-cholesterol level 
identified by genetic study of single-nucleotide polymorphisms in PCSK9, ABACG8 and 
APOE (Benn et al., 2011). This study has left unsettled the issue of the potential cause-effect 
relationship between LDL-cholesterol lowering by statin use and cancer. However, a recent 
metaanalysis of data on cancer from 166,000 paricipants in 25 randomized trials, it has been 
concluded that, at least in the five years treatment period  no evidence emerged of any effect of 
statin therapy on cancer incidence or mortality at any particular site (Emerson et al., 2010). Has 
the story come to an end?   
  
Ultrasound Imaging – Medical Applications  100 
adding hsCRP to Framingham risk variables and CCS did not increase risk prediction. In 
any case, and in complete agreement with the authors, in asymptomatic subjects and for all 
individuals, the first-line recommendation remains a healthy lifestyle including quit 
smoking, regular physical activity, healthy diet, blood pressure and weight control. The 
efforts that are necessary to implement effective lifestyle modification in larger cohorts must 
be weighed against the costs of extended risk assessment and, for what CCS is concerned, 
the risk attributable to radiation exposure (see later). Being hsCRP a nonspecific marker of 
inflammation, it has been suggested that among the other inflammatory markers 
interleukine-6 may provide valuable additional prognostic information. In conclusion, at 
present time it appears that hsCRP should not be considered neither a major player in the 
atherosclerotic process nor a major predictor for future events, but may be thought to better 
stratify the risk and to support clinical decision in the individual patient.  
Finally, as far as the lipoprotein-(a) [Lp(a)] is concerned, the results from the recently 
published Young Finnish Study [a prospective population-based cohort study of 939 men 
and 1,141 women followed-up from the mean age of 17 and 38 years with repeated Lp(a) 
and both carotid IMT and flow-mediated dilation tests] do not provide any support for an 
early atherogenic effect of increased Lp (a) plasma levels (Kivimaki et al., 2010).   
3.4 Adiponectin  
Adiponectin is the most abundant adipokine released by adipocytes in response to 
extracellular stimuli and metabolic changes (Berseghian, 2011). It is predominately, but 
not exclusively, produced by adipose tissue and recent studies suggest that it is also 
synthesized and secreted by human cardiomyocytes (Pineiro et al., 2005). It is reduced in 
obesity and type 2 diabetes and low plasma concentration has been associated with an 
increased risk of CAD and acute coronary syndrome in several though not all studies. 
Low plasma levels of adiponectin are also associated with increased NO inactivation 
combined with decreased NO production, both of which contribute to endothelial 
dysfunction, the first step in atherosclerosis. Adiponectin is thought to be also involved in 
the regulation of necrotic core development. In patients with stable CAD and in acute 
coronary syndrome, a decrease in plasma adiponectin values has been found to be 
associated with an increase in necrotic core in both culprit and non-culprit lesions 
assessed by intravascular ultrasounds, suggesting that in this clinical setting lower 
adiponectin levels reflect plaque vulnerability (Otake et al., 2008). Accordingly, the 
association of decreased plasma adiponectin level and increased necrotic core ratio has 
not been demonstrated in patients with stable CAD (Sawada et al., 2010). Although 
produced by adipocytes, adiponectin exhibits plasma levels inversely proportional to 
body mass index and visceral adiposity (Bajaj & Ben-Yehuda, 2006). Adiponectin is 
thought to decrease atherosclerosis progression through inhibition of both neointimal 
thickening and SMC proliferation and migration into the intima. As recently suggested by 
Barseghian et al. (Barseghian et al., 2011) direct adiponectin administration in humans is 
premature and warrants further investigation but indirect methods such as lifestyle 
modifications and pharmacological interventions may be used to increase adiponectin 
plasma levels at present time (Hermann et al., 2006). On this line, a meta-analysis of 19 
studies confirmed an increase of endogenous adiponectin levels with thiazolidinediones 
use. Accordingly, pioglitazone exhibited the potential of coronary plaque stabilization in 
patients with type 2 diabetes by increasing adiponectin levels and reducing the necrotic-
core component (Ogasawara et al., 2009; Riera-Guardia & Rothenbacher, 2008). 
Atherosclerotic Plaque Regression and Arterial Reverse Remodelling in Carotid  
and Femoral Arteries by Statin Use in Primary Prevention Setting: Ultrasound Findings 101 
3.5 Lipids and stroke prevention 
The stroke represents the second leading cause of death and is a major contributor to 
health-care cost. As recently reviewed by Endres et al (Endres et al., 2011) variations have 
been found between the main risk factors for haemorrhagic vs ischemic stroke and 
overwhelming evidence suggests that hypertension is a major cause of brain damage and 
that brain benefits more from high blood pressure treatment.  Moreover, it has been 
indicated (Pischon et al., 2007) that the main modifiable risk factors such as diabetes, 
smoking, hypertension, and hypercholesterolemia, explain only 55% of variance for stroke 
events compared to 88% variance for myocardial infarction. In that review (Endres et al., 
2011) it has been underlined that actually no randomized clinical trial exists providing a 
blood pressure target for effective prevention of first strokes. In several studies a close 
relationship between cholesterol plasma levels and stroke has not been found and 
hypercholesterolemia is thought to have major responsibility in atherothrombotic stroke 
only Endres et al., 2011). Although it is still unsettled whether statin use is useful in 
primary prevention of atherothrombotic stroke in subjects with mild 
hypercholesterolemia, evidence exists on the other side (Naghavi et al,. 2003) that even 
mild carotid atherosclerosis in apparently healthy subjects, and independently of lipid 
plasma values, identifies those subjects with more or less generalized subclinical disease 
which should be appropriately treated with statins.    
3.6 LDL-cholesterol and cancer 
Several cancer subtypes (gastrointestinal, hematological, female-specific, urologic and lung 
cancer) have been observed to be associated with low LDL-cholesterol levels and the 
mechanisms by which preclinical cancer might induce low LDL-cholesterol plasma levels 
are largely unknown. The issue of a potential increased risk of cancer in patients treated 
with hypolipidemic drugs has been already faced in previous pages (see section 3.1) where 
substantial evidence has been provided on the safety of statin use. The problem of an 
increased risk of cancer by hypolipidemic drugs has been raised since the late seventhies by 
the Clofibrate trial, a WHO Cooperative Trial on primary prevention of ischemic heart 
disease using clofibrate (Oliver et al., 1978). In this study a 47% excess mortality occurred in 
the treated group during the study period but it has not continued in the follow-up period 
with only 5% excess mortality after treatment has ended. Recent meta-analyses (Benn et al., 
2011) from more than 90,000 patients have lessened the concern, raised in the previous three 
decades, on risk of cancer using LDL-cholesterol lowering drugs (Rose et al. 1974). However, 
the pendulum of the potential damage from cholesterol lowering thearpy has been again a 
little bit forced forward by the results from two studies in Denmark – the Copenhagen City 
Heart Study (CCHS) and the Copenhagen General Population Study (CGPS) on 59,566 and 
6,816 subjects respectively– which have shown that, indipendently of statin use, participants 
with low plasma cholesterol level (<87 mg/dL) were associated with a 47% increased risk of 
cancer, a finding not observed in those patients with innate low plasma LDL-cholesterol level 
identified by genetic study of single-nucleotide polymorphisms in PCSK9, ABACG8 and 
APOE (Benn et al., 2011). This study has left unsettled the issue of the potential cause-effect 
relationship between LDL-cholesterol lowering by statin use and cancer. However, a recent 
metaanalysis of data on cancer from 166,000 paricipants in 25 randomized trials, it has been 
concluded that, at least in the five years treatment period  no evidence emerged of any effect of 
statin therapy on cancer incidence or mortality at any particular site (Emerson et al., 2010). Has 
the story come to an end?   
  
Ultrasound Imaging – Medical Applications  102 
4. Imaging of atherosclerosis  
Atherosclerosis has been generally viewed as a chronic and inevitably progressive disease 
characterized by continuous accumulation of atheromatous plaque within the arterial wall. In 
the last 25 years an important step-up progression occurred with the introduction of a variety 
of anti-atherosclerotic therapies, the most important of which are the so called statins, which 
rank among the most extensively studied therapies in contemporary medicine, opening the 
door to an effective anti-atherosclerotic treatment in addition to standard non pharmacologic 
measures. Almost simultaneously, invasive and non-invasive imaging techniques of 
atherosclerosis have been attempted in the course of years and an extraordinary development 
in non-invasive assessment has been realized during the last two decades. X-ray angiography 
is still considered the gold standard imaging technique for vessel patency studies but it does 
not usually allow obtaining information on plaque structure as well as differentiating stable 
from unstable plaques and the risk of rupture. This technique typically suffers from these 
limitations and even to day many cardiologists unfortunately still behave as if the absence of 
angiographic abnormalities indicates the normality of coronary artery anatomy and absence of 
atherosclerosis (Davis et al., 2004) In a decreasing degree of complexity the new imaging 
modalities are represented by the following: 1) magnetic resonance imaging (MRI), 2) CT 
angiography, 3) CCS ,4) B-mode ultrasonography of carotid and femoral arteries as well as 
abdominal aorta. All these methods are used in clinical setting and the type of investigation 
closely dependent on the clinical problem the individual patient has and on which techniques 
are locally available. As it has already been discussed in previous pages high-quality studies 
have demonstrated that a correlation exits between the severity of atherosclerosis in one 
arterial territory and involvement of other arteries and that these tests can predict the risk of 
future CAD events (Fowkes et al., 2008). Accordingly, noninvasive atherosclerosis imaging has 
evolved into a central method in clinical cardiology and both CCS and B-mode 
ultrasonography have recently become the most used techniques as first line approach for 
atherosclerosis detection in primary prevention setting (Greenland et al., 2003). Expert 
recommendations have endorsed the use of these imaging modalities in primary prevention 
(Stein et al., 2008) allowing a step-up progression towards an individualised CAD prevention 
through more effective use of drugs. According to 2009 Canadian Lipid Guidelines (Genest et 
al., 2009) the screening for high risk subjects should include the following as Class I 
Recommendation Grade, Level of Evidence C: 
 All men over 40 and postmenopausal women 
 Anyone with atherosclerosis or diabetes regardless of age 
 Anyone with family history of premature (< 60 yrs) cardiovascular event  
 All patients with hypertension or dyslipidemia 
 All patients with inflammatory diseases such as lupus, rheumatoid arthritis and 
psoriasis 
 Children of patients with severe dyslipidemia 
 Subjects with xanthomas, xanthelasma or premature arcus corneus 
 Erectile dysfunction 
 Chronic renal disease. 
Moreover, the following test for atherosclerosis are suggested as Class IIa Recommendation 
Grade, Level of Evidence C :  
 Ankle brachial index 
 Exercise stress test 
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 Carotid B mode ultrasonography 
 Cardiac Computed Tomography 
These guidelines (Genest et al., 2009) indicate that the presence of atherosclerosis in one of 
these tests places the individual in the high risk category. In the following pages in addition 
to a brief review on the usefulness of noninvasive techniques the attention will be focused 
on noninvasive plaque imaging by ultrasound (which is available in every clinical setting) 
enabling first line study of plaque burden and structure with assessment of potential 
regression during statin treatment.  
4.1 Magnetic resonance and CT imaging 
Due to inability of surface ultrasound to imaging coronary artery circulation, attention has 
focused on other techniques such as CT and MRI (Kim et al., 2001). As far as MRI is 
concerned , appropriate sequences are needed for plaque imaging and the contrast-
enhanced MRI used for clinical purposes is inadequate to this end (Fig. 3). 
 
 
Fig. 3. Contrast-Enhanced MRI (left panel) and B-mode ultrasonography (right panel) of the 
left crotid artery in a patient with carotid atherosclerosis. In this case the MRI exam has been 
perfomed for the clinical purpose of a better assessment of vessel stenosis. Plaque imaging 
would have required a different exam with T1-T2 weighted sequences. 
Due to its non-invasiveness carotid MRI has been recently proposed  as tool for monitoring 
individual response to cardiovascular therapy (Yuan, 2008). High-resolution MRI has been 
recently used for the noninvasive evaluation of carotid plaques showing that is possible to 
analyze the structure and molecules inside the plaque and to distinguish symptomatic from 
asymptomatic plaques and patients with low versus high risk through identification of iron 
deposition (Raman et al., 2008). Moreover, discrimination between lipid core, fibrous cap, 
intraplaque haemorrhage and calcification as well as distinguishing macrophage-rich from 
macrophage–poor lesions is possible (Kooi et al., 2003). From these studies emerged the 
finding that patients with a lipid-rich necrotic core with or without intraplaque 
haemorrhage represent the desired phenotype for monitoring treatment effects. It has been 
recently also suggested (Underhill et al., 20011) that throughout advanced tissue specific 
sequences, acquisition resolution and scan time, in association with techniques allowing 
monitoring of inflammation and mechanical forces, this technique will enable early 
assessment of response to therapy.  
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These guidelines (Genest et al., 2009) indicate that the presence of atherosclerosis in one of 
these tests places the individual in the high risk category. In the following pages in addition 
to a brief review on the usefulness of noninvasive techniques the attention will be focused 
on noninvasive plaque imaging by ultrasound (which is available in every clinical setting) 
enabling first line study of plaque burden and structure with assessment of potential 
regression during statin treatment.  
4.1 Magnetic resonance and CT imaging 
Due to inability of surface ultrasound to imaging coronary artery circulation, attention has 
focused on other techniques such as CT and MRI (Kim et al., 2001). As far as MRI is 
concerned , appropriate sequences are needed for plaque imaging and the contrast-
enhanced MRI used for clinical purposes is inadequate to this end (Fig. 3). 
 
 
Fig. 3. Contrast-Enhanced MRI (left panel) and B-mode ultrasonography (right panel) of the 
left crotid artery in a patient with carotid atherosclerosis. In this case the MRI exam has been 
perfomed for the clinical purpose of a better assessment of vessel stenosis. Plaque imaging 
would have required a different exam with T1-T2 weighted sequences. 
Due to its non-invasiveness carotid MRI has been recently proposed  as tool for monitoring 
individual response to cardiovascular therapy (Yuan, 2008). High-resolution MRI has been 
recently used for the noninvasive evaluation of carotid plaques showing that is possible to 
analyze the structure and molecules inside the plaque and to distinguish symptomatic from 
asymptomatic plaques and patients with low versus high risk through identification of iron 
deposition (Raman et al., 2008). Moreover, discrimination between lipid core, fibrous cap, 
intraplaque haemorrhage and calcification as well as distinguishing macrophage-rich from 
macrophage–poor lesions is possible (Kooi et al., 2003). From these studies emerged the 
finding that patients with a lipid-rich necrotic core with or without intraplaque 
haemorrhage represent the desired phenotype for monitoring treatment effects. It has been 
recently also suggested (Underhill et al., 20011) that throughout advanced tissue specific 
sequences, acquisition resolution and scan time, in association with techniques allowing 
monitoring of inflammation and mechanical forces, this technique will enable early 
assessment of response to therapy.  
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As far as CT is concerned, significant advances in the last ten years helped this technology to 
evolve as a real non-invasive alternative to conventional catheter based coronary 
angiography with the additional great advantage of the possibility of establishing the 
atherosclerotic burden and plaque characteristics with a radiation exposure less than 1mSv 
(when a heart rate is kept <60 bpm) which is less than the radiation dose of current CCS 
imaging. But new evidence that even low-dose ionizing radiation from cardiac imaging and 
therapeutic procedures is associated with an increased risk of cancer (Eisenberg et al., 2011), 
suggests that a new word of caution is worthy on the issue and that if the benefits to 
patients of a single cardiac imaging test probably outweigh any small excess risk of cancer, 
repeated examinations can induce more harm than good.   
4.2 B-mode ultrasound and CCS 
During the last 25 years, after the seminal papers by Pignoli and his coworkers (Pignoli, 
1984; Poli et al., 1984)  in mid eighties, on the feasibility of direct measurement of arterial 
wall thickness with B-mode imaging in vitro of specimens of human aortic and common 
carotid arteries, the use of this noninvasive approach through the measurement of the 
carotid intima-media thickness (CIMT) has become the standard reference method in 
assessing the presence and the amount of clinical atherosclerosis. Since early studies 
(Salonen & Salonen, 1991) it has been demonstrated that the presence of different degrees of 
carotid atherosclerosis (normal, thickening, plaque, stenosis) was associated with a progressive 
increase of coronary events incidence during a 4-years follow-up period. But at present, after 
dozens of published studies, the evidence to quantitatively support the use of a CIMT 
measurement to help in risk stratification on top of a risk function is limited (Platinga et al., 
2009). As it will be reported later on, plaque detection by B-Mode ultrasound has become the 
method of choice for early detection and follow-up treatment in patients deemed to be at 
higher risk because of preclincal atherosclerosis by carotid and/or femoral plaques, a more 
reliable manifestation of atherosclerosis as well as stronger prognosticator for future events. 
Carotid artery plaque are defined as the presence of focal thickening 50% greater than that of 
the surrounding vessel wall, with a minimal thickness of 1.2 mm (Hurst et al., 2010)Cardiac 
CT began with electron-beam CT in the early 1980s and continues with multidetector CT. In 
early studies with electron-beam CT high risk subjects have been identified by a score 
greater than 80-160 (O’Rourke et al., 2000). The advent of modern CT and high resolution 
MRI, ranked these techniques at the first approach in the assessment of preclinical 
atherosclerosis by the American Heart Association guidelines (Greenland et al., 2007). 
Quantification of coronary artery calcium, the so called coronary calcium score (CCS), as an 
estimate of atherosclerotic plaque burden has become the current major application of non-
contrast CT. Plaque burden is quantified by the Agatston score: according to different 
tertiles of CCS values (Tertile I = CCS 0-99, Tertile II = CCS 100-309, Tertile III = CCS ≥ 400) 
the estimated annual risk of CAD death or myocardial infarction rate appears to be 0,4%, 
1,3% and 2.4% respectively (Greenland et al., 2007). It has been generally suggested that a 
zero CCS might exclude the need for coronary angiography among asymptomatic 
patients. However, it has been also shown in studies that increasing the cut-point for 
calcification markedly improved the specificity but decreased the sensitivity. For patients 
with CCS >100 the sensitivity to predict significant coronary artery stenosis on 
angiography was 87% and the specifity 79% (Haberl et al., 2001). Of note, in a meta-
analysis a CCS grater than 400 was associated with an increased risk of CAD (Third 
Report of NCEP, 2002). But a number of recent studies challenged this statement. The first 
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study (Lester et al., 2009) in a young to middle-aged population with a low Framingham 
risk score where CCS was less sensitive than CIMT in the identification of preclinical 
atherosclerosis. The second from Mohlenkamp et al. (Mohlenkamp et al., 2011)  in a group 
of 1934 healthy participants in whom, despite an improved discrimination was possible 
by adding CCS to traditional risk factors, the reclassification and the overall event rates 
appeared to low to justify CCS testing in all subjects. Moreover, and in contrast with the 
published recommendations on the subject, a third new study from Gottlieb et al. 
(Gottlieb et al., 2011) showed that even total coronary occlusion frequently occurs in the 
absence of any detectable calcification, definitely suggesting that a zero CCS value does 
not exclude obstructive stenosis or even the need for revascularization among patients 
with high enough clinical suspicion of coronary artery disease to be referred for coronary 
angiography. The finding of very low or even absent coronary calcium by CT in patients 
with documented carotid and femoral atherosclerosis has been found in a preliminary 
study from our group (Fig. 3) suggesting that B-Mode ultrasound imaging of carotid and 
femoral arteries probably overcomes the CCS approach  for preclinical screening of 
atherosclerosis. As far as the effect on CCS by statin treatment is concerned, initial 
retrospective studies and observational data suggested that statin treatment resulted in 
reduction of coronary calcium but a recent exam of five randomized controlled trials 
proved that statin treatment does not reduce CCS values, with similar progression in 
either the treated and placebo group (Gill Jr, 2010).  
 
 
Fig. 4. Relationship between carotid and/or femoral atherosclerosis as assessed by B-Mode 
ultrasound (2D-ECHO) and CCS by compute tomography in 23 men, 35 to 65 y.o. The 
amount of carotid atherosclerosis has been arbitrarily graded into 6 grades from low to 
severe according to the amount of plaques in both arteries (IMT value has not been taken 
into account). CCS has been graded according to Agatstone score units. Close relationship 
exists on the presence and the amount of atherosclerosis between the two methods, with 
ultrasound findings being more sensitive than CCS in identifying subjects with 
atherosclerosis. These findings have been confirmed in studies and  support the view that 
ultrasounds should be considered the first line approach in the screening for atherosclerosis 
in apparently healthy people with CV risk factors.  
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As far as CT is concerned, significant advances in the last ten years helped this technology to 
evolve as a real non-invasive alternative to conventional catheter based coronary 
angiography with the additional great advantage of the possibility of establishing the 
atherosclerotic burden and plaque characteristics with a radiation exposure less than 1mSv 
(when a heart rate is kept <60 bpm) which is less than the radiation dose of current CCS 
imaging. But new evidence that even low-dose ionizing radiation from cardiac imaging and 
therapeutic procedures is associated with an increased risk of cancer (Eisenberg et al., 2011), 
suggests that a new word of caution is worthy on the issue and that if the benefits to 
patients of a single cardiac imaging test probably outweigh any small excess risk of cancer, 
repeated examinations can induce more harm than good.   
4.2 B-mode ultrasound and CCS 
During the last 25 years, after the seminal papers by Pignoli and his coworkers (Pignoli, 
1984; Poli et al., 1984)  in mid eighties, on the feasibility of direct measurement of arterial 
wall thickness with B-mode imaging in vitro of specimens of human aortic and common 
carotid arteries, the use of this noninvasive approach through the measurement of the 
carotid intima-media thickness (CIMT) has become the standard reference method in 
assessing the presence and the amount of clinical atherosclerosis. Since early studies 
(Salonen & Salonen, 1991) it has been demonstrated that the presence of different degrees of 
carotid atherosclerosis (normal, thickening, plaque, stenosis) was associated with a progressive 
increase of coronary events incidence during a 4-years follow-up period. But at present, after 
dozens of published studies, the evidence to quantitatively support the use of a CIMT 
measurement to help in risk stratification on top of a risk function is limited (Platinga et al., 
2009). As it will be reported later on, plaque detection by B-Mode ultrasound has become the 
method of choice for early detection and follow-up treatment in patients deemed to be at 
higher risk because of preclincal atherosclerosis by carotid and/or femoral plaques, a more 
reliable manifestation of atherosclerosis as well as stronger prognosticator for future events. 
Carotid artery plaque are defined as the presence of focal thickening 50% greater than that of 
the surrounding vessel wall, with a minimal thickness of 1.2 mm (Hurst et al., 2010)Cardiac 
CT began with electron-beam CT in the early 1980s and continues with multidetector CT. In 
early studies with electron-beam CT high risk subjects have been identified by a score 
greater than 80-160 (O’Rourke et al., 2000). The advent of modern CT and high resolution 
MRI, ranked these techniques at the first approach in the assessment of preclinical 
atherosclerosis by the American Heart Association guidelines (Greenland et al., 2007). 
Quantification of coronary artery calcium, the so called coronary calcium score (CCS), as an 
estimate of atherosclerotic plaque burden has become the current major application of non-
contrast CT. Plaque burden is quantified by the Agatston score: according to different 
tertiles of CCS values (Tertile I = CCS 0-99, Tertile II = CCS 100-309, Tertile III = CCS ≥ 400) 
the estimated annual risk of CAD death or myocardial infarction rate appears to be 0,4%, 
1,3% and 2.4% respectively (Greenland et al., 2007). It has been generally suggested that a 
zero CCS might exclude the need for coronary angiography among asymptomatic 
patients. However, it has been also shown in studies that increasing the cut-point for 
calcification markedly improved the specificity but decreased the sensitivity. For patients 
with CCS >100 the sensitivity to predict significant coronary artery stenosis on 
angiography was 87% and the specifity 79% (Haberl et al., 2001). Of note, in a meta-
analysis a CCS grater than 400 was associated with an increased risk of CAD (Third 
Report of NCEP, 2002). But a number of recent studies challenged this statement. The first 
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study (Lester et al., 2009) in a young to middle-aged population with a low Framingham 
risk score where CCS was less sensitive than CIMT in the identification of preclinical 
atherosclerosis. The second from Mohlenkamp et al. (Mohlenkamp et al., 2011)  in a group 
of 1934 healthy participants in whom, despite an improved discrimination was possible 
by adding CCS to traditional risk factors, the reclassification and the overall event rates 
appeared to low to justify CCS testing in all subjects. Moreover, and in contrast with the 
published recommendations on the subject, a third new study from Gottlieb et al. 
(Gottlieb et al., 2011) showed that even total coronary occlusion frequently occurs in the 
absence of any detectable calcification, definitely suggesting that a zero CCS value does 
not exclude obstructive stenosis or even the need for revascularization among patients 
with high enough clinical suspicion of coronary artery disease to be referred for coronary 
angiography. The finding of very low or even absent coronary calcium by CT in patients 
with documented carotid and femoral atherosclerosis has been found in a preliminary 
study from our group (Fig. 3) suggesting that B-Mode ultrasound imaging of carotid and 
femoral arteries probably overcomes the CCS approach  for preclinical screening of 
atherosclerosis. As far as the effect on CCS by statin treatment is concerned, initial 
retrospective studies and observational data suggested that statin treatment resulted in 
reduction of coronary calcium but a recent exam of five randomized controlled trials 
proved that statin treatment does not reduce CCS values, with similar progression in 
either the treated and placebo group (Gill Jr, 2010).  
 
 
Fig. 4. Relationship between carotid and/or femoral atherosclerosis as assessed by B-Mode 
ultrasound (2D-ECHO) and CCS by compute tomography in 23 men, 35 to 65 y.o. The 
amount of carotid atherosclerosis has been arbitrarily graded into 6 grades from low to 
severe according to the amount of plaques in both arteries (IMT value has not been taken 
into account). CCS has been graded according to Agatstone score units. Close relationship 
exists on the presence and the amount of atherosclerosis between the two methods, with 
ultrasound findings being more sensitive than CCS in identifying subjects with 
atherosclerosis. These findings have been confirmed in studies and  support the view that 
ultrasounds should be considered the first line approach in the screening for atherosclerosis 
in apparently healthy people with CV risk factors.  
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Of note, other clinical circumstances have been suggested to take advantage from use of 
CCS measurement, these include: 1) distinguishing ischemic from non-ischemic etiology of 
dilated cardiomyopathy, 2) identifying patients in emergency department with chest pain 
and nonspecific ECG,  3) predicting very low subsequent event rates in patients with acute 
MI and negative CCS test. However, and differently from asymptomatic patients setting, 
prognostic studies in symptomatic patients are lacking probably because a very large 
number of patients is needed in this setting to obtain the evidence. In any case, according to 
2007 guidelines (Greenland et al., 2007) clinical monitoring of CCS progression is not 
recommended.  
Finally, as far as the role of the race is concerned, despite a generally higher prevalence of 
cardiovascular risk factors also included a broad trait of endothelial dysfunction in this 
population group (Friedewald et al., 2008) a lower prevalence and extent of coronary 
calcification has been demonstrated in blacks. Accordingly, the Prospective Army 
Coronary Calcium (PACC) Project has found a higher prevalence of CCS in white (19.2%) 
than in black (10.3 %) military personnel with a mean age of 42 years (Mohlenkamp et al., 
2011). Higher CCS scores have been also found in whites compared with blacks in the 
Cardiovascular Health Study (Raman et al., 2008) and lower prevalence of coronary 
calcium has been observed in Japanese (13%) than in the American men (47%). Overall, as 
reported in recent guidelines, despite a higher prevalence of cardiovascular risk factors in 
blacks, the majority of studies demonstrated a lower prevalence and amount of coronary 
calcification compared to whites. The recently published MESA study (Multi-Ethnic Study 
of Atherosclerosis) showed that traditional CV-risk-factor-based prediction models, such 
as the Framingham score, are improved by the addition of CCS especially in patients at 
intermediate risk for future coronary artery disease, ultimately suggesting the superiority 
of CCS and CIMT vs the Framingham risk score for risk prediction. In line with these 
conclusions are the results from the recent Heinz Nixdorf Recall study of 4,129 subjects 
(age 45 to 75 years, 53% female) without overt coronary artery disease at baseline  
in whom traditional risk factors and CCS scores were measured. The CCS resulted in a 
high reclassification rate in the intermediate-risk cohort, demonstrating the benefit of 
imaging of subclinical coronary atherosclerosis in carefully selected individuals with 
intermediate risk (Erbel R, et al. 2008)In any case, in the recently published ESNIER (Early 
Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective 
randomized trial, it has been shown  that compared with no scanning, the simple 
randomization to CAC scanning appears to improve patients’ lifestyle health behaviours 
(Rozanski et al. 2011).   
As far as the CIMT is concerned, a recent reclassification analysis of the ten-year follow-up 
of the Carotid Atherosclerosis Progression Study (CAPS) has challenged its value as a 
marker of future CV events rate and did not support its clinical usefulness for risk 
stratification in primary prevention setting (Lorentz et al, 2010).  But evidence has been 
provided that when associated with risk factor assessment the CIMT may still be a valid tool 
in risk prediction in dyslipidemic patients (Baldassarre et al, 2007). The bottom line was that 
we have clear evidence that these two noninvasive methods of risk assessment are superior 
to Framingham risk score alone, and we think that the time has come to incorporate into 
new guidelines the cheaper, and completely safe, B-Mode ultrasound technique in primary 
prevention setting mainly focused on plaque detection. 
The new high-resolution imaging technologies have enhanced our understanding of the 
atherosclerotic disease process and recently a new modified American Heart Association 
Atherosclerotic Plaque Regression and Arterial Reverse Remodelling in Carotid  
and Femoral Arteries by Statin Use in Primary Prevention Setting: Ultrasound Findings 107 
classification scheme system based on morphological plaque features and the propensity of 
plaque for thrombosis has been suggested for use (Donnelly et al., 2010). Based on lipid 
deposition, fibrous cap thickening, lipid pool transition into necrotic core, calcium 
deposition, plaque disruption, haemorrhage and thrombosis, a number of categories of 
coronary atherosclerotic lesions have been identified and reported in Table 1 (Stary et al. 
1994; Virmani et al. 1999; Virmani et al 2000; Donnelly et al, 2010).  
Present status of CT technology clearly indicate that its diagnostic accuracy for  the 
detection of the presence of atherosclerosis is superior over the detection of significant 
stenosis ultimately suggesting a progressive shift of this technique in the future towards the 
study of the atherosclerotic process per se rather than to simply assess the stenosis severity 




Although primarily established for coronary lesions, in accordance with the recently 
emerged clinically relevant idea that carotid and femoral arteries can be considered the 
“sentinel vessels” of the coronary artery status (Heinecke, 2011., Joy & Hegel, 2008) we 
think that this classification can be usefully applied to the analysis of these vessels.  
As atherosclerosis begins early in life and then remains clinically silent for decades, a 
distinct opportunity for early intervention comes from the identification of subclinical 
stages of the disease. Accordingly, the concept that atherosclerosis must be viewed as a 
preventable disease, which should be approached not only in terms of risk-factor control 
but also in terms of early disease detection, plaque prevention and plaque stabilization, 
has rapidly gained acceptance (Naghavi et al., 2003). But even plaque regression (the holy 
grail for therapeutic interventions) appears possible and has become a new target in our 
clinical practice during the last ten years. Together with a proposal for a strategy for 
primary CV disease prevention this evidence will be accordingly presented in the 
following pages. 
4.3 Preclinical atherosclerosis and risk prediction 
Coronary atherosclerosis starts early in the life and it is progressive in nature and when  
angiografically identified as minimal vessel stenosis its burden is already diffuse. By the 
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marker of future CV events rate and did not support its clinical usefulness for risk 
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provided that when associated with risk factor assessment the CIMT may still be a valid tool 
in risk prediction in dyslipidemic patients (Baldassarre et al, 2007). The bottom line was that 
we have clear evidence that these two noninvasive methods of risk assessment are superior 
to Framingham risk score alone, and we think that the time has come to incorporate into 
new guidelines the cheaper, and completely safe, B-Mode ultrasound technique in primary 
prevention setting mainly focused on plaque detection. 
The new high-resolution imaging technologies have enhanced our understanding of the 
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time a patient has developed minor obstructive disease on angiography, an extensive 
systemic atheroma is already present. This finding underscores the importance of an 
aggressive risk factor modification  (and statin use) since early stages of atherosclerosis in 
asymptomatic subjects (Lavoie et al., 2010). In recent years several studies addressed the 
prognostic implications of detecting asymptomatic atherosclerosis in the general 
apparently healthy population. Pathological, epidemiological and clinical studies indicate 
tha atherosclerosis is a systemic disease which develops with a variable extension and 
severity in all conduit arteries. In particular, an almost constant association exists between 
carotid, femoral, and coronary artery disease, with first clinical manifestation usually  
due to a CAD. Ten years ago in the CAFES-CAVE study (Belcaro  et al., 2001), subclinical 
carotid and femoral artery plaques have been found strongly and independently 
associated with future adverse cardiovascular events rate in low risk subjects  
by Framingham criteria. Similarly, the presence of peripheral (occlusive or sub-occlusive) 
artery disease independently predicted myocardial infarction and death in 1,325 
individuals with either carotid or femoral plaques by ultrasound (Lamina et al., 2006). 
And early atherosclerosis (increased IMT) in femoral arteries predicted single-vessel  
CAD whereas advanced atherosclerotic (plaques) was usually associated with more 
severe CAD (Sosnowski et al., 2007). Evidence of the systemic nature of the atherosclerotic 
process comes also fromseveral studies of prevalence of occult CAD in patients with 
peripheral artery disease or stroke. In a recent study in patients with cerebral infarction 
without history of CAD (Amarenco et al., 2011) it has been shown that a silent CAD was 
present in 62% of patients and that 31% and 26% had a 3 vessel disease and vessel stenosis 
> 50% respectively, and similar findings have been reported in another recent study in 
which the atherosclerotic process was quite advanced in coronary as well as in peripheral 
arteries of patients at their first presentation for acute coronary artery disease (Kranjec, 
2011). Evidence of high prevalence of subclinical atherosclerosis in the general population 
comes also from another recent study on a randomly selected sample of 292 subjects 
(mean age 59.5 years, 50% women) from the offspring cohort of the Framingham Heart 
Study free of clinically apparent cardiovascular disease, who exhibited high levels of 
subclinical atherosclerosis on more than 2 imaging tests including MRI of abdominal and 
thoracic aorta, coronary artery calcification by EBCT, and CIMT by ultrasonography 
(Kathiresan et al., 2007).  Also on this line are the results from the mass screening recently 
introduced in United Kingdom where an ultrasound scan of the abdomen is offered to all 
men over 64 years for the screening of abdominal aorta aneurysm by ultrasonography. In 
a large randomized trial in 67,770 men, age 65 to 74 years, it has been shown that in the 
group invited for screening the mortality was halved (because of elective surgery): an 
approach that additionally proved to be highly cost-effective (Kim et al., 2007).   
As far as the role of carotid IMT as a predictor of future events is concerned, in a recent 
meta-anlaysis of 41 randomized trials it has been shown (Costanzo et al., 2010)  that 
regression or slowed progression of carotid IMT by cardiovascular drugs is not 
accompanied by reduction in cardiovascular events, definitely suggesting that this 
parameter has a very limited role in cardiovascular risk prediction. Similarly, a recent 
review including 13.145 patients (Masson et al., 2011) has shown that presence of carotid 
plaques predicted future risk better than IMT value, supporting the view that when 
detecting plaque we are not just evaluating a surrogate objective but a process that in itself 
indicates the presence of the atherosclerotic disease. 
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The American Society of Echocardiography consensus document (Stein et al., 2008)  
and the recently published Canadian guidelines (Genest et al., 2009) which formally 
classify patients with subclinical atherosclerosis as high risk and recommend preventive 
measures as intensive as those to be used in patients with clinically established 
atherosclerotic disease, are both in line with this suggestion. Neither those persons with a 
past history of intensive professional sport activity appear protected by the atherosclerotic 
assault of modern life as demonstrated by a recent paper in which former professional 
football players, despite their elite athletic histories, have a similar prevalence of 
advanced subclinical atherosclerosis as a clinically referred population of overweight and 
obese men (Hurst et al., 2010). In response to the wall lipid infiltration and plaque 
formation the arterial wall changes its structure according to two types of anatomical 
remodelling, positive and negative. Positive remodelling is characterized by outward 
expansion and negative remodelling by vessel shrinkage. Paradoxically the apparent 
beneficial and more frequent phenomenon of outward wall expansion is associated with 
the feature of unstable lesions (fig. 1) i.e. with histological characteristics of plaque 
vulnerability such as a large lipid core and high plaque macrophage content (Pasternak et 
al., 1998). These important morphological features have been studied in coronary vessels 
by intravascular ultrasound (IVUS) and angioscopy, but optical coherence tomography 
with its unique ability of identifying lipid content, fibrous cap thickness and its 
macrophage density, is the method of choice (Yabushita et al., 2002; Raffel et al., 2008).  
Recently, a first report on virtual histology-IVUS assessment of natural history (1 year 
follow-up with repeated examinations) of coronary artery lesions morphology has been 
published (Kubo et al., 2010). In this study it has been demonstrated that most thin 
capped fibroatheroma had plaque progression (most stabilized or healed but new 
developed) whereas fibrotic and fibrocalcific plaque did not demonstrate any geometric 
changes during the follow-up and no spontaneous plaque regression has been observed, 
as usual.        
AS highlighted in previous pages an ischemic event is usually associated with an 
advanced atherosclerotic lesion. And since early regression studies (Blankenhorn et al., 
1978; Corti et al., 2001), the evidence clearly emerged that  persistent and marked 
reduction of total and LDL cholesterol plasma levels (with LDL-cholesterol in the range of  
50 mg /dl) is the key element for obtaining atherosclerosis regression and significant 
inverse remodelling with lumen preservation of both aorta and carotid arteries at 12 
months, and that the degree of LDL-cholesterol reduction rather than the statin dose was 
associated with plaque regression. According to this line of conduct we have had 
evidence in the last 10 years on the possibility to induce plaque regression even up to 
complete disappearance: moreover we have realized how B-mode ultrasound imaging can 
help us and motivate patients in many ways in primary prevention setting. As it will be 
suggested in the next pages, our experience has confirmed the hypothesis that lipid 
lowering therapy selectively depletes the atherosclerotic plaques lipid content and 
prevents plaque disruption.  
5. Plaque monitoring by ultrasound imaging and plaque regression by  
statin use 
Notwithstanding large-scale clinical trials have proved that both primary and secondary 
prevention reduce myocardial infarction, stroke and overall mortality, the optimal level of 
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time a patient has developed minor obstructive disease on angiography, an extensive 
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plasma lipids to achieve these goals remains unresolved. Recent trend suggests “the lower 
the better” for all risk factors, but recent data suggest that lipid lowering appears to have 
larger impact than blood pressure lowering on plaque progression (Chhatriwalla et al., 
2009) and hence also  supporting the view that only intensive plasma lipid reduction can 
induced plaque regression. As already mentioned in previous pages, in vivo evidence of 
atherosclerosis regression in thoracic aorta by statin use has been first reported ten years 
ago (Corti et al., 2001) using MRI. More recently using dedicated carotid MRI protocol 
(Underhill et al., 2009) it has been demonstrated that intraplaque haemorrhage and statin 
therapy were key determinants of opposite changes in plaque burden: being intraplaque 
haemorrhage associated with accelerated plaque growth, whereas statin therapy was 
associated with plaque stabilization by slowing or halting lesion progression. According 
to these authors the phase of 16% to 49% of plaque induced vessel stenosis is probably a 
critical stage of the plaque natural history, whereas plaque regression has been associated 
with statin use. 
In the following pages we describe the process of atherosclerosis regression as it has been 
documented in a group of selected statin treated subjects in a primary prevention setting 
during the last ten years in our echo-lab. To be included in this retrospective analysis the 
subjects should have had at least two B-mode ultrasound plaque imaging examinations of 
at least 2 years apart during an uninterrupted statin treatment. Twelve subjects have been 
found to match such criteria. These subjects have been treated with simvastatin or 
rosuvastatin at a dosage aimed obtaining a total cholesterol plasma level kept round 140 
mg/dl. None of them have had any CV events during the study period. The most 
representative structural findings associated with plaques regression are presented in the 
following pages and proposed as reference structural changes to be routinely examined in 
patients for an office-based practice as an alternative to the more demanding and 
expensive MRI based analyses.   
As largely reported in previous page, evidence exists on the possibility to identify subjects 
with preclinical atherosclerosis who can take advantage from its early detection by 
improving a safer life style and by statin use in particular. In fact, the possibility to 
monitor plaque dimension and structure changes along time with a completely 
noninvasive approach by using ultrasounds allows a safe and personalized treatment 
approach in the course of years, with an improved patient’ and doctor’ satisfaction. To 
recognize the great advancement in the field of primary prevention and of usefulness of 
early atherosclerotic disease detection by the way we are suggesting, a citation is worthy 
of David Blankenhorn’s intuition and early demonstration of this possibility more than 30 
years ago in California and summarized in the following lines from a  paper (George 
Lyman Duff Memorial Lecture) co-authored with Howard Hodis (Blankenhorn DH & 
Hodis HN, 1994): “Coronary atherosclerosis is ubiquitous, but we know that some 
individuals develop more severe coronary atherosclerosis at an earlier age than others. A 
case finding and treatment strategy based on noninvasive imaging would benefit those 
with premature atherosclerosis who are not recognized with current risk factor screening 
until they develop symptoms. Screening for peripheral vessel changes indicative of high 
risk is possible and cost effective with procedures now available“. The following cases we 
are going to describe closely match this position and add new evidence on the real 
possibility by the simple and totally noninvasive ultrasound exam to characterize carotid 
and femoral artery plaque structure and the profound changes induced by statin 
treatment (Fig 4 to 9).  
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Fig. 4. Upper left panel - B-mode ultrasound of the right carotid artery bifurcation in a 
asymptomatic 50 y.o. man with hypercholesterolemia (280-300 mg/dl). A soft and lipid-rich 
atherosclerotic plaque (arrow) about 4 mm in thickness and 7 mm in length is present at the 
posterior wall of the carotid artery bifurcation associated with outward remodeling of the 
arterial wall. These charcteristics allow classification of the plaque as an advanced 
atherosclerotic plaque type IV lesion (see pag 12).  Upper right panel - Imaging of the same 
artery after three years 20 mg simvastatin treatment and plasma total cholesterol level kept 
around 150 mg/dl. A marked reduction of plaque dimension is shown (arrow) associated 
with arterial wall reverse remodeling. Lower panel: imaging of the same artery (with same 
magnification) obtained three years after spontaneous statin treatment interruption. New 
plaque progression can be appreciated with an associated IMT increase. Legend: ECA = 
external carotid artery, ICA = internal carotid artery.  
 
 
Fig. 5. B-Mode ultrasound (with plaque outlining) of the right carotid artery in a 66 y.o. man 
with hypercholesterolemia (250 mg/dl) followed-up for 4 years during statin therapy 
(rosuvastatin 10 mg/day). Left panel: Lipid rich plaque with a small (white) calcium deposit. 
Right panel: Same imaging 4 years later demonstrating plaque volume reduction with almost 
complete regression of the echolucent lipid-rich areas, leaving intact the small nucleus of 
calcium deposit within the plaque. Almost complete reverse remodelling of the posterior 
vessel wall also occurred.   
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Fig. 6. B-Mode ultrasonography imaging in a short axis (left side) and long axis view (right 
side) of the right carotid artery in asymptomatic man with hypercholesterolemia (240 
mg/dl) followed-up for 6 years during statin therapy. 
Upper line: At first examination (age 59 years) a small echolucent plaque was present in the 
far field of common carotid artery, better appreciated in its extension in the high lightened 
short axis view. Bottom line: Same imaging showing a complete plaque regression after five 
years of Simvastatin (20 mg/day) treatment. No further examinations were performed 
during this period. Arterial reverse remodelling, better appreciated in the short axis view, 
also occurred in association with plaque regression. Cholesterol plasma levels have been 
kept around 140 mg/dl during the whole treatment period.            
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Fig. 7. Left panel: B-Mode ultrasonography imaging in a long- and short-axis view (with 
colour Doppler flow imaging) of femoral arteries in a 69 y.o. healthy man during a 20 
months treatment period with rosuvastatin 20 mg/day and cholesterol plasma level kept 
around 140 mg/dl. Plaque volume reduction and inverse arterial remodelling haves 
occurred by statin treatment. Far field endothelial surface, total plaque area, and echo-lucent 
area within the plaques have been manually outlined for better understanding of the plaque 
structural changes. Plaque volume reduction and arterial reverse remodelling are better 
appreciated in the short axis view. Right panel: Further  plaque reduction in the long axis 
view occurred after additional 10 months of statin treatment. 
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Fig. 8. Left carotid plaque monitoring during a 2.5 years follow-up period in a 55 y.o. subject 
during statin treatment (rosuvastatin 20 mg/day) with a reduction of cholesterol level from 
200 mg/dl to around 140 mg/dl. with HDL Cholesterol increase from 50 to 75 mg/dl. The 
plaque border and the echolucent areas within the plaque have been outlined for a better 
understanding of the structural findings associated with plaque regression. At first imaging 
(May 2008) the plaque exhibits the characteristics of a rupture-prone (vulnerable/instable) 
plaque represented by the triad of a very thin fibrous cap combined with large echolucent 
(lipid/necrotic) core and positive (outward) arterial wall remodelling. An impressive 
volume reduction (~75%) occurred during the treatment period. In this case, the close 
temporal images’ sequence allowed superior understanding of structural modifications 
associated with plaque regression and stabilization. According to these changes the 
following observations can be done: 1) The amount of baseline echolucent areas within the 
plaque predicts the regression potential by statin treatment, even to almost complete plaque 
regression when the echolucent area is predominant, 2) the reabsorbtion of these areas is 
progressive and is accompanied by plaque volume reduction and structural findings 
suggesting plaque stabilization (the arrows in the imaging of march 2009 indicate a partial 
plaque collapse due to early marked reduction of underlying echolucent area), 3) in 
association with plaque volume reduction a progressive reverse arterial wall remodelling 
also occurred, 4) the time interval needed for early regression appreciation appears to be 10 
to 12 months. As occurred in this case, plaque regression appears to depend on “robust 
measures” such as marked reduction in plasma concentrations of LDL cholesterol and large 
increases in the reverse transport of lipids out of the plaque by an increased HDL-
cholesterol.  
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Fig. 9. Same case of the figure 8.  Plaque and vessel luminal area (by manual outlining) in a 
long and a short axis view respectively, by B-mode ultrasound imaging of the carotid artery 
obtained during the study period. This analysis adds further information on the 
characteristics of the process of plaque reduction, vessel inverse remodelling and reduced 
vulnerability in this patient. 
6. Conclusions 
After arteriographic studies on atherosclerosis regression by lipid lowering drugs 
pioneered by Blankenorn in late seventhies, conclusive demonstration of the plaque lipid 
depletion hypothesis in human beings during lipid lowering therapy has been possible 
only in recent years using ultrasound and MRI. During the last few years the sonographic 
characteristics of carotid plaques have been thoroughly studied by sophisticated methods 
enabling semiquantitative analysis of their structure (Reiter et al., 2007). However, as in 
depth discussed in this chapter we think that the simple, non-invasive, relatively cheap 
and totally innocuous B-Mode ultrasound examination of carotid and/or femoral arteries 
represents the first choice and still largely unmet opportunity for atherosclerosis 
screening of asymptomatic subjects deemed at intermediate risk by traditional risk factors 
(fig 10).  
As already discussed, due to the associated radiation risk, the use of CCS as a screening tool 
in primary prevention setting (usually requiring subsequent examinations) should be 
considered in specific circumstances only as alternative to arterial ultrasound scanning 
when this imaging modality is not available. Definite superiority of the B-mode ultrasound 
approach is greatly supported by the possibility to monitor the natural course of plaque 
structural changes and, of outmost importance, to assess the drugs’ effect which we have 
observed to occur during statin use in a very short period of time, ten to twelve months 
apart.  
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Fig. 10. Algorithm for cardiovascular risk assessment and as decision making approach 
using B-Mode ultrasound examination of carotid (and femoral) arteries for preclinical 
atherosclerosis screening in subjects deemed to be at intermediate risk by traditional risk 
factors. RFC = Risk factor control. (Modified by Gepner et al., 2007) 
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1. Introduction 
Hepatology is an excellent example of how results deriving from basic science influence our 
everyday clinical practice. This involves diagnostic procedures as well as therapeutic 
developments. The role of diagnostic imaging in the assessment of liver disease continues to 
gain in importance. Imaging of the liver has progressed rapidly during the past decade with 
continued advancement of current ultrasound, computed tomography, and magnetic 
resonance imaging. Refinement enabling better anatomic characterization of disease and 
significant strength from the addition of new techniques and high resolution images were 
seen. Improvements in ultrasound (US) scanners over the past few decades have been 
remarkable: advances such as color Doppler and harmonic imaging have increased image 
quality and accuracy. Ultrasound is usually the first imaging modality in the evaluation of 
liver disease because it is easy to perform, widely available, relatively inexpensive and is 
cost effective. US can detect morphological changes in the liver and characterize focal 
lesions (cystic or solid) with high accuracy. Color Doppler sonography is a well established 
method for assessment of the hepatic vasculature, offering hemodynamic and anatomical 
information. 
2. Hepatic ultrasound in rodents 
An important challenge in pre-clinical in vivo studies is to follow up the evolution of the 
disease induced in animal models without sacrifice them. In this context, noninvasive 
methods available for the diagnosis and prognosis of liver diseases bring a significant 
contribution for the progress of this field of study. Prior animal research may support the 
step forward to human clinical trials. 
Rodents represent an important animal group used in experimental model of liver diseases. 
Steatosis, cirrhosis and some hepatic focal lesions can be induced in mice and rats by 
administration of toxins, among which carbon tetrachloride (CCL4), ally alcohol, retrorsine 
and 2-acetylaminofluorene (2-AAF), by surgical insult such as bile duct ligation or hepatic 
resection, and virus infection. The induced hepatopathies may present change in liver size, 
shape, position, or opacity and these parameters can be evaluated by ultrasound imaging. 
US imaging is an ideal complementary diagnostic tool to evaluate the liver. Hepatic 
ultrasound can noninvasively examine the internal architecture of the liver parenchyma, 
biliary system, portal and hepatic vascular supply. Also, ultrasonography allows assessment 
  
Ultrasound Imaging – Medical Applications  126 
Underhill, HR., Yuan, C., Yamikh, VL., Chu, B., Oikawa, M., Polissar, NL., Schwarts, SM., 
Jarwick, GP., & Hatsukami, TS. (2009). Arterial Remodeling in subclinical carotid 
Artery Disease. J Am Coll Cardiol img, 2, 1381-1389.  
Underhill HR, Yuan C. (2011). Carotid MRI: a tool for monitoring individual response to 
cardiovascular therapy? Exp Rev Cardiovasc Ther, 9, 63-80. 
Valgimigli, M., Rodriguez-Granillo, GA., Garcia-Garcia, HM., Malagutti, P., Regar, E., de Jaegere, 
P., de Feyter, P., & Serruys, PW. (2006). Distance from opstium as an indipendent 
determinant of coronary plaque composition in vivo: an intrvascular ultrasound study 
based radiofrequency data analysis in humans. Eur Heart, 27(6), 655-63. 
van Velzen, JE., Schuijf, JD., de Graaf, FR., Boersma, E., Pundziute, G., Spanó, F., Boogers, MJ., 
Schalij, MJ., Kroft, LJ., de Roos, AJ., Jukema, W., van der Wall, EE., & Bax, JJ. (2011). 
Diagnostic performance of non-invasive multidetector computed tomography coronary 
angiography to detect coronary artery disease using different endpoints: detection of 
significant stenosis vs. detection of atherosclerosis. Eur Heart J, 32, 637-645. 
Virmani, R., Frank, D., Kolodgie, FD., Allen, P., Burke. Farb, A., Schwartz, SM., Strong, JP., 
Malcom, GT., McMahan, CA., Tracy, RE., Newman, WP., Herderick, EE., & Cornhill, 
JF. For the Pathobiological Determinants of Atherosclerosis in Youth Research Group. 
(1999). Prevalence and Extent of Atherosclerosis in Adolescent and Young Adults. 
Implications for Prevention From the Pathobiological Determinants of 
Atherosclerosis in Youth Study. JAMA,:281:727-73. 
Virmani, R., Frank, D., Kolodgie, FD, Allen, P., Burke, Farb, A., & Stephen, M. (2000). Lessons 
From Sudden Coronary Death. A Comprehensive Morphological Classification 
Scheme for Atherosclerotic Lesions.  Arterioscler Thromb Vasc Biol;20,1262-1275. 
Virmani, R., Kolodgie, FD, & Burke, AP. (2005). Atherosclerotic plaque progression and 
vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. 
Arterioscler Thromb Vasc Biol,;25:2054- 61. 
Waters, DD., Guyton, JR., Herrington, DM., McGowan, MP., Wenger, NK., & Shear, C.(2004) 
For the TNT Steering Committee Members and Investigators. Treating to New 
Targets (TNT) Study: Does Lowering Low-Density Lipoprotein Cholesterol Levels 
Below Currently Recommended Guidelines Yield Incremental Clinical Benefit?. Am J 
Cardiol, 93,154–158. 
Westover, MB., Bianchi, MT., Echman, MH., & Greenberg, SM. (2011). Statin Use Following 
Intracerebral Hemorrage: A Decision Analysis. Arch Neurol, 0: 20103491-2. 
Wurtz, P., Soininen, P., Kangas, AJ., Makinen, VP., Groop, PH., Savolainen, MJ., Viikari, JS., 
Kahonen, M., Lehtimaki, T., Raitakari, OT., & Ala-Korpela, M. (2011).  
Characterization of systemic metabolic phenotypes associated with subclinical 
atherosclerosis. Mol Biosyst, 7(2),385-93. 
Yerramasu, A., & Venuraju, S. Lahiri. (2011). Evolving role of cardiac CT in the diagnosis of 
coronary artery disease Postgrad Med J, 87, 180-188. 
Yuan, C. (2008). Carotid Atherosclerosis and Magnetic Resonance Imaging. J Am Coll Cardiol 
Img, 1,58-60. 
Yusuf, S., Hawken, S., & Ounpuu, S. (2004). INTERHEART Study Investigators: Effect of 
potentially modifiable risk factor associated with myocardial infarction in 52 
countries (The INTERHART study): case-control study. Lancet, 364, 937-95. 
7 
Ultrasonic Imaging in Liver Disease:  
From Bench to Bedside 
Celia Resende, Andréia Lessa and Regina C. S. Goldenberg 
Universidade Federal do Rio de Janeiro 
Brazil 
1. Introduction 
Hepatology is an excellent example of how results deriving from basic science influence our 
everyday clinical practice. This involves diagnostic procedures as well as therapeutic 
developments. The role of diagnostic imaging in the assessment of liver disease continues to 
gain in importance. Imaging of the liver has progressed rapidly during the past decade with 
continued advancement of current ultrasound, computed tomography, and magnetic 
resonance imaging. Refinement enabling better anatomic characterization of disease and 
significant strength from the addition of new techniques and high resolution images were 
seen. Improvements in ultrasound (US) scanners over the past few decades have been 
remarkable: advances such as color Doppler and harmonic imaging have increased image 
quality and accuracy. Ultrasound is usually the first imaging modality in the evaluation of 
liver disease because it is easy to perform, widely available, relatively inexpensive and is 
cost effective. US can detect morphological changes in the liver and characterize focal 
lesions (cystic or solid) with high accuracy. Color Doppler sonography is a well established 
method for assessment of the hepatic vasculature, offering hemodynamic and anatomical 
information. 
2. Hepatic ultrasound in rodents 
An important challenge in pre-clinical in vivo studies is to follow up the evolution of the 
disease induced in animal models without sacrifice them. In this context, noninvasive 
methods available for the diagnosis and prognosis of liver diseases bring a significant 
contribution for the progress of this field of study. Prior animal research may support the 
step forward to human clinical trials. 
Rodents represent an important animal group used in experimental model of liver diseases. 
Steatosis, cirrhosis and some hepatic focal lesions can be induced in mice and rats by 
administration of toxins, among which carbon tetrachloride (CCL4), ally alcohol, retrorsine 
and 2-acetylaminofluorene (2-AAF), by surgical insult such as bile duct ligation or hepatic 
resection, and virus infection. The induced hepatopathies may present change in liver size, 
shape, position, or opacity and these parameters can be evaluated by ultrasound imaging. 
US imaging is an ideal complementary diagnostic tool to evaluate the liver. Hepatic 
ultrasound can noninvasively examine the internal architecture of the liver parenchyma, 
biliary system, portal and hepatic vascular supply. Also, ultrasonography allows assessment 
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of changes in liver echogenicity, which correlates with disease (Lessa et al., 2010); identifies 
focal verses diffuse disease processes (Lima et al., 2008); detects vascular and biliary 
abnormalities (Partington & Biller, 1995). Additionally, besides being a noninvasive method, 
US is innocuous, reliable, rapid, reproducible and inexpensive, with high accuracy in 
evaluating liver disease. 
2.1 Scanning techniques for hepatic ultrasound in rodents 
Tranquilization is always required. In our experience, animals are successfully anesthetized 
using Ketamine (0.5mL/kg) and Xilazin (1mL/kg) intraperitoneally or by inhalation of 
Isoflurane, USP. If possible, the rodent should be fasting for 12 hours. This preparation may 
prevent vomiting and aspiration during anesthesia and helps reducing the sonographic 
barriers of excessive gas in the stomach and intestine. 
The ventral abdomen must be shaved or have the hair removed with a commercially 
available hair remover creme to reduce imaging artifacts in the ultrasonographic 
examination. A sound-conducting gel is applied and the US examination can be performed 
in rats using a multifrequencial linear transducer (7.5 to 12MHz) attached to a conventional 
ultrasound machine or can be performed in mice and in rats using mechanical sector high 
resolution transducers (30 MHz and 40 MHz) in a dedicated ultrasound equipment for small 
animals (Vevo 770 - Visualsonics – Canada). 
The animals are positioned in dorsal recumbence on a rectangular table for liver, hepatic 
artery and portal vein scanning. The liver is assessed by placing the transducer just distal to 
the last right costal cartilages and angling its beam cranially, obtaining multiple transversal 
and longitudinal scans (Fig. 1A-D). The hepatic artery and portal vein are scanned in the 
longitudinal views.  
 
 
Fig. 1. Liver scanning: [1.A] Longitudinal scans are made by angling the transducer beam 
from right to left; [1.B] Transversal scans are made by angling the transducer beam from 
cranial to caudal; [1.C] High resolution mechanical sector transducer; [1.D] Dedicated 
ultrasound table with inhalatory anesthesia system. 
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2.2 The normal hepatic ultrasound 
In order to standardize normal US parameters, our research group has examined 276 
healthy Wistar rats. Such as described in small animals, the liver is bounded cranially by the 
concave highly echogenic curvilinear structure of the diaphragm-lung interface. It is 
bordered caudally by the fluid and gas reverberations in the fundus and body of the 
stomach to the left, and the pylorus and right kidney to the right. The anatomy divides the 
rat liver in four lobes: the right lateral lobe, middle, left lateral and caudate lobes, which in 
turn have independent portal and arterial vascularization and a separate biliar drainage. 
The right lateral lobe is subdivided into two segments, anterior and posterior, the last one 
adjacent to the right kidney and placed behind the inferior vena cava. The left lateral lobe is 
located on the left, in front of the stomach. In the midline, the caudate lobe is located 
dorsally and the median lobe lies ventrally. 
The liver has homogeneous parenchyma with medium level echogenicity and straight 
hepatic surface as normal characteristics (Fig. 2A) (Dias et al., 2008; Lessa et al., 2010; 
Manheimer et al., 2009). In the 276 rats we examined, the transverse diameter of the liver 
measures from 3.5 to 3.8 cm and the portal vein caliber between 1.5 mm and 1.6 mm. The 
hepatic parenchyma is less echogenic than the right renal cortex in the great majority of 
rodents. Similar echogenicity in both organ parenchymas is observed in less than 5% of 
them (Lessa et al., 2008). The ultrasonographer should attempt to obtain images of the liver 
adjacent to the right kidney (longitudinal scan) (Fig. 2B). These images have to be made with 
proper control settings to prevent an incorrect diagnosis of diffuse hepatic disease. The 
hepatic parenchyma contains variably sized circular and tubular anechoic structures that 
represent the hepatic and portal veins (Partington & Biller, 1995).  
 
 
Fig. 2. Liver sonograms of a healthy rat: [2.A] Transversal sonogram shows homogeneous 
liver parenchyma, with medium level echogenicity and a regular hepatic surface 
(arrowheads); [2.B] Longitudinal sonogram presents right renal cortex more echogenic than 
liver parenchyma.  
The caudal vena cava and the portal vein are parallel and run longitudinally.  The portal 
vein caliber is measured in the mid-point of the main portal vein (Fig. 3A). Intrahepatic bile 
ducts are not identified routinely with ultrasound. Rats do not have gallbladder but mice do 
have it. The spleen has a homogeneous parenchyma (Fig.3B).  
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Fig. 3. [3.A] Longitudinal sonogram: portal vein (PV) (arrows) and the caudal vena cava 
(CVC) (arrowheads) in a healthy rat; [3B] Spleen sonogram: measurement of its area.   
In high resolution ultrasound equipment specially designed to evaluate small animals the 
liver parenchyma and the relationship between liver/kidney echogenicity in rodents can be 
accurately examined. The portal vein caliber of the mice measures around 1.0 mm and the 
hepatic artery around 0.2 mm. This equipment allows to use the Doppler method to 
evaluate vascular resistance. The hepatic artery has a normal low resistance flow with the 
resistive index (RI) measuring around 0.50 (Fig. 4A-C). Resistive index (RI) is calculated 





    
Fig. 4. [4.A] Longitudinal scan: normal liver parenchyma less echogenic than the renal 
cortex. [4B] Longitudinal scan:  normal portal vein (PV) - caliber: 0.85 mm. [4C] Doppler 
spectrum: normal low resistance flow of the hepatic artery with high diastolic flow. 
2.3 Difuse hepatic disease 
Difuse hepatic disease may cause a change in the echogenicity of hepatic parenchyma (Dias 
et al., 2008; Lessa et al., 2010). Increased echogenicity is identified as hepatic echogenicity 
equal or greater than the renal cortex and similar to the spleen (Lessa et al., 2010; Lima et al., 
2008; Partington & Biller, 1995). Diseases that may cause an increase in hepatic echogenicity 
include cirrhosis, hepatic steatosis, steroid hepatopathy, lymphosarcoma, and long-term 
cholangiohepatitis (Partington & Biller, 1995).  
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In 2005, Lee et al. demonstrated that B-mode mean grey level has a close correlation with 
fatty change and it is useful for the diagnosis of liver fibrosis (Lee et al., 2005). In 2008, it was 
described that US revealed steatosis based on liver echogenicity relative to the kidney and 
could detect focal lesions up to 0.5 mm in a rat model of NASH (non-alcoholic 
steatohepatitis) with cirrhosis (Lima et al., 2008).  
In 2010, our group determined the reliability of US findings in the assessment of fatty liver 
disease and cirrhosis in rats in comparison to histological results by following up a rat 
model of hepatic disease induced by dual exposure to CCl4 and ethanol (Lessa et al., 2010). 
In brief, ultrasound analysis was performed after 4, 8 and 15 weeks of liver injury induction, 
following the scanning techniques for hepatic ultrasound in rodents described above. 
Ultrasonographic findings were analyzed based on our previous observations and on 
criteria for US diagnosis in humans according to the following classification: 
A. Liver echogenicity (Fig. 5) - four patterns: (0) homogeneous liver parenchyma with 
medium level echogenicity and a regular hepatic surface; (1) diffusely increased 
parenchymal echogenicity, reduced visualization of the diaphragm and small peripheral 
vessels  with no change on liver surface; (2) discrete coarse and heterogeneous parenchymal 
echogenicity, dotted or slightly irregular liver surface; (3) extensive coarse and 
heterogeneous parenchymal echogenicity, irregular or nodular hepatic surface with 
underlying regenerative nodules; 
 
 
Fig. 5. Liver echogenicity patterns:  
[5A] Pattern 0  
[5B] Pattern 1 
[5C] Pattern 2 
[5D] Pattern 3 
B. Inversion of the echographic relationship between the liver and the renal cortex (Fig. 6). 
This finding was considered to be positive if the echogenicity of the liver parenchyma was 
greater or equal to the right renal cortex, instead of lesser than it; 
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Fig. 6. Relationship between liver and right kidney echogenicities: Longitudinal scan       
[6A] Liver is less echogenic than right renal cortex; [6B] Hepatic echogenicity is equal to the 
right renal cortex in a cirrhotic liver; [6C] Hepatic parenchyma is more echogenic than right 
renal cortex in a steatotic liver. 
C. Increased portal vein caliber (PVC). PVC was considered to be abnormal if equal or 
greater than 2.1 mm; 
D. Presence of ascites; 
E. Spleen area; 
F. Doppler waveforms of the hepatic artery shows an increase in the resistive index due to 
the difficult inflow related to the presence of diffuse liver disease. 
The liver parenchymal echogenicity changes correlates to the time of injury induction. The 
first pattern of liver echogenicity (pattern 0) is identified in normal rats. The pattern 1 
correlates to fatty liver without/with minimal fibrosis. The pattern 2 corresponds to 
steatosis associated to different degrees of fibrosis and pattern 3 correlates to cirrhosis. 
Cirrhosis may present nodules from macronodular regeneration (Lessa et al., 2010; 
Partington & Biller, 1995). As these nodules are most commonly isoechoic, their 
identification by ultrasound is difficult (Biller et al., 1992).  
The hepatic echogenicity increases due to the presence of fatty infiltration and/or fibrosis, 
changing the relation between liver and right renal cortex (Biller et al., 1992). In our 
experience, this inversion had high sensitivity (90%), specificity (100%), positive and 
negative predictive values (100% and 76.9% respectively), and accuracy (92.5 %) for the 
detection of hepatic steatosis (Lessa et al., 2010), which is compatible with the findings 
described in the literature (Biller et al., 1992; Palmentiere et al., 2006).  
Rats with mild hepatic steatosis can appear to be normal in US examination (Lessa et al., 
2010). The US has been reported to have sensitivity of 90-91% for the detection of moderate 
to marked steatosis, but its sensitivity decreases to 30–64% when fatty liver is mild (Biller et 
al., 1992; Palmentiere et al., 2006). In addition, it is important to exclude kidney diseases 
when using this approach (Biller et al., 1992). 
The evaluation of portal hypertension is important to access the severity of the disease. One 
of its most important signs is the widening of the portal vein (Fig.7). The PVC presented 
statistically significant differences (p<0.001) between cirrhotic and non-cirrhotic rats. The 
increase in its caliber, which was greater or equal to 2.1mm, can be considered a relevant 
ultrasound parameter, with sensitivity of 100% and specificity of 90.5 % (Lessa et al., 2010). 
Additionally, a 50% increase in PVC after cirrhosis induction can be another good parameter 
for advanced hepatic fibrotic change (Mannheimer et al., 2009). 
Among the imaging diagnostic methods, the ultrasound is considered ideal for the study of 
ascites, which can be observed even when mild. Considering diffuse hepatic disease, the 
presence of ascites invariably corresponds to cirrhosis (Fig. 8)  
 




Fig. 7. Portal vein caliber (PVC): Longitudinal scans - [7A] Straight and thin portal vein 
(caliber=1.4 mm) in a healthy rat (arrows); [7B] Tortuous and dilated portal vein (caliber=2.2 
mm) in a cirrhotic rat (arrows). 
 
 
Fig. 8. [8A] Transversal liver sonogram shows a small cirrhotic liver with marked ascites; 
[8B] Longitudinal sonogram presents a great amount of ascites surrounding the spleen. 
2.4 Focal liver lesions 
Focal hepatic lesions are more easily detected by ultrasound when these lesions have  
a different echogenicity than the surrounding normal liver. Focal hepatic diseases  
include cysts, hematomas, abscess, granulomas, regenerative nodules, primary and 
metastatic neoplasms (Partington & Biller, 1995). US usually detects and characterize 
these lesions. 
Regenerative hepatic nodules are benign reorganized masses of hepatic tissue that contain 
lipid, blood-filled sinusoids, lymphocytes and areas of atrophied or necrotic hepatocytes. 
These nodules are most commonly isoechoic and can be multiple and variably sized  
(Fig. 9). 
Primary hepatic neoplasia may appear as solitary or multiple focal lesions that can be hypo, 
iso or hyperechoic in relation to normal liver.  Also it can appear as a very large, moderately 
circumscribed or infiltrating mass. The US appearance of liver neoplasia is not specific for 
the histopathological cell type (Partington & Biller, 1995). 
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Fig. 9. Transversal sonogram shows a cirrhotic liver with an isoechoic regenerative nodule 
(arrow).  
3.  Human liver ultrasound imaging 
The liver is the largest abdominal organ weighting 1.5 kg and lying in the right side of the 
upper abdomen under the right hemidiaphragm and extending across the midline to the left 
hypochondrium. The parenchymal echoes are a mid-grey and consist of a uniform, sponge-
like pattern interrupted by the vessels. In transverse sections the wedge shape of the liver is 
seen, tapering to the left (Fig.10A).  The caudate lobe is seen as an extension of the right lobe 
in transverse sections and as an almond-shaped structure posterior to the left lobe in 
longitudinal views (Fig.10B). In the longitudinal sections the liver has a triangular shape, the 
right lobe larger than the left (Fig. 10C).  
 
 
Fig. 10. [A] Transversal section of normal liver with the hepatic veins draining into the 
inferior vena cava. [B] Longitudinal scan of the left and caudate lobe being separated by the 
fissure of the ligamentum venosum (arrowhead); [C] Longitudinal scan of the liver: normal 
left lobe and right lobe. 
3.1 Technique 
The liver is best imaged with the patient supine or in a right anterior oblique position. 
Intercostal imaging is always required, in which case the transducer is placed parallel to the 
adjacent ribs to avoid acoustic shadowing. Multiplanar imaging of the liver is obtained.  
Sagittal, transverse, coronal and subcostal oblique views are required.  A 5-2 MHz curved 
array transducer with appropriate gain and depth settings permits adequate visualization of 
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liver should be imaged in real-time in the sagittal and transverse or oblique planes. The left 
lobe is usually best imaged with the patient supine and the transducer placed in an anterior 
subxiphoid position. Real-time imaging during suspended deep inspiration allows the most 
superior aspects of the left lobe to be visualized. The right lobe usually requires an 
intercostal or subcostal oblique approach with the patient supine and in the left-side-down 
decubitus position. Certain regions are more difficult to image such as the high dome and 
the lateral aspect of the right lobe of the liver, usually best imaged from subcostal oblique 
and intercostal planes in suspended inspiration. The patient should be fasting for at least 6 
hours prior to the exam to limit bowel gas and so that the gallbladder is not contracted. 
3.2 Focal liver lesions 
Liver masses are increasingly being identified due to the widespread use of imaging   
modalities. The majority of these lesions are detected incidentally in asymptomatic patients.  
Characterization of a liver mass on sonography is based on the appearance of the mass on 
gray scale imaging as well as on vascular information that may be obtained on Doppler 
examination.  
3.2.1 Hepatic cysts 
Simple cysts are usually described as congenital lesions, but are probably better considered 
developmental, since their frequency increases with age. Simple hepatic cysts are usually 
solitary, have a thin epithelial lining, and contain watery fluid. Their size varies from less 
than 1 cm to more than 20 cm in diameter. Simple cysts are found 4 times more frequently in 
females than males. Symptoms are rare, but may occur from mass effect, rupture, 
hemorrhage or infection. The classic sonographic findings are well known: a well defined, 
anechoic lesion with a well-demarcated, thin wall and good distal sonic enhancement (Fig. 
11A). Thin septations are frequent, and should not suggest a different diagnosis. 
Occasionally there may occur cyst hemorrhage or infection when it will contain internal 
echoes and septations, a thickened wall and may appear solid (Fig. 11B). If thick septae or 
nodules are seen, differential diagnosis of biliary cystadenomas and cystic metastases must 
be considered. Acquired cysts are usually secondary to trauma, inflammation or parasitic 
infection and are indistinguishable from primary cysts. Cyst ablation with alcohol or 
surgical excision can be performed if indicated. 
 
 
Fig. 11. [A] Hepatic cyst: a well defined, anechoic lesion with a thin wall and good distal 
enhancement; [B] Hemorrhagic cyst - a well defined cystic lesion with internal amorphous 
echoes and septation; [C] Polycystic liver disease: multiple anechoic cysts of varying sizes, 
thin walls and posterior distal enhancement. Note that some cysts contain internal echoes 
with fluid/fluid level due to internal hemorrhage. 
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right lobe larger than the left (Fig. 10C).  
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liver should be imaged in real-time in the sagittal and transverse or oblique planes. The left 
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decubitus position. Certain regions are more difficult to image such as the high dome and 
the lateral aspect of the right lobe of the liver, usually best imaged from subcostal oblique 
and intercostal planes in suspended inspiration. The patient should be fasting for at least 6 
hours prior to the exam to limit bowel gas and so that the gallbladder is not contracted. 
3.2 Focal liver lesions 
Liver masses are increasingly being identified due to the widespread use of imaging   
modalities. The majority of these lesions are detected incidentally in asymptomatic patients.  
Characterization of a liver mass on sonography is based on the appearance of the mass on 
gray scale imaging as well as on vascular information that may be obtained on Doppler 
examination.  
3.2.1 Hepatic cysts 
Simple cysts are usually described as congenital lesions, but are probably better considered 
developmental, since their frequency increases with age. Simple hepatic cysts are usually 
solitary, have a thin epithelial lining, and contain watery fluid. Their size varies from less 
than 1 cm to more than 20 cm in diameter. Simple cysts are found 4 times more frequently in 
females than males. Symptoms are rare, but may occur from mass effect, rupture, 
hemorrhage or infection. The classic sonographic findings are well known: a well defined, 
anechoic lesion with a well-demarcated, thin wall and good distal sonic enhancement (Fig. 
11A). Thin septations are frequent, and should not suggest a different diagnosis. 
Occasionally there may occur cyst hemorrhage or infection when it will contain internal 
echoes and septations, a thickened wall and may appear solid (Fig. 11B). If thick septae or 
nodules are seen, differential diagnosis of biliary cystadenomas and cystic metastases must 
be considered. Acquired cysts are usually secondary to trauma, inflammation or parasitic 
infection and are indistinguishable from primary cysts. Cyst ablation with alcohol or 
surgical excision can be performed if indicated. 
 
 
Fig. 11. [A] Hepatic cyst: a well defined, anechoic lesion with a thin wall and good distal 
enhancement; [B] Hemorrhagic cyst - a well defined cystic lesion with internal amorphous 
echoes and septation; [C] Polycystic liver disease: multiple anechoic cysts of varying sizes, 
thin walls and posterior distal enhancement. Note that some cysts contain internal echoes 
with fluid/fluid level due to internal hemorrhage. 
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Polycystic renal disease is a relatively common congenital condition and has an autosomal 
dominant mode of inheritance. Liver cysts are associated with this condition in 
approximately 57% to 74% (Levine et al., 1985). The most common presentation is 
hepatomegaly.  The ultrasound appearance of multiple cysts of varying sizes, thin walls and 
posterior acoustic accentuation is characteristic (Fig. 11C). Hemorrhage or infection in the 
cysts may produce internal echoes. Acoustic accentuation beyond each cyst may produce 
the impression of an abnormal liver parenchymal texture. There may be cysts in other 
organs like pancreas, spleen, ovaries and lungs. Usually they do not require any treatment 
and complications are rare including hemorrhage, rupture or infection. 
3.2.2 Biliary hamartomas (von Meyenburg Complexes) 
Bile duct hamartomas are small focal developmental lesions composed of groups of dilated 
intrahepatic bile ducts with a collagenous stroma. They are benign liver malformations that 
are detected incidentally in 0.6 to 5.6% of reported autopsy series (Redston & Wanless, 
1996). Commonly they are documented on sonograms as bright echogenic foci with distal 
ringdown or comet tail artifacts, diffusely distributed until the periphery of the liver (Fig. 
12A-B) that could be related to the presence of tiny cysts beyond the resolution of the 
ultrasound equipment or to the cholesterol crystals within the dilated tubules. They may 
also appear as well-defined small hypoechoic solid nodules (Fig. 12C-D). 
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Fig. 12. Biliary hamartomas: [A-B] multiple bright echogenic foci some of them with distal 
ringdown or comet tail artifacts, diffusely distributed until the periphery of the liver; [C-D] 
Small hypoechoic nodule that on MRI was confirmed to be von Meyenburg complex. 
3.2.3 Hydatid disease 
The liver is the most frequently involved organ in hydatid disease but other sites may be 
involved, such as the lungs, the bones, the brain and the peritoneal cavity.  In the liver the 
right lobe is more frequently involved where they form slow-growing cysts. Lewall & 
McCorkell (1985) proposed four groups of sonographic features of hepatic hydatid disease:  
solitary cysts containing sand; cysts with detached endocyst secondary to rupture; cysts 
with daughter cysts; and densely calcified masses. The distinction between simple and 
hydatid cysts may be one of the following features: wall calcification, debris consisting  
of sand and the two layers of the wall resulted from detachment and collapse of the inner 
germinal layer from the exocyst. The development of daughter cysts produces a 
characteristic appearance.    
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3.2.4 Hepatic abscess 
Liver abscesses are frequently related to direct extension from the biliary tract infection in 
patients with suppurative cholangitis and cholecystitis or to complications of an intra-
abdominal infection with direct portal venous system spread to the liver, such as 
diverticulitis or appendicitis. They may also be present in the liver as a result of blunt or 
penetrating trauma or through the hepatic artery in patients with osteomyelitis and 
subacute bacterial endocarditis. No cause can be found in approximately 50% of the cases of 
hepatic abscesses (Wilson & Withers, 2005). 
Sonographically, pyogenic liver abscess has a variable appearance. Typically, pyogenic 
abscesses are poorly defined, irregularly marginated, and primarily hypoechoic. Irregular 
areas of increased echogenicity are frequent (Fig.13A-B). Bright punctate echoes often 
represent gas within the abscess. On occasion, a diffusely hyperechoic appearance may be 
noted, related to large amounts of gas from gas-forming organisms (Fig. 13C-D). Fluid-fluid 
interfaces, internal septations and debris can be observed. The abscess wall can vary from 
well-defined to irregular and thick. Diffuse microabscesses may occasionally cause a 
confusing sonographic pattern of increased irregular hepatic echogenicity. The differential 
diagnosis of pyogenic liver abscess includes complicated hepatic cysts with hemorrhage, 
hematoma, amebic infection and necrotic neoplasm.  
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Fig. 13. [A-B] Hepatic abscess - Thick wall fluid collection with hyperechoic heterogeneous 
internal echoes; [C-D] Gas forming abscess - diffusely irregular hyperechoic lesion with 
posterior accoustic attenuation. 
Entamoeba histolytica primarily infects the colon. Transmission is by the fecal-oral route. 
Amebic liver abscess is the most common non-enteric complication of amebiasis. The most 
common presenting symptom is pain. An amebic abscess may be indistinguishable from a 
pyogenic abscess. Sonographic features include lack of a significant wall echo, symmetric 
oval or round configuration, hypoechogenicity compared to normal liver with a 
homogeneous pattern of internal echoes, increased sound transmission and subcapsular 
location (Fig. 14). Ralls et al. (1987a) in a review of 112 amebic lesions described two 
sonographic patterns that were more prevalent in amebic abscesses: round or oval shapes in 
82% versus 60% of pyogenic abscess and hypoechoic appearance with fine internal echoes at 
high gain in 58% versus 36% of pyogenic abscesses. The majority of hepatic amebic 
abscesses disappear with amebicidal drugs (Ralls et al., 1987b). 
3.2.5 Cavernous hemangioma 
Cavernous hemangiomas are the most frequently encountered benign tumor of the liver and 
are seen in 1 to 4% of the population as an incidental finding. These lesions are most  
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are seen in 1 to 4% of the population as an incidental finding. These lesions are most  
 
 




Fig. 14. Amebic abscess: lack of significant wall echo, round hypoechoic liver lesion with 
increased sound transmission and subcapsular location. 
commonly seen in women with a female/male ratio of 5:1 (Snover, 2009). Hemangiomas are 
composed of dilated endothelial-lined vascular channels, infiltrated by varying degrees of 
fibrous stroma. 
The typical hemangioma is a uniformly well circumscribed hyperechoic mass less than 3 cm 
in diameter. These lesions are often small and can be multiple (Fig. 15A-B). The increased 
echogenicity has been related to the numerous interfaces between the walls of the cavernous 
sinuses and the blood within them. In the setting of hepatic steatosis or cirrhosis, however, 
they may appear hypoechoic. Although this lesion is hyperechoic, in many cases 
hemangiomas will exhibit posterior acoustic enhancement because the dilated, fluid-filled 
sacs of blood do not attenuate sound. An atypical but not uncommon sonographic 
appearance of the hemangioma is a lesion with an echogenic rim and an internal hypoechoic 
pattern (Wilson & Withers, 2005) (Fig.15C-D). Larger lesions tend to be heterogeneous with 
central hypoechoic foci corresponding to fibrous collagen scars, large vascular spaces, or 
both. Calcification is rare. Hemangiomas only rarely demonstrate internal flow on Doppler 
studies, due to the multidirectionality and slow velocity of flow. There are potentially 
significant lesions that may mimic the morphology of a hemangioma on ultrasound and 
produce a single mass or multiple masses of uniform increased echogenicity such as 
metastases from a colon primary tumor; small hepatocellular carcinomas (HCC) may show 
this morphology. Caturelli et al. (2001) in a prospective evaluation of 1982 patients with 
newly diagnosed cirrhosis found that 50% of echogenic liver lesions suggestive of  
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Fig. 15. Hemangioma: [A-B] Typical hemangioma: hyperechoic round lesion at the posterior 
segment of the right lobe of the liver with posterior acoustic enhancement; [C-D] Multiple 
hemangiomas: Multiple echogenic lesions with central hypoechoic areas. 
 
Ultrasonic Imaging in Liver Disease: From Bench to Bedside 
 
139 
hemangiomas had the diagnosis of HCC. These results emphasize the importance to prove 
the diagnosis of all masses with this morphology in high-risk patients. 
3.2.6 Focal nodular hyperplasia 
Focal nodular hyperplasia (FNH) is the second most commonly encountered benign liver 
lesion and is seen most often as an incidental observation in a young adult female. FNH is 
not an actual neoplastic tumor but represents instead a hyperplastic response to an 
underlying vascular malformation in the liver. Histologically, it is made up of normal liver 
components, including hepatocytes and Kupffer cells. FNH is a hypervascular lesion, often 
showing a central stellate vascularity and a large and tortuous feeding artery. On 
sonography, FNH is often a subtle liver mass that is difficult to differentiate in echogenicity 
from the adjacent liver parenchyma (Fig.16A-B). The lesions may be slightly hypoechoic, 
isoechoic, or slightly hyperechoic than the surrounding liver. Use of color and power 
Doppler US may add information concerning the vascularity of the suspected FNH.  
In addition, use of US contrast media to characterize FNH has been reported. These lesions 
usually produce a contour abnormality to the surface of the liver or may displace the normal 
blood vessels within the parenchyma. The central scar may be seen on gray-scale sonograms 
as a hypoechoic linear or stellate areas within the central portion of the mass. Well-
developed peripheral and central blood vessels are seen to course within the central scar 
with either a linear or stellate configuration (Fig.16C-D).  Spectral interrogation usually 
shows predominantly arterial signals centrally. 
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Fig. 16. Focal Nodular Hyperplasia. [A-B] Isoechoic large lesion in the right lobe deforming 
the contour of the liver with a subtle hypoechoic central area; [C-D] Color Doppler showing 
stellate pattern blood vessels within the central scar. 
3.2.7 Hepatic adenoma 
Hepatic adenomas (HA) are less common than FNH, benign neoplasms, usually solitary and 
well encapsulated, ranging in size from 8 to 15 cm, which have a small risk for malignant 
transformation into hepatocellular carcinoma, as well as a propensity for hemorrhage and 
rupture. The majority of these lesions occur in young women taking oral contraceptives. The 
risk of developing HAs is related to both the duration of use and dose of hormones. These 
lesions regress when oral contraceptives are discontinued (Fig.17A-F). Other populations 
noted to have an increased incidence of HAs include individuals with type I glycogen 
storage disease. In these patients, hepatic adenomas tend to be multiple. The sonographic 
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Fig. 16. Focal Nodular Hyperplasia. [A-B] Isoechoic large lesion in the right lobe deforming 
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Hepatic adenomas (HA) are less common than FNH, benign neoplasms, usually solitary and 
well encapsulated, ranging in size from 8 to 15 cm, which have a small risk for malignant 
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appearance is nonspecific. Although in 70% to 80% of cases, HAs present as a solitary and 
large hyperechoic lesion with central anechoic areas, corresponding to zones of internal 
hemorrhage, they can be isoechoic or complex masses. It is difficult to distinguish hepatic 
adenoma from FNH. Color Doppler evaluation can be helpful, demonstrating peripheral 
and intratumoral vessels showing increased venous structures within the center of the mass 
and a paucity of arterial vessels (Fig.17G-H). These lesions are substantially less vascular 













Fig. 17. Hepatic Adenoma: [A-F] Isoechoic lesion in the left lobe of the liver that diminished 
in size as oral contraceptives were discontinued (A-B: 1st exam, C-D: 2nd exam, E-F: 3rd exam- 
every two months); [G-H] Color Doppler showing predominantly peripheral vessels. 
3.2.8 Hepatocellular carcinoma   
Hepatocellular carcinoma (HCC) is the commonest primary liver cancer, comprising 80% of 
primary liver malignancies in the United States. The majority of HCC patients (95% in the 
western, 60% in Asian countries) will develop the disease on the ground of preexisting liver 
cirrhosis. Alcoholic cirrhosis-related HCC has a lower frequency (10% of autopsied patients) 
than HBV or HCV (Parkin et al., 2005). Although α-fetoprotein (AFP) is a known and 
specific tumor maker for HCC, it is not suitable for the screening and surveillance of HCC 
because of its poor predictive value and low sensitivity. The use of imaging modalities is 
essential for the screening, diagnosis and treatment of HCC. US plays a major role among 
them, because it provides real-time and noninvasive observation by a simple and easy 
technique. The development of digital technology has led to the detection of blood flow by 
color Doppler US, and the sensitivity for detecting tumor vascularity has shown remarkable 
improvement with the introduction of microbubble contrast agents.  Screening generally 
consists of serologic testing for alpha-fetoprotein and/or hepatitis B and C, often coupled 
with sonography of the liver. Some studies showed that surveillance based on US and AFP 
every 6-12 months improved the survival of patients (Bolondi et al., 2001; Sangiovanni et al., 
2004). Pathologically HCC occurs in three forms: 1. Solitary tumor; 2. Multiples nodules; 3. 
Diffuse infiltration. Sonographic findings in HCC are variable, and may cause difficulty in 
distinguishing advanced HCC from metastatic disease. This is less of a problem in screening 
programs, where HCCs less than 5 cm are often detected. In these small lesions, sonographic 
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findings are not as diverse. About 75% of small HCCs (<5 cm) are hypoechoic (Fig.18A-B). 
As HCCs enlarge, they tend to develop hypoechoic peripheral rims. With further 
progression, lesions become more numerous and heterogeneous. Some hepatocellular 
carcinomas, even small lesions, undergo fatty metamorphosis, causing increased 
echogenicity and potential confusion with hemangioma. Hepatocellular carcinomas arising 
in normal livers are uncommon. Fibrolamellar HCC, which accounts for 2% of 
hepatocellular carcinoma, but 25% to 50% of HCC in young adults, often arises as a single 
well-circumscribed lesion with lobulated margins in an otherwise normal liver. Other 
features may include a “central scar” and a high prevalence of calcification. Vascular 
invasion is common and should suggest the diagnosis of HCC. HCC invades portal veins 
more frequently than hepatic veins. Intravascular tumor is usually reflective and expands 
the vessel, but positive differentiation from blood thrombus depends on detecting arterial 
Doppler signals from within the thrombus (Fig. 18C-F); only venous signals are found in 
blood thrombus as it is recanalized. HCC has a characteristic hypervascular appearance 
with centripetal blood flow, and a basket pattern is one of the typical findings of HCC by 
color Doppler imaging (Tanaka et al., 1990). Using microbubble contrast agents HCC shows 
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Fig. 18. Hepatocellular Carcinoma: [A-B] Lobulated hypoechoic lesion in the periphery of 
the right lobe; [C-F] Hipoechoic lesion in segment IV with portal tumoral thrombus. Note on 
color Doppler that the lesion has intra and peripheral vascularity (E) and that there is 
arterial flow inside the portal vein (F). 
3.2.9 Cholangiocarcinoma 
Cholangiocarcinoma arises from the bile ducts, and account for about 10% of all primary 
liver cancers. Cholangiocarcinoma is associated with hemochromatosis, ulcerative colitis, 
Caroli disease and choledochal cyst. Cholangiocarcinoma has two forms, peripheral 
cholangiocarcinoma (PCC) and hilar cholangiocarcinoma, also known as Klatskin tumor, 
when it involves the confluence of the left and right hepatic ducts at the porta hepatis. In the 
 
Ultrasound Imaging – Medical Applications 
 
140 
appearance is nonspecific. Although in 70% to 80% of cases, HAs present as a solitary and 
large hyperechoic lesion with central anechoic areas, corresponding to zones of internal 
hemorrhage, they can be isoechoic or complex masses. It is difficult to distinguish hepatic 
adenoma from FNH. Color Doppler evaluation can be helpful, demonstrating peripheral 
and intratumoral vessels showing increased venous structures within the center of the mass 
and a paucity of arterial vessels (Fig.17G-H). These lesions are substantially less vascular 













Fig. 17. Hepatic Adenoma: [A-F] Isoechoic lesion in the left lobe of the liver that diminished 
in size as oral contraceptives were discontinued (A-B: 1st exam, C-D: 2nd exam, E-F: 3rd exam- 
every two months); [G-H] Color Doppler showing predominantly peripheral vessels. 
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findings are not as diverse. About 75% of small HCCs (<5 cm) are hypoechoic (Fig.18A-B). 
As HCCs enlarge, they tend to develop hypoechoic peripheral rims. With further 
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United States, PCC is 3 times more common than hilar cholangiocarcinoma. The prevalence 
is equal in Japan. PCC is usually a large tumor, while hilar cholangiocarcinoma presents 
earlier with ductal obstruction and jaundice, and is usually not associated with a large mass. 
Hemochromatosis is associated with both PCC (9% of patients) and HCC (18% of patients). 
The sonographic findings in PCC are variable. In general, cholangiocarcinomas are hard  
to visualize with all modalities. Some investigators report predominance of hypoechoic 
lesions, and others predominantly hyperechoic lesions. Our experience suggests that slightly 
hypoechoic lesions are more frequent. Portal venous invasion is frequent. Sonography  
is generally superior to multiphase helical CT in demonstrating masses associated with hilar 
cholangiocarcinomas. Dilatation of the biliary tree can be followed down to the point  
of obstruction, where it may be possible to detect a solid, poorly reflective mass which,  






Fig. 19. Cholangiocarcinoma: large hilar hypoechoic mass with right and left intrahepatic 
bile ducts dilatation. 
3.2.10 Metastatic disease 
In the United States, metastatic disease is by far the most common significant focal liver lesion. 
Metastases are 18 to 20 times more common than hepatocellular carcinoma (HCC) and 
produce symptoms 10 times more frequently. In one large autopsy series (Edmonson, 1987), 
38% of all patients with carcinoma had hepatic metastases. The most common carcinomas 
metastasizing to the liver include, in order of decreasing frequency: gallbladder, colon, 
stomach, pancreas, breast and lung. Metastatic disease is multifocal in approximately 90% of 
patients. Most metastases to the liver are blood-borne via the hepatic artery or portal vein. The 
portal vein provides direct access to the liver for tumor cells originating from the 
gastrointestinal tract and probably accounts for the high frequency of liver metastases from 
organs that drain into the portal circulation. Virtually any sonographic appearance may occur 
in liver metastasis. The following sonographic appearances of metastatic liver disease have 
been described: echogenic, hypoechoic, target, calcified, cystic and diffuse. Hypoechoic halos 
are common. The presence of a hypoechoic halo surrounding a liver mass has been regarded 
as an ominous sign with a high association with malignancy, particularly metastatic disease. 
Wernecke et al. (1992) described the importance of the hypoechoic halo in the differentiation of 
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malignant from benign focal hepatic lesions. Its identification has a positive and negative 
predictive value of 86% and 88%, respectively. Echogenic metastases tend to arise from a 
gastrointestinal origin or from HCC (Fig.20A). While it must be emphasized that sonographic 
appearance is a poor predictor of the primary tumor, certain patterns may be suggestive. For 
example, large to moderate-sized hyperechoic metastases, especially those with 
microcalcifications, should suggest the possibility of a colonic primary. A target or bull’s eye 
appearance with varying rings of hypo- and hyperechogenicity are common (Fig. 20B). Ill-
defined infiltrative disease with focal nodularity is another fairly frequent pattern. Metastasis 
and HCC may be impossible to distinguish sonographically, although the presence of 
underlying liver disease favors HCC. Invasion of the portal or hepatic veins suggests 
hepatocellular carcinoma, rather than metastasis. Most liver metastases that are hypoechoic are 
hypovascular. Colon, lung, breast, and gastric cancers are the most common causes of 
hypovascular liver metastases (Fig.20C). The most common causes of hypervascular hepatic 
metastases include neuroendocrine tumors (eg, carcinoid, pheochromocytoma, and islet cell 
tumors), renal cell carcinoma, melanoma, choriocarcinoma, and thyroid carcinoma. Breast 





Fig. 20. Metastases: [A] Multiple echogenic nodular lesions due to HCC metastases (gray 
arrowheads); [B] Bull’s eye appearance and another echogenic lesion secondary to colon 
carcinoma (arrow); [C] Multiple hypoechoic nodular lesions; metastases from 
cholangiocarcinoma (white arrowheads). 
3.3 Diffuse liver disease 
Recent innovations in imaging technology and contrast media development have 
augmented the role of radiology in the detection, characterization, and follow up of diffuse 
liver diseases. Although biopsy still remains the gold standard for establishing the diagnosis 
of diffuse liver disease, imaging is used to narrow the differential diagnosis, to follow up 
patients in which the diagnosis has been made, to detect complications, and to monitor 
response to therapy. 
3.3.1 Fatty liver 
Hepatic steatosis or fatty changes is an acquired, reversible disorder of metabolism and can 
result from a variety of pathologic processes including increased production or mobilization of 
fatty acids (e.g., hyperalimentation, starvation, obesity, steroid use, diabetes mellitus, and 
gastrointestinal bypass surgery) or decreased hepatic clearance of fatty acids from 
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hepatocellular injury (e.g., alcoholic liver disease, hepatitis, drug-induced liver disease, and 
liver transplantation). The distribution of steatosis can be quite variable, ranging from focal to 
regional to diffuse. Histopathologically, the hallmark of all forms of fatty liver is the 
accumulation of fat globules within the hepatocytes. If accompanied by inflammation but not 
associated with alcohol abuse, the condition is called nonalcoholic steatohepatitis. Probably the 
most common cause of a fatty liver is obesity. Correction of the primary abnormality will 
usually reverse the process, although it is now recognized that fatty infiltration of the liver is 
the precursor for significant chronic disease in a percentage of patients. 
Diffuse steatosis is common. It has been detected in up to 7% of abdominal CT 
examinations, and a relatively recent autopsy series found significant steatotic changes in 
7% of nonobese patients and 29% of obese patients (El-Hassan et al., 1992; Wanless & Lentz, 
1990).  Generally, patients with steatosis are asymptomatic, although some individuals may 
present with abnormal liver function tests or right upper quadrant pain, the latter probably 
due to distention of Glisson’s liver capsule from hepatomegaly. In patients with pure 
hepatic steatosis without coexistent hepatocytic injury, weight reduction or stopping the 
underlying etiologic factor usually reduces the amount of fatty change. 
Sonography of fatty infiltration may be varied. Mild steatosis is detected when there is 
minimal diffuse increase in hepatic echogenicity with normal visualization of diaphragm 
and intrahepatic vessels (Fig.21A). Moderate steatosis is seen as moderate increase in 
hepatic echogenicity with slightly impaired visualization of intrahepatic vessels and 
diaphragm (Fig.21B). Severe steatosis is diagnosed when there is marked increase in 
echogenicity with poor penetration of the posterior segment of the right lobe of the liver and 
poor or nonvisualization of hepatic vessels and diaphragm (Fig.21C-D), the so-called bright 
liver on ultrasound (Taylor et al., 1986). Significant findings include hepatomegaly, 
decreased sonographic visualization of portal and hepatic veins and an unusual “fine” liver 






Fig. 21. Diffuse steatosis: [A] Mild steatosis: minimal diffuse increase in hepatic echogenicity 
with normal visualization of diaphragm and intrahepatic vessels; [B]Moderate steatosis: 
moderate increase in hepatic echogenicity with slightly impaired visualization of 
intrahepatic vessels and diaphragm; [C-D] Severe steatosis: marked increase in hepatic 
echogenicity with nonvisualization of hepatic vessels and diaphragm. 
3.3.2 Focal steatosis and focal sparing 
Hepatic fatty change is not always uniform but can present as a focal or regional area of 
steatosis in an otherwise normal liver (focal steatosis) or as subtotal fatty change with sparing 
of certain areas (focal sparing) (Baker et al., 1985).  Both processes are common and may cause 
considerable diagnostic confusion, especially in the workout of primary or metastatic 
malignant liver disease (Baker et al., 1985). Aberrant blood supply to those areas has been 
demonstrated to be the underlying etiology for nonuniform change (Arai et al., 1988). In 
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individuals with focal fatty sparing, it is assumed that the spared regions do not have a normal 
portal blood supply and therefore do not receive lipid-rich blood from the gut. Because of their 
underlying vascular aberrance, most of these spared areas have a characteristic location. For 
example, focal fatty sparing of the medial segment of the left liver lobe results from blood 
supply through the gastric veins, whereas aberrant blood supply from the internal thoracic 
artery has been established in some lesions around the falciform ligament (Matsui et al., 1995). 
Other characteristic locations include areas adjacent to the gallbladder fossa, the subcapsular 
region, and the porta hepatis. Islands of normal liver parenchyma may appear as hypoechoic 




Fig. 22. Multifocal steatosis: multifocal increase in echogenicity of the liver parenchyma, 
sparing the segment IV that appears hypoechoic. 
Less clear is why the same areas that can present as focal fatty sparing also have focal fatty 
infiltration. It is hypothesized that decreased delivery of unknown substances from the 
portal vein and relative ischemia from the paucity of portal blood supply are the main 
causative factors. In focal fatty infiltration, regions of increased echogenicity are present 
within a background of normal liver parenchyma and may present as a pseudonodular 
lesion (Fig.23).  On imaging, several observational clues assist with correct identification of 
focal fatty change or focal spared areas:  
1) typical periligamentous and periportal location,  
2) lack of mass effect,  
3) sharply angulated boundaries,  
4) nonspherical shape,  
5) absence of vascular displacement or distortion, and  




Fig. 23. Pseudonodular steatosis: Echogenic nodule (white arrow) in segment IVB anterior to 
the bifurcation of the portal vein that was confirmed to be a focal nodular steatosis in the 
MRI exam. 
 
Ultrasound Imaging – Medical Applications 
 
144 
hepatocellular injury (e.g., alcoholic liver disease, hepatitis, drug-induced liver disease, and 
liver transplantation). The distribution of steatosis can be quite variable, ranging from focal to 
regional to diffuse. Histopathologically, the hallmark of all forms of fatty liver is the 
accumulation of fat globules within the hepatocytes. If accompanied by inflammation but not 
associated with alcohol abuse, the condition is called nonalcoholic steatohepatitis. Probably the 
most common cause of a fatty liver is obesity. Correction of the primary abnormality will 
usually reverse the process, although it is now recognized that fatty infiltration of the liver is 
the precursor for significant chronic disease in a percentage of patients. 
Diffuse steatosis is common. It has been detected in up to 7% of abdominal CT 
examinations, and a relatively recent autopsy series found significant steatotic changes in 
7% of nonobese patients and 29% of obese patients (El-Hassan et al., 1992; Wanless & Lentz, 
1990).  Generally, patients with steatosis are asymptomatic, although some individuals may 
present with abnormal liver function tests or right upper quadrant pain, the latter probably 
due to distention of Glisson’s liver capsule from hepatomegaly. In patients with pure 
hepatic steatosis without coexistent hepatocytic injury, weight reduction or stopping the 
underlying etiologic factor usually reduces the amount of fatty change. 
Sonography of fatty infiltration may be varied. Mild steatosis is detected when there is 
minimal diffuse increase in hepatic echogenicity with normal visualization of diaphragm 
and intrahepatic vessels (Fig.21A). Moderate steatosis is seen as moderate increase in 
hepatic echogenicity with slightly impaired visualization of intrahepatic vessels and 
diaphragm (Fig.21B). Severe steatosis is diagnosed when there is marked increase in 
echogenicity with poor penetration of the posterior segment of the right lobe of the liver and 
poor or nonvisualization of hepatic vessels and diaphragm (Fig.21C-D), the so-called bright 
liver on ultrasound (Taylor et al., 1986). Significant findings include hepatomegaly, 
decreased sonographic visualization of portal and hepatic veins and an unusual “fine” liver 






Fig. 21. Diffuse steatosis: [A] Mild steatosis: minimal diffuse increase in hepatic echogenicity 
with normal visualization of diaphragm and intrahepatic vessels; [B]Moderate steatosis: 
moderate increase in hepatic echogenicity with slightly impaired visualization of 
intrahepatic vessels and diaphragm; [C-D] Severe steatosis: marked increase in hepatic 
echogenicity with nonvisualization of hepatic vessels and diaphragm. 
3.3.2 Focal steatosis and focal sparing 
Hepatic fatty change is not always uniform but can present as a focal or regional area of 
steatosis in an otherwise normal liver (focal steatosis) or as subtotal fatty change with sparing 
of certain areas (focal sparing) (Baker et al., 1985).  Both processes are common and may cause 
considerable diagnostic confusion, especially in the workout of primary or metastatic 
malignant liver disease (Baker et al., 1985). Aberrant blood supply to those areas has been 
demonstrated to be the underlying etiology for nonuniform change (Arai et al., 1988). In 
 
Ultrasonic Imaging in Liver Disease: From Bench to Bedside 
 
145 
individuals with focal fatty sparing, it is assumed that the spared regions do not have a normal 
portal blood supply and therefore do not receive lipid-rich blood from the gut. Because of their 
underlying vascular aberrance, most of these spared areas have a characteristic location. For 
example, focal fatty sparing of the medial segment of the left liver lobe results from blood 
supply through the gastric veins, whereas aberrant blood supply from the internal thoracic 
artery has been established in some lesions around the falciform ligament (Matsui et al., 1995). 
Other characteristic locations include areas adjacent to the gallbladder fossa, the subcapsular 
region, and the porta hepatis. Islands of normal liver parenchyma may appear as hypoechoic 




Fig. 22. Multifocal steatosis: multifocal increase in echogenicity of the liver parenchyma, 
sparing the segment IV that appears hypoechoic. 
Less clear is why the same areas that can present as focal fatty sparing also have focal fatty 
infiltration. It is hypothesized that decreased delivery of unknown substances from the 
portal vein and relative ischemia from the paucity of portal blood supply are the main 
causative factors. In focal fatty infiltration, regions of increased echogenicity are present 
within a background of normal liver parenchyma and may present as a pseudonodular 
lesion (Fig.23).  On imaging, several observational clues assist with correct identification of 
focal fatty change or focal spared areas:  
1) typical periligamentous and periportal location,  
2) lack of mass effect,  
3) sharply angulated boundaries,  
4) nonspherical shape,  
5) absence of vascular displacement or distortion, and  




Fig. 23. Pseudonodular steatosis: Echogenic nodule (white arrow) in segment IVB anterior to 
the bifurcation of the portal vein that was confirmed to be a focal nodular steatosis in the 
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Cirrhosis is defined by the World Health Organization (WHO) as a diffuse process 
characterized by fibrosis and the conversion of normal liver architecture into structurally 
abnormal nodules. Liver cirrhosis is caused by diffuse fibrosis and regenerating nodules 
that result from liver cell necrosis and degeneration. It is characterized by architectural 
distortion and the development of a spectrum of nodules, ranging from benign regenerating 
nodules to HCC (Brown et al., 1997). In cirrhosis, in its early stages, the liver may appear 
normal. With progression of the disease, nodularity of the liver surface and generalized 
heterogeneity of the hepatic parenchyma can be seen. The porta hepatis and interlobar 
fissure frequently appear widened due to shrinkage of the right lobe and the medial 
segment of the left lobe, with concomitant enlargement of the caudate lobe and the lateral 
segment of the left lobe. The gross morphologic appearance of the cirrhotic liver is 
categorized by the size of the parenchymal nodules: micronodular, macronodular, or mixed.  
Micronodular cirrhosis is characterized by regenerative nodules of relatively uniform small 
size, ranging from 0.1 to 1.0 cm in diameter. This pattern is most commonly seen in chronic 
alcoholic cirrhosis. In macronodular cirrhosis, the parenchymal nodules are larger, coarser, 
and more variable in size, up to 5.0 cm in diameter. The most common cause of 
macronodular cirrhosis is chronic viral hepatitis. 
The sonographic patterns associated with cirrhosis are: 
1. Volume redistribution - In the early stages of cirrhosis, the liver may be enlarged, 
whereas in the advanced stages, the liver is often small, with relative enlargement of the 
caudate and the left lobe, and reduction of the size of the right lobe (Fig.24A). A ratio of 
caudate lobe to right lobe can be derived from a transverse scan of the liver 
immediately below the portal vein bifurcation: this is less than 0.6 in normal subject and 
greater than 0.65 in cirrhosis, with 100% specificity but sensitivities of 84% and 43% in 
two different series (Giorgio et al., 1986; Harbin et al., 1980); 
2. Coarse echotexture - Increased echogenicity and coarse echotexture are frequent 
observations in diffuse liver disease (Fig.24B); 
3. Nodular surface - Irregularity of the liver surface (Fig.24C); 
4. Regenerative and dysplastic nodules - Regenerative nodules tend to be isoechoic or 
hypoechoic with a thin echogenic border. They may give a generalized granularity to 
the liver echotexture in forms of micronodular cirrhosis (Fig.24D). The larger nodules of 
macronodular disease may give an ultrasonically recognizable surface nodularity. 
Dysplastic nodules are considered premalignant.  
Other ultrasound findings in cirrhosis are related to the complications associated with 
hepatocellular failure and portal hypertension: these include ascites, splenomegaly, the 
development of collateral venous channels and other abnormalities of the portal venous 
system.  
3.4 Portal hypertension  
Portal hypertension develops when increased resistance to portal flow and/or increased 
portal blood flow occur.  Normal portal vein pressure is 5 to 10 mm Hg (14cm H2O). Portal 
hypertension is defined by a wedged hepatic vein pressure or direct portal vein pressure of 
more than 5 mm Hg greater than inferior vena cava pressure, splenic vein pressure of 
greater than 15 mm Hg, or portal vein pressure of greater than 30 cm H2O. They result in 
enlargement of the extrahepatic portal vessels, the development of spontaneous 
portosystemic collaterals and slow portal vein flow. Portal hypertension can be classified in  
 
 










Fig. 24. Cirrhosis: [A] Volume redistribution with enlargement of the left and caudate lobes;  
[B] Volume redistribution with coarse echotexture; [C] Longitudinal scans showing 
lobulated contour; [D] Multiple small hypoechoic nodules along the entire liver parenchyma  
(regenerative). 
several ways. We find that the easiest method is to divide it into intrahepatic, extrahepatic, 
and hyperdynamic. Extrahepatic portal hypertension can be subdivided into prehepatic 
(portal vein thrombosis, compression, and stenosis) and posthepatic (hepatic vein or inferior 
vena cava [IVC] thrombosis, compression, or stenosis). The extrahepatic presinusoidal 
portal hypertension should be suspected in any patient who presents with clinical signs of 
portal hypertension - ascites, splenomegaly and varices - and a normal liver biopsy. 
Thrombosis of the portal venous system occurs in children secondary to umbilical vein 
catheterization, omphalitis and neonatal sepsis. In adults, the causes of portal vein 
thrombosis include trauma, sepsis, HCC, pancreatic carcinoma, pancreatitis, portacaval 
shunts, splenomegaly and hypercoagulable states. Hyperdynamic refers to conditions that 
cause arterial portal fistulas or arteriovenous malformations. Extrahepatic portal 
hypertension and hyperdynamic portal hypertension are much less common than the 
intrahepatic category.  Intrahepatic portal hypertension is subdivided into presinusoidal 
and postsinusoidal.  The intrahepatic presinusoidal causes of portal hypertension include 
hepatic fibrosis, sarcoidosis, schistosomiasis, and lymphoma. Postsinusoidal includes 
cirrhosis and venoocclusive disease (Ralls, 1990).  
Cirrhosis is the most common cause of intrahepatic portal hypertension. It causes 
hepatocellular death and parenchymal degeneration and regeneration. This results in 
bridging fibrosis that affects the central venules that drain the sinusoids, as well as the 
sinusoids themselves. The fibrosis causes increased resistance to blood flow. Initially, portal 
vein flow volume is maintained, but at a higher portal pressure.  As the process progresses, 
the resistance to inflow in the liver equalizes with resistance to flow in portosystemic 
collaterals. At this point, portal flow starts to be diverted into the collaterals. As portal 
inflow to the liver decreases, hepatic arterial flow increases, and the arteries become larger 
and more tortuous. Eventually, resistance to arterial inflow reaches a point where arterial 
flow starts to shunt into the portal vein system. This initially produces portal vein flow 
reversal in isolated peripheral portal vein branches. But as more and more peripheral 
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portosystemic collaterals and slow portal vein flow. Portal hypertension can be classified in  
 
 










Fig. 24. Cirrhosis: [A] Volume redistribution with enlargement of the left and caudate lobes;  
[B] Volume redistribution with coarse echotexture; [C] Longitudinal scans showing 
lobulated contour; [D] Multiple small hypoechoic nodules along the entire liver parenchyma  
(regenerative). 
several ways. We find that the easiest method is to divide it into intrahepatic, extrahepatic, 
and hyperdynamic. Extrahepatic portal hypertension can be subdivided into prehepatic 
(portal vein thrombosis, compression, and stenosis) and posthepatic (hepatic vein or inferior 
vena cava [IVC] thrombosis, compression, or stenosis). The extrahepatic presinusoidal 
portal hypertension should be suspected in any patient who presents with clinical signs of 
portal hypertension - ascites, splenomegaly and varices - and a normal liver biopsy. 
Thrombosis of the portal venous system occurs in children secondary to umbilical vein 
catheterization, omphalitis and neonatal sepsis. In adults, the causes of portal vein 
thrombosis include trauma, sepsis, HCC, pancreatic carcinoma, pancreatitis, portacaval 
shunts, splenomegaly and hypercoagulable states. Hyperdynamic refers to conditions that 
cause arterial portal fistulas or arteriovenous malformations. Extrahepatic portal 
hypertension and hyperdynamic portal hypertension are much less common than the 
intrahepatic category.  Intrahepatic portal hypertension is subdivided into presinusoidal 
and postsinusoidal.  The intrahepatic presinusoidal causes of portal hypertension include 
hepatic fibrosis, sarcoidosis, schistosomiasis, and lymphoma. Postsinusoidal includes 
cirrhosis and venoocclusive disease (Ralls, 1990).  
Cirrhosis is the most common cause of intrahepatic portal hypertension. It causes 
hepatocellular death and parenchymal degeneration and regeneration. This results in 
bridging fibrosis that affects the central venules that drain the sinusoids, as well as the 
sinusoids themselves. The fibrosis causes increased resistance to blood flow. Initially, portal 
vein flow volume is maintained, but at a higher portal pressure.  As the process progresses, 
the resistance to inflow in the liver equalizes with resistance to flow in portosystemic 
collaterals. At this point, portal flow starts to be diverted into the collaterals. As portal 
inflow to the liver decreases, hepatic arterial flow increases, and the arteries become larger 
and more tortuous. Eventually, resistance to arterial inflow reaches a point where arterial 
flow starts to shunt into the portal vein system. This initially produces portal vein flow 
reversal in isolated peripheral portal vein branches. But as more and more peripheral 
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branches reverse, flow in the major branches and eventually the main portal vein reverses 
(Ralls, 1990).  
There are several sonographic findings of portal hypertension. Dilatations of the portal, 
mesenteric and splenic veins are all potential indicators of elevated pressures. Weinreb 
(1982) found 13 mm as the cutoff for upper limit of normal portal vein diameter. In general, 
an unusually large portal vein is a good sign of portal hypertension, but a normal size portal 
vein certainly does not exclude the diagnosis. Lack of caliber variation of the splenic and 
mesenteric vein during respiration is another parameter that has been investigated. This 
approach had a sensitivity of 80% and specificity of 100% in diagnosing portal hypertension 
(Bolondi et al., 1982).   
A variety of Doppler techniques have been used to evaluate patients with suspected portal 
hypertension. Simple measurements of portal vein velocity are one such approach. Zirone et 
al. (1992) found a sensitivity of 88% and a specificity of 96% using a mean portal vein 
velocity cutoff of 15 cm/sec.  Although there is general agreement that portal vein velocities 
usually decrease with portal hypertension, the expected values in control subjects and 
cirrhotic patients vary considerably. Mean portal venous flow velocity is approximately 15 
to 18 cm/sec. Sources of variability include interobserver variability, intermachine 
variability, presence of variable collateral pathways (especially recanalized umbilical veins), 
and variations caused by differences in patient positioning, different phases of respiration, 
states of fasting, exercise status and cardiac output. These variations probably also account 
for the fact that portal velocities tend to decrease as portal pressures increase, but the 
correlation is not statistically significant (Choi et al., 2003; Haag et al., 1999). As portal 
hypertension develops, the flow in the portal vein loses its ondulatory pattern and becomes 
monophasic (Fig.25A-B). As the severity of portal hypertension increases, flow becomes 
biphasic and finally hepatofugal (Fig.25C). The ratio of portal vein cross-sectional area and 
portal velocity has been called the congestion index and has also been used to diagnose 
portal hypertension. Moriyasu et al. (1986) described this index based on the assumption 
that portal vein cross-sectional area will increase and the portal velocity will decrease in the 
setting of portal hypertension, resulting in a quotient that increases dramatically. In this 
study, it was shown that the congestion index was 2.5 times higher in patients with cirrhosis 
and portal hypertension than in control subjects. Normal values were described to be up to 
0.099 cm x sec. The sensitivity of congestion index measurements ranges from 67% to 95% 




Fig. 25. Portal vein flow: [A] Ondulatory normal pattern; [B] Loss of ondulatory flow, 
mantaining the normal hepatopetal flow; [C]Hepatofugal portal vein flow as seen with the 
blue color inside the vein and the graphs below the baseline. 
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Alterations in the hepatic venous waveform can also occur with cirrhosis and portal 
hypertension. In general, the normal pulsatility of hepatic veins is either blunted or 
completely eliminated in patients with cirrhosis (Fig.26A-C). In fact, complete loss of any 
pulsatility has been shown to correlate with a higher Child-Pugh score and decreased 
survival rate (Ohta et al., 1995). The mechanism for this loss of hepatic vein pulsatility is 
unclear, but is likely related to hepatic vein loss of compliance due to hepatic fibrosis or 
stenosis, which can be caused by impression on the hepatic veins by regenerating nodules 
(Lorenz & Winsberg, 1996). 
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Fig. 26. Hepatic vein flow: [A] Normal triphasic flow; [B] Biphasic flow; [C] Monophasic 
(portalized) flow. 
Although measurement of vessel diameters and velocities and calculation of various indices 
have shown promise in certain studies, the most reliable and widely used approach for the 
diagnosis of portal hypertension is the detection of portal systemic collaterals. The left 
gastric vein is the most prevalent portal systemic collateral present in 80% to 90% of patients 
with portal hypertension (Burcharth, 1979; Nunez et al., 1978) and its presence implies an 
increased risk for variceal hemorrhage. Sonographically, the left gastric vein is identified as 
a vessel communicating with the superior aspect of the portal or splenic vein in the region of 
the confluence (Fig. 27). The left lobe of the liver serves as an acoustic window, and when 
the left lobe is small, it may be difficult to visualize this vein. It extends superiorly and to the 
left and typically travels immediately anterior to the bifurcation of the celiac axis. The upper 
limit of normal for the vein diameter is 5 to 6 mm (Lafortune et al., 1984; Wachsberg & 
Simmons, 1994). Unfortunately, dilatation of the left gastric vein above a diameter of 6 mm 
occurs in only 25% of patients with portal hypertension, and it is not necessarily present for 
variceal hemorrhage to occur (Wachsberg & Simmons, 1994). On the other hand, the left 
gastric collateral was the only portal systemic collateral visualized in approximately 75% of 
patients. Other tributaries of the portal system can function as portal systemic collaterals 
and include short gastric veins and branches of the superior and inferior mesenteric veins. 
Identification of hepatofugal flow in any of these vessels is adequate to establish the 
diagnosis of portal hypertension.  
Normally, the umbilical vein is an obliterated fibrous remnant that runs in the ligamentum 
teres. It can be identified in some patients as a hypoechoic band running within the fat of the 
ligamentum teres. It extends from the umbilicus to the most anterior aspect of the umbilical 
segment of the left portal vein. In individuals with no portal hypertension, no flow is 
present in the obliterated umbilical vein, and the fibrous remnant measures less than 3 mm 
(Gibson et al., 1989). In the setting of portal hypertension, the umbilical vein recanalizes and 
develops hepatofugal flow. The recanalized umbilical vein is best seen by scanning the left 
lobe of the liver and identifying the umbilical segment of the left portal vein. The umbilical 
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for the fact that portal velocities tend to decrease as portal pressures increase, but the 
correlation is not statistically significant (Choi et al., 2003; Haag et al., 1999). As portal 
hypertension develops, the flow in the portal vein loses its ondulatory pattern and becomes 
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portal velocity has been called the congestion index and has also been used to diagnose 
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study, it was shown that the congestion index was 2.5 times higher in patients with cirrhosis 
and portal hypertension than in control subjects. Normal values were described to be up to 
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Alterations in the hepatic venous waveform can also occur with cirrhosis and portal 
hypertension. In general, the normal pulsatility of hepatic veins is either blunted or 
completely eliminated in patients with cirrhosis (Fig.26A-C). In fact, complete loss of any 
pulsatility has been shown to correlate with a higher Child-Pugh score and decreased 
survival rate (Ohta et al., 1995). The mechanism for this loss of hepatic vein pulsatility is 
unclear, but is likely related to hepatic vein loss of compliance due to hepatic fibrosis or 
stenosis, which can be caused by impression on the hepatic veins by regenerating nodules 
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occurs in only 25% of patients with portal hypertension, and it is not necessarily present for 
variceal hemorrhage to occur (Wachsberg & Simmons, 1994). On the other hand, the left 
gastric collateral was the only portal systemic collateral visualized in approximately 75% of 
patients. Other tributaries of the portal system can function as portal systemic collaterals 
and include short gastric veins and branches of the superior and inferior mesenteric veins. 
Identification of hepatofugal flow in any of these vessels is adequate to establish the 
diagnosis of portal hypertension.  
Normally, the umbilical vein is an obliterated fibrous remnant that runs in the ligamentum 
teres. It can be identified in some patients as a hypoechoic band running within the fat of the 
ligamentum teres. It extends from the umbilicus to the most anterior aspect of the umbilical 
segment of the left portal vein. In individuals with no portal hypertension, no flow is 
present in the obliterated umbilical vein, and the fibrous remnant measures less than 3 mm 
(Gibson et al., 1989). In the setting of portal hypertension, the umbilical vein recanalizes and 
develops hepatofugal flow. The recanalized umbilical vein is best seen by scanning the left 
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vein itself travels inferiorly from the umbilical segment of the left portal vein and exits the 
liver where it extends inferiorly along the abdominal wall to the umbilical area (Fig.28A-B). 
From there, it extends further inferiorly to communicate with the inferior epigastric veins. 
Ultimately, it communicates with the iliofemoral system and in this way diverts blood back 
to the systemic circulation.  Although these 2 collaterals are the easiest and most productive 
to analyze, there are other collaterals that can be detected sonographically, albeit with more 
difficulty in some cases. These include short gastric, splenorenal, splenoretroperitoneal, 
superior mesenteric, and inferior mesenteric collaterals.  
 
 










Fig. 28. Umbilical vein: [A-B] Recanalized umbilical vein from the falciform ligament to the 
anterior abdominal wall in the umbilical area going down to the hypogastrium. 
Splenorenal collaterals are large spontaneous porto-systemic shunts from the splenic hilum 
or capsule to the left renal vein. It is often difficult to trace these collaterals from the splenic 
vein to the renal vein in continuity. Many times, the detection of multiple collaterals around 
the splenic hilum and an enlarged left renal vein is enough to make the presumptive 
diagnosis of a splenorenal collateral (Fig.29A-B). Splenoretroperitoneal collaterals may 
communicate with perivertebral vessels or gonadal vessels. Superior mesenteric collaterals 
communicate with pancreaticoduodenal veins and retroperitoneal/perivertebral veins. 
Inferior mesenteric collaterals communicate with retroperitoneal veins and hemorrhoidal 
veins. As mentioned earlier, as portal hypertension progresses, flow reversal occurs in 
isolated peripheral portal vein branches (Ralls, 1990; Wachsberg et al., 2002). It is very 
important to realize that most patients with portal hypertension maintain antegrade flow in 
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the main portal vein. In addition to reversed flow, slow flow that alternates between 
antegrade and retrograde is another sign of portal hypertension. 
 
Left renal 




Fig. 29. Splenorenal shunt: [A] Dilated left renal vein; [B] Splenorenal shunt: splenic flow in 
blue going to the renal vein in red. 
Portal vein thrombosis has been associated with chronic hepatitis, hepatocellular carcinoma, 
metastatic liver disease, carcinoma of the pancreas, chronic pancreatitis, septicemia, trauma, 
splenectomy, portocaval shunts and hypercoagulable states. Sonographic findings of portal 
vein thrombosis is best visualized in B-mode image and confirmed with color Doppler and 
include echogenic thrombus within the lumen of the vein, portal vein collaterals, expansion 
of the caliber of the vein and cavernous transformations. Cavernous transformation of the 
portal vein refers to numerous wormlike vessels at the porta hepatis, which represent 
periportal collateral circulation. Acute thrombus may appear relatively anechoic and may be 
overlooked unless Doppler interrogation is performed. Malignant thrombosis of the portal 
vein has a high association with HCC and is often expansive. Doppler sonography is useful 
in distinguishing between benign and malignant portal vein thrombi in patients with 
cirrhosis. Both benign and malignant thrombi may demonstrate continuous blood flow. 
Pulsatile arterial flow has been found to be 95% specific for the diagnosis of malignant 
portal vein thrombosis (Fig.18F). The sensitivity was only 62% because many malignant 
thrombi can be hypovascular (Dodd et al., 1995).  
The normal hepatic artery in a fasting patient has a low resistance Doppler flow profile with 
an expected RI ranging from 0.55 to 0.7 (Fig.30A). During systole, the velocity is 
approximately 30-60 cm/sec; while during diastole, it normally slows to approximately 10-
20 cm/sec, which is normally less than the velocity of the portal vein flow. The systolic 
acceleration time is typically less than 0.07 s. Liver disease may manifest in the hepatic 
artery as abnormally elevated (RI >0.7) or decreased (RI <0.55) resistance. High resistance is 
a nonspecific finding that may be seen in the postprandial state, patients of advanced age, 
and diffuse peripheral microvascular compression or disease, as seen in chronic 
hepatocellular disease including cirrhosis, hepatic venous congestion, cold ischemia 
(posttransplantation) and any stage of transplant rejection (Martínez-Noguera et al., 2002).  
The effect of cirrhosis on hepatic arterial microcirculation is complex and variable. Arterial 
resistance has been shown to be decreased, normal, or increased in cirrhotic patients 
(Vassiliades et al., 1993). Some aspects of the disease process, such as inflammatory edema, 
arterial compression by regenerative nodules and arterial compression by stiff noncompliant 
(fibrotic) parenchyma, have been thought to increase resistance (Fig.30B) (Alpern et al., 1987; 
Sacerdoti et al., 1995). Other aspects, such as the “hepatic arterial buffer response” 
(compensatory small artery proliferation and increased numbers of arteriolar beds) and 
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Pulsatile arterial flow has been found to be 95% specific for the diagnosis of malignant 
portal vein thrombosis (Fig.18F). The sensitivity was only 62% because many malignant 
thrombi can be hypovascular (Dodd et al., 1995).  
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an expected RI ranging from 0.55 to 0.7 (Fig.30A). During systole, the velocity is 
approximately 30-60 cm/sec; while during diastole, it normally slows to approximately 10-
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arteriovenous shunting, are thought to decrease resistance (Lautt & Greenway, 1987). The 
overall balance of these factors presumably dictates the observed resistance, and it has been 
shown that hepatic arterial RI is not useful for diagnosing cirrhosis or predicting its severity 
(Lim et al., 2005; Vassiliades et al., 1993). It is important to compare the resistive indexes to 




Fig. 30. HEPATIC ARTERY: [A] Normal low resistance flow in hepatic artery; [B] High 
resistance flow seen in the hepatic artery of the cirrhotic patient. 
3.5 Liver transplantation 
Liver transplantation has rapidly advanced from an experimental therapy to a mainstream 
treatment option for a wide range of acute and chronic liver diseases. Indications for liver 
transplant have evolved to include previously contraindicated conditions such as 
hepatocellular carcinoma and alcohol-related liver disease. Cirrhosis from chronic hepatitis 
C infection remains the most common indication today. The progressive improvement in 
survival from liver transplantation over the past few years has been due to a combination of 
factors, including better patient selection, improved organ preservation, developments in 
surgical technique, modern immunosuppressive agents and improved postoperative 
management. Overall posttransplant outcomes have steadily improved, with unadjusted 5-
year patient survival rates of 77% among patients transplanted with MELD (Model for End-
Stage Liver Disease) score between 15 and 20, and 72% for those with MELD scores between 
21 and 30 (Merion, 2010). Ultrasound plays an important role in patient selection and 
management, being used in the pre-operative, operative and postoperative periods.  
4. Conclusion 
In conclusion, US imaging is an ideal complementary diagnostic tool to evaluate the liver 
from bench to bedside. Hepatic US can examine the internal architecture of the liver 
parenchyma, biliary system, portal and hepatic vascular supply. US can be regarded as a 
noninvasive method valid for follow-up studies of experimental hepatic diseases in rodents 
for pre-clinical drug or cell based therapy. Also, is the test of choice for assessment and 
follow-up of patients with suspected diffuse or focal hepatic disease, portal hypertension 
and screening for vascular and biliary complications following liver transplantation. 
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arteriovenous shunting, are thought to decrease resistance (Lautt & Greenway, 1987). The 
overall balance of these factors presumably dictates the observed resistance, and it has been 
shown that hepatic arterial RI is not useful for diagnosing cirrhosis or predicting its severity 
(Lim et al., 2005; Vassiliades et al., 1993). It is important to compare the resistive indexes to 




Fig. 30. HEPATIC ARTERY: [A] Normal low resistance flow in hepatic artery; [B] High 
resistance flow seen in the hepatic artery of the cirrhotic patient. 
3.5 Liver transplantation 
Liver transplantation has rapidly advanced from an experimental therapy to a mainstream 
treatment option for a wide range of acute and chronic liver diseases. Indications for liver 
transplant have evolved to include previously contraindicated conditions such as 
hepatocellular carcinoma and alcohol-related liver disease. Cirrhosis from chronic hepatitis 
C infection remains the most common indication today. The progressive improvement in 
survival from liver transplantation over the past few years has been due to a combination of 
factors, including better patient selection, improved organ preservation, developments in 
surgical technique, modern immunosuppressive agents and improved postoperative 
management. Overall posttransplant outcomes have steadily improved, with unadjusted 5-
year patient survival rates of 77% among patients transplanted with MELD (Model for End-
Stage Liver Disease) score between 15 and 20, and 72% for those with MELD scores between 
21 and 30 (Merion, 2010). Ultrasound plays an important role in patient selection and 
management, being used in the pre-operative, operative and postoperative periods.  
4. Conclusion 
In conclusion, US imaging is an ideal complementary diagnostic tool to evaluate the liver 
from bench to bedside. Hepatic US can examine the internal architecture of the liver 
parenchyma, biliary system, portal and hepatic vascular supply. US can be regarded as a 
noninvasive method valid for follow-up studies of experimental hepatic diseases in rodents 
for pre-clinical drug or cell based therapy. Also, is the test of choice for assessment and 
follow-up of patients with suspected diffuse or focal hepatic disease, portal hypertension 
and screening for vascular and biliary complications following liver transplantation. 
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1. Introduction 
Endobronchial ultrasound (EBUS) visualizes structures within and adjacent to the airway 
(1). Most operators do not follow any standard positions of imaging during EBUS and use 
the computed tomography scan as a roadmap for imaging of the lymph nodes. A small 
window angle (50 to 75 degrees) in linear EBUS as compared with linear endoscopic US (130 
to 180 degrees) makes visualization of the anatomic ultrasound landmarks difficult with 
EBUS. For better orientation, it is useful to recognize key anatomic landmarks and their 
relationship to the airways, apart from observing the position of the probe while performing 
EBUS. In this section we describe the mediastinal and parabronchial anatomy of different 
parts of the respiratory tract which is practically important during EBUS. 
2. The ten commandments of imaging 
2.1 Instrument and comparison of available scopes 
Two types of scopes are available. Broadly the major difference is in the diameter and field 
of view. The diameter of pentax scope is larger than Olympus scope (7.4 mm vs 6.9 mm.) 
The field of vision and depth in imaging of the pentax scope is larger (field of vision 75° vs 
50°, depth 5 cm vs approximately 2 cm) 
2.2 Indication of EBUS 
The main indications are evaluation of benign and malignant mediastinal lymphadenopathy. 
The role of linear EBUS for T staging of lung cancer is not yet defined.  Limited assessment of 
M staging and loco regional spread of lung cancer is possible. 
2.3 Alternative modalities of imaging and tissue sampling 
Majority of lymph nodes can be seen by EBUS and EUS both while doing endoscopic 
imaging. The choice to do FNA by EBUS or EUS rest on the experience of the 
endosonographer. Some endosonographer are more experienced in EBUS while others are 
more experienced in EUS. However for persons who are experienced in both it may be 
difficult to choose between the two for FNAC if both are approachable. 
2.4 Optimization of the imaging 
a. The ultrasound waves are high frequency sound waves.  
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50°, depth 5 cm vs approximately 2 cm) 
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M staging and loco regional spread of lung cancer is possible. 
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Majority of lymph nodes can be seen by EBUS and EUS both while doing endoscopic 
imaging. The choice to do FNA by EBUS or EUS rest on the experience of the 
endosonographer. Some endosonographer are more experienced in EBUS while others are 
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difficult to choose between the two for FNAC if both are approachable. 
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b. Ultrasound beam loses strength of the beam over time or distance travelled and the 
echoes that return from deeper structures are weak compared to those returning from 
the close structures. This phenomenon is called attenuation.  
c. Attenuated waves need to be amplified before analysis. The echoes that come from 
deep within the body are more attenuated and need more amplification to make a 
smooth image. This is done by Time-Gain Compensation (TGC). The images thus 
amplified contain echoes of approximately equal strength from all the depths of tissue.  
d. The waves make image. Images have resolution. The ability of the beam to differentiate 
two objects is called spatial resolution. Higher spatial resolution shows two points as 
separate while low spatial resolution shows them as a single blurred point.  
e. Resolution has two main dimensions. Analysis along the length is called axial 
resolution, analysis along the breadth is called lateral resolution. 
f. Axial resolution is determined by the frequency. Axial resolution is most important in 
determination of quality. High frequency shortens the pulse length and gives a better 
axial resolution. The frequency is inversely proportional to the penetration depth. At 5 
M Hz ultrasound penetrates approximately 6 cm while at 10 M Hz the penetration field 
of ultrasound is about 3 cm. 
g. Lateral resolution is determined by focal length. Lateral resolution differentiates 
between two points lying horizontal to the ultrasound beam. It is determined by the 
width of the Ultrasound beam. Changing focus of the beam to the level of investigation 
gives optimum lateral resolution at the point of focus. 
h. Image depends on resolution. Changing frequency improves axial resolution while 
changing the focus improves lateral resolution.  
So optimization of image is done by following techniques.  
1. Choose the correct frequency  2. Focus the area  
2.5 Orientation of imaging 
The cranial caudal convention for longitudinal abdominal imaging and linear EBUS varies 
throughout the world. Endosonographers and radiologists all over the world do not yet have a 
universal convention on the demonstration of images in linear EBUS so far as cranial and 
caudal is concerned. In UK, USA and France the patient’s cranial (head) and caudal (feet) are 
to the right and left of the screen respectively.  In Japan and Germany the direction is reversed. 
We will follow the cranial to right and caudal to left convention for our presentation. 
2.6 Providing anaesthesia 
Some professionals prefer local anaethesia for EBUS. Others prefer general anaethesia. 
2.7 Position of patient. Supine, left lateral or sitting. To each his own 
Most of the conventional bronchoscopist use two hands to maneoure the scope. The EBUS 
operator who hold the echoendoscope in both hands cannot get used to manipulating the 
knobs of the ultrasound screen. The left lateral position of EBUS allows the operator to 
intermittently remove the right hand for manipulation of the screen.  
2.8 Artifacts in imaging 
There are two main artifacts during imaging from tracheobronchial tree.  The artifacts of 
cartilage gradually disappear as the scope is advanced more distally into the trachea-
bronchial tree. Mirror image artifact is created by vessels. 
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Fig. 1. Fig. A. The standard method of screening for EBUS requires positioning of the probe 
in the upper part of screen. Fig B. Keeping the probe in the lower part of the screen is 
generally not recomonded Fig. C & D. show the different convention of imaging followed by 
operators all over the world.  
2.9 Air is the enemy water is the friend 
There are two methods of establishing contact. Simple apposition of the probe against the 
wall may be enough to establish contact and use of balloon is not usually required with 
pentax scope. Generally the limited range of imaging 50° vs 75° requires contact with a 
balloon in Olympus EBUS scope. 
2.10 There are three main movements of echoendoscope  
2.10.1 In and out movement  
In and out movements are done to position the scope at the desired cm landmark of imaging 
and is the key movement for changing the position.  
2.10.2 Clockwise or anticlockwise rotation  
In a linear EBUS scope where the imaging is in a longitudinal axis clockwise or 
anticlockwise rotation is the key movement for changing the view. Rotation changes the 
field totally in a linear scope only. Rotation alone brings no change in view in a radial EUS 
scope. 
2.10.3 Angulations of scope, up or down  
Angulations of scope, up or down is required for achieving close contact with the wall of 
trachea. 
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3. The CM landmarks in EBUS during imaging from mediastinum 
While doing EBUS the operator generally enters the trachea approximately at 15 cm distance 
from the incisor. The trachea is about 10 cm long so the carina is generally reached when the 
scope lies at about 25 cm distance. The left bronchus is about 5 cm long and the lower end of 
left main stem bronchus is reached at an approximate distance of 30 cm. Similarly the 30 cm 
distance is the lower limit of reach in the right bronchus which includes 2.5 cm of right main 
stem bronchus and 2.5 cm of intermediate bronchus. The diameter of EBUS scope generally 
does not allow any further negotiation beyond the reach of intermediate bronchus on the 
right and left main stem bronchus on the left side. While doing imaging from the respiratory 
tract an additional cm landmark of importance is upper border of arch of aorta which lies at 
about 22cm distance. The lower border of arch of aorta lies at about 23 to 24 cm. The lower 
border of azygos vein and the upper border of left pulmonary artery lie approximately at 25 
cm distance. 
The trachea lies in front of esophagus which commences at the level of the cricoid cartilage 
at about 15 cm distance from incisor teeth. For the purpose of description, the esophagus can 
be divided into cervical (CE) from cricoid to 18 cm, upper thoracic [TE (U)] from 18-25 cm, 
till approximately the tracheal bifurcation), mid thoracic [TE (M)] from 25-32 cm, till 
approximately below the subcarinal area and lower thoracic [TE (L)] from 32-38 cm 
segments. While doing imaging from the trachea certain cm landmark of importance are 
upper border of arch of aorta (23cm), the lower end of trachea (25 cm), lower border of arch 
of aorta (25 cm), the lower border of azygos vein (25 cm), the upper border of left 
pulmonary artery (25 cm) and the upper border of left atrium (30 cm).  While pushing the 
EBUS scope into esophagus the crux of diaphragm is seen at 40 cm. 
 
 
Fig. 2. This figure shows the important CM landmarks while imaging with EBUS scope. 
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4. Applied anatomy of mediastinum 
4.1 The compartments of mediastinum 
It is important to have a brief idea of mediastinum before discussing the mediastinal 
structures. For descriptive purposes, the mediastinum is arbitrarily subdivided by a 
transverse plane that passes through the sternal angle and the lower border of the fourth 
thoracic vertebra. The superior mediastinum is above this plane and is limited superiorly by 
the superior thoracic aperture; the inferior mediastinum is below the plane, and the 
diaphragm limits it inferiorly. The inferior mediastinum is further compartmentalized based 
on its relation to the pericardial sac: the sac and its contents compose the middle 
mediastinum; between the sac and the sternum is the anterior mediastinum; between the 
vertebral bodies and the pericardial sac is the posterior mediastinum. The contents of the 
posterior mediastinum include the esophagus; the descending thoracic aorta and its 
branches; the veins of the azygos system and the thoracic duct.  
 
 
Fig. 3. The compartments of mediastinum are shown. 
4.2 The trachea  
The trachea is about 10 cm long and present from 15 to 25 cm distance from incisor. It is kept 
patent by a series of cartilages embedded transversely in its wall.The posterior wall of 
trachea is flat where the ends of cartilage bar are united by trachealis muscle and fibroelastic 
tissue. This surface is applied to esophagus. The cervical part of trachea is about 3-4 cm in 
length and is related to lobes of the thyroid gland before it enters superior mediastinum 
where it lies in midline. The division of the trachea into principal bronchi takes place behind 
the ascending aorta, to the right of, and below, the arch of the aorta, approximately at the 
level of sternal angle (level of fourth thoracic spine). The lower end of the trachea is 
displaced slightly to the right of the midline by the arch of the aorta, which occupies the 
angle between the trachea and the left bronchus. 
On the right, the superior lobar bronchus branches off the principal bronchus before the 
later enters the hilum. The remaining main stem intermediate bronchus, gives off, more 
distally, the middle lobe bronchus, which runs forward and downward. The intermediate 
bronchus continues as inferior lobar bronchus.The left principal bronchus gives off the 
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superior lobar bronchus as soon as it has entered the hilum, and the remaining main stem 
becomes the bronchus of the inferior lobe. 
 
 
Fig. 4. The right principal bronchus is wider, shorter (about 2.5 cm) and more vertical than 
the left, leaves the trachea at an angle of about 25° and enters the right lung opposite the T5 
vertebra. The left principal bronchus is narrower and more transverse than the right, leaves 
the trachea at an angle of about 45°, is nearly 5 cm long and enters the root of the left lung 
opposite the T6 vertebra. 
 
 
Fig. 5. The relationship of trachea to esophagus and paratracheal vascular structures 
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The figure 5 A shows six different positions (which will be discussed in later part of chapter)  
of imaging by Endobronchial ultrasound. 1 Imaging from the upper trachea, 2. Imaging from 
the lower trachea, 3. Imaging from the right main bronchus, 4. Imaging from Intermediate 
bronchus, 5. Imaging from upper part of left bronchus, 6. Imaging from the distal part of  
left bronchus. Fig. B. to F shows the relationship of parabonchial & vascular structures  
to trachea. Fig. B relationship of tracheobronchial tree to esophagus. Fig. C. relationship  
of tracheobronchial tree to azygos vein and superior vena cava. Fig. D. relationship  
of tracheobronchial tree to arch of aorta. Fig. E.  relationship of tracheobronchial tree to 
pulmonary trunk and the two branches of pulmonary trunk. Fig. F. relationship of 
tracheobronchial tree to left atrium and the draining veins of the left atrium.  
4.3 The right bronchus 
The right bronchus passes behind the ascending aorta and the superior vena cava towards 
the root of lung. Two structures are related to anterior wall of right main bronchus, in the 
upper part the ascending aorta lies anteromedially and the superior vena cava is placed 
anterolaterally. The right pulmonary artery lies in close relationship with the intermediate 
bronchus. The right pulmonary artery initially lies first below and medial to intermediate 
bronchus, then in front of it and finally lies lateral and behind the intermediate bronchus. 
The azygos vein lies behind the right bronchus for some length and then arches over it to 
drain into superior vena cava. 
 
 
Fig. 6. The mediastinal surface of right lung is seen in this figure which shows relations of 
right bronchus. The right main bronchus is related anteriorly to superior vena cava and the 
azygos vein goes posterior to right main bronchus. It is important to note that azygous vein 
passes behind the root of lung and can be seen in posterior relation of right main bronchus 
as well as the intermediate bronchus. 
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superior lobar bronchus as soon as it has entered the hilum, and the remaining main stem 
becomes the bronchus of the inferior lobe. 
 
 
Fig. 4. The right principal bronchus is wider, shorter (about 2.5 cm) and more vertical than 
the left, leaves the trachea at an angle of about 25° and enters the right lung opposite the T5 
vertebra. The left principal bronchus is narrower and more transverse than the right, leaves 
the trachea at an angle of about 45°, is nearly 5 cm long and enters the root of the left lung 
opposite the T6 vertebra. 
 
 
Fig. 5. The relationship of trachea to esophagus and paratracheal vascular structures 
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The figure 5 A shows six different positions (which will be discussed in later part of chapter)  
of imaging by Endobronchial ultrasound. 1 Imaging from the upper trachea, 2. Imaging from 
the lower trachea, 3. Imaging from the right main bronchus, 4. Imaging from Intermediate 
bronchus, 5. Imaging from upper part of left bronchus, 6. Imaging from the distal part of  
left bronchus. Fig. B. to F shows the relationship of parabonchial & vascular structures  
to trachea. Fig. B relationship of tracheobronchial tree to esophagus. Fig. C. relationship  
of tracheobronchial tree to azygos vein and superior vena cava. Fig. D. relationship  
of tracheobronchial tree to arch of aorta. Fig. E.  relationship of tracheobronchial tree to 
pulmonary trunk and the two branches of pulmonary trunk. Fig. F. relationship of 
tracheobronchial tree to left atrium and the draining veins of the left atrium.  
4.3 The right bronchus 
The right bronchus passes behind the ascending aorta and the superior vena cava towards 
the root of lung. Two structures are related to anterior wall of right main bronchus, in the 
upper part the ascending aorta lies anteromedially and the superior vena cava is placed 
anterolaterally. The right pulmonary artery lies in close relationship with the intermediate 
bronchus. The right pulmonary artery initially lies first below and medial to intermediate 
bronchus, then in front of it and finally lies lateral and behind the intermediate bronchus. 
The azygos vein lies behind the right bronchus for some length and then arches over it to 
drain into superior vena cava. 
 
 
Fig. 6. The mediastinal surface of right lung is seen in this figure which shows relations of 
right bronchus. The right main bronchus is related anteriorly to superior vena cava and the 
azygos vein goes posterior to right main bronchus. It is important to note that azygous vein 
passes behind the root of lung and can be seen in posterior relation of right main bronchus 
as well as the intermediate bronchus. 
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4.4 The left bronchus 
The left bronchus, in its course toward the hilus, passes through the loop formed by the 
arch of the aorta, emerging from behind the ascending aorta and passing downward and 
to the left in front of the descending aorta before it enters the lung. Two structures are 
placed in anterior wall of left bronchus. The arch of aorta lies close to upper part of left 
main bronchus and the left pulmonary artery ascends over its anterior surface   just distal 
to the arch of the aorta.  
 
 
Fig. 7. The mediastinal surface of left lung is seen in this figure which shows relations of left 
bronchus. The left main bronchus is related anteriorly to ascending aorta in the upper part 
and the left pulmonary artery in the lower part. The descending aorta and esophagus lies 
behind the left bronchus. 
4.5 The root of lung and pulmonary ligament 
The roots of the lungs are posterior to the upper part of the pericardial sac. Most posterior in 
the upper part of each root is the bronchus, in front of it are the pulmonary artery and, in an 
even more anterior plane, the superior pulmonary vein. The arrangement of the pulmonary 
artery, pulmonary vein and bronchus in right and left lung root is slightly different. The left 
pulmonary artery is located above, rather than directly in front of, the left bronchus.  
Usually, two bronchi the upper lobe bronchus and the bronchus intermedius are seen at the 
right hilum when the entire lung is removed. In the left hilum, only one bronchus is seen. 
The pulmonary ligament is the inferior redundant part of the pleura that surrounds the root 
of the lung and provides the dead space in which the root of the lung may move up and 
down during respiration. 
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Fig. 8. It is important to know the relations at the root of the lung as the endosonographer is 
looking at structures from inside out. The relationship of the structures can be imagined 
after placing the scope inside the bronchus. Generally the veins lie most anteriorly. The 
artery lie behind the vein and the bronchus is the posterior most structure in the root of 
lung. The relations of structure at root of lung are different for right and left lung. 
4.7 The aorta 
As soon as the ascending aorta emerges from the pericardial sac, it begins to arch backward, 
and the segment that runs in a nearly sagittal plane in the superior mediastinum is known 
as the arch of the aorta. The arch of aorta begins behind manubrium sterni and runs first 
upwards backwards to the left and in front of trachea. It is then directed backwards on the 
left side of trachea and continues downwards on the left side of T4 vertebra and at the lower 
border of T-4 continues as descending aorta. The left common carotid the left subclavian and 
the brachiocephalic arteries arise from the convexity of arch. They are crossed anteriorly by 
the left brachiocephalic vein just above the convexity of arch of aorta. 
The space below the concavity of arch of aorta is sometimes called as subaortic tunnel. 
The bifurcation of pulmonary trunk the right pulmonary artery and the left bronchus lies 
in this inferior concavity. The trachea and esophagus fit into the slight concavity that faces 
to the right.  
4.8 The esophagus 
For most of the length the esophagus lies in the posterior mediastinum, with the descending 
thoracic aorta posteriorly to its left. On its right side, it is covered by mediastinal pleura. The 
right pulmonary artery, the left principal bronchus, the transverse and oblique sinuses of the 
pericardium and the left atrium lie anterior to the esophagus.  
4.9 The pulmonary trunk, the right pulmonary artery and left pulmonary artery  
The pulmonary trunk (length approximately 5 cm) lies a little to the left of midline in the chest 
and divides into left and right branches. The left pulmonary artery immediately leaves the 
pericardial sac and just outside the pericardial sac is connected to the arch of the aorta by the 
ligamentum arteriosum. The upper border of the left pulmonary artery lies at a little higher 
level than the upper border of right pulmonary artery. The RPA runs horizontally behind the 
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4.4 The left bronchus 
The left bronchus, in its course toward the hilus, passes through the loop formed by the 
arch of the aorta, emerging from behind the ascending aorta and passing downward and 
to the left in front of the descending aorta before it enters the lung. Two structures are 
placed in anterior wall of left bronchus. The arch of aorta lies close to upper part of left 
main bronchus and the left pulmonary artery ascends over its anterior surface   just distal 
to the arch of the aorta.  
 
 
Fig. 7. The mediastinal surface of left lung is seen in this figure which shows relations of left 
bronchus. The left main bronchus is related anteriorly to ascending aorta in the upper part 
and the left pulmonary artery in the lower part. The descending aorta and esophagus lies 
behind the left bronchus. 
4.5 The root of lung and pulmonary ligament 
The roots of the lungs are posterior to the upper part of the pericardial sac. Most posterior in 
the upper part of each root is the bronchus, in front of it are the pulmonary artery and, in an 
even more anterior plane, the superior pulmonary vein. The arrangement of the pulmonary 
artery, pulmonary vein and bronchus in right and left lung root is slightly different. The left 
pulmonary artery is located above, rather than directly in front of, the left bronchus.  
Usually, two bronchi the upper lobe bronchus and the bronchus intermedius are seen at the 
right hilum when the entire lung is removed. In the left hilum, only one bronchus is seen. 
The pulmonary ligament is the inferior redundant part of the pleura that surrounds the root 
of the lung and provides the dead space in which the root of the lung may move up and 
down during respiration. 
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Fig. 8. It is important to know the relations at the root of the lung as the endosonographer is 
looking at structures from inside out. The relationship of the structures can be imagined 
after placing the scope inside the bronchus. Generally the veins lie most anteriorly. The 
artery lie behind the vein and the bronchus is the posterior most structure in the root of 
lung. The relations of structure at root of lung are different for right and left lung. 
4.7 The aorta 
As soon as the ascending aorta emerges from the pericardial sac, it begins to arch backward, 
and the segment that runs in a nearly sagittal plane in the superior mediastinum is known 
as the arch of the aorta. The arch of aorta begins behind manubrium sterni and runs first 
upwards backwards to the left and in front of trachea. It is then directed backwards on the 
left side of trachea and continues downwards on the left side of T4 vertebra and at the lower 
border of T-4 continues as descending aorta. The left common carotid the left subclavian and 
the brachiocephalic arteries arise from the convexity of arch. They are crossed anteriorly by 
the left brachiocephalic vein just above the convexity of arch of aorta. 
The space below the concavity of arch of aorta is sometimes called as subaortic tunnel. 
The bifurcation of pulmonary trunk the right pulmonary artery and the left bronchus lies 
in this inferior concavity. The trachea and esophagus fit into the slight concavity that faces 
to the right.  
4.8 The esophagus 
For most of the length the esophagus lies in the posterior mediastinum, with the descending 
thoracic aorta posteriorly to its left. On its right side, it is covered by mediastinal pleura. The 
right pulmonary artery, the left principal bronchus, the transverse and oblique sinuses of the 
pericardium and the left atrium lie anterior to the esophagus.  
4.9 The pulmonary trunk, the right pulmonary artery and left pulmonary artery  
The pulmonary trunk (length approximately 5 cm) lies a little to the left of midline in the chest 
and divides into left and right branches. The left pulmonary artery immediately leaves the 
pericardial sac and just outside the pericardial sac is connected to the arch of the aorta by the 
ligamentum arteriosum. The upper border of the left pulmonary artery lies at a little higher 
level than the upper border of right pulmonary artery. The RPA runs horizontally behind the 
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ascending aorta and superior vena cava before it leaves the pericardial sac in the concavity 
of the arch of the aorta. The right pulmonary artery emerges from the sac posterior to the 
superior vena cava and crosses the intermediate bronchus distal to the origin of the superior 
lobe bronchus. Soon after leaving the pericardial sac both right and left pulmonary arteries 
arch over the respective principal bronchi as they enter the hila of the lungs. The 
relationship of these pulmonary artery to the bronchus is more or less fixed and it gives a 
fair idea of the position to the endosonographer. The left pulmonary artery crosses the left 
principal bronchus and at the hilum, is superior to it, whereas the right pulmonary artery 
crosses the intermediate bronchus, having given off a major branch to the upper lobe before 
it enters the hilum. The ascending aorta, SVC and upper right pulmonary vein lie anterior to 
RPA. The esophagus and right bronchus lie posterior to RPA. The left bronchus and 
descending aorta lie posterior to LPA.  
 
 
Fig. 9. The bifurcation of the pulmonary trunk takes place on the left of the ascending aorta 
in the concavity of the aortic arch. As a result the RPA (length approximately 2-3 cm) is 
longer than LPA and much of it is covered by serous pericardium. 
 
 
Fig. 10. The left atrium forms the lower boundary of subcarinal space. The veins coming to 
the left atrium have no intrapericardial course. The right superior pulmonary vein passes 
behind superior vena cava. Right inferior pulmonary vein crosses the esophagus.  
4.10 The pulmonary veins and the left atrium  
The left atrium has two portions. The posterior half of the chamber, into which the four 
pulmonary veins empty and the anterior half. There are four pulmonary veins, two each 
(superior and inferior), on the right and left sides. On the left side the superior and inferior 
veins drain the upper and lower lobes of the lung, respectively. The superior pulmonary 
vein is the most anterior structure, and the inferior pulmonary vein is the most inferior 
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structure in the root of the lung. Thus on both sides, the principal order of the structures in 
an anteroposterior direction in root of lung is vein, artery, bronchus. The inferior pulmonary 
veins lie below the bronchus on both sides, and below them is the pulmonary ligament into 
which they can expand. The right inferior pulmonary vein crosses the esophagus and the 
right superior pulmonary vein crosses right pulmonary artery and right bronchus. On the 
right side the superior vein crosses behind the superior vena cava; and the inferior vein 
crosses behind the right atrium before they pierce the pericardial sac over the left atrium. 
The left inferior pulmonary vein cross the descending aorta.  
Stations of EBUs Imaging  





















RPA RPA LPA, DA LPA 
Main Veins LBCV, RBCV AV, SVC SVC RPV — LPV 
Group of 
Lymph Node 
2R, 2L, 3a, 
3p
4R, 4L, 5 & 
6 7,  10R 7, 8, 11R 7, 10L 7, 8, 11L 
Vertebral 
Landmark T-3 T-4 
T-5 Upper 
Border T-5 T-6 T-6 
Other 





Table 1. The Imaging of the peribronchial structures can be done from six stations. Although 
there is no sharp boundary between the six stations, the structures mentioned at each station 
are generally seen in the positioned mentioned in the table.  
5. Technique of imaging by EBUS scope  
This evaluation can be done in patients referred for EBUS on an outpatient basis, under 
conscious sedation using midazolam and oral xylocaine spray. A linear EBUS scope (Pentax 
EB-1970UK) with 100° field of view, 45° forward oblique angle, a window angle of 75° and a 
distal end optic width of 7.4 mm was used for the purpose of description in this chapter. 
Imaging was done after endoscopic visualization from intrathoracic part of trachea and 
bronchus from six positions. Clockwise or anticlockwise rotation was done after apposition 
against the wall to change the axis of imaging. Cranial side left and caudal side right 
imaging convention was followed. 
5.1 Imaging from upper trachea 
Imaging is done 5 cm above carina where a clockwise and anticlockwise rotation from 
anterior wall of trachea to 90° on either side will show the right and left lateral tracheal walls 
and 180° rotation will show the esophagus behind the posterior wall of trachea (Fig 11 & 12). 
The presence of air in trachea and cartilage in the wall create prominent artifacts during 
imaging (Fig. 13 & 14).  
On clockwise rotation, the brachiocephalic veins are seen joining near the right anterolateral 
wall of trachea to form the superior vena cava. The lower border of left brachiocephalic vein 
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ascending aorta and superior vena cava before it leaves the pericardial sac in the concavity 
of the arch of the aorta. The right pulmonary artery emerges from the sac posterior to the 
superior vena cava and crosses the intermediate bronchus distal to the origin of the superior 
lobe bronchus. Soon after leaving the pericardial sac both right and left pulmonary arteries 
arch over the respective principal bronchi as they enter the hila of the lungs. The 
relationship of these pulmonary artery to the bronchus is more or less fixed and it gives a 
fair idea of the position to the endosonographer. The left pulmonary artery crosses the left 
principal bronchus and at the hilum, is superior to it, whereas the right pulmonary artery 
crosses the intermediate bronchus, having given off a major branch to the upper lobe before 
it enters the hilum. The ascending aorta, SVC and upper right pulmonary vein lie anterior to 
RPA. The esophagus and right bronchus lie posterior to RPA. The left bronchus and 
descending aorta lie posterior to LPA.  
 
 
Fig. 9. The bifurcation of the pulmonary trunk takes place on the left of the ascending aorta 
in the concavity of the aortic arch. As a result the RPA (length approximately 2-3 cm) is 
longer than LPA and much of it is covered by serous pericardium. 
 
 
Fig. 10. The left atrium forms the lower boundary of subcarinal space. The veins coming to 
the left atrium have no intrapericardial course. The right superior pulmonary vein passes 
behind superior vena cava. Right inferior pulmonary vein crosses the esophagus.  
4.10 The pulmonary veins and the left atrium  
The left atrium has two portions. The posterior half of the chamber, into which the four 
pulmonary veins empty and the anterior half. There are four pulmonary veins, two each 
(superior and inferior), on the right and left sides. On the left side the superior and inferior 
veins drain the upper and lower lobes of the lung, respectively. The superior pulmonary 
vein is the most anterior structure, and the inferior pulmonary vein is the most inferior 
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structure in the root of the lung. Thus on both sides, the principal order of the structures in 
an anteroposterior direction in root of lung is vein, artery, bronchus. The inferior pulmonary 
veins lie below the bronchus on both sides, and below them is the pulmonary ligament into 
which they can expand. The right inferior pulmonary vein crosses the esophagus and the 
right superior pulmonary vein crosses right pulmonary artery and right bronchus. On the 
right side the superior vein crosses behind the superior vena cava; and the inferior vein 
crosses behind the right atrium before they pierce the pericardial sac over the left atrium. 
The left inferior pulmonary vein cross the descending aorta.  
Stations of EBUs Imaging  
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Table 1. The Imaging of the peribronchial structures can be done from six stations. Although 
there is no sharp boundary between the six stations, the structures mentioned at each station 
are generally seen in the positioned mentioned in the table.  
5. Technique of imaging by EBUS scope  
This evaluation can be done in patients referred for EBUS on an outpatient basis, under 
conscious sedation using midazolam and oral xylocaine spray. A linear EBUS scope (Pentax 
EB-1970UK) with 100° field of view, 45° forward oblique angle, a window angle of 75° and a 
distal end optic width of 7.4 mm was used for the purpose of description in this chapter. 
Imaging was done after endoscopic visualization from intrathoracic part of trachea and 
bronchus from six positions. Clockwise or anticlockwise rotation was done after apposition 
against the wall to change the axis of imaging. Cranial side left and caudal side right 
imaging convention was followed. 
5.1 Imaging from upper trachea 
Imaging is done 5 cm above carina where a clockwise and anticlockwise rotation from 
anterior wall of trachea to 90° on either side will show the right and left lateral tracheal walls 
and 180° rotation will show the esophagus behind the posterior wall of trachea (Fig 11 & 12). 
The presence of air in trachea and cartilage in the wall create prominent artifacts during 
imaging (Fig. 13 & 14).  
On clockwise rotation, the brachiocephalic veins are seen joining near the right anterolateral 
wall of trachea to form the superior vena cava. The lower border of left brachiocephalic vein 
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forms the upper boundary of station 2R and superior vena cava forms the posterior 
boundary of station 3a. 
On anti clockwise rotation, the upper margin of the arch of aorta is seen from which the origin 
of left common carotid artery (left posterior boundary of station 3a), left subclavian artery and 
brachiocephalic trunk can be seen (Fig 11). Brachiocephalic trunk crosses to the right side of 
trachea, the left common carotid artery runs  close to left wall of trachea and the left subclavian 
artery goes close to apex of lung where it creates mirror image artifact (Fig. 15 & 16). The 
transverse plane through the superior border of aortic arch makes lower border of the station 
2L on the left and a transverse plane through the lower border of brachiocephalic vein forms 
lower border of 2R lymph nodes on the right side (Figures 17 & 18). 
 
 
Fig. 11. Imaging from upper trachea - when the scope is positioned in upper trachea the great 
vessels of neck can be seen. Clock wise rotation of the scope shows the Right Brachiocephalic 
vein and Brachiocephalic Trunk. The Left common carotid artery and Left Brachiocephalic 
vein are seen anterior to the trachea and may be more easily seen on anticlockwise rotation. 
Further anticlockwise rotation may show the Left subclavian artery. A rotation of 180° shows 
the esophagus lying posterior to trachealis muscle behind the posterior wall of trachea. The 
yellow beam shows the area of imaging on rotation. 1 = Imaging anterior to trachea, where 
station 3a (prevascular) lymph nodes are seen, 2 = Imaging posterior to trachea, where station 
3b lymph nodes are seen, 3 = Imaging of the right lateral side of trachea, where station 2R lymph 
nodes, 4 = Imaging of the left lateral side of trachea, where station 2L lymph nodes are seen.  
 
 
Fig. 12. Imaging of esophagus from trachea -180° rotation from the anterior wall of trachea 
shows membranous posterior wall of trachea made of trachealis muscle and the multilayered 
esophagus with air, forming a hyper-echogeneic line in the middle lying behind trachea. 
 








Fig. 13. Imaging of great vessels of neck: Imaging from upper trachea shows reverberation 
artifact. The trachea has 15 to 20 incomplete horizontally stacked ‘C’ shaped cartilaginous 
rings, each of 4 mm vertical diameter, which create alternating zones of reverberation 
artifact due to cartilage. The breadth of one artifact is likely to match with the breadth of 
each cartilage (4 mm). Once the arch of aorta is visualized pulling back a little will show the 








Fig. 14. Imaging from upper trachea. The air forms dirty comet tail artifact which goes to the 
periphery of the screen in this picture. 
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forms the upper boundary of station 2R and superior vena cava forms the posterior 
boundary of station 3a. 
On anti clockwise rotation, the upper margin of the arch of aorta is seen from which the origin 
of left common carotid artery (left posterior boundary of station 3a), left subclavian artery and 
brachiocephalic trunk can be seen (Fig 11). Brachiocephalic trunk crosses to the right side of 
trachea, the left common carotid artery runs  close to left wall of trachea and the left subclavian 
artery goes close to apex of lung where it creates mirror image artifact (Fig. 15 & 16). The 
transverse plane through the superior border of aortic arch makes lower border of the station 
2L on the left and a transverse plane through the lower border of brachiocephalic vein forms 
lower border of 2R lymph nodes on the right side (Figures 17 & 18). 
 
 
Fig. 11. Imaging from upper trachea - when the scope is positioned in upper trachea the great 
vessels of neck can be seen. Clock wise rotation of the scope shows the Right Brachiocephalic 
vein and Brachiocephalic Trunk. The Left common carotid artery and Left Brachiocephalic 
vein are seen anterior to the trachea and may be more easily seen on anticlockwise rotation. 
Further anticlockwise rotation may show the Left subclavian artery. A rotation of 180° shows 
the esophagus lying posterior to trachealis muscle behind the posterior wall of trachea. The 
yellow beam shows the area of imaging on rotation. 1 = Imaging anterior to trachea, where 
station 3a (prevascular) lymph nodes are seen, 2 = Imaging posterior to trachea, where station 
3b lymph nodes are seen, 3 = Imaging of the right lateral side of trachea, where station 2R lymph 
nodes, 4 = Imaging of the left lateral side of trachea, where station 2L lymph nodes are seen.  
 
 
Fig. 12. Imaging of esophagus from trachea -180° rotation from the anterior wall of trachea 
shows membranous posterior wall of trachea made of trachealis muscle and the multilayered 
esophagus with air, forming a hyper-echogeneic line in the middle lying behind trachea. 
 








Fig. 13. Imaging of great vessels of neck: Imaging from upper trachea shows reverberation 
artifact. The trachea has 15 to 20 incomplete horizontally stacked ‘C’ shaped cartilaginous 
rings, each of 4 mm vertical diameter, which create alternating zones of reverberation 
artifact due to cartilage. The breadth of one artifact is likely to match with the breadth of 
each cartilage (4 mm). Once the arch of aorta is visualized pulling back a little will show the 








Fig. 14. Imaging from upper trachea. The air forms dirty comet tail artifact which goes to the 
periphery of the screen in this picture. 
 







Fig. 15. The left subclavian artery is seen at a little distance away from the trachea with the 
mirror image artifact due to sharp interface with the left lung (the left common carotid 








Fig. 16. A 28 year old lady is referred for evaluation of mediastinal lymphadenopathy. 
Imaging is done from upper trachea. The application of pulse Doppler on the mirror image 
confirms the arterial wave form on the mirror image also. 
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Fig. 17. Imaging is done from upper trachea and reveals a lymph node in front of trachea 
(Station-4L). The left subclavian artery is seen in the lower part of the screen and one lymph 
node is seen between the left subclavian artery and left common carotid artery (Station–2L).  
 
 
Fig. 18. Imaging is done from upper trachea. Once the arch of aorta is visualized pulling 
back a little will show the left common carotid coming out from the top of the arch of aorta. 
The left common carotid artery is seen in this figure and the left brachiocephalic vein is seen 
crossing in front of left common carotid artery. Vertical yellow line denotes the superior 
margin of the Aortic arch. 
5.2 Station 2: Imaging from lower trachea 
A clockwise rotation from above carina shows the right anterolateral wall of the distal one 
third of trachea where the superior vena cava is seen. If clockwise rotation is continued, the 
azygos vein can be seen joining the superior vena cava in the right tracheobronchial corner 
as a kidney-shaped vessel. The inferior border of station 4R is formed by the inferior margin 
of the azygos vein (Fig. 19, 20 & 21).  
An anti-clockwise rotation shows the pulsatile arch of aorta in the left anterolateral wall of 
distal one third of trachea, the superior margin of which forms the boundary between the 
 







Fig. 15. The left subclavian artery is seen at a little distance away from the trachea with the 
mirror image artifact due to sharp interface with the left lung (the left common carotid 








Fig. 16. A 28 year old lady is referred for evaluation of mediastinal lymphadenopathy. 
Imaging is done from upper trachea. The application of pulse Doppler on the mirror image 
confirms the arterial wave form on the mirror image also. 
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Fig. 17. Imaging is done from upper trachea and reveals a lymph node in front of trachea 
(Station-4L). The left subclavian artery is seen in the lower part of the screen and one lymph 
node is seen between the left subclavian artery and left common carotid artery (Station–2L).  
 
 
Fig. 18. Imaging is done from upper trachea. Once the arch of aorta is visualized pulling 
back a little will show the left common carotid coming out from the top of the arch of aorta. 
The left common carotid artery is seen in this figure and the left brachiocephalic vein is seen 
crossing in front of left common carotid artery. Vertical yellow line denotes the superior 
margin of the Aortic arch. 
5.2 Station 2: Imaging from lower trachea 
A clockwise rotation from above carina shows the right anterolateral wall of the distal one 
third of trachea where the superior vena cava is seen. If clockwise rotation is continued, the 
azygos vein can be seen joining the superior vena cava in the right tracheobronchial corner 
as a kidney-shaped vessel. The inferior border of station 4R is formed by the inferior margin 
of the azygos vein (Fig. 19, 20 & 21).  
An anti-clockwise rotation shows the pulsatile arch of aorta in the left anterolateral wall of 
distal one third of trachea, the superior margin of which forms the boundary between the 
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station 4L and 2L lymph node stations. Determination of the lower boundary of station 4L and 
5 is done from left bronchus after clear visualization of upper rim of left pulmonary artery. 
Two transverse lines across the upper and lower border of arch are important in 
determining the area of lymph nodes of station 6 which are better seen by endoscopic 
ultrasound (Fig. 22). 
 
 
Fig. 19. Cross-sectional illustration from the lower trachea. The arch of the Azygos vein is 
seen entering the superior vena cava posteriorly on the right lateral side and the arch of 
aorta is seen in the left lateral side. The illustration shows the station 4R (right para–and pre-
tracheal), 4L (lateral to the left lateral margin of trachea), 6 (lateral to the ascending aorta 
and arch) and 3a (prevascular) lymph nodes.  
 
 
Fig. 20. Illustration of the structures at the lower trachea. The upper level of aortic arch lies 
anterior and to left of the distal one-third of the trachea. The arch of Azygos vein passes 
forwards arching over right stem bronchus to open into Superior vena cava, whereas the 
arch of Aorta passes backwards arching over the left stem bronchus to continue as 
descending Aorta. Blue line = left lateral border of trachea, the boundary between 2R/4R 
and 2L/4L, Green line = Inferior margin of Azygos vein = lower boundary of station 4R, 
Orange line = Superior margin of Left Pulmonary artery, lower boundary of station 4-L and 
5. Lymph node stations: 3a = Pretracheal, 4L = Left Paratracheal, 4R = Right Paratracheal & 
pretracheal, 5= Subaortic nodes lateral to ligamentum arteriosum. 6 = Lateral to ascending 
Aorta and arch. 
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Fig. 21. EBUS image from lower trachea shows the azygos vein joining the superior vena 
cava posteriorly. The right pulmonary artery is seen just below the union of azygos vein 
joining the superior vena cava. Vertical yellow line depicts the caudal margin of the azygos 
vein as it joins superior vena cava.  
 
 
Fig. 22. This is the only EUS image in this article which is given to clarify the borders. EUS 
image shows the arch of aorta and the left pulmonary artery with lymph nodes (1, 2 & 3). 
Vertical lines represent–yellow line: upper margin of the arch of aorta, orange line: lower 
margin of the arch of aorta, blue line: upper margin of the left pulmonary artery. Left right 
dotted arrow = location of station 6 node. Left right solid arrow = location of station 4L 
node.). As the ligamentum arteriosum can not be visualized clearly by EBUS, it is often 
difficult to differentiate the station 4L from the station 5 lymph nodes. Lymph node no. 1= 
station 2L, No. 2 = station 6 & No. 3= station 5 node. 
5.3 Station 3: Imaging from right main bronchus 
From the right main bronchus, the subcarinal space, the right pulmonary artery, right 
pulmonary vein, superior vena cava and ascending aorta are seen close to the anterior wall 
(Fig. 23, 24, 25 & 26, 27 & 28). Turning the scope anti-clockwise shows station 7 nodes of 
subcarinal area (Fig 29). Station 10R lymph nodes are seen close to the right main bronchus. 
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station 4L and 2L lymph node stations. Determination of the lower boundary of station 4L and 
5 is done from left bronchus after clear visualization of upper rim of left pulmonary artery. 
Two transverse lines across the upper and lower border of arch are important in 
determining the area of lymph nodes of station 6 which are better seen by endoscopic 
ultrasound (Fig. 22). 
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and 2L/4L, Green line = Inferior margin of Azygos vein = lower boundary of station 4R, 
Orange line = Superior margin of Left Pulmonary artery, lower boundary of station 4-L and 
5. Lymph node stations: 3a = Pretracheal, 4L = Left Paratracheal, 4R = Right Paratracheal & 
pretracheal, 5= Subaortic nodes lateral to ligamentum arteriosum. 6 = Lateral to ascending 
Aorta and arch. 
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Fig. 23., 24., 25. & 26. Bronchoscopy showed extrinsic compression on the right bronchus. 
EBUS was done from the right bronchus. Four pulsations are seen. One by one placement of 
the pulse doppler is done over the pulsations. The pulse Doppler is placed on pulsation 1 in 
this figure and characterizes it as superior vena cava. The superior vena cava can be 
followed up by pulling up the scope into right lateral wall of trachea. The rest of the vessels 
are as follows–2: Right pulmonary vein, 3: Right pulmonary artery, 4: Ascending aorta.  
SVC = Superior vena cava 
 
 
Fig. 27. The 25 cm landmark is an important landmark for EBUS as the trachea divides into 
right and left bronchus which move towards the respective lungs and opens up a subcarinal 
window anterior to esophagus. The new IASC classification has redefined the boundaries of 
subcarinal area (SCA). It is a pyramidal space the tip of which lies at the tracheal bifurcation. 
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The right boundary (5 cm) is formed by right bronchus (2.5 cm) and intermediate bronchus 
(2.5 cm). The left boundary is formed by left main bronchus. (5 cm) The lower limit of SCA 
is formed by an oblique line drawn from   the lower border of intermediate bronchus to the 
lower border of left main bronchus.  Just above the origin of apical segment of left lower 
lobe bronchus (approximately 5 cm long). The upper border of the left atrium is about 3 to 4 
cm in breadth and occupies the middle part of this oblique line. More laterally the inferior 
pulmonary veins form a part of the lower border of subcarinal area which is generally 
=>1cm for the RIPV and =<, 1cm for LIPV. The dotted blue line shows an axial plane 
through sub-carinal area which roughly corresponds to the upper border of 10R and 10L. 
The green line shows the lower border of 10 R. The green bracket shows the area of hilum 
on the right side which lies opposite sub carinal area on the right side. There is a division 
between 11s and 11i on the right side. The former indicate the nodes between upper lobe 
and intermediate bronchus, the latter are situated in between middle and lower lobe. The 
orange line shows the lower border of 11S on the right side and lies opposite sub carinal 
area on the right side. The orange arrow shows the inter lobar area on the right side which 
lies opposite SCA. The blue line with arrows shows the lower limit of SCA. The magenta 
line shows the lower border of 10 L on the left side and the magenta bracket shows the area 
of 10 L lymph node which lies opposite SCA on the left side. The 11i lymph node lies above 
the purple line on the right side and the 11L lie above the brown line on the left side. The 
hilar nodes of station 10 are situated immediately adjacent to the mainstem bronchus but 
caudal to the inferior border of azygos vein on the right and superior rim pulmonary veins 
and artery on the left. Yellow star on 25 cm line = carina, white star on 25 cm line = upper 





Fig. 28. Imaging from the right main bronchus (Station 3A)—the right main bronchus is 
Broader, more vertical and about 2.5 cm long. The right pulmonary artery lies immediately 
anterior to the right main stem bronchus near the origin of the right upper lobe bronchus. 
The superior vena cava and the ascending aorta lie in front of right pulmonary artery. 
Imaging from the right bronchus can be done by clockwise and anticlockwise rotation. 
Clockwise rotation will show the right pulmonary artery superior vena cava and ascending 
aorta. Anticlockwise rotation will show the subcarinal space. Yellow beam shows the area of 
imaging.     
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Fig. 29. E-BUS Image from the right main bronchus with anti-clockwise rotation 
demonstrates station 7 lymph node (subcarinal).  
5.4 Station 4: Imaging from intermediate bronchus 
Imaging from right intermediate bronchus the subcarinal area (station 7 & 8 nodes) left 
atrium mitral valve and left ventricle are seen anteriorly (Fig. 30 & 31).  On pushing down 
endoscopic visualization of inferior border of right intermediate bronchus demarcates the 







Fig. 30. Imaging from the intermediate bronchus (station 4). The intermediate bronchus lies 
posterior to the pulmonary veins and the left atrium. On a clockwise rotation the pulmonary 
veins can be followed into the lung and on anticlockwise rotation they can be followed into 
the left atrium. From the left atrium the left ventricle and mitral valve can be visualized. 
Yellow beam shows the area of imaging. 
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Fig. 31. E-BUS from the lowest part of right intermediate bronchus shows a lymph node 
between the bronchus and left atrium (Station-8). The left atrium mitral valve and left 
ventricle are seen in this image. 
5.5 Station 5: Imaging from upper part of left main bronchus  
The left pulmonary artery is seen in the anterior wall of bronchus. On anticlockwise 
rotation, the probe faces the posterior wall of left main bronchus where the descending 
aorta, esophagus and vertebral column are seen (Fig. 32, 33). A clockwise rotation shows 
station 7 lymph nodes (Fig. 34). Station 10 L lymph nodes are seen near the left main 
bronchus on anti-clockwise rotation (Fig. 35). 
 
 
Fig. 32. Imaging from the left main bronchus-The left main pulmonary artery is seen in the 
anterior wall. The left main bronchus is narrower, less vertical and 5 cm long. It passes to the 
left inferior to aortic arch through Subaortic Tunnel.  From the left main bronchus  
subcarinal area is identified from the left side by turning the scope in a clockwise direction. 
It is important to note that in left main bronchus clockwise rotation is required to see the 
subcarinal area whereas in right main bronchus anticlockwise rotation is required to see the 
subcarinal area. Identification of the main pulmonary trunk is also possible by clockwise 
rotation. On anti-clockwise rotation the descending aorta can be visualized and followed up 
by slow withdrawal along the left wall of bronchus to the aortic arch. Yellow beam shows 
the area of imaging.  
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Fig. 30. Imaging from the intermediate bronchus (station 4). The intermediate bronchus lies 
posterior to the pulmonary veins and the left atrium. On a clockwise rotation the pulmonary 
veins can be followed into the lung and on anticlockwise rotation they can be followed into 
the left atrium. From the left atrium the left ventricle and mitral valve can be visualized. 
Yellow beam shows the area of imaging. 
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Fig. 33. EBUS Image demonstrates the descending aorta after anticlockwise rotation from 
the left main bronchus. 
 
 
Fig. 34. EBUS image from the left bronchus on clockwise rotation shows station 7 lymph 
node with the pulmonary trunk lying near  the lymph node.  
 
 
Fig. 35. EBUS from the left bronchus shows the left pulmonary artery anterior to the left 
bronchus. The lymph node 1 is seen lying close to the bronchus below the upper rim of left 
pulmonary artery and belongs to station 10-L. The lymph node 2 is lying away from the 
pulmonary artery after its branching and belongs to station 11-L. Yellow arrow shows the 
course of pulmonary artery dividing into two branches. 
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5.6 Station 6: Imaging from lower part of left main bronchus 
With the scope in lower part of left bronchus just above the secondary carina the left atrium 
and station 8 lymph nodes can be identified anteriorly. It is often possible to get a four 
chambered view of heart with a 75° EBUS scope (Fig. 36). The lymph nodes of station 11L 
are seen below the secondary carina. 
 
 
Fig. 36. When the scope is pushed further Down into the left bronchus (Station 6). The left 
pulmonary vein is seen draining into the left atrium. The mitral valve, the left ventricle, the 
aortic valve and the ascending aorta are seen in this position. It is important to note that the 
aortic valve is seen in the root of ascending aorta in front of upper part of left atrium. The 
lymph node for station 8 is seen at the level of left atrium.  
6. Comparison of EBUS and EUS  
No standard comparison has been made till now and the choice of procedure (EBUS first or 
EUS first) is still under debate.  The reasons to choose EUS FNA over EBUS FNA for lymph 
nodes are—  
1. EUS scope has a large diameter and it is easier to pass the FNAC needle through the 
channel of the scope.  
2. The field of vision is more with a EUS scope (130° to 180°) as compared to EBUS scope 
(50 to 70°). 
3. The use of elevator allows more angles for the operator to enter the lymph node.  
4. The use of right and left knobs allows more angles for entry into the lymph node.   
5. The presence of cartilage during entry from trachea may be difficult 
7. Abbreviations  
GV neck = great vessels of neck, AA = arch of aorta, Arc. AV = Arch of azygos vein,BT = 
Brachiocephalic Trunk, LCC = Left Common Carotid Artery, LSCA = Left Subclavian 
Artery, SVC = Superior Vena Cava, RPA = Right Pulmonary Artery, LPA = Left Pulmonary 
Artery, DA = Descending Aorta, LBCV = Left Brachiocephalic Vein, RBCV = Right 
Brachiocephalic Vein, AV = Azygos Vein, RPV = Right Pulmonary Vein, LPV = Left 
Pulmonary Vein, T = Thoracic Vertebra, R = Right, L = Left. Fig. 5 SVC = Superior vena 
cava, Arc. A = Arch of aorta, AV = Azygos vein, AA = Ascending aorta, RPA = Right 
pulmonary artery, DA = Descending aorta, LPA = Left pulmonary artery, PT = Pulmonary 
trunk, LB = Left bronchus, RB = Right bronchus, UT = Upper trachea, LT = Lower trachea, 
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Fig. 33. EBUS Image demonstrates the descending aorta after anticlockwise rotation from 
the left main bronchus. 
 
 
Fig. 34. EBUS image from the left bronchus on clockwise rotation shows station 7 lymph 
node with the pulmonary trunk lying near  the lymph node.  
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pulmonary artery after its branching and belongs to station 11-L. Yellow arrow shows the 
course of pulmonary artery dividing into two branches. 
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Es = esophagus. Tr. = Trachea, Es. = Esophagus, PT = Pulmonary trunk, DA = Descending 
aorta, Es. = Esophagus, Lig. art. = Ligamentum arteri-osum. SCA = Subcarinal area,  TD = 
Thoracic duct, LA = Left atrium, MV = Mitral valve, LV = Left ventricle, RV = Right 
ventricle, RA = Right atrium, RPV = Right pulmonary vein, LPV = Left pulmonary vein,  
RA = Reverberation artifact, SCA = sub carinal area, RMB = right main bronchus, LMB = left 
main bronchus, TA = Truncus anterior, AP window = aortopulmonary window 
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Ultrasound examination of the fetal palate is known to be problematic. The difficulties 
identified include shadowing by facial bones, its curved anatomy, and its location deep 
inside the fetal head especially for the posterior part of palate.  The soft tissues in the area, 
e.g. the fetal tongue, also make it more difficult to delineate the palate. Antenatal detection 
rate of fetal cleft palate has remained low especially when it is an isolated defect without 
concomitant cleft lip. The reported detection rate is virtually 0% in these cases (Grandjean et 
al., 1999; Clementi et.al.. 2000; Shaikh et.al., 2001; Wayne et al., 2002; Hanikeri et al., 2006; 
Offerdal et al., 2008; Demircioglu et al., 2008). Various methods for examination of the fetal 
palate have been proposed, including the use of 2-dimensional (2D) and 3-dimensional (3D) 
ultrasound technology. In this chapter, ultrasound imaging of the fetal palate will be 
revisited. How these problems may be resolved with ultrasound technology will be 
discussed.  
2. The development of the fetal palate 
The fetal palate forms between week 5 to 12 (Moore & Persaud, 2003).  
Early in the 6th week, the medial nasal prominences merge to form the median palatine 
process, or the primary palate, the premaxillary part of the maxilla.  
The secondary palate develops early in the 6th week from the lateral palatine processes or 
the palatal shelves. They are 2 mesenchymal projections that extend from the internal 
aspects of the maxillary prominences. They elongate and ascent to a horizonatal position 
superior to the tongue at the 7th to 8th week, fuse with the nasal septum and the posterior 
part of the primary palate. The primary and secondary palates become ossified. The 
posterior part of the lateral palatal processes extends beyond the nasal septum forming the 
soft palate and uvula, and does not become ossified. (Fig. 1) 
The fetal palate curves from the premaxilla to the tip of the uvula making almost a 90 
degrees turn (Fig. 2). It is like a part of a sphere, with every point on it making a different 
tangent to any reference plane one may set on this sphere.  
Facial clefts could be unilateral, bilateral or midline; anterior, involving the lip with or 
without the primary palate, or posterior, involving the secondary palate, with or without 
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involvement of the lip and primary palate, or sometimes involving the uvula only. Overall 




Fig. 1. Development of the fetal palate from the seventh (a), eighth (b) to the tenth (c) week. 
The images on the left: the palate as seen from below; on the right, coronal plane through 
the nasal septum and the developing palate; mpp, median palatine process; lpp, lateral 
palatine process; ns, nasal septum; t, tongue. 
 




Fig. 2. Sagittal section of a 24 weeks fetus. The soft palate is between the arrows. The vomer 
bone is outlined. From “Prenatal ultrasound examination of the secondary palate” by Prof. 
Stuart Campbell, picture courtesy of Dr. Gonzalo Moscoso with thanks, in Ultrasound 
Obstet Gynecol 2007; 29(2): 124-127. Copyright International Society of Ultrasound in 
Obstetrics and Gynecology, 2007. Reproduced with permission. Permission is granted by 
John Wiley & Son Ltd. on behalf of the ISUOG.  
quarter the palate only (Offerdal 2008). Therefore assessment of the fetal lip or palate is not 
complete without the examination of both and the examination of the palate extends from 
the premaxilla to the tip of the uvula.  
3. The use of ultrasound in imaging the fetal palate 
3.1 Two-dimensional ultrasound 
Before the advent of 3D ultrasound, facial clefts were diagnosed by the 2D oblique face view 
(Pilu et al., 1986)(Fig. 3). The presence of cleft lip detected in this view leads to further 
assessment of the fetal palate.   
The conventional assessment of the fetal face and anterior part of the palate involves the 
evaluation of these structures in the axial and coronal planes, which could be obtained in 68-
95% of fetuses in the mid-trimester (Pretorius 1995, Babcook 1996). The structures to be 
assessed in the orthogonal planes are as follows: 
 
Coronal plane Axial plane Sagittal view 
Soft tissue in the upper lip Soft tissue of upper lip  Soft tissue of upper lip 
- Alveolar ridge of the maxilla 
Any presence of pre-
maxillary protrusion 
Table 1. The structures to be evaluated on the conventional 2D planes in assessment of fetal 
lip and palate 
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Fig. 3. The 2D view through the lower part of the fetal face showing the nose and the lips.  
The sagittal view (or the facial profile) is not always helpful especially in the case of 
unilateral facial cleft because the view could be very much near normal.  
The primary palate and part of the secondary palate are bony. The soft palate including the 
uvula, is made up of soft tissue. The primary palate is superficial, lying just behind the fetal 
lip. In contrast, the secondary palate has a dome further inside the head, enclosed by the 
facial bones (Fig. 2). There are soft tissues present close to the secondary palate in the area 
e.g. the fetal tongue and the pharynx. The presence of fluid in the oral and pharyngeal 
cavity and the movement of the tongue may help to define the palate. However, it is known 
that the hard palate is more difficult to define consistently and the soft palate could not be 
recognised discretely on 2D ultrasound (Filly & Feldstein, 2000).  
3.2 Three-dimensional ultrasound  
Ulm et al (1998) used 3D ultrasound to evaluate fetal tooth germs and found it superior to 
2D ultrasound with a detection rate of 88-94% versus 56-62%, and noted its usefulness for 
characterization of facial clefts (Uml et al., 1999).  
Fig. 4 and Fig. 5 show the axial plane of the palate in same fetus in 2D and 3D respectively. 
The application of 3D ultrasound allows the clear visualization of the alveolar ridge in 
details. The application of 3D ultrasound allows the clear visualization of the alveolar ridge.  
Johnson et al. (2000) pointed out the advantages of 3D ultrasound: 
a. The fetal face may be viewed in a standard orientation. 
b. Interactive display allows the manipulation and scrutinization without the concern for 
fetal movement 
c. Allow artefacts to be detected  
d. Allow serial views 
e. Allow exact location of the planar images be identified in relation to the rendered image 
f. The rendered image allows the family to see the fetal abnormality and the associated 
abnormality. 
Up to this time, shadowing by the alveolar ridge and the facial bones is still an issue for 
viewing the secondary palate even on 3D ultrasound. Campbell & Lees (2003) introduced 
the use of three-dimensional reverse face (3D RF) view for the diagnosis of cleft palate (Fig. 
6). The usefulness of this technique in the antenatal diagnosis of cleft palate was confirmed 
 
 




Fig. 4. 2D ultrasound image of the plate. The primary and secondary palate can be seen in 
this axial plane. The posterior nasal spine is indicated by the arrow. However, due to the 
anatomy of the palate, the under-surface of the soft palate cannot be seen because it is 
almost vertical to the insonation beam (Please refer to Fig. 2).  
 
 
Fig. 5. Axial view on 3D ultrasound. The alveolar ridge is clearly shown in 3D compared 
with the 2D image in the same fetus in Fig. 4. The arrow points to the tip of the uvula, with 
the posterior nasal spine in the background. 
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in 8 cases of suspected craniofacial clefts except in a case of a cleft in the soft palate 
(Campbell et al., 2005). The face is turned through 180 degrees to be viewed in the reverse 
direction after a 3D volume is obtained on the fetal face. The shadowing by the alveolar 
ridge could be largely avoided with clearer demarcation of the edge of the facial cleft with 
this method.  
 
 
Fig. 6. The reverse face view. The intact palate can be seen as a distinct horizontal line 
separating the nasal and the oral cavities.  
To avoid acoustic shadowing from the alveolar ridge, Pilu & Segata (2006) suggested that 
the secondary palate to be insonated at a 45 degrees angle in the sagittal plane and 3D 
ultrasound to be used to construct axial and coronal planes (Fig. 7). 
With this method, they were able to obtain satisfactory views of the secondary palate in 10 
of 15 cases between 19-28 weeks. They examined the tomographic ultrasound images (TUI) 
in the orthogonal planes. They confirmed that the axial plane (Fig. 8) allowed the assessment 
of alveolar ridge defect in cleft lip and palate. However, the tongue might still obscure the 
edges of the defect in facial cleft. Tomographic ultrasound images of the secondary palate in 
the coronal plane (Fig. 9) allowed the examination of the secondary palate in serial sections 
along its length and the edges of the defect appeared to be demarcated. This echoes the 
finding of Campbell et al. (2003). Although part of the soft palate could be visualized in the 
sagittal plane, it was not demonstrated in the axial and coronal planes. The limitation with 
this technique is unfavourable fetal position. (Pilu & Segata 2006)  
 













Fig. 8. TUI of the axial view 
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Fig. 9. TUI of the coronal view. The coronal views of the secondary palate could be assessed 
along the length of the palate in a serial fashion. 
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Platt et al. (2006) demonstrated the use of the “flipped face” view in antenatal diagnosis of 
facial clefts. Following acquisition of the 3D volume of the fetal face, the volume is rotated to 
view the palate from below in a thick slice (Fig. 10). They commented that with this method, 
the full length and width of the mouth and palate in the axial plane could be examined in 2 
minutes.   
 
 
Fig. 10. The “flipped face” view. The alveolar ridge is well seen in this fetus at 18 weeks. The 
tip of the uvula is visible.  
Wong et al (2007, 2008, 2009, and 2010) proposed a rotational method to view the secondary 
palate especially the soft palate, by rotating the orthogonal planes including the “flipped 
face” view and the reverse face view to the oblique planes (Fig. 11). With this method, one 
could view the surfaces of the soft palate at different angles from above or below or from the 
side with a stored 3D volume of the face. The uvula allows the soft palate to be identified 
(Fig. 5). The soft tissue around the palate does not appear to affect the view. Similar to the 
reverse face view, the shadowing by the facial bones and alveolar ridge could largely be 
avoided because the insonation plane is different from the examination plane.The authors 
reported the usefulness of this technique in assessing the extent of fetal cleft palate (Wong et 
al., 2010). However, the application of this method in assessing isolated clefts in the soft 
palate remains to be tested as this is a less common entity.  
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Fig. 11. The oblique axial plane. This is obtained by rotating the axial plane to an oblique 
plane. The under-surface of the soft palate including the uvula could be seen.  
4. Conclusion 
We have witnessed the advancement of ultrasound technology in the last few decades, and 
the increase use of 3D ultrasound in the examination of the fetus in the past 20 years.  All the 
precious experience by previous researchers has contributed to our understand of the issues 
in the application of ultrasound on examination of the fetal palate and the ways to overcome 
them. We look forward to see what appears to be a difficult task in the past may possibly be 
incorporated into routine ultrasound examination of the fetus. 
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Ultrasound scanning has become one of the most important noninvasive investigations used 
in the assessment of vascular diseases. Duplex ultrasound is currently the main diagnostic 
modality used in deep venous thrombosis and carotid disease. It enables monitoring of 
bypasses for patency and neointimal hyperplasia as well as transcranial examination of 
brain vessels in subarachnoid hemorrhage.  
Nowdays, the role of the vascular laboratory is continuously changing with the introduction 
of new technology. New interventions such as carotid stenting and endovascular aneurysm 
repair have necessitated the use of duplex ultrasound for detecting in-stent restenosis or 
endoleaks. Ultrasound is also used intra-operatively in evaluating endovenous procedures 
such as laser and radiofrequency ablation and the patency of in situ vein bypasses. Arterial 
mapping of the lower extremity by duplex ultrasound has replaced contrast angiography 
(CA) and magnetic resonance angiography (MRA) for lower extremity bypass procedures.  
Most recently, a variety of new applications for vascular ultrasound has arised. Contrast-
enhanced ultrasound imaging allows the assessment of microcirculation and can be used for 
delivery of drugs and genetic therapies. Physicians use three-dimensional ultrasound to 
assess carotid plaque volume and monitor its evolution with time and its response to 
various treatments. In the aera of atherosclerosis, ultrasound has provided a non-invasive 
way of assessing the elastic properties of an artery and to evaluate the patient’s risks of 
adverse cardiovascular events. Finally, intravascular ultrasound has opened new frontiers in 
the measuring of intimal thickness and assessing vulnerable plaques. 
2. Ultrasound in the era of atherosclerotic disease  
2.1 Intravascular ultrasound (IVUS) 
Intravascular ultrasound is a promising and rapidly evolving technique that provides high-
quality images of the vessel’s wall and lumen (Houslay & Uren, 2005) (Fig. 1).  
Angiography, the traditionally used “gold-standard” in the imaging of vascular 
morphology (Liu & Goldberg, 1999) has multiple disadvantages, such as depiction only of 
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contrast agent filled lumen and not the vessel wall, as well as the risk of contrast-induced 
nenal failure. Moreover, it underestimates the plaque burden, especially for the detection of 
concentrical lumen narrowing (Liu & Goldberg, 1999). 
 
 
Fig. 1. Intravascular ultrasound (IVUS) advancing via the inferior vena cava (IVC) at various 
levels depicting the right atrium (A), the hepatic veins (B), the renal veins (C), and the 
infrarenal IVC (D) 
With the use of high-frequency catheter based transducers, all basic components of the 
vessel are identified: the cross sectional luminal size, shape and vessel wall, as well as the 
various layers of the wall such as the intima, media, adventitia and perivascular structures 
(Liu & Goldberg, 1999). 
In conventional gray-scale intravascular sonography arteries can be classified as elastic 
(lying centrally in the arterial tree) or muscular (peripherally distributed). Calcifications are 
demonstrated as hyperechoic areas, whereas hemorrage or fat deposition inside an 
atheromatic plaque is hypoechoic. Subsequently, the plaque is subclassified as lipid, 
calcified and fibrous, according to its differential acoustic properties (Liu & Goldberg, 1999). 
Furthermore, the concommitant use of colour-flow intravascular sonography allows for a 
real-time dynamic assessment of plaque morphology and provides a better understanding 
of the blood flow, the lumen size and the success of endovascular treatment (Zacharatos et 
al., 2010). Hence, the physician can obtain a realistic virtual histology map of the patient’s 
arteries, visualize the atheroma without the need of true histologic sections of the diseased 
coronary arteries and tailor his treatments (Fayad & Fuster, 2001; Martin et al., 1997). 
The correlation of IVUS plaque characteristics and histopathologic speciments is well 
validated in literature (Potkin et al., 1990).The CAPITAL study showed a strong correlation 
of IVUS findings with histologic speciments from endarterectomy (Diethrich et al., 2007) 
while Potkin et al compared IVUS with coronary histopathologic speciments, to show that 
fibrous and calcified plaques were identified with good precision (Potkin et al., 1990). 
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In patients with coronal artery stenosis IVUS can act as a prognostication tool, as vulnerable 
plaques, heavy in fat deposition are considered at higher risk for cardiovascular events and 
might need more aggressive treatment. In addition, plaque regression in respond to lipid 
lower therapies with statins has been successfully monitored by the use of serial IVUS (Crouse 
et al., 2007; Nissen, 2005; Nissen et al., 2008). Many dynamic phenomena in the setting of an 
atheroma, such as positive and negative remodeling or restenosis after angioplasty and 
stenting are timely demonstrated and treated accordingly (Liu & Goldberg, 1999). 
The concommitant use of intravascular elastography(Fayad & Fuster, 2001) (images 
obtained from cardiac IVUS images associated with intraluminar pressures during the 
cardiac circle) expands the frontiers of the IVUS technique, as it illustrates the mechanical 
properties of the vessel wall and provides strain information. IVUS allows a direct 
visualization of the processes associated with lumen expansion by ballon dilation. It is 
believed that about 80% of the post-dilation increase in the lumen area is due to an increase 
in vessel size, and 20% is due to a reduction in plaque area, due to axial plaque 
redistribution (Liu & Goldberg, 1999). 
IVUS can be utilized as a means of planning and evaluating the effects of vascular 
brachytherapy in the treatment of post-stent restenosis (Carlier et al., 2000). Apart from 
coronal artery disease, it is a safe method of choosing the appropriate intervention 
procedure in peripheral vascular disease (Fig. 2) and carotid stenting (Liu & Goldberg, 
1999). It’s only risk, the disruption of a plaque and release of embolic material, seems minor 
compared to it’s numerous advantages. 
 
 
Fig. 2. Obstruction of the iliac vein: pre-intervention imaging (A) and post-intervention 
result (B) by intravascular ultrasound (IVUS) 
2.2 3D ultrasound 
Three-dimentional ultrasound is a recent development that came as an answer to the 
multiple problems inherent to 2D ultrasound images, leading to incorrect quantification of 
plaque morphology, difficult localization and significant operator dependence (Fenster et 
al., 2004) (Fig. 3).  
3D imaging of atherosclerotic plaques can allow reproducible quantitative monitoring of 
plaque progression and regression and provide important information regarding the 
plaques’ response to therapy, as its morphology and geometry is accessed (Weyman, 2009). 
With this technique vascular branches, accessory vessels and their intimate relationships can 
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be easily demonstrated (Liu & Goldberg, 1999). Arterial dissections, aneurysms and aortic 




Fig. 3. 3D IVUS of an iliac artery 
Although the importance of 3D imaging has been demonstrated in several studies, the 
widespread use of this technique has been prevented by inherent disadvantages, such as the 
slow frame rate, the lengthy analysis time and the limited spacial resolutions (Weyman, 2009). 
The combination of contrast with 3D ultrasound will likely compensate for the latter and 
should enhance its value in areas such as stress echocardiography (Liu & Goldberg, 1999). 
2.3 Flow mediated dilatation (FMD) and carotid intima-media thickness 
Endothelial dysfunction and its effect on modulation of vascular tone is considered to play 
an important role in the pathogenesis of the atherosclerotic process (Ghiadoni et al., 2008). 
The degree of vasodilation is a measure of endothelial function; the greater the vasodilation, 
the higher the endothelial function. 
A novel non invasive technique called the “flow-mediated dilation” (FMD) of the brachial 
artery is nowdays widely used in current clinical practice to assess the function of the 
endothelium and its relationship to coronary artery disease. Ischemia of the brachial artery 
is induced by the inflation of an arterial cuff for five minutes. After cuff deflation brachial 
artery flow increases and this also increases shear stress of the artery resulting in 
vasodilation. It is believed that the endothelium locally produces NO in response to stress 
induced phosphorylation of the endothelial NO synthase (Ghiadoni et al., 2008). In arteries 
with impaired NO production, due to decreased endothelial function the above response is 
diminished. 
Decreased brachial artery FMD has been associated with all the major risk factors for 
cardiovascular disease, such as smoking, diabetes, advanced age and hypercholesterolemia. 
Faulx et al have demonstrated that FMD was almost as sensitive and more specific in 
detecting coronary artery disease in comparison to stress electrocardiography (Faulx et al., 
2003). Lerman et al showed that FMD significantly predicted cardiovascular events, 
independently of traditionally used cardiovascular risk factors (Lerman & Zeiher, 2005).  
Limitations of this promising technique are the potential small vessel size of the brachial 
artery that often renders the measurement erroneous and the ambiguity in image timing 
after cuff deflation (Faulx et al., 2003).  
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Another marker used to quantify atherosclerosis by B-mode ultrasound is the measurement 
of carotid intima-media thickness (CIMT) (de Groot et al., 2008; Labropoulos et al.,  Dec 
2005). A simple distance measurement between the leading edges of the lumen-intima and 
media-adventitia ultrasound interfaces is performed and this measurement can be used to 
measure the degree of existing atherosclerosis and future cardiovascular disease risk (de 
Groot et al., 2008; Bots et al., 1997; Chambless et al., 1997). Futhermore, several studies in 
literature have proved the efficacy of CIMT in monitoring the patient’s response to lipid 
lowering therapies (Blankenhorn et al., 1993; de Groot et al., 1998; Furberg et al., 1994; 
Smilde et al., 2001). 
3. Pre-operative ultrasound use 
In patients with lower extremity ischemia, angiography has traditionally been considered 
the “gold standard” of arterial mapping. However, in recent years, duplex ultrasonography 
(DA) has gained a major role in the pre-operative evaluation of patients undergoing lower 
extremity bypass (Ascher et al., 1999; Grassbaugh et al., 2003; Ligush et al., 1998; Pemberton 
et al., 1996; Proia et al., 2001). Mazzariol et al reported that the use of dupplex 
ultrasonography can provide enough information for surgery in more than 83% of patients 
with arterial stenosis and that an abnornal femoral artery waveform was 100% predictive for 
detecting stenosis greater than 80% (Mazzariol et al., 2000) Proia et al have also confirmed 
these results (Proia et al., 2001). 
In comparison with conventional angiography or MRA, DA has a lower sensitivity for 
detecting arterial disease of the lower extremity. Moreover, it is often cumbersome and time-
consuming to scan the entire arterial tree from the aorta to the pedal vessels. Imaging can 
also be obscured in obese patients or heavily calcified vessels. Nevertheless, the simplicity 
and safety of this technique underlines its importance as a first-line examination before 
planning a bypass surgery (Pearce & Astleford, 2004). 
4. Intra-operative and post-operative ultrasound 
Completion angiography has been traditionally used as an adjunctive technique after 
bypass procedures to scan the graft for anatomic and flow abnormalities. Nowdays, duplex 
scanning is used as a safer alternative to visualize these abnormalities (Johnson et al., 2000). 
Defective grafts are identified by direct measurement of PSV and ratio at the lesion devided 
by proximal velocity (Johnson et al., 2000). 
Moreover, surveillance Duplex ultrasound has acquired an important role in the post-
operative assessment of patients following lower extremity revascularization. It enables 
prompt detection of hemodynamically significant lesions and early intervention (Bandyk, 
2002, Mills et al., 2001). Patients undergoing EVAR (endovascular aneurysm repair) are also 
monitored by serial ultrasound examinations (Bendick et al., 2003; Carter  et al., 2000; 
McWilliams et al., 1999; Pearce & Astleford, 2004). The value of duplex ultrasound scanning 
in this group of patients is that repeated studies can be performed frequently to detect an 
endoleak or a restenosis, without the risk of contrast-induced nephropathy or the presence 
of adjuscent metal artifacts. 
Carotid artery stenting (CAS) is currently being clinically evaluated as an alternative  
to conventional carotid endarterectomy (CEA). Dupplex ultrasound is commonly used to 
monitor restenosis in patients following CEA. Several authors in literature begin to report 
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their experience in the use of ultrasonography as a follow-up tool in CAS too (Lal  et  
al., 2004). 
5. Ultrasound in venous disease 
In the field of deep venous thrombosis ultrasound is nowdays the sole diagnostic modality 
in most centers and has contibuted extensively in our understanding of the natural history 
and the pathophysiology of the disease (Labropoulos et al.,  Feb 2005; Labropoulos et al., Jan 
2010; Apr 2010) (Figures 4, 5). 
 
 
Fig. 4. Acute thrombosis in the common femoral vein. There is absence of color, the vein is 




Fig. 5. Chronic inferior vana cava (IVC) obstruction with partial recanalization. The lumen of 
IVC is smaller compared to the adjacent aorta. The azygos vein is dilated and larger than the 
aorta. 
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Duplex ultrasound is also used as a follow-up tool to detect venous reflux up to six months 
after treatment (Labropoulos et al., Feb 2005) (Fig. 6) and to investigate conditions such as 
thrombus neovascularization (Labropoulos et al., Sep 2005). 
 
 
Fig. 6. Chronic thrombus with partial recanalization in great saphenous vein. Flow channels 
with reflux are seen over the old thrombus that is seen as an echogenic band in the lumen 
Patients undergoing varicose vein stripping and venous ablative surgery routinely undergo 
preoperative ultrasound scanning to assure that the deep venous system is clot-free and to 
identify the location of perforators and accessory veins as well as the presence of lesser 
saphenous reflux. Intraoperatively, the use of ultrasound allows for placement of a catheter 
under direct guidance close to the sapheno-femoral junction, and then the anesthesia agent 
is injected (Min et al., 2001; Pichot  et al., 2004). Successful ablation is then established by 
monitoring venous occlusion by means of ultrasonography. 
6. Contrast-enhanced ultrasound 
Gramiak was the first to describe contrast enhanced ultrasound in 1969, using air bubbles in 
the aorta (Gramiak et al., 1969). In modern clinical practice contrast agents for ultrasound 
use are microbubbles of different gases, 1-7μm in diameter (Cosgrove, 2006). The gas can be 
air, which unfortunately dissolves quickly in water or blood, or newer agents such as 
sulphur hexafloride, perfluocarbons or heavy gases, which minimally dissolve in water 
(Cosgrove, 2006). In order to reach and persist in systemic circulation the microbubbles are 
stabilized with albumin, simple phospholipids micelles, bilayered membranes and 
biocompatible polymers (Cosgrove, 2006). Inside the vessels microbubbles expand and 
contract in the alternating pressure waves of the ultrasound beam, while tissues are almost 
incompressible. Special software using multiple pulse sequences enhances this blood-tisue 
border detection (Weyman, 2009). Adverse effects of contrast agents are headache, bruising, 
injection site pain, paresthesias and burning. 
Microbubbles are currently used to improve Doppler studies especially when flow 
information makes conventional imaging difficult, a technique called “Doppler rescue” 
(Cosgrove, 2006). Common applications include imaging of the basilar and vertebral 
arteries, transcranial ultrasound examinations in patients with severe hyperostosis of the 
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their experience in the use of ultrasonography as a follow-up tool in CAS too (Lal  et  
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Duplex ultrasound is also used as a follow-up tool to detect venous reflux up to six months 
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arteries, transcranial ultrasound examinations in patients with severe hyperostosis of the 
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skull, measurement of internal carotid stenosis in calcified arteries (Cosgrove, 2006) and 
differentiation of subtotal stenosis from occlusion in acute stroke (Seidel & Meairs, 2009). 
Moreover, contrast enhanced ultrasound has been used in renal artery stenosis, portal and 
hepatic artery examinations (e.g. in cirrhosis, tips shunts or after liver transplantation) 
(Furlow, 2009) and in liver oncology (Wilson & Burns, 2006) (Fig. 7). 
 
 
Fig. 7. Contrast-enhanced ultrasound of an hepatic hemangioma 
Neurosurgeons can intra-operatively assess vascular pathologies such as middle cerebral 
artery aneurysms and arteriovenous malformations in real time and make appropriate 
surgical planning (Hölscher et al., 2007).  
The microbubbles used in contrast-enhanced ultrasound techniques after attachment of 
antibodies or other ligants to their shell can bind to specific cell receptors in areas of disease 
(Voigt, 2009), thus provide information about the stage of the disease (Lindner, 2009). 
Several promising studies have targeted pathologic processes with contrast-enhanced 
ultrasound (Lindner, 2009; Voigt, 2009), such as angiogenesis (by targeting endothelial 
integrins) (Lerman & Zeiher, 2005), thrombus (by targeting IIbIIIa receptors or fibrinogen) 
(Alonso et al., 2007), inflammation (by targeting ICAM-1, VCAM-1 P- and L- selectin) and 
plaque (by targeting ICAM-1, VCAM-1 and several angiogenesis markers) (Voigt, 2009). In 
fact, it is believed that by targeting plaque inflammation and neovascularization we could 
identify patients at high risk for cardiovascular events well before angiography (Lindner, 
2009; Voigt, 2009) or even recognise “vulnerable plaques” and begin early treatment 
(Vicenzini et al., 2009). 
Several future promising therapeutic applications of microbubbles are under research. 
Therapeutic agents, genes, siRNAs, drugs and molecules can be attached to or dissolved 
within the surface shell or deposited within the bubbles themselves (Hernot & Klibanov, 
2008; Hynynen, 2008; Weyman, 2009). 
Local cavitation due to microbubble destruction can produce clot fragmentation and 
enhance thrombolysis (Medel  et al., 2009; Trübestein et al., 1976). Continuous transcranial 
Doppler has been shown to augment the t-PA induced arterial recanalization in stroke 
victims (Alexandrov et al., 2004). Future studies need to be performed in order to improve 
the safety profile and therapeutic indexes of these challenging techniques. 
 




Ultrasound imaging in vascular diseases has evolved during the past years due to new 
challenging technologies. Virtually all peripheral arterial and venous structures can be 
visualized with color duplex ultrasound. In the era of atherosclerosis, the use of 
intravascular ultrasound, contrast-enhanced ultrasound, 3D ultrasound, flow mediated 
dilatation and carotid intima media thickness techniques allow for more precise and 
localized diagnosis, treatment and follow-up. Ultrasound techniques routinely performed 
before, during or after surgical procedures are nowdays commonplace. The low cost and 
noninvasive aspect of most ultrasound methods make it the technique of choice in studying 
the human vasculature. 
8. References 
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, 
Saqqur M, Demchuk AM, Moyé LA, Hill MD & Wojner AW. Ultrasound-enhanced 
systemic thrombolysis for acute ischemic stroke. N Engl J Med, Vol. 351, No. 21, 
(Nov 2004), pp. 2170-2178 
Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S, Schneider M, Hennerici 
M, Allémann E, Meairs S. Molecular imaging of human thrombus with novel 
abciximab immunobubbles and ultrasound. Stroke, Vol. 38, No. 5, (May 2007), pp. 
1508-1514 
Ascher E, Mazzariol F, Hingorani A, Salles-Cunha S & Gade P. The use of Duplex 
ultrasound arterial mapping as an alternative to conventional arteriography for 
primary and secondary infrapopliteal bypasses. Am J Surg, Vol. 178, No. 2, (Aug 
1999), pp. 162–165 
Bandyk DF. Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, 
and is it cost effective? J Am Coll Surg, Vol. 194, No. 1 suppl, (Jan 2002), pp. 540-552 
Bendick PJ, Bove PG, Long GW, Zelenock GB, Brown OW & Shanley CJ. Efficacy of 
ultrasound scan contrast agents in the noninvasive follow-up of aortic stent grafts. J 
Vasc Surg, Vol. 37, No. 2, (Feb 2003), pp. 381–385 
Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH, Mack WJ & 
Alaupovic P. Beneficial effects of colestipol niacin therapy on the common carotid 
artery. Two- and four-year reduction of intima-media thickness measured by 
ultrasound. Circulation, Vol. 88, No. 1, (Jul 1993), pp. 20-28 
Bots ML, Hoes AW, Koudstaal PJ, Hofman A & Grobbee DE. Common carotid ntima-media 
thickness and risk of stroke and myocardial infarction: the Rotterdam Study. 
Circulation, Vol. 96, No. 5, (Sep 1997), pp. 1432-1437 
Carlier SG, Coen VL, Sabaté M, Kay IP, Ligthart JM, Van Der Giessen WJ, Levendag PC, 
Bom K & Serruys PW. The role of intravascular ultrasound imaging in vascular 
brachytherapy. Int J Cardiovasc Intervent, Vol. 3, No. 1, (Mar 2000), pp. 3-12 
Carter KA, Nelms CR, Bloch PHS, Gregory RT, Parent EN &  DeMasi RJ. Doppler waveform 
assessment of endoleak following endovascular repair of abdominal aortic 
aneurysm: predictors of endoleak thrombosis. J Vasc Technol, Vol. 24, No. 2, (2000), 
pp. 119 122 
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR &  Clegg LX. 
Association of coronary heart disease incidence with carotid arterial wall thickness 
and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 
1987-1993. Am J Epidemiol, Vol. 146, No. 6, (Sep 1997), pp. 483-494 
 
Ultrasound Imaging – Medical Applications 
 
202 
skull, measurement of internal carotid stenosis in calcified arteries (Cosgrove, 2006) and 
differentiation of subtotal stenosis from occlusion in acute stroke (Seidel & Meairs, 2009). 
Moreover, contrast enhanced ultrasound has been used in renal artery stenosis, portal and 
hepatic artery examinations (e.g. in cirrhosis, tips shunts or after liver transplantation) 
(Furlow, 2009) and in liver oncology (Wilson & Burns, 2006) (Fig. 7). 
 
 
Fig. 7. Contrast-enhanced ultrasound of an hepatic hemangioma 
Neurosurgeons can intra-operatively assess vascular pathologies such as middle cerebral 
artery aneurysms and arteriovenous malformations in real time and make appropriate 
surgical planning (Hölscher et al., 2007).  
The microbubbles used in contrast-enhanced ultrasound techniques after attachment of 
antibodies or other ligants to their shell can bind to specific cell receptors in areas of disease 
(Voigt, 2009), thus provide information about the stage of the disease (Lindner, 2009). 
Several promising studies have targeted pathologic processes with contrast-enhanced 
ultrasound (Lindner, 2009; Voigt, 2009), such as angiogenesis (by targeting endothelial 
integrins) (Lerman & Zeiher, 2005), thrombus (by targeting IIbIIIa receptors or fibrinogen) 
(Alonso et al., 2007), inflammation (by targeting ICAM-1, VCAM-1 P- and L- selectin) and 
plaque (by targeting ICAM-1, VCAM-1 and several angiogenesis markers) (Voigt, 2009). In 
fact, it is believed that by targeting plaque inflammation and neovascularization we could 
identify patients at high risk for cardiovascular events well before angiography (Lindner, 
2009; Voigt, 2009) or even recognise “vulnerable plaques” and begin early treatment 
(Vicenzini et al., 2009). 
Several future promising therapeutic applications of microbubbles are under research. 
Therapeutic agents, genes, siRNAs, drugs and molecules can be attached to or dissolved 
within the surface shell or deposited within the bubbles themselves (Hernot & Klibanov, 
2008; Hynynen, 2008; Weyman, 2009). 
Local cavitation due to microbubble destruction can produce clot fragmentation and 
enhance thrombolysis (Medel  et al., 2009; Trübestein et al., 1976). Continuous transcranial 
Doppler has been shown to augment the t-PA induced arterial recanalization in stroke 
victims (Alexandrov et al., 2004). Future studies need to be performed in order to improve 
the safety profile and therapeutic indexes of these challenging techniques. 
 




Ultrasound imaging in vascular diseases has evolved during the past years due to new 
challenging technologies. Virtually all peripheral arterial and venous structures can be 
visualized with color duplex ultrasound. In the era of atherosclerosis, the use of 
intravascular ultrasound, contrast-enhanced ultrasound, 3D ultrasound, flow mediated 
dilatation and carotid intima media thickness techniques allow for more precise and 
localized diagnosis, treatment and follow-up. Ultrasound techniques routinely performed 
before, during or after surgical procedures are nowdays commonplace. The low cost and 
noninvasive aspect of most ultrasound methods make it the technique of choice in studying 
the human vasculature. 
8. References 
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, 
Saqqur M, Demchuk AM, Moyé LA, Hill MD & Wojner AW. Ultrasound-enhanced 
systemic thrombolysis for acute ischemic stroke. N Engl J Med, Vol. 351, No. 21, 
(Nov 2004), pp. 2170-2178 
Alonso A, Della Martina A, Stroick M, Fatar M, Griebe M, Pochon S, Schneider M, Hennerici 
M, Allémann E, Meairs S. Molecular imaging of human thrombus with novel 
abciximab immunobubbles and ultrasound. Stroke, Vol. 38, No. 5, (May 2007), pp. 
1508-1514 
Ascher E, Mazzariol F, Hingorani A, Salles-Cunha S & Gade P. The use of Duplex 
ultrasound arterial mapping as an alternative to conventional arteriography for 
primary and secondary infrapopliteal bypasses. Am J Surg, Vol. 178, No. 2, (Aug 
1999), pp. 162–165 
Bandyk DF. Infrainguinal vein bypass graft surveillance: how to do it, when to intervene, 
and is it cost effective? J Am Coll Surg, Vol. 194, No. 1 suppl, (Jan 2002), pp. 540-552 
Bendick PJ, Bove PG, Long GW, Zelenock GB, Brown OW & Shanley CJ. Efficacy of 
ultrasound scan contrast agents in the noninvasive follow-up of aortic stent grafts. J 
Vasc Surg, Vol. 37, No. 2, (Feb 2003), pp. 381–385 
Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH, Mack WJ & 
Alaupovic P. Beneficial effects of colestipol niacin therapy on the common carotid 
artery. Two- and four-year reduction of intima-media thickness measured by 
ultrasound. Circulation, Vol. 88, No. 1, (Jul 1993), pp. 20-28 
Bots ML, Hoes AW, Koudstaal PJ, Hofman A & Grobbee DE. Common carotid ntima-media 
thickness and risk of stroke and myocardial infarction: the Rotterdam Study. 
Circulation, Vol. 96, No. 5, (Sep 1997), pp. 1432-1437 
Carlier SG, Coen VL, Sabaté M, Kay IP, Ligthart JM, Van Der Giessen WJ, Levendag PC, 
Bom K & Serruys PW. The role of intravascular ultrasound imaging in vascular 
brachytherapy. Int J Cardiovasc Intervent, Vol. 3, No. 1, (Mar 2000), pp. 3-12 
Carter KA, Nelms CR, Bloch PHS, Gregory RT, Parent EN &  DeMasi RJ. Doppler waveform 
assessment of endoleak following endovascular repair of abdominal aortic 
aneurysm: predictors of endoleak thrombosis. J Vasc Technol, Vol. 24, No. 2, (2000), 
pp. 119 122 
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR &  Clegg LX. 
Association of coronary heart disease incidence with carotid arterial wall thickness 
and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 
1987-1993. Am J Epidemiol, Vol. 146, No. 6, (Sep 1997), pp. 483-494 
 
Ultrasound Imaging – Medical Applications 
 
204 
Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol, Vol. 60, No. 3, (Dec 
2006), pp. 324-330 
Crouse JRr, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH Grobbee DE & Bots 
ML. Effect of rosuvastatin on progression of carotid Intima media thickness in low-
risk individuals with 
subclinical atherosclerosis: the METEOR Trial. JAMA, Vol. 297, No. 12, (Mar 2007), pp. 1344-
1353 
de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, 
van der Steen AF, Bom N, Lie KI & Bruschke AV. B-mode ultrasound assessment of 
pravastatin treatment effect on carotid and femoral artery walls and its correlations 
with coronary arteriographic findings: a report of the Regression Growth 
Evaluation Statin Study (REGRESS). J Am Coll Cardiol, Vol. 31, No. 7, (Jun 1998), pp. 
1561-1567 
de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML & Kastelein 
JJ. Measurement of carotid intima-media thickness to assess progression and 
regression of atherosclerosis. Nat Clin Pract Cardiovasc Med, Vol. 5, No. 5, (May 
2008), pp. 280 288 
Diethrich EB, Pauliina Margolis M, Reid DB, Burke A, Ramaiah V, Rodriguez - Lopez JA, 
Wheatley G, Olsen D & Virmani R. Virtual histology intravascular ultrasound 
assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology 
Evaluation (CAPITAL) study. J Endovasc Ther, Vol. 14, No. 5, (Oct 2007), pp. 676-86 
Faulx MD, Wright AT & Hoit BD. Detection of endothelial dysfunction with brachial artery 
ultrasound scanning. Am Heart J, Vol. 145, No. 6, (Jun 2003), pp. 943-951 
Fayad ZA & Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. 
Circ Res, Vol. 89, No. 4, (Aug 2001), pp. 305-316 
Fenster A, Landry A, Downey DB, Hegele RA & Spence JD. 3D ultrasound imaging of the 
carotid arteries. Curr Drug Targets Cardiovasc Haematol Disord, Vol. 4, No. 2, (Jun 
2004), pp. 161-175 
Furberg CD, Adams HPJ, Applegate WB, Byington RP, Espeland MA, Hartwell T, 
Hunninghake DB, Lefkowitz DS, Probstfield J & Riley WA. Effect of lovastatin on 
early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid 
Artery Progression Study (ACAPS) Research Group. Circulation, Vol. 90, No. 4, (Oct 
1994), pp. 1679-1687 
Furlow B. Contrast-enhanced ultrasound. Radiol Technol, Vol. 80, No. 6, (Jul Aug 2009), pp. 
547S-561S 
Ghiadoni L, Versari D, Giannarelli C, Faita F & Taddei S. Non-invasive diagnostic tools for 
investigating endothelial dysfunction. Curr Pharm, Vol. 14,  No. 35, (Dec 2008), pp. 
3715-3722 
Gramiak R, Shah PM & Kramer DH: Ultrasound cardiography: contrast studies in anatomy 
and function. Radiology, Vol. 92, No. 5, (Apr 1969), pp. 939-948 
Grassbaugh JA, Nelson PR, Rzucidlo EM, Schermerhorn ML, Fillinger MF, Powell RJ, 
Zwolak RM, Cronenwett JL & Walsh DB. Blinded comparison of preoperative 
duplex ultrasound scanning and contrast arteriography for planning 
revascularization at the level of the tibia. J Vasc Surg, Vol. 37, No 6, (Jun 2003), pp. 
1186-1190 
Hernot S & Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. 
Adv Drug Deliv Rev, Vol. 60, No. 10, (Jun 2008), pp. 1153-1166 
Hölscher T, Ozgur B, Singel S, Wilkening WG, Mattrey RF & Sang H. Intraoperative 
ultrasound using phase inversion harmonic imaging: first experiences. 
 
Ultrasound Imaging in Vascular Diseases 
 
205 
Neurosurgery, Vol. 60, No. 4, Suppl. 2,  (Apr 2007), pp. 382-386, discussion 386-387 
Houslay ES & Uren NG. Intravascular ultrasound: defining plaque regression. Hosp 
Med, Vol. 66, No. 1, (Jan 2005), pp. 27-31   
Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev, Vol. 
60, No. 10, (Jun 2008), pp. 1209-1217 
Johnson BL, Bandyk DF, Back MR, Avino AJ & Roth SM. Intraoperative duplex monitoring 
of infrainguinal vein bypass procedures. J Vasc Surg, Vol. 31, No. 4, (Apr 2000), pp. 
678-690 
Labropoulos N, Bhatti AF, Amaral S, Leon L, Borge M, Rodriguez H &  Kalman P. 
Neovascularization in acute venous thrombosis. J Vasc Surg, Vol. 42, No. 3, (Sep 
2005), pp. 515-518 
Labropoulos N, Kokkosis AA, Spentzouris G, Gasparis AP & Tassiopoulos AK. The 
distribution and significance of varicosities in the saphenous trunks. J Vasc Surg, 
Vol. 51, No 1, (Jan 2010), pp. 96 
Labropoulos N, Leon L, Kwon S, Tassiopoulos A, Gonzalez-Fajardo JA, Kang SS, Mansour 
MA & Littooy FN. Study of the venous reflux progression. J Vasc Surg, Vol. 41, No. 
2, (Feb 2005), pp. 291-295 
Labropoulos N, Leon LRJ, Brewster LP, Pryor L, Tiongson J, Kang SS, Mansour MA & 
Kalman P. Are your arteries older than your age?. Eur J Vasc Endovasc Surg, Vol. 30, 
No. 6, (Dec 2005), pp. 588-596 
Labropoulos N, Jen J, Jen H, Gasparis AP & Tassiopoulos AK: Recurrent deep vein 
thrombosis: long-term incidence and natural history. Ann Surg, Vol. 251, No. 4, 
(Apr 2010), pp. 749-753 
Lal BK, Hobson RW 2nd, Goldstein J, Chakhtoura EY & Duran WN. Carotid artery stenting: 
is there a need to revise ultrasound velocity criteria? J Vasc Surg, Vol. 39, No.1, (Jan 
2004), pp. 58–66 
Lerman A & Zeiher AM. Endothelial function: cardiac events. Circulation, Vol.  111, No. 3, 
(Jan 2005), pp. 363-368 
Ligush J Jr, Reavis SW, Preisser JS & Hansen KJ. Duplex ultrasound scanning Defines 
operative strategies for patients with limb-threatening ischemia. J Vasc Surg, Vol. 
28, No. 3, (Sep 1998), pp. 482–490 
Lindner JR. Contrast ultrasound molecular imaging of inflammation in cardiovascular 
disease. Cardiovasc Res, Vol. 84, No. 2, (Nov 2009), pp. 182-189 
Liu JB & Goldberg BB.  2-D and 3-D endoluminal ultrasound: vascular and nonvascular 
applications. Ultrasound Med Biol, Vol. 5, No. 2, (Feb 1999), pp. 159-173 
Martin AJ, Ryan LK, Gotlieb AI, Henkelman RM & Foster FS . Arterial imaging: comparison 
of high-resolution US and MR imaging with histologic correlation. Radiographics, 
Vol. 17, No. 1, (Jan- Feb 1997), pp. 189-202 
Mazzariol F, Ascher E, Hingorani A, Gunduz Y, Yorkovich W & Salles-Cunha S. Lower-
extremity revascularisation without preoperative contrast arteriography in 185 
cases: lessons learned with duplex ultrasound arterial mapping. Eur J Vasc Endovasc 
Surg, Vol. 19, No. 5, (May 2000), pp. 509-515 
McWilliams RG, Martin J, White D, Gould DA, Harris PL, Fear SC, Brennan J, Gilling-Smith 
GL, Bakran A & Rowlands PC. Use of contrast-enhanced ultrasound in follow-up 
after endovascular aortic aneurysm repair. J Vasc Interven Radiol , Vol. 10, No. 8, 
(Sep 1999), pp. 1107–1114 
Medel R, Crowley RW, McKisic MS, Dumont AS & Kassell NF. Sonothrombolysis: an 
emerging modality for the management of stroke. Neurosurgery, Vol. 65, No. 5, 
(Nov 2009), pp. 979-993, discussion 993 
 
Ultrasound Imaging – Medical Applications 
 
204 
Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol, Vol. 60, No. 3, (Dec 
2006), pp. 324-330 
Crouse JRr, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH Grobbee DE & Bots 
ML. Effect of rosuvastatin on progression of carotid Intima media thickness in low-
risk individuals with 
subclinical atherosclerosis: the METEOR Trial. JAMA, Vol. 297, No. 12, (Mar 2007), pp. 1344-
1353 
de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, 
van der Steen AF, Bom N, Lie KI & Bruschke AV. B-mode ultrasound assessment of 
pravastatin treatment effect on carotid and femoral artery walls and its correlations 
with coronary arteriographic findings: a report of the Regression Growth 
Evaluation Statin Study (REGRESS). J Am Coll Cardiol, Vol. 31, No. 7, (Jun 1998), pp. 
1561-1567 
de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML & Kastelein 
JJ. Measurement of carotid intima-media thickness to assess progression and 
regression of atherosclerosis. Nat Clin Pract Cardiovasc Med, Vol. 5, No. 5, (May 
2008), pp. 280 288 
Diethrich EB, Pauliina Margolis M, Reid DB, Burke A, Ramaiah V, Rodriguez - Lopez JA, 
Wheatley G, Olsen D & Virmani R. Virtual histology intravascular ultrasound 
assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology 
Evaluation (CAPITAL) study. J Endovasc Ther, Vol. 14, No. 5, (Oct 2007), pp. 676-86 
Faulx MD, Wright AT & Hoit BD. Detection of endothelial dysfunction with brachial artery 
ultrasound scanning. Am Heart J, Vol. 145, No. 6, (Jun 2003), pp. 943-951 
Fayad ZA & Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. 
Circ Res, Vol. 89, No. 4, (Aug 2001), pp. 305-316 
Fenster A, Landry A, Downey DB, Hegele RA & Spence JD. 3D ultrasound imaging of the 
carotid arteries. Curr Drug Targets Cardiovasc Haematol Disord, Vol. 4, No. 2, (Jun 
2004), pp. 161-175 
Furberg CD, Adams HPJ, Applegate WB, Byington RP, Espeland MA, Hartwell T, 
Hunninghake DB, Lefkowitz DS, Probstfield J & Riley WA. Effect of lovastatin on 
early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid 
Artery Progression Study (ACAPS) Research Group. Circulation, Vol. 90, No. 4, (Oct 
1994), pp. 1679-1687 
Furlow B. Contrast-enhanced ultrasound. Radiol Technol, Vol. 80, No. 6, (Jul Aug 2009), pp. 
547S-561S 
Ghiadoni L, Versari D, Giannarelli C, Faita F & Taddei S. Non-invasive diagnostic tools for 
investigating endothelial dysfunction. Curr Pharm, Vol. 14,  No. 35, (Dec 2008), pp. 
3715-3722 
Gramiak R, Shah PM & Kramer DH: Ultrasound cardiography: contrast studies in anatomy 
and function. Radiology, Vol. 92, No. 5, (Apr 1969), pp. 939-948 
Grassbaugh JA, Nelson PR, Rzucidlo EM, Schermerhorn ML, Fillinger MF, Powell RJ, 
Zwolak RM, Cronenwett JL & Walsh DB. Blinded comparison of preoperative 
duplex ultrasound scanning and contrast arteriography for planning 
revascularization at the level of the tibia. J Vasc Surg, Vol. 37, No 6, (Jun 2003), pp. 
1186-1190 
Hernot S & Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. 
Adv Drug Deliv Rev, Vol. 60, No. 10, (Jun 2008), pp. 1153-1166 
Hölscher T, Ozgur B, Singel S, Wilkening WG, Mattrey RF & Sang H. Intraoperative 
ultrasound using phase inversion harmonic imaging: first experiences. 
 
Ultrasound Imaging in Vascular Diseases 
 
205 
Neurosurgery, Vol. 60, No. 4, Suppl. 2,  (Apr 2007), pp. 382-386, discussion 386-387 
Houslay ES & Uren NG. Intravascular ultrasound: defining plaque regression. Hosp 
Med, Vol. 66, No. 1, (Jan 2005), pp. 27-31   
Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev, Vol. 
60, No. 10, (Jun 2008), pp. 1209-1217 
Johnson BL, Bandyk DF, Back MR, Avino AJ & Roth SM. Intraoperative duplex monitoring 
of infrainguinal vein bypass procedures. J Vasc Surg, Vol. 31, No. 4, (Apr 2000), pp. 
678-690 
Labropoulos N, Bhatti AF, Amaral S, Leon L, Borge M, Rodriguez H &  Kalman P. 
Neovascularization in acute venous thrombosis. J Vasc Surg, Vol. 42, No. 3, (Sep 
2005), pp. 515-518 
Labropoulos N, Kokkosis AA, Spentzouris G, Gasparis AP & Tassiopoulos AK. The 
distribution and significance of varicosities in the saphenous trunks. J Vasc Surg, 
Vol. 51, No 1, (Jan 2010), pp. 96 
Labropoulos N, Leon L, Kwon S, Tassiopoulos A, Gonzalez-Fajardo JA, Kang SS, Mansour 
MA & Littooy FN. Study of the venous reflux progression. J Vasc Surg, Vol. 41, No. 
2, (Feb 2005), pp. 291-295 
Labropoulos N, Leon LRJ, Brewster LP, Pryor L, Tiongson J, Kang SS, Mansour MA & 
Kalman P. Are your arteries older than your age?. Eur J Vasc Endovasc Surg, Vol. 30, 
No. 6, (Dec 2005), pp. 588-596 
Labropoulos N, Jen J, Jen H, Gasparis AP & Tassiopoulos AK: Recurrent deep vein 
thrombosis: long-term incidence and natural history. Ann Surg, Vol. 251, No. 4, 
(Apr 2010), pp. 749-753 
Lal BK, Hobson RW 2nd, Goldstein J, Chakhtoura EY & Duran WN. Carotid artery stenting: 
is there a need to revise ultrasound velocity criteria? J Vasc Surg, Vol. 39, No.1, (Jan 
2004), pp. 58–66 
Lerman A & Zeiher AM. Endothelial function: cardiac events. Circulation, Vol.  111, No. 3, 
(Jan 2005), pp. 363-368 
Ligush J Jr, Reavis SW, Preisser JS & Hansen KJ. Duplex ultrasound scanning Defines 
operative strategies for patients with limb-threatening ischemia. J Vasc Surg, Vol. 
28, No. 3, (Sep 1998), pp. 482–490 
Lindner JR. Contrast ultrasound molecular imaging of inflammation in cardiovascular 
disease. Cardiovasc Res, Vol. 84, No. 2, (Nov 2009), pp. 182-189 
Liu JB & Goldberg BB.  2-D and 3-D endoluminal ultrasound: vascular and nonvascular 
applications. Ultrasound Med Biol, Vol. 5, No. 2, (Feb 1999), pp. 159-173 
Martin AJ, Ryan LK, Gotlieb AI, Henkelman RM & Foster FS . Arterial imaging: comparison 
of high-resolution US and MR imaging with histologic correlation. Radiographics, 
Vol. 17, No. 1, (Jan- Feb 1997), pp. 189-202 
Mazzariol F, Ascher E, Hingorani A, Gunduz Y, Yorkovich W & Salles-Cunha S. Lower-
extremity revascularisation without preoperative contrast arteriography in 185 
cases: lessons learned with duplex ultrasound arterial mapping. Eur J Vasc Endovasc 
Surg, Vol. 19, No. 5, (May 2000), pp. 509-515 
McWilliams RG, Martin J, White D, Gould DA, Harris PL, Fear SC, Brennan J, Gilling-Smith 
GL, Bakran A & Rowlands PC. Use of contrast-enhanced ultrasound in follow-up 
after endovascular aortic aneurysm repair. J Vasc Interven Radiol , Vol. 10, No. 8, 
(Sep 1999), pp. 1107–1114 
Medel R, Crowley RW, McKisic MS, Dumont AS & Kassell NF. Sonothrombolysis: an 
emerging modality for the management of stroke. Neurosurgery, Vol. 65, No. 5, 
(Nov 2009), pp. 979-993, discussion 993 
 
Ultrasound Imaging – Medical Applications 
 
206 
Mills JL Sr, Wixon CL, James DC, Devine J, Westerband A & Hughes JD. The natural history 
of intermediate and critical vein graft stenosis: recommendations for continued 
surveillance or repair. J Vasc Surg, Vol. 33, No. 2, (Feb 2001), pp. 273–278 
[discussion 278–280] 
Min RJ, Zimmet SE, Isaacs MN & Forrestal MD. Endovenous laser treatment of the 
incompetent greater saphenous vein. J Vasc Interven Radiol, Vol. 12, No. 10, (Oct 
2001), pp. 1167–1171 
Nissen SE. Effect of intensive lipid lowering on progression of coronary atherosclerosis: 
evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive 
Lipid Lowering (REVERSAL) trial. Am J Cardiol, Vol. 96, No. 5A, (Sep 2005), pp. 
61F-68F 
Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, 
Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, 
Bhatt DL, Lincoff AM & Tuzcu EM. Effect of rimonabant on progression of 
atherosclerosis in patients with abdominal obesity and coronary artery disease: the 
STRADIVARIUS randomized controlled trial. JAMA, Vol. 299, No. 13, (Apr 2008), 
pp. 1547-1560 
Pearce WH & Astleford P: What's new in vascular ultrasound. Surg Clin North Am, Vol. 84, 
No. 4, (Aug 2004), pp. 1113-1126 
Pemberton M, Nydahl S, Hartshorne T, Naylor AR, Bell PR & London NJ. Colour-coded 
duplex imaging can safely replace diagnostic arteriography in patients with lower-
limb arterial disease. Br J Surg, Vol. 83, No. 12, (Dec 1996), pp. 1725–1728 
Pichot O, Kabnick LS, Creton D, Merchant RF, Schuller-Petroviae S & Chandler JG. Duplex 
ultrasound scan findings two years after great saphenous vein radiofrequency 
endovenous obliteration. J Vasc Surg, Vol. 39, No. 1, (Jan 2004), pp. 189–195 
Potkin BN, Bartorelli AL, Gessert JM, Neville RF, Almagor Y, Roberts WC, & Leon MB. 
Coronary artery imaging with intravascular high frequency ultrasound. Circulation, 
Vol. 81, No. 5, (May 1990), pp. 1575-1585 
Proia RR, Walsh DB, Nelson PR, Powell RJ, Zwolak RM, Fillinger MF &  Cronenwett JL. 
Early results of infragenicular revascularization based solely on duplex 
arteriography. J Vasc Surg, Vol. 33, No. 6, (Jun  2001), pp. 1165–1170 
Seidel G & Meairs S. Ultrasound contrast agents in ischemic stroke. Cerebrovasc Dis, Vol. 27, 
No. Suppl 2 (2009), pp. 25-39 
Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ & Stalenhoef AF. Effect of 
aggressive versus conventional lipid lowering on atherosclerosis progression in 
familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind 
trial. Lancet, Vol. 357, No. 9256, (Feb 2001), pp. 577-581 
Trübestein G, Engel C, Etzel F, Sobbe A, Cremer H & Stumpff U. Thrombolysis by 
ultrasound. Clin Sci Mol Med, Vol. Suppl 3, (Dec 1976), pp. 697s-698s 
Vicenzini E, Giannoni MF, Benedetti-Valentini F & Lenzi GL. Imaging of carotid plaque 
angiogenesis. Cerebrovasc Dis, Vol. 27, No. Suppl 2, (2009), pp.48-54 
Voigt JU. Ultrasound molecular imaging. Methods, Vol. 48, No. 2, (Jun 2009), pp. 92-97 
Weyman AE. Future directions in echocardiography. Rev Cardiovasc Med, Vol. 10, No. 1, 
(Winter 2009), pp. 4-13 
Wilson SR & Burns PN. Microbubble contrast for radiological imaging: 2. Applications. 
Ultrasound Q, Vol. 22, No. 1, (Mar 2006), pp: 15-18 
Zacharatos H, Hassan AE & Qureshi A. (2010). Intravascular ultrasound: principles and 
cerebrovascular applications. AJNR Am J Neuroradiol, Vol. 31, No. 4, (Apr 2010), pp. 
586-597 
11 
The Role of Obstetric Ultrasound in Reducing 
Maternal and Perinatal Mortality 
Yaw Amo Wiafe, Alexander T. Odoi and Edward T. Dassah 
Komfo Anokye Teaching Hospital 
Ghana 
1. Introduction 
The joy that every expectant couple, family, or community has when a woman gets pregnant is 
suddenly turned into sorrow and mourning when the woman dies during pregnancy or child 
birth, or when the baby dies. According to the World Health Organization (WHO), the five 
major causes of maternal mortality are hemorrhage, sepsis, complications of abortion, 
eclampsia, and obstructed labour (Bale et al, 2003).  
The WHO similarly lists the most common causes of neonatal mortality as infections, birth 
asphyxia, birth injuries, preterm births, and birth defects (Bale et al., 2003). It is worth noting 
that these mortality causes are conditions for which timely ultrasound imaging could be of 
immense help in early diagnosis and hence intervention, leading to the reduction of 
mortality rates among mothers and their babies. 
It is also notable that most of these avoidable deaths (99%) occur in developing countries, 
where ultrasound imaging is currently underutilized, and financial constraints have been 
cited as the main reason. However, the usefulness of ultrasound imaging in preventing 
these needless deaths has not been fully exploited. It is anticipated that low resource settings 
could benefit by prudent application of this modern technology which is a relatively 
affordable and safe imaging modality. In recent times technology has made this modality so 
affordable and widely available, that it is unacceptable to watch such needless deaths occur 
when ultrasound application could help improve survival rates.  
This chapter discusses the usefulness of ultrasound imaging at various stages of pregnancy, 
whether in apparently normal or high risk situations. Current advances in obstetric ultrasound 
application and imaging techniques that are helpful for improving pregnancy outcome are 
discussed. The chapter also addresses the availability of more affordable but high quality 
ultrasound equipment that can improve obstetric healthcare, accentuating the need to 
implement sustainable ultrasound practice standards in developing countries where the 
current rate of maternal and perinatal mortalities is unacceptably high.  
It must be emphasised that the objective and focus of this chapter is the role ultrasound 
plays in the diagnosis and in some cases follow-up or interventionary guidance, not the 
management of the various conditions. Readers may consult other literature for the specific 
management of these conditions. 
2. Reducing mortality rates by ultrasound imaging in the first trimester 
Ectopic pregnancy, abortion, and gestational trophoblastic diseases (GTDs) are the 
commonest conditions of the first-trimester that can cause maternal mortality, due to the 
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possibility of severe haemorrhage, shock or sepsis. Patients usually present with bleeding 
and/or pain but can also remain asymptomatic for a long time. In some cases patients don’t 
even realize that they are pregnant, particularly in some cases of ectopic pregnancy and 
missed abortion. Ultrasound imaging is extremely useful for obtaining accurate diagnosis 
for these first trimester conditions. It is therefore important to exclude early pregnancy 
pathology in every woman of reproductive age who presents with amenorrhoea, abnormal 
bleeding and/or pain, using diagnostic ultrasound imaging in combination with beta 
human chorionic gonadotropin (β-HCG). This approach to medical care can potentially 
reduce maternal mortality rates. 
In terms of perinatal mortality the role of ultrasound imaging in detecting markers for 
chromosomal anomalies and structural defects in the fetus to enable early intervention or 
close monitoring is very important. 
2.1.1 Ectopic pregnancy 
Ectopic pregnancy accounts for 9% of all pregnancy-related deaths (Uzelac and Garmel, 2007). 
However, because of improved diagnostic capabilities, notably in ultrasound imaging, the 
incidence of mortality has relatively declined in the US and other developed countries since 
the 1970s, despite the increasing number of ectopic pregnancies (Lawson et al, 1988; Levine, 
2000). This implies that improving on the use of ultrasound imaging in developing countries 
could equally improve survival rates of deaths caused by ectopic gestation. 
In the evaluation of suspected ectopic pregnancy β-HCG and ultrasound complement each 
other. Transvaginal sonography (TVS) is able to reliably identify an intrauterine gestational 
sac when the serum β-HCG is 1000mIU/ml and transabdominal sonography (TAS) when 
the β-HCG level is 1800-3600mIU/ml. Thus TVS detects either a normal or an abnormal 
intrauterine gestational sac earlier than TAS. With TVS the transducer is closer to the uterus 
and adnexae allowing higher frequencies to be used, since there are fewer tissue interfaces 
with less beam scatter and the effect of abdominal wall fat is avoided, (details of the TVS 
technique are described in another section of this chapter).  
In sonographic diagnosis of ectopic pregnancy, TVS may reveal only a thickened 
decidualised endometrium. With more advanced ectopic pregnancies, decidual sloughing 
with resultant fluid or blood in the cavity may lead to the formation of a small and irregular 
intrauterine structure, the so-called pseudogestational sac. Diagnostic accuracy is further 
enhanced by the use of transvaginal colour Doppler sonography (TV-CDS) compared with 
the use of TVS alone, which will detect an increased peritrophoblastic flow on colour 
Doppler at the site of implantation. 
In a patient with a positive β-HCG who has no sonographic evidence of an intrauterine 
pregnancy, the presence of an adnexal mass is suggestive of ectopic pregnancy with a 
positive predictive value of 70% to 75% (Nyberg et al, 1991).  
In some cases, an echogenic adnexal ring will be seen separate from the ovary, known as 
tubal ring. Tubal ring has been detected in 68% of unruptured tubal pregnancies using TVS, 
with a positive predictive value of 100% (Fleischer et al, 1990; Nyberg et al, 1991)  
The specific diagnosis of ectopic pregnancy however, is the demonstration of a gestational 
sac with an embryo in the adnexa (Nyberg et al, 1991) (Figure 1). A live extrauterine fetus 
can be detected with TVS in 17% to 28% of patients with ectopic pregnancies (Thorsen et al, 
1990; Fleischer et al, 1990) compared with approximately 10% with TAS (Mahony et al, 
1985), implying that an examiner should progress to TVS if TAS findings are suboptimal. 
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With TV-CDS an adnexal peritrophoblastic flow with a high-velocity and low-resistance 
spectral pattern may be demonstrated, separate from the ovary (Pellerito et al, 1992). 
Also the presence of free fluid in the pouch of Douglas is a nonspecific finding that suggests 
the presence of an ectopic pregnancy in the appropriate clinical setting. The amount of fluid 
and the echogenicity of the fluid are important clues in predicting the presence of a 
ruptured ectopic pregnancy. Large amounts of fluid and increased echogenicity of the fluid 
are both more indicative of a ruptured ectopic pregnancy (Frates et al, 1994).  In patients 
with suspected ectopic pregnancy, the combination of an adnexal mass and echogenic free 
fluid is associated with a 97% positive predictive value for ruptured ectopic pregnancy 
(Nyberg et al, 1991). Detecting the ectopic pregnancy before rupture will avoid blood loss and 
consequent morbidity and mortality (Dassah et al, 2009). Even when rupture has occurred 
early detection by ultrasound imaging will obviously help to prevent further blood loss. 
 
           
              (a)         (b) 
Fig. 1. (a)&(b) shows a right adnexal ectopic gestation with a live embryo demonstrated by 
M mode assessment of fetal heart rate (FHR). 
2.1.2 Abortion 
Unsafe abortion is known to account for 13% of maternal mortality (WHO 2005). Regardless 
of whether an abortion is spontaneous or induced, subsequent events and the care received 
determine whether the abortion is safe or unsafe. If an incomplete abortion is not 
appropriately treated, it can lead to haemorrhage, shock, sepsis and death. Ultrasound 
imaging is useful for obtaining definitive diagnosis, as the symptoms of incomplete abortion 
and ectopic pregnancy may be similar. Moreover if a miscarriage is assumed to have 
occurred, or termination of pregnancy is carried out without an initial ultrasound imaging, 
one may not know whether subsequent complaints of bleeding and pain are caused by 
retained products of conception, ectopic pregnancy or even a haemorrhagic corpus luteum. 
Additionally, early ultrasound imaging may prevent uterine perforation which can occur 
during evacuation of an incomplete abortion or termination of pregnancy as a result of 
retroverted/retroflexed uterus. Ultrasound is also useful in determining which pregnancies 
are viable and which are most likely to miscarry. Ultrasound findings of incomplete 
abortion may vary depending on the amount of products expelled; it may appear as a 
reduced sac-size with irregular shape, and/or an echogenic material representing placental 
tissue within the uterus.  An irregular gestational sac without a yolk sac or embryo is 
consistent with a blighted ovum (Figures 2A and 2B), whereas a foetus without a cardiac 
activity is consistent with a missed abortion (Figure 2c). 
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Where available it is important to use TAS or TVS with colour and spectral Doppler 
application when excluding retained products of conception from a tissue that is no longer 
viable and is likely to be expelled spontaneously. Colour Doppler will usually demonstrate 
a focally increased colour Doppler flow in the region of retained products, if present.  
 
   
                 (a)    (b)        (c) 
Fig. 2. (a),(b) and (c) A&B: Blighted Ovum; C: Missed Abortion- Note the non-viable embryo. 
In B there is increased vascularity on colour Doppler at implantation site. 
2.1.3 Gestational trophoblastic diseases 
Gestational trophoblastic diseases are a spectrum of benign and malignant conditions of the 
trophoblast comprising hydatidiform mole, invasive mole, choriocarcinoma, placental site 
trophoblastic tumour, and epithelioid trophoblastic tumour. Aside vaginal bleeding or 
brownish spotting which is common with early pregnancy conditions,  molar pregnancies 
may present with a larger-than-date uterus, hyperemesis, passage of grape-like vesicles per 
vaginum, preeclampsia and hyperthyroidism. Complications of molar pregnancy can be 
life-threatening and include: (1) Haemorrhage from an existing mole or local invasion; (2) 
Anaemia due to maternal blood loss; (3) Rupture of, or haemorrhage into theca lutein cysts; 
(4)Pulmonary embolism or pulmonary oedema due to the migration of trophoblastic tissue 
through the uterine veins, and (4) Progression to malignancy.  
The role of ultrasound imaging in GTDs is based on providing evidence for the diagnosis of 
hydatiform mole. Once diagnosed, tumor response to therapy can also be monitored, and 
the presence of metastatic sites can be ascertained.  
The characteristic sonographic appearance in most molar pregnancies is the demonstration of 
hydropic villi. The typical sonographic appearance of a complete mole is that of a complex and 
echogenic intrauterine mass containing many small cystic spaces, which correspond to the 
hydropic villi on gross pathology (Benson et al, 2000) (Figure 3a). One may also see a large, 
central fluid collection that mimics an anembryonic gestation or abortion (Figure3c -& d). 
Occasionally, there is merely a central mass of variable echogenicity. Colour Doppler 
sonography is used to detect areas of increased blood flow within the myometrium(Kawano, 
et al, 1996) (Figure 3b) and can be used as a means of monitoring the effectiveness of 
chemotherapy (Bidzinski et al, 1999). Even though best practice requires that all products of 
conception from non-viable pregnancies should be examined histologically, irrespective of 
ultrasonographic findings, ultrasound will in the first place determine whether the pregnancy 
is viable or not. This does not downplay the importance of ultrasound in this condition. 
Secondly in rural settings access to histological report may delay, or may not be available at all. 
Ultrasound imaging will therefore assist in the initial diagnoses and in carefully selecting those 
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patients at higher risk for malignancy for histological evaluation, especially where the 
laboratory facilities for histology are not available. 
 
   
               (a)       (b) 
     
                  (c)         (d) 
Fig. 3. (a) is a typical appearance of complete mole as described in the text 
(b) shows increased flow within myometrium in regions of invasion of a mole 
(c) & (d) are sagittal and transverse views of the same case respectively, showing atypical 
appearance of molar pregnancy 
2.2 Gestational age estimation 
In the first trimester a patient can benefit from ultrasound imaging in the estimation of 
gestational age (GA), particularly those who cannot recall their last menstrual period (LMP), 
or those who do not have regular 28 day menstrual cycle.  Gestational age has emerged as 
one of the most important predictors of perinatal mortality (Markestad et al, 2005). The 
outcome of pregnancy is more closely related to gestational age as determined by 
ultrasound imaging. Accurate GA enables future detection of intrauterine growth restriction 
(IUGR), large for gestational age (LGA), and also essential in decision making for delivery or 
conditions such as premature rupture of membrane (PROM), postdates, placenta previa, 
hypertensive disorders, etc. The most accurate estimation of GA therefore, is done in the 
first trimester (7-13weeks gestation) using the crown-rump length (CRL), and is even more 
reliable than using clinical date (Eik-Nes et al, 2000). A CRL is determined by measuring the 
maximal straight line distance from the fetal head to the rump (Figure 4a & b). 
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                 (a)    (b)        (c) 
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             (a)       (b) 
Fig. 4. CRL measurement can be used for pregnancy dating in early first trimester as figure 
4a, and late first trimester as figure 4b. This is the most accurate way to date a pregnancy 
2.3 Multiple pregnancy 
Ultrasonography is the diagnostic tool of choice for detecting a multiple pregnancy (as early 
as five weeks gestation) using TVS. The perinatal mortality rate in twins is about 5-times 
higher than in singletons, with higher incidence in monochorionic (5%) than dichorionic 
(2%) twin pregnancies (Sebire et al 1997).  Again, the prevalence of pre-eclampsia is about 4-
times greater in twin than in singleton pregnancies (Savvidou et al 2001). Other 
complications include increased risk of miscarriage and pre-term delivery.  There is 
increased risk of placenta previa, malpresentation, and abruptio placenta. Anaemia is three 
times more common compared to singletons. The risk of atonic postpartum haemorrhage is 
also far higher in twins. Also,there is increased risk of operative intervention to the mother. 
Increased surveillance in the antepartum period is therefore required, making early 
detection by ultrasound imaging an appropriate practice.   
In the first trimester, dichorionic twins can easily be distinguished by the presence of a thick 
septum between the chorionic sacs; the septum forms the chorionic component of the  
inter-twin membrane. This septum becomes thinner as the pregnancy progresses, but 
remains thicker and easier to identify at the base of the membrane as a triangular tissue 
projection, the so-called lambda sign (Sepulveda et al 1996). Sonographic examination of the 
base of the inter-twin membrane for the presence or absence of the lambda sign (Figure 5) 
provides reliable distinction between dichorionic and monochorionic pregnancies. This 
definitive diagnosis of chorionicity may not be possible with second and third trimester 
scans; hence the importance of first trimester scans. 
 
    
      (a)                 (b) 
Fig. 5. (a) shows the triangular tissue projection (lambda sign). This is absent in figure 5b 
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2.4 Early detection of chromosomal and structural anomalies (11-14weeks’-scan) 
Late first trimester ultrasound imaging for anomaly detection is typically performed at 11-14 
weeks primarily for measuring nuchal translucency (NT). The NT is ultrasound description 
of a subcutaneous physiologic fluid collection between the skin and the cervical spine of the 
foetus which can be used for obtaining diagnostic information when the CRL of the foetus is 
45 – 84mm (figure 6a & b ) NT increases with GA hence accurate CRL is needed for 
interpretation of NT measurement.  
Measurement of the NT is useful for determining aneuploidy, a major cause of perinatal 
mortality. At 11 - 14 weeks, all major chromosomal defects are associated with increased NT 
thickness (Nicolaides et al 1992). In a chromosomally normal fetus, increased NT thickness 
is also associated with major abnormalities of the heart and great vessels, diaphragmatic 
hernia, exomphalos and asphyxiating thoracic atrophy (Souka et al, 2004). Further 
sonographic evaluation with echocardiography and/or 3D imaging may therefore be 
requested to rule out these anomalies. Other defects detectable at this gestational age are: 
acrania, anencephaly, encephalocele, gastroschisis, cleft palate, etc.  
The role of ultrasound imaging in early prediction of aneuploidy and structural defects 
reduces the number of perinatal deaths resulting from birth defects, as it offers the couple an 
opportunity to decide whether or not to terminate the chromosomally abnormal fetus. 
Termination of pregnancy at this early gestation is associated with less maternal morbidity 
and mortality. 
In developed countries, the practice of early termination of chromosomally abnormal foetus 
has significantly reduced perinatal mortality (Briker et al, 2000), and may become useful in 
developing countries; since with increasing education, women in these countries are now 
giving birth later in life, putting them at greater risk of having chromosomally abnormal 
babies.  
Invasive prenatal testing by amniocentesis or chorionic villous sampling, which is needed 
for a definitive diagnosis, also requires ultrasound guidance. This invasive procedure can 
unfortunately result in the miscarriage of a normal pregnancy. 
The important role of ultrasound, therefore, is based on the fact that most foetuses with 
chromosomal abnormalities have either major structural malformations or minor 
abnormalities (markers) that can be sonographically detected at this early stage of 
pregnancy (Nicolaides, 1993), and enable termination of pregnancy with less morbidity and 
mortality.  
Even if the couple decides to keep the pregnancy, the knowledge of structural defects 
enables referral to a tertiary centre to improve post-delivery care. 
Table 1 show first trimester anomalies (markers) associated with aneuploidy, based on the 
reported findings of Nicolaides (2004).  
Even though NT can be accurately measured with TAS in about 95% of cases, whereTAS 
assessment of NT and structural abnormalities are inclusive, a combination of TAS and TVS 
is required. The advantage of TAS is that it allows flexibility of probe manipulation. 
However, TVS offers better resolution and visualisation.  
In a study by Braithwaite et al, which compared foetal anatomy at 12 to 13 weeks using TVS 
and TAS, they found that a complete survey of the anatomy was possible in 72% of women 
using TAS, 82% with TVS, and 95% by combining the two (Braithwaite et al. 1996). 
Additional sonographic findings by M-mode assessment of fetal heart rate is also useful for 
predicting aneuploidy in the late first trimester ultrasound imaging. The normal fetal heart 
rate (FHR) increases from about 100 bpm at 5 weeks of gestation to 170 bpm at 10 weeks, 
and then decreases to 155 bpm by 14 weeks (Nicolaides et al, 2004). At 10–14 weeks, trisomy 
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13 and Turner’s syndrome are associated with tachycardia, whereas in trisomy 18 and 
triploidy there is fetal bradycardia (Liao et al 2001). In trisomy 21, there is a mild increase in 
FHR (Nicolaides et al 2004). 
The detection rate of the additional structural abnormalities, some of which are listed in 
table 1, depends very much on the skill and experience of the sonographer, and to a lesser 
extent on the machine. With state of the art ultrasound machine many structural 
abnormalities have been detected in recent years. In five separate studies of screening an 
unselected population in the first trimester, the detection rates of fetal abnormality ranged 
from 33%-64.7% (Peregrine and Pandya, 2005).  
The importance of 3-D ultrasound imaging especially in high-risk families further enhances 
detection of abnormality (Pretorius et al, 1995). Some investigators have suggested that 3-D 
ultrasound imaging is the tool of choice in evaluating the skeletal structures and the thorax, 
especially the long bones, due to capability of rotating the volumes (Ploeckinger-Ulm et al, 
1996). However, fast movement of the foetus, and the positioning of the extremities adjacent 
to the uterine wall,  can potentially be an obstacle in their evaluation.  Although 4-D 
imaging may prove to be more useful, the primary stumbling blocks remain the same. 
 
    
                (a)       (b) 
Fig. 6. (a)-(b) shows the NT region; zoom the image closer as in 6b for a clear visualization of 
the NT space. 
 
Aneuploidy Ultrasound findings 
Trisomy 21 Absent nasal bone(60-70% of cases), short maxilla (25% of cases), Abnormal ductus venosus waveform (80% of cases) 
Trisomy 18 
Absent nasal bone (55% of cases),  Single umbilical artery 
(75% of cases), exomphalos (30% of cases), bradycardia and 
early onset of fetal growth restriction 
Trisomy 13 
Holoprosencephaly, tachycardia (70% of cases), exomphalos 
(40% of cases), megacyst, and early onset of fetal growth 
restriction 
Turner’s syndrome Tachycardia (50% of cases), and early onset of fetal growth restriction 
Triploidy 
Holoprosencephaly, exomphalos, bradycardia (30% of cases), 
posterior fossa cyst (40% of cases), molar changes in placenta 
(30% of cases), and early onset of fetal growth restriction 
Table 1. Sonographic markers for aneuploidy in first trimester 
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3. Reducing mortality rates by ultrasound imaging in the second trimester 
Second trimester ultrasound imaging is typically performed between 18 and 24 weeks of 
gestation. Ultrasound imaging is performed to evaluate fetal and maternal structures for 
abnormalities that could lead to maternal and/or perinatal mortality. The structures evaluated 
are fetal anatomy, fetal biometry, amniotic fluid volume, placenta, maternal cervix  and 
Doppler velocimetry of uterine and umbilical arteries . The purpose is to exclude findings 
associated with fetal chromosomal abnormalities, pre-term delivery, IUGR and pre-eclampsia.  
Pre-eclampsia and intrauterine growth restriction remain the two most important causes of 
maternal and neonatal death that need to be detected as early as possible (Sibai, Dekker , 
Kupferminc, 2005; Walker, 2000).These 2 conditions are thought to be the result of abnormal 
placentation in which there is failure of trophoblastic invasion of the spiral artries resulting 
in increased vascular resistance in the uteroplacental circulation (Pijnenborg et al, 1991). 
Pre-eclampsia can cause serious maternal complications including the HELLP syndrome 
(microangiopathic Hemolysis, Elevated Liver enzymes, Low Platelet count), eclampsia, 
coagulopathy, stroke and death (Wen et al, 2005; Roberts JM and Cooper DW, 2001).  
Early prediction of pre-eclampsia and intrauterine growth restriction by ultrasound imaging 
in the second trimester is therefore paramount to providing appropriate antenatal 
surveillance and therapy in an effort to improve pregnancy outcomes. It must be pointed 
out, however, that prediction of these conditions in the second trimester is only possible if 
accurate dating from either early ultrasound examination or known conception dates has 
been previously established.   
3.1 Assessment of fetal anatomy in the second trimester 
The use of ultrasound imaging to exclude fetal structural defect in the second trimester has 
been a common practice in most developed countries for sometime. Over the past decade 
researchers have identified specific structural defects/markers and their specific syndromal 
pattern of abnormalities, most of which have been listed in table 2. The overall risk of 
chromosomal abnormalities increases with the total number of defects that are identified 
(Nicolaides et al, 1992). Considering that birth defects are among the list of common causes of 
perinatal mortality, detection of these defects by ultrasound imaging assists mothers to know 
their risk of chromosomal abnormalities. Based on the ultrasound findings they can consider 
termination, particularly if the mother’s conditions such as age, medical history, and previous 
pregnancies, puts her at risk of losing her own life. In resource-poor countries where expensive 
invasive procedures such as amniocentesis may not be cost-effective or readily available,  
ultrasound imaging may be the only affordable modality for determining a woman’s risk of 
delivering a chromosomally abnormal baby who is more likely to die in the perinatal period 
than a chromosomally normal baby, so that they might consider termination. Even in pregnant 
women with high risk factors who can afford invasive procedures, ultrasound imaging is still 
indicated, as the initial less expensive and non-invasive procedure before ultrasound-guided 
amniocentesis is considered. If no defect is detected on ultrasound imaging, the mother’s risk of 
chromosomal abnormality is reduced, and she may decide not to proceed with an amniocentesis 
proecudure with its associated risk of miscarriage. 
3.2 Assessment of fetal size (biometry) 
Second trimester clinical determination of gestational age/fetal size using LMP and uterine 
size are rather subjective. This is because clinical dating can be negatively affected by wrong 
information on LMP, maternal body habitus, fibroids and multiple pregnancy.  
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The indication for ultrasound imaging, however,  may be requested, not just  for estimating 
gestational age (and date of delivery), but more importantly, to exclude intra-uterine growth 
restriction (IUGR).  
 




Brachycephaly, mild ventriculomegaly, flattening of the face, 
nuchal edema, atrioventricular septal defects, duodenal atresia and 
echogenic bowel, mild hydronephrosis, shortening of the limbs, 




strawberry-shaped head, choroid plexus cyst, absent corpus 
callosum, Dandy-Walker complex, facial cleft, micrognathia, 
nuchal edema, heart defects, diaphragmatic hernia, esophageal 
atresia, exomphalos, renal defects, myelomeningocele, growth 
retardation and shortening of the limbs, radial aplasia, overlapping 
fingers, and talipes or rocker bottom feet 
Trisomy 13 
 
Holoprosencephaly, microcephaly, cardiac abnormalities, enlarged 
and echogenic kidneys, exomphalos and postaxial polydactyly 
Triploidy              IUGR, molar placenta, mild ventriculomegaly, micrognathia, 
cardiac abnormalities, myelomeningocoele, syndactyly, and ‘hitch-
hiker’ toe deformity. 
Turner syndrome 
 
cystic hygromata, generalized edema, mild pleural effusion and 
ascites, and cardiac abnormalities 
Table 2. Sonographic markers for aneuploidy in second trimester 
Many sonographic parameters have been used for estimating gestational age in the second 
and third trimesters. The commonly used parameters are: fetal head circumference (HC) and 
biparietal diameter (BPD), abdominal circumference (AC) and femur length (FL).  
The measurements obtained from these parameters are used in conjuction with other 
sonographic findings including oligohydramnios (subjectively assessed) and the placental 
size and echotexture. In twin pregnancy, twin-to-twin transfustion can also be determined 
by measuring the size of the fetuses using the same parameters stated for assessing each 
fetus. 
3.3 Assessment of placenta 
Evaluation of the placental size, location and the retroplacental area should be part of every 
antenatal ultrasound examination performed in the second trimester. Placental size is a 
reflection of the health and size of the fetus and correlates with pregnancy outcome (Dawn, 
1995; Theam et al, 2001). Also, there is positive correlation between placental volume and 
neonatal birth weight and babies length (Sivaro et al, 2002).  
The size is estimated by either measuring the placental thickness or its volume (Geirsson et 
al., 1985). A thin placenta (<10mm) may be due to IUGR, placental infarction, or pre-
clampsia (Chase and Cayea, 1991). In recent times, the development of 3D ultrasound has 
improved the clinical ability to obtain a placental volume measurement (Jurkovie et al., 
1994).  
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Secondly, placental previa must be excluded. Placental previa refers to a placenta that is 
close to the maternal internal cervical os, or covers the os either partially or completely.  
It is a dangerous and sometimes fatal condition for mother and/or baby due to the 
possibility of severe haemorrhage. Accurate and timely diagnosis of placenta previa is 
therefore indispensable. Fortunately, major degrees of placenta previa are easily recognised 
by ultrasound imaging around 18-20 weeks gestation. Although TAS imaging may be 
unable to see the precise relationship between the lower placental edge and the internal os 
in cases of suspected minor previa, further TAS evaluation in the third trimester will usually 
delineate the placental site, and should be performed first with a partially filled bladder and 
then with an empty bladder, to avoid false positive diagnoses. Where concerns persists, a 
TVS in the third trimester will accurately define the relationship between the lower edge of 
the placenta and the internal cervical os (Figure 8b). As a general guide, a placenta-internal 
os distance of  >2cm is required for safe vaginal delivery.  
Another important concept in ultrasound imaging of the placenta is observation of the 
retroplacental hypoechoic complex which is composed of uteroplacental vessels, myometrium 
and decidua. Absence of the hypoechoic space may be seen in placenta percreta, a condition 
where the placenta has invaded the whole myometrial thickness. It is therefore logical to 
exclude placental percreta in pregnant women at high risk, as it could result in severe 
hemorrhage and maternal death.  
3.4 Assessment of maternal cervix 
Assessment of the cervix can assist in management decisions by predicting those patients 
who are at risk of preterm birth. Shortening of the cervix (Iams et al, 1996; Welsh A, 
Nicolaides, 2002) or dilatation/funneling of the internal os (Guzman et al, 2001) is 
associated with increased risk of premature delivery. Early prediction is important 
because premature birth is responsible for 75% of neonatal mortality and morbidity (Iams 
JD, 2003). In the past, clinical examination was the only method available for evaluation of 
the cervix. 
However, clinical examination is subjective. This is especially true when it comes to 
estimation of the length of the cervix. Furthermore, detection of changes in the internal 
cervical os or cervical canal is impossible with a closed external os.  When cervical dilatation 
or shortening of the cervix is noted by ultrasound imaging, cervical cerclage (and sometimes 
conservative management with bed rest) can help reduce the likelihood of premature births 
that are caused by cervical incompetence, thereby reducing perinatal mortality. 
There are three approaches to scanning the cervix: TAS, TVS and transperineal (translabial). 
TVS approach is the gold-standard technique for optimal imaging, and should be employed 
when imaging by the TAS approach is suboptimal. Generally in our practice TAS approach 
has been accurate in the second trimester, but difficulty may occur in the third trimester as 
the pregnancy advances which may require the use of TVS. In assessing the cervix with TVS, 
scan gel is applied to the tip of the transvaginal transducer, which is then covered with a 
clean or sterile condom or glove to avoid cross infection. Lubricating gel is applied over 
the cover and the transducer tip is introduced into the vagina, about 2-3cm depth and 
away from the cervix. Sonographic visualization starts as soon as the transducer is 
introduced. Inserting the transducer tip too far can cause the examiner to miss seeing the 
cervix and lower uterine segment as the transducer tip reaches the posterior or anterior 
fornix. The cervical length is measured by orienting the transducer in the sagittal plane 
(figure 8a). The transducer is then oriented in the coronal plane to assess the internal os 
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Secondly, placental previa must be excluded. Placental previa refers to a placenta that is 
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that are caused by cervical incompetence, thereby reducing perinatal mortality. 
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introduced. Inserting the transducer tip too far can cause the examiner to miss seeing the 
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and the canal for further evaluation of any dilatation, funneling of the internal os, or 
ballooning of the lower uterine segment which may appear as a bulging of amniotic fluid 
sac into the cervical canal.  
 
   
     (a)       (b) 
Fig. 8. (a) and (b) - TVS demonstration of cervical length. Measurement of the distance of the 
placenta from the internal os can be made 
3.5 Doppler velocimetry of the second trimester  
Doppler assessment of uterine and umbilical arteries is a reliable technique for predicting 
the level of risk for preeclampsia and intrauterine growth restriction, preterm delivery, 
gestational diabetes and fetal asphyxia (Martin et al, 2001, Reese et al, 1994; Bromley et al, 
1994). Uterine artery assessment may be performed via the TVS or TAS route in the second 
trimester (18-22weeks) for high risk population.  A high resistance waveform in  uterine 
artery, or a waveform with a notch (Figure 9), implies inadequate trophoblastic invasion of 
the endometrial and myometrial spiral vessels.  
Umbilical artery assessment is performed via the TAS route. Increased umbilical artery 
systolic/diastolic (S/D) ratio, or reduced diastolic flow, is also an indication of a rising 
placental vascular insufficiency. The diastolic flow may eventually disappear (figure 10a) or 
may even reverse in direction (Figure 10b), indicating that events may lead to intra-uterine 
death. These are clinically significant findings for uteroplacental vascular resistance 
associated with risk of hypertensive disorders, small for gestational age, preterm delivery, 
and gestational diabetes. Early detection improves management leading to improved 
survival. 
4. Reducing mortality rates by ultrasound imaging in the third trimester 
Maternal death may occur in the third trimester of pregnancy due to conditions such as 
antepartum hemorrhage, hypertensive disorders ,thromboembolism, chorioamnionitis, 
cardiac disease, anaemia (sickle cell disease), rupture of uterine scar, etc.  
Perinatal mortality may also be caused by conditions such as prematurity, macrosomia,  
IUGR, infections, maternal diabetes, and maternal isoimmunisation. Additionally, all the 
major causes of maternal death may also lead to perinatal death. 
Ultrasound imaging plays a role in the assessment of fetal growth and well being, fetal 
presention, placental location, ultrasound-guided procedures; all of which are useful for 
management decisions if an intervention should be carried out to improve survival rates.  
 




Fig. 9. Uterine artery waveform with a notch.  
 
         
        (a)      (b) 
Fig. 10. (a)-(b) Umbilical artery waveform; a (absent diastole) and b (reversed diastole) 
4.1 Disproportionate fetal growth (IUGR and LGA)  
Perinatal death may occur in cases of IUGR due to increased risk of fetal hypoxia and 
acidosis, neonatal hypoglycemia, meconium aspiration syndrome, etc.  
Serial ultrasound examinations are important in documenting growth and excluding 
structural anomalies. Accurate early dating of the pregnancy is very important for 
comparison purposes.  It must be emphasized again that the establishment of conditions 
such as IUGR  later in a pregnancy is only possible if accurate dating from either early 
ultrasound examination or known conception dates has been previously established.   
Once true dating of the pregnancy has been established, measurements of the fetal head 
(BPD and HC), abdomen (AC) and femur (FL)may be obtained for comparison purposes. 
From these measurements, the estimated fetal weight (EFW) can be calculated using one of 
several published formulae on EFW. This is then plotted on a percentile growth chart, 
showing the estimated fetal weight versus gestational age.  IUGR is suspected if the 
estimated weight is below the 10th percentile. Antenatal diagnosis of IUGR is however not 
precise because the EFW cannot be directly measured, but calculated from a combination of 
measured parameters with a prediction error rate 10-20% (Degani, 2001). Abdominal 
circumference measurement is the most useful measurement for evaluating fetal growth, as 
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it reflects the volume of fetal subcutaneous fat and the size of the liver which in turn 
correlate with the degree of fetal nutrition. Moreover, fetal hypoxia is more common when 
the abdominal circumference is below the 5th percentile (Degani, 2001).  
Decreased amniotic fluid volume is clinically associated with IUGR and may be the earliest 
sign detected on ultrasound. Therefore liquor volume measurement should be carried out in 
cases of suspected IUGR. In the third trimester, amniotic fluid index (AFI) is the most 
commonly used method of amniotic fluid volume assessment, as it is easy to perform and is 
reproducible. This is the sum of the largest vertical pocket of amniotic fluid measured in 
centimetres in each of the four quadrants of the uterus.  The deepest (largest) vertical pocket 
is used for the assessment, particularly in multiple pregnancies. In twin pregnancies 
measurement of the deepest vertical pocket of each individual fetus is taken. An AFI of less 
than 5cm, or a largest single vertical pocket of less than 2cm is considered oligohydramnios.    
In addition, umbilical artery (UA) Doppler velocimetry can estimate the likelihood of 
adverse perinatal outcome in IUGR fetuses, and may be useful in determining the intensity 
of fetal surveillance. In the early phase of fetal hypoxia retrograde diastolic flow in the UA is 
a sign of severe hypoxemia and acidemia (Baschat and Weiner, 2000). Doppler flow study is 
therefore helpful in terms of reducing intervention and improving the overall fetal outcome.    
In addition, abnormal middle cerebral artery (MCA) and UA S/D ratio are strongly 
associated with low birth weight and low umbilical artery pH in fetuses with suspected 
IUGR, and occurrence of fetal distress. An abnormal Doppler cerebro-placental ratio, (i.e. 
MCA pulsatile index divided by UA pulsatile index) also has been associated with a 
statistically significant increase in perinatal mortality (Sterne et al, 2001). In addition to the 
AU and MCA, the descending aorta has an altered perfusion in fetuses with both IUGR.  
A careful and targeted ultrasound examination is therefore necessary to determine the 
degree of fetal well being using these sonographic parameters. 
On the other hand, LGA fetuses, defined as fetuses above the 90th percentile of weight for 
any specific gestational age, are also associated with increased perinatal mortality. Generally 
macrosomia is when the fetus has an EFW of 4.5kg or more. The risk of perinatal morbidity 
and mortality is greater for babies with birth weight of 4kg or more. Causes of macrosmia 
include diabetes, obesity, postdatism and previous macrosomic babies. Complications 
include stillbirth, shoulder dystocia (during delivery), birth trauma, etc. 
4.2 Hypertensive disorders in pregnancy 
Hypertensive disorders are among the 5 most common causes of maternal mortality in the 
world, and the leading cause in the authors’ center. This disorder comprise gestational 
hypertension, pregnancy induced hypertension that may progress to preeclampsia (mild or 
severe) and eclampsia, chronic hypertension, chronic hypertension with superimposed 
preeclampsia and/or superimposed eclampsia.  
Ultrasound imaging is useful in preventing maternal and perinatal mortality due to accurate 
dating of gestational age, especially when obtained in the first trimester. Ultrasound is also 
used for monitoring fetal growth and well being to enable early intervention when 
necessary. 
Moreover, with an accurate gestational age of 32-34 weeks, delivery can be effected if any 
maternal or fetal complication sets in, once there is very high chance of neonatal survival. 
The role of ultrasound in antenatal fetal monitoring therefore, is through biometric 
measurement to detect IUGR, EFW, biophysical profile (BPP) and Doppler velocimetry to 
evaluate uteroplacental blood flow and fetal circulation.  
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The biophysical profile (BPP) is a useful method of predicting antepartum fetal acidemia. 
Studies in centers at 4 different geographic locations demonstrated reduction in perinatal 
mortality in high risk patients who were managed on the basis of BPP (Harman, 2005). 
Although the BPP test can be used as a primary method of fetal surveillance, it can be 
especially helpful in cases where the non-stress test (NST) is not reactive. There is some 
evidence that the BPP may even be useful during labour as an adjunct to fetal heart rate 
monitoring (Kim et al, 2003).The five components of a BPP integrate fetal cardiac activity, 
amniotic fluid assessment, fetal breathing, fetal movement and tone. Each component is 
scored 2 if present or reassuring and 0 if abnormal. Fetal breathing is the first parameter 
affected, and is probably as reliable as the NST in predicting early fetal acidosis. As the 
insult becomes more profound and chronic, fetal breathing, then body movement, then 
tone are compromised. The amount of amniotic fluid reflects the placental health as well 
as fetal well being, and is a marker for chronic hypoxia when reduced.  The fetal health 
can therefore be accurately predicted, allowing the pregnancy to continue with low risk of 
fetal loss and long term morbidity if the score is normal. Timely intervention can be 
executed when fetal compromise is detected, to lower perinatal mortality. A BPP test can 
be completed in as little as five minutes if the fetus is active and awake, or can take as 
long as 30 minutes. Stimulation of the fetus by shaking the probe is appropriate for 
shortening the time of the study. 
4.3 Antepartum haemorrhage (placenta previa, abruption and vasa previa) 
Placenta previa can lead to severe hemorrhage and profound shock in the antenatal period, 
during delivery and immediately after delivery.  
Perinata death may occur in cases of placental previa due to the likelihood of preterm delivery, 
severe malformations in central nervous, cardiovascular, or gastrointestinal systems which 
may occur in the process of labour and delivery, and stillbirth from maternal shock.  
Ultrasound diagnosis of placenta previa was described in the section on second trimester 
ultrasound imaging. In the third trimester, repeat scan is recommended for all patients who 
were diagnosed of placenta previa in the second trimester, and new patients reporting for 
the first time in the third trimester with antepartum hemorrhage must be scanned.  
Abruptio placenta refers to premature separation of a normally situated placenta. 
After the separation bleeding may be concealed beneath the placenta with seeping into 
the myometrium or track down per vaginum (revealed). Concealed abruptio placentae 
have more severe complications. Maternal death may occur due to the likelihood of severe 
hemorrhage (ante- and postpartum), shock, disseminated intravascular coagulation and 
renal failure. Perinatal mortality is mainly due to fetal hypoxia from the premature 
separation of the placenta, IUGR, low birth weight, congenital malformation, and fetal 
anemia. 
The diagnosis of abruptio placenta is usually clinical, but ultrasound can be helpful in 
some concealed cases with large retroplacental clot. This appears as hyperechoic, 
isoechoic, or sonolucent in comparison with the placenta, depending on the age of the 
clot. Resolving clot appears hyperchoic within one week and sonolucent within 2 weeks. 
Abruptio placenta may also present as an abnormal thickening or rounding of the 
placental edge.  
However ultrasound is not an accurate tool in the diagnosis of abruption. Its main 
usefulness is in excluding placenta previa, as a number of placenta previa cases may also 
have abruption. The size of the clot, and the fetal growth and liquor volume are closely 
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the myometrium or track down per vaginum (revealed). Concealed abruptio placentae 
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monitored in such cases. This is useful during conservative management to achieve fetal 
maturity. Intervention is carried out if clot enlarges, fetal distress sets in, or severe growth 
restriction sets in. If IUGR sets in, ultrasound plays further role in monitoring fetal well 
being through BPP and Doppler velocimetry.  
Vasa previa is a condition in which the umbilical vessels divide within the amniotic 
membrane before they reach the placenta (velamentous cord insertion). These vessels may 
cross the internal os below the fetal presenting part, which is called vasa previa. The vessels 
may rupture spontaneously and cause rapid fetal exsanguination. This condition can easily 
be detected by ultrasound imaging with colour Doppler application. Appropriate 
intervention can then be executed before rupture occurs.  
4.4 Deep vein thrombosis and thrombo embolism 
Pregnancy significantly increases the risk of venous thromboembolism (VTE) due to 
increased concentration of clotting factors (fibrinogen, factors VII, VIII, X, XII) and venous 
stasis. Pulmonary embolism is a common cause of death. Fatal pulmonary thromboembolism 
(PTE) usually occurs after delivery, more commonly following caesarean section. Majority 
occurs within 2 days of delivery but may occur as late as 42 days. Antenatal PTE can occur at 
any trimester but more common in third trimester. Clinical diagnosis of the condition is 
inaccurate and unreliable, and the most reliable diagnostic modality of venography 
(considered previously to be the gold standard) is not suitable in pregnancy due to small 
risk of radiation and contrast agents. 
The use of duplex ultrasound imaging with compression is therefore recommended, as it is 
non-invasive and has a high degree of accuracy for detecting thrombus in femoropopliteal 
and calf veins. The iliac veins may however not be well seen during pregnancy, and may 
require magnetic resonance imaging. The details of the scanning techniques and the 
diagnostic features of thrombosed vein, are described in a separate chapter of this book.   
4.5 Rh Isoimunisation 
The Rhesus (Rh) antigens are lipoproteins on the red blood cell membrane. The mother may 
be isoimmunized through incompatible blood transfusion or following feto-maternal 
hemorrhage between a fetus with incompatible rhesus status and the mother. Rh- positive 
fetal red cells entering into the maternal circulation will provoke antibody formation against 
the fetal red blood cells leading to fetal hemolysis and fetal anemia. Severe fetal anemia may 
result in hydropic fetus with ascites, pericardial effusion and heart failure. 
To determine the severity of the anemia, duplex ultrasound imaging of the proximal third of 
the MCA can be estimated. High peak velocity blood flow of the MCA correlates well with 
severe fetal anemia (Mari et al, 2000). This test may be performed at two weeks interval in 
these patients, thus avoiding more invasive diagnostic interventions until there is evidence 
of severe anemia. If severe anemia is suspected, ultrasound-guided cordoscentesis is helpful 
in detecting the degree of fetal anemia. Ultrasound-guided amnioscentesis is also helpful, in 
detecting the level of bilirubin in the amniotic fluid as a measure of fetal hemolysis using 
spectrophotometry. 
Furthermore, ultrasound plays an important role in monitoring the iso-immunized patient 
for hydrops through evaluation of fetal heart size, detection of pericardial effusion and fetal 
ascites, and measurement of amniotic fluid volume (Roman and Martin, 2007). 
In terms of treatment, if the fetus is preterm, ultrasound-guided intrauterine transfusion 
can be performed directly into the umbilical veins (Roman and Martin, 2007). Other 
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interventions aided by ultrasound include aspiration of pericardial effusion and ascites, 
and ultrasound-guided amniocentesis to test for fetal lung maturity before expediting 
delivery. 
4.6 Abnormal lie and malpresentation 
Malpresentation can cause, birth injury and umbilical cord compression and prolapse 
during delivery, which can lead to perinatal death. 
Ultrasound is used to confirm abnormal lie and malpresentation of the fetus, so that a 
decision on the route of delivery can be made. If there is no contraindication external 
cephalic version can be done under ultrasound guidance at 37 weeks gestation to achieve 
vaginal delivery. 
4.7 Cesarean scar rupture 
Uterine rupture carries with it a high rate of maternal and perinatal mortality and is 
estimated to occur in up to 4% of pregnancies with history of caesarean delivery ( ). This 
rupture may occur silently (asymptomatically) in the antenatal period, commonly in the 
third trimester. Ultrasound has been found to be useful in diagnosing silent rupture or scar 
dehiscence in the antenatal period. 
5. Labour, delivery and post-delivery issues 
Most maternal deaths occur during labour and delivery, and most perinatal deaths are due 
to events that occur during labour and delivery. Causes of maternal death at this stage 
include: prolonged labour with its sequel of water and electrolyte imbalance, obstructed 
labour with sequel of water and electrolyte imbalance and uterine rupture, eclampsia, 
hemorrhage and thromboembolism, and complications of anesthesia for cesarean section; all 
of which may lead to perinatal death as well.  
During delivery, perinatal death may also result from vacuum delivery complications, 
which include subgaleal hemorrhage, subdural hematoma, cerebral infaction, skull fracture, 
and neonatal jaundice (Odoi and Opare Addo, 2002). Birth injuries sustained during 
shoulder dystocia and breech delivery can all result in perinatal death. Almost all of these 
could be prevented by proper case selection, and good labour management including use of 
partograph. 
Ultrasound imaging is helpful in the delivery process, including assessing cervical length 
during induction, knowing the head position and descent during labour, case selection for 
vagina birth after caesarean section (VBAC), detection of uterine rupture, preventing 
obstructed labour, identifying cause of intrapartum hemorrhage and monitoring fetal 
heart. 
5.1 Induction delivery interval: cervical length and dilatation 
The success of labour induction is directly related to the favourability of the cervix shown by 
the Bishop score. Ultrasound accurately measures the cervical length and dilatation to help 
determine the score to avoid prolonged labour [Rane et al, 2005].  
The assessment of the cervical length was described in the second trimester. 
Secondly, TVS measurement of fetal head to perineum distance and, TAS measurement of 
fetal head position, offers the most accurate prediction of successful induction of labour 
[Eggebø et al, 2008]. 
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detecting the level of bilirubin in the amniotic fluid as a measure of fetal hemolysis using 
spectrophotometry. 
Furthermore, ultrasound plays an important role in monitoring the iso-immunized patient 
for hydrops through evaluation of fetal heart size, detection of pericardial effusion and fetal 
ascites, and measurement of amniotic fluid volume (Roman and Martin, 2007). 
In terms of treatment, if the fetus is preterm, ultrasound-guided intrauterine transfusion 
can be performed directly into the umbilical veins (Roman and Martin, 2007). Other 
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interventions aided by ultrasound include aspiration of pericardial effusion and ascites, 
and ultrasound-guided amniocentesis to test for fetal lung maturity before expediting 
delivery. 
4.6 Abnormal lie and malpresentation 
Malpresentation can cause, birth injury and umbilical cord compression and prolapse 
during delivery, which can lead to perinatal death. 
Ultrasound is used to confirm abnormal lie and malpresentation of the fetus, so that a 
decision on the route of delivery can be made. If there is no contraindication external 
cephalic version can be done under ultrasound guidance at 37 weeks gestation to achieve 
vaginal delivery. 
4.7 Cesarean scar rupture 
Uterine rupture carries with it a high rate of maternal and perinatal mortality and is 
estimated to occur in up to 4% of pregnancies with history of caesarean delivery ( ). This 
rupture may occur silently (asymptomatically) in the antenatal period, commonly in the 
third trimester. Ultrasound has been found to be useful in diagnosing silent rupture or scar 
dehiscence in the antenatal period. 
5. Labour, delivery and post-delivery issues 
Most maternal deaths occur during labour and delivery, and most perinatal deaths are due 
to events that occur during labour and delivery. Causes of maternal death at this stage 
include: prolonged labour with its sequel of water and electrolyte imbalance, obstructed 
labour with sequel of water and electrolyte imbalance and uterine rupture, eclampsia, 
hemorrhage and thromboembolism, and complications of anesthesia for cesarean section; all 
of which may lead to perinatal death as well.  
During delivery, perinatal death may also result from vacuum delivery complications, 
which include subgaleal hemorrhage, subdural hematoma, cerebral infaction, skull fracture, 
and neonatal jaundice (Odoi and Opare Addo, 2002). Birth injuries sustained during 
shoulder dystocia and breech delivery can all result in perinatal death. Almost all of these 
could be prevented by proper case selection, and good labour management including use of 
partograph. 
Ultrasound imaging is helpful in the delivery process, including assessing cervical length 
during induction, knowing the head position and descent during labour, case selection for 
vagina birth after caesarean section (VBAC), detection of uterine rupture, preventing 
obstructed labour, identifying cause of intrapartum hemorrhage and monitoring fetal 
heart. 
5.1 Induction delivery interval: cervical length and dilatation 
The success of labour induction is directly related to the favourability of the cervix shown by 
the Bishop score. Ultrasound accurately measures the cervical length and dilatation to help 
determine the score to avoid prolonged labour [Rane et al, 2005].  
The assessment of the cervical length was described in the second trimester. 
Secondly, TVS measurement of fetal head to perineum distance and, TAS measurement of 
fetal head position, offers the most accurate prediction of successful induction of labour 
[Eggebø et al, 2008]. 
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5.1.1 Progress of labour in terms of head descent and position 
Studies have shown that sonographic measurement of head position and descent is more 
accurate than digital examination.  More recently, it has been suggested that the angle 
formed by a line connecting the lowest point of the fetal head to the inferior edge of the 
pubic symphysis provides an objective, accurate and reproducible means of assessing 
descent, using the translabial sonography approach. At angle of progression of about 120 
degrees or more, there is a high probability of either spontaneous vaginal delivery or an 
easy and successful vacuum extraction [Kalache et al, 2009]. Also, the gold standard 
technique for assessing fetal head position during labour is transabdominal suprapubic 
transverse ultrasound [Sherer et al, 2002]. Therefore lack of progress as shown by 
partographic presentation of this sonographic finding prompts intervention. 
5.1.2 Selection of cases for vaginal birth after Caesarean section (VBAC) 
The main concern about VBAC is the uterine scar rupture. Predisposing factors to uterine 
rupture include fetal size and scar thickness. The estimation of fetal size and weight aids 
selection of cases. Studies have found that the antepartum uterine scar thickness inversely 
correlates with the risk of intrapartum uterine rupture, and that intrapartum assessment of 
uterine scar can predict uterine rupture with a high degree of accuracy. There is evidence 
that ultrasound imaging may be useful in determining the uterine scar thickness [Asakura, 
2000] and aid in case selection for VBAC. 
5.1.3 Detection of uterine rupture 
Uterine rupture during labour and delivery is mostly diagnosed clinically; hence if clinical 
diagnosis is clear, precious time should not be wasted on ultrasound imaging [Yeboah  
et al, 2010].  
However where the clinical features are not obvious, as may occur in pre-labour silent 
rupture, or occasionally in labour especially with epidural, ultrasound imaging may show 
the rent in the uterine wall [Ogbole et al, 2008], with herniated membrane as a cystic 
structure through the defect [Acton et al, 2004]. 
5.1.4 Head position for vacuum 
The success of vacuum delivery depends, among other conditions, on where the cap is 
positioned. Wrong placement may deflex the fetal head and lead to failure of the procedure. 
The cap must be placed at or close to the flexion point on the vertex. Ultrasound aided 
examination has been shown to detect this flexion point better than digital examination 
alone [Wong, 2007; Molina and Nicholides, 2010]  
5.1.5 Cord presentation  
This condition, if not detected will lead to umbilical cord prolapse when the fetal 
membranes rupture. It may be difficult to feel a presenting cord. Colour Doppler 
sonography can clearly detect this cord to direct appropriate intervention to avert fetal or 
neonatal death.  
5.1.6 Preventing obstructed labour 
Fetal macrosomia, malpresentation and abnormal lie are all causes of obstructed labour. 
Apart from macrosomia, all the other conditions also predispose to cord prolapse. 
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Ultrasound is useful in detecting all these for appropriate intervention to prevent  
the obstruction or cord prolapse by assessing fetal biometry and EFW, and presentation / 
lie. 
5.1.7 Fetal heart rate detection 
Occasionally the fetal heart rate may not be heard with the Pinard fetal stethoscope.  
As ultrasound is becoming more and more available than sonicaid (audio Doppler) or 
cardiotocography (CTG) machine, especially in low-income countries, ultrasound is used to 
check the fetal condition and if fetus is alive and in distress, prompt delivery by caesarean 
section or vacuum will prevent perinatal death. 
5.1.8 Version in the second stage of labour for second twin 
There is increased perinatal mortality associated with the second twin compared to the first 
twin due to cord accidents, premature separation of the placenta and other factors after 
delivery of the first twin. There is therefore the need to expedite delivery of the second twin 
as early as possible. After delivery of the first twin, if the second twin is not cephalic, 
external cephalic version (if membranes are intact) or internal podalic version (if membranes 
are intact or just ruptured) may be done under ultrasound guidance to achieve vaginal 
delivery  
5.2 Post-partum complications 
Uterine inversion leading to hemorrhage and shock, retained products of conception 
leading to hemorrhage and infection, puerperal sepsis, postpartum eclampsia, and 
thromboembolism are major causes of maternal death after delivery. 
The usefulness of ultrasound imaging in detecting thromboembolism and the imaging 
technique has been discussed earlier.  
In some cases of uterine inversion where clinical diagnosis is not obvious, ultrasound  
has been used to elicit the diagnosis [Momin et al, 2009] to enable appropriate management. 
In cases of retained products of conception ultrasound can differentiate between retained 
products and endometritis [Zuckerman et al 1997]  Even tiny retained products of 
conception as occurs in first trimester miscarriage is accurately detected by TVS with 
Doppler application [Ustunyurt et al., 2007] 
5.2.1 Postpartum detection of uterine rupture 
Sometimes the suspicion of uterine rupture does not arise until after delivery, especially if it 
occurs in the second stage of labour. There is evidence that ultrasound can detect caesarean 
section scar rupture after delivery (Henrich et al, 2005) and even scar defect after the 
puerperium (Amstrong et al, 2003).  Others have suggested that a combined anterior uterine 
wall and bladder thickness (<3mm) associated with ballooning of the lower segment 
indicates a defect in the myometrium (Champmank, 1994). 
5.2.2 Postpartum detection of broad ligament hematoma 
Broad ligament hematoma may occur when there is uterine rupture or cervical tear with 
upper extension, and can cause shock in the post-partum period that may be out of 
proportion. Ultrasound imaging can aid the detection of the hematoma. 
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5.2.3 Puerperal sepsis 
Apart from aiding in the diagnosis of postpartum endometritis, ultrasound accurately 
detects pelvic abscess, which may appear as a focal collection, either hypoechoic or complex. 
6. Routine obstetric ultrasound- would it improve survival rates in the 
developing world? 
Routine obstetric scanning refers to regular ultrasound imaging for each and every 
pregnancy conducted either at the first, second or third trimester to separate specific 
pregnancy abnormalities from normally progressing pregnancies. In many developed 
countries, such as Great Britain, Germany, France and those of Scandinavia, routine 
obstetric ultrasound imaging at about 18 weeks’ has become standard of care.  In United 
States routine ultrasound was not endorsed untle recently when the American College  
of Obstetricians and Gynecologists (2007) recommended routine aneuploidy screening  
for pregnant women.  One published large-scale observational study in Sweden 
concluded that a significant benefit could be obtained from even a single routine obstetric 
ultrasound at approximately 15 weeks ‘gestation (Waldenstrom et al, 1988). Among the 
important benefits of routine ultrasound are the accuracy in gestational age 
determination, and detection of multiple pregnancies (Neilson et al 1998). In most 
developing countries, accurate estimation of gestational age by ultrasound imaging is 
likely to be more beneficial and significant than developed countries, as the majority of 
pregnant women in those areas cannot recall their LMP (van Dyk et al, 2008) probably due 
to the high illiteracy rates among the pregnant women. This makes them far more 
vulnerable to unrecognized preterm delivery (a major cause of perinatal mortality), and 
post-maturity syndromes associated with fetal distress and long-term development 
disorders.  
However, the impact of routine ultrasound imaging in terms of significantly improving 
the over-all pregnancy outcome has been disputed by many observational studies 
conducted mostly in developed countries.  But considering the fact that there are no 
sufficient studies conducted in developing countries, it is still unclear whether the impact 
as described in developed countries will produce similar results in developing countries. 
Until then, one cannot rule out the possible impact routine ultrasound imaging can have 
in developing countries, as most of the victims of maternal and perinatal mortality live in 
these areas.   
The major challenge for routine ultrasound however, has been cost effectiveness.  
In England routine antenatal ultrasound screening has been estimated to cost the National 
Health Service (NHS) £14 to £16 per scan, while the family contribute between £9 and £15 
per scan, giving an indication of how expensive routine ultrasound can be for developing 
coutries  (Henderson et al 2002).  But the Canadian and most European health policy-
makers support the view that the benefits of routine ultrasound outweigh the cost, and in 
those countries routine ultrasound screening is either a national policy or a 
recommendation (Saari-Kemppainen et al., 1990; Public Health Agency of Canada, 2006). 
Moreover, maternal and newborn deaths is said to be representing an estimated annual 
global financial loss of $15 billion in potential productivity (USAID, 2001). So that if 
observational studies on the significant impact of routine obstetric ultrasound  in 
developing countries should show a positive impact, there may be the need for 
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international support to assist in financing routine ultrasound imaging in antenatal care 
for developing countries, as part of efforts to reach the Millennium Development Goals on 
reducing  maternal and neonatal deaths. 
Secondly, routine ultrasound has also been critisized for prompting unncessary intevention, 
creating anxiety related to false-positive diagnoses and giving false assurances to women 
who may be dissuaded from undergoing further examination because of a normal 
ultrasound. Therefore we recommend that if some form of routine ultrasound imaging will 
ever be considered for developing countries, then standardized guidelines will have to be in 
place in terms of training qualified personnel, quality assurance of ultrasound machine and 
regulating ultrasound practice to minimize such problems.  
7. Sustainability of ultrasound imaging for the developing world 
WHO has recommended ultrasound for dissemination to developing nations during the 
second phase of its earlier basic radiology system initiative (WHO, 1998). Ultrasound was 
described as a "sustainable technology" for developing and low-resource countries, 
because of its relatively low cost of purchase, low cost for maintenance and supplies, 
portability, and durability in comparison with all other imaging modalities (Goldberg, 
2003).  Currently the increasing availability of affordable and smaller ultrasound scanners 
is a clear indication of the sustainability of ultrasound for the developing world and its 
potential role in reducing maternal and perinatal mortality(Harris and Mark, 2009). A 
market survey we conducted (unpublished) revealed that a new ultrasound machine 
could cost as low as $5000, and can be used for basic obstetric assessment such as 
gestational age, foetal viability, placental position, and may even be used for foetal 
anatomical survey. Further evaluation with more sophisticated and relatively expensive 
machines can then be arranged for selected cases with suspected anomalies, as a form of 
‘level 2’ or ‘level 3’ scanning conducted by an advanced practitioner or specialist.  
Moreover the practice of donating slightly used but good quality machines continues to 
be helpful and should be encouraged.  
Manufacturers of ultrasound systems must support developing countries by providing 
offices, sales representatives, and applications personnel in these regions, so that they can 
assist with the dissemination of equipment, initial installation and instruction on equipment 
usage, and equipment maintenance. 
Lack of adequately trained physicians and sonographers, and limited means of equipment 
maintenance in developing countries has been a major challenge (Munjanja, 1993). Even 
though some developed countries around the world have made a concerted effort to 
provide education, it continues to be provided in a random fashion and has never been 
able to keep up with the need for adequate training for physicians and sonographers. One 
proposal at using a low cost system for training ultrasound imaging techniques has been 
via use of a PC platform that uses interface components from the Nintendo Wii games 
console (as a simulator) to aid remote mentoring by experienced ultrasound professionals. 
The proposers cited their experience with this technique in Ghana as an example (Ap 
Cenydd et al, 2009). 
Another recommendation has been to  incorporate a diploma in clinical ultrasound for 
medical graduates of local universities (Mindel, 1997). The use of existing allied health 
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5.2.3 Puerperal sepsis 
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international support to assist in financing routine ultrasound imaging in antenatal care 
for developing countries, as part of efforts to reach the Millennium Development Goals on 
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place in terms of training qualified personnel, quality assurance of ultrasound machine and 
regulating ultrasound practice to minimize such problems.  
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provide education, it continues to be provided in a random fashion and has never been 
able to keep up with the need for adequate training for physicians and sonographers. One 
proposal at using a low cost system for training ultrasound imaging techniques has been 
via use of a PC platform that uses interface components from the Nintendo Wii games 
console (as a simulator) to aid remote mentoring by experienced ultrasound professionals. 
The proposers cited their experience with this technique in Ghana as an example (Ap 
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Another recommendation has been to  incorporate a diploma in clinical ultrasound for 
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professionals such as nurses/midwives or radiographers who have received additional 
training in ultrasound has been valuable in some developed countries, and may be cost-
effective in developing countries. A new model in developing countries is the creation of 
Bachelor degree programs in Sonography in existing university settings. Graduates of 
these university sonography programss may be utilized as sonographers, or professionals 
in ultrasound imaging and may help to ease the pressure on doctors in developing 
countries.  It is the belief of the authors that a three-pronged approach must be utilized for 
the sustainability of ultrasound in developing countries:  First, the development of a new 
career path through the university setting for sonographers;  Second, the creation of long-
term comprehensive sonography education programs for physicians; and Thirdly, 
involvement of government agencies and institutions for regulatory policy setting.  
Clearly, creative and novel approaches that serve the unique situations of developing 
countries and address the need for both trained operators of ultrasound equipment and 
people with biotechnical skills for ongoing maintenance would be highly beneficial 
(Spencer and Adler, 2008). 
8. Conclusion 
In spite of increasing technological advancement, including ultrasound imaging, maternal 
and perinatal mortality globally have not decreased and indeed in some developing 
countries there is increase. 
The major causes of maternal mortality include abortion related complications, hemorrhage 
from various conditions, hypertensive disorders, thrombo-embolism, obstructed labour, 
prolonged labour, ruptured uterus and puerperal infection. Causes of perinatal mortality 
include prematurity, birth asphyxia, congenital malformations, IUGR, traumatic delivery, 
and cord prolapsed. A significant number of these conditions that lead to maternal death 
also lead to perinatal death. 
Fortunately, ultrasound is a non-invasive and safe tool that can aid in the diagnosis of most 
of these conditions, prevent the effects of these complications and in some cases guide in 
treatment. Thus wider use of ultrasound is advocated in obstetric practice. It is important for 
every medical doctor in the obstetric unit and indeed midwives to be trained in basic use of 
ultrasound in obstetrics.  The need for advanced practice training for specialist obstetricians 
as sonologists, and professional sonographers as advanced ultrasound practitioners is 
recommended for the future in developing countries as currently practiced in some 
developed countries.  
Governments should be committed to the purchase and maintenance of ultrasound 
machines for healthcare facilities, especially in obstetric units. A more widespread use of 
ultrasound imaging and improvement in treatment approach should lead to reduction in 
maternal and perinatal mortality. 
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1. Introduction 
The stomach is the most common extranodal site of non-Hodgkin lymphoma (NHL) 
accounting for 7.1 to 10% of adult NHL (Danzon et al., 2009). The most frequent histotypes 
of gastric lymphomas are MALT lymphomas that arise from the stomach-associated 
lymphatic tissue and the Diffuse Large B-Cell Lymphoma (DLBCL) (Koch et al., 2001).  
Several studies have observed that in recent years both gastric-NHL incidence and survival 
are increasing (Danzon et al., 2009). Furthermore, the management of gastric lymphomas 
has changed during the last two decades with a strong reduction of surgery in flavor to 
conservative treatments (Yoon S.S. et al., 2004). Indeed, the progress in biologic 
understanding of the pathogenesis, the introduction of Helicobacter pylori (HP) eradication 
therapy and the introduction of conservative treatment have definitely changed the 
approach to the disease and gastrectomy is no longer the first choice (Fischbach, 2010). The 
role of HP is a consolidated finding and several studies have confirmed that a simple 
antibiotic therapy (AT) for HP eradication is an effective treatment for MALT lymphomas 
with limited extension (Fischback et al., 2004), whereas, for advanced gastric lymphomas, 
the golden standard of treatment is the antineoplastic chemotherapy with alkylating agents 
in monochemotherapy such as Clorambucil for MALT lymphomas and polichemotherapy 
together with immunotherapy such as R-CHOP for DLBCL (Zucca & Dreyling, 2010).  
The loco-regional staging of gastric lymphomas with limited disease is important in order 
to better understand how to treat patients and endoscopic ultrasound (EUS) technique 
plays in this context a pivotal role by giving information for the prevision of response to 
HP eradication therapy since this therapy has shown to induce a high percentage of 
histological remission (up to 88%) when the disease is confined to mucosa and submucosa 
(Caletti et al., 2002).  
However, the importance of EUS in assessing the response to treatment and the follow-up is 
controversial. During the last decade, some reports indicated the importance of EUS in 
evaluating the response to treatment and also in long-term follow-up of gastric lymphomas 
with limited disease (Yeh et al., 2003), whereas other recent reports indicated the importance 
of EUS also in the follow-up of local-advanced MALT lymphoma (Pavlović et al., 2005). That 
notwithstanding, the latest ESMO clinical guidelines for diagnosis, treatment and follow-up 
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of gastric lymphomas does not recommend the usage of EUS in assessing the response to 
treatment and the follow-up in these patients (Zucca & Dreyling, 2010).  
Based on the fact that the importance of EUS in initial assessment in gastric lymphoma is 
incontrovertible and that its role in follow-up is not clearly established (Zucca & Dreyling, 
2010), the present work is focused in better define its role in diagnosis and follow-up.  
A review of the literature will evaluate the publications on reliability of EUS in the 
management of patients affected by gastric lymphoma. Finally, we will present our centre 
experience in the management of gastric lymphomas.    
2. Primary gastrointestinal non Hodgkin’s lymphomas:  
general concepts on epidemiology, histology and clinical presentation  
Primary gastric NHL (PGL) accounts for 30-45% of extra nodal lymphomas in western 
countries (Feng et al., 2009) and 80% of extra-nodal lymphomas in eastern countries, with an 
incidence of 0.51 and 0.29 for male and female respectively, showing an upward trend in 
both incidence and survival (Danzon et al., 2009).  
The age of patients at diagnosis is on average 51-66 years (Danzon et al., 2009; Feng et al., 
2009) with a male-female ratio of 1:1.3, even if it depends on the histotype. The most 
frequent histotype is MALT lymphoma, a type of indolent disease, that arise from the 
marginal zone of ‘’acquired’’ stomach-associated lymphatic tissue and the Diffuse Large B-
Cell Lymphoma (DLBCL), a form of aggressive malignancy (Koch et al., 2001).   
The differential diagnosis between these two lymphomas is based on morphological and 
immune-histo-chemical evaluation. 
Macroscopically, PGL lies in the sub-mucosa layer and is morfologically characterized by 
small cells with dense/ moderately dispersed nuclear chromatin, not noticeable nucleoli, 
abundant pale cytoplasm and low proliferation rate, being similar to centrocytes. In one third 
of PGL of MALT type plasmacytic differentiation could be noticed. This cells infiltrate around 
reactive follicles in an external zone called ‘’marginal zone’’ converging in a larger mass. 
Often, lympho- epitheliod degeneration occurs with lymphoma cells disrupting the epithelium 
organization with eosinophilic degeneration of epithelial cells (Swerdlow et al., 2008).   
Occasionally, transformed centroblast may be present in the context of PGL of MALT type, 
but the presence of transformed cells with round and vescicular nuclei, scanty and 
amphophilic cytoplasm, organized in solid or sheet-like aggregates should testify the 
presence of DLBCL. Additionally, in some cases, a low grade component may be present in 
the context of high grade lymphoma, approximately in one fifth of cases (Koch et al., 2005). 
Immunophenotypic assays can help in differential diagnosis between MALT lymphoma, 
DLBCL and reactive inflammatory processes, being CD20, CD21, CD35 positive CD5, CD10, 
CD23 negative Additionally, polimerase chain reaction (PCR), detecting the product of the 
translocation t(14;18)(q21;q21) may be useful in confirming the diagnosis of PGL (Swerdlow 
et al., 2008). 
The behaviour of these histotype is quite different, being the MALT lymphoma usually 
localized with multiple localizations up to 25% of cases, meanwhile DLBCL often evolve 
infiltrating other layers of stomach with a rapidly growing mass with one or more nodal 
sites, with crucial implication in clinical manifestation and care. 
The clinical presentation of PGL may vary according to the histological type of lymphoma. 
The majority of patients with PGL of MALT type present at diagnosis unspecific symptoms, 
related to the presence of lymphoma and the location of the malignancy.  
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In a report, the German group, in the context of the GIT NHL 01/92 study (Koch et al, 2001), 
showed that patients present especially epigastric pain (80.5%), loss of appetite (46.5%), loss 
of weight (23.2%), related either to ‘’B’’ lymphoma symptoms either to the loss of appetite, 
fever and night sweats (11.9%). The median duration from beginning of symptoms to 
diagnosis was 93 days. General symptoms include fatigue, due to blood loss and consequent 
anemia. In some cases, the formation of ulcers in the stomach may determine hemorrhages 
and haematemesis or melena, especially in DLBCL. 
Mainly, symptoms are divided into two different clusters: non-alarm symptoms and alarm 
symptoms (Andriani et al., 2006). Non-alarm symptoms include Epigastric/abdominal pain, 
dyspepsia, and heartburn; meanwhile alarm symptoms comprise weight loss, vomiting, 
haematemesis/melena, anemia, perforation (table 1). 
 
 MALT DLBCL 
ALARM SYMPTOMS (28%) (54%) 
NON ALARM SYMPTOMS (72%) (46%) 
Table 1. Symptoms at presentation in PGL of MALT type and DLBCL (Andriani et al., 2010) 
3. Role of endoscopic ultrasound in diagnosis of disease  
The unspecific clinical presentation leads to an endoscopic evaluation revealing different 
patterns. These lesions are more frequent at antrum and gastric body (77%) respect to the 
fundus (8%), and only in 15% of cases they occur diffusely.  
On the whole, three main patterns could be detected using gastroscopy (Kelessis et al, 2003):  
1. Ulcerative (28-85%); 
2. Polipoid (5-44%); 
3. Diffuse infiltrative (5-44%). 
Usually, DLBCLs have a macroscopic presentation that may lead clinicians to suspect 
malignancies prior to histological confirmation, appearing as exophytic masses (fig. 1) or 
ulcerative lesion (fig. 2-9) or petechial hemorrhages, meanwhile low grade lymphomas 
appear as flat lesions, and/or enlarged gastric folds, and/or ulcers and/or erosions (Zullo et 
al., 2010). It is also to be considered that these lesions are not specific of lymphomas, for 
example petechial haemorrhages can be found in FANS-related gastritis; therefore 
histological evaluation is mandatory (Fig. 3). 
 It is also noteworthy that endoscopic ultrasound (EUS) assay is of great help in determine 
the differential diagnosis of large gastric folds and can spare the performance of 
unnecessary invasive procedures. Indeed, large gastric folds are found in several benign 
situations, such as Zollinger-Ellison syndrome, Menetrier’s disease or lymphoid hyperplasia 
and malignancies, such as adenocarcinoma. Recently, the application of diathermic snare 
has been proposed, but is not routinely performed because the risk of major complications, 
including hemorrhages and perforations. EUS findings are able to predict malignancies, 
especially the evaluation of gastric wall thickness (especially if ≥ 4 mm), the no preserved 
wall architecture and the enlargement of deep layers (Ginès t al., 2006). This is particularly 
useful in the diagnosis of plastic linitis, even if more additional studies are needed 
(Andriulli et al., 1990). Additionally, EUS keeps also a pivotal role in defining the diagnosis 
of PGL. In a recent report, Fusaroli & Caletti (Fusaroli and Caletti, 2006) observed that, in 
some series of gastric malignancies, traditional biopsies are positive in 50% of cases and the  
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Fig. 1. Endoscopy:  Polipoid lesion in the gastric antrum (left panel); histology: MALT 
Lymphoma; EUS (radial scanning) showing an irregularity of the gastric wall limited to the 
second layer (stage: T2 N0). 
 
 
Fig. 2. Endoscopy: gastric ulcer (panel on the left); EUS (radial scanning ): irregular 
circumferential  thickening of the  gastric body  with disruption of the layers and 
penetration of the serosa (T3 N0). Horizontal extension of the lesion bigger than endoscopic 
appearance  
usage of large forceps has slightly increased the diagnostic sensitivity. In this prospect, EUS 
features have improved the diagnostic accuracy up to 89% (Nagler, 2011), due to the 
peculiar echographic presentation of different malignancies, independently from the 
accuracy of the staging. Usually, gastric adenocarcinoma have a vertical extension with the 
involvement of all the layers of the gastric wall, differently from the PGL that have an 
horizontal growth pattern involving the gastric wall sparing the first layer. Due to this 
assertion, EUS is able to predict the presence of PGL more than endoscopy and biopsy 
alone. Furthermore, the detection of pathological nodes is a sign that induce a strong suspect 
of gastric malignancies. An additional advantage from using EUS in establishing diagnosis 
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of PGL is related to the reduced risk of minor and major complication following biopsy, 
principally in presence of vascular alterations (Chen et al., 1999).   
 
 
Fig. 3. Endoscopy: Micronodular gastritis. Histology revealed a low-grade MALT lynphoma  
That notwithstanding, the bioptic evaluation represents the golden standard to define 
diagnosis of malignancies, especially in presence of sub-epithelial lesions (Karaca et al., 
2010). Over the 70 publications about EUS in the management of PGL, researched using 
MeSH database, from 1996 to 2011, only 6 of them (8.5%) discussed the role of EUS in 
determining the diagnosis of PGL. In spite of a great initial emphasis, especially when the 
tumor is localized to the gastric wall (Chen et al., 1999; Yücel et al., 1999; Caletti et al., 2000), 
subsequent studies have not confirmed these findings, giving a major importance to the 
ability to augment, together with bioptic evaluation, the accuracy of diagnosis (Ginès et al., 
2006; Karaca et al., 2010; Nagler et al., 2011).   
Biopsy is usually taken in the context of the endoscopic lesions and also randomly, in at 
least 8-12 regions, in order to clarify the amount of gastric wall involved by the disease and 
if some aggregates have transformed into more aggressive types of lymphomas. 
Considering that the new-formed MALT tissue in the stomach lays in the sub-mucosa, 
biopsies must be taken in depth; otherwise the risk is to underestimate the diagnosis. 
However, the introduction of large-valve biopsy forceps has improved the rate in obtaining 
the bioptic tissue on which establish the diagnosis (Boot & Jong, 2002) and the application of 
fine needle ago-biopsy (FNAB) EUS-guided as well (Fusaroli & Caletti, 2007) (fig. 4).  
Definitive diagnosis is based on morphological and immunophenotypic evaluation. In 
regard to PGL of MALT type, it has been developed a score, namely Wotherspoon score, 
useful to differentiate it from reactive inflamation, taking into account the presence of 
limpho-epithelioid lesions (LEL) and the formation of follicles (table 2).  
Additionally, PCR for the detection of t(14;18)(q21;q21) can be also performed cause it 
confirms the occurrence of malignancy and, on the other hand, can assess the  likelihood of 
response to the treatment. Furthermore, documentation of HP infection is mandatory and 
could be performed histologically, using Hematoxylin-Eosin and modified Giemsa staining, 
or with culture, urea breath test, antigen stool test or serological analysis. 
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Fig. 4. EUS-guided FNAB:  needle in perigastric node for cytological examination.    
 
SCORE DESCRIPTION HISTOLOGY 
0 Normal Scattered plasma cells in lamina propria. No lymphoid follicles 
I Chronic active gastritis Small clusters of lymphocytes in lamina propria. No lymphoid follicles. No LEL 
II Chronic active gastritis with florid lymphoid follicle formation 
Prominent lymphoid follicles with 
surrounding mantle zone and plasma 
cells. No LEL 
III Suspicious lymphoid infiltrate, probably reactive 
Lymphoid follicles surrounded by small 
lymphocytes that infiltrate diffusely in 
lamina propria and occasionally into 
epithelium 
IV Suspicious lymphoid infiltrate, probably lymphoma 
Lymphoid follicles surrounded by 
marginal zone cells that infiltrate 
diffusely in lamina propria and into 
epithelium in small groups 
V MALT lymphoma 
Presence of dense infiltrate of marginal 
zone cells in lamina propria with 
prominent LEL 
Table 2. Wotherspoon’s score for MALT lymphoma diagnosis (Hummel et al., 2006). 
4. Endoscopic ultrasound in staging of disease 
After diagnosis, the subsequent step is the staging of disease. This, together with the HP 
infection, is the most important factor in establishing the treatment needed and the 
prognostic status.  
Usually, staging is based on three main classifications (table 3): 
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1. Ann Arbor classification modified by Mussshoff and Radaszkiewics (Radaszkiewicz et 
al., 1992); 
2. Paris classification, that reproduce the TNM (Tumor-Node-Metastasis) classification for 
gastric cancer (Ruskoné-Fourmestraux et al., 2003); 
3. Lugano classification (Rohatiner et al., 1994). 
 
Lugano TNM Ann Arbor Extension 
I T1-3 N0 M0 IE Mucosa, sub-mucosa, muscolaris propria (fig.5-6-9) 
II1 
II2 
T1-3 N1 M0 





III T4 N0 MO IIIE Invasion of serosa and surrounding organs (Fig. 12) 
IV T1-4 N3 M0 T1-4 N0-3 M1 
IIIE 
IVE 
Extranodal dissemination or lymph node on 
both sides of diaphragm.  
Metastasis (e.g. bone marrow) 
Table 3. Staging of PGL: comparison between different systems. 
 
 
Fig. 5. EUS (radial scanning): thickening of the second layer of the gastric wall, 
corresponding to mucosa (stage: T1m N0)  
Physical examination is useful in order to detect palpable nodes, masses in the abdomen and 
Waldeyer’s ring involvement. Particular importance must be given to the general condition 
of patients, stratified with the ECOG performance status (PS), since it is a direct 
manifestation of the aggressiveness and stage of disease. The latest ESMO guidelines 
recommend additional work-up studies including complete blood counts, LDH and 2-
microglobulin evaluation and a bone marrow aspirate and biopsy, even if a bone marrow 
involvement is rare. 
Spiral-CT scan of neck, thorax, abdomen and pelvis with intravenous contrast is useful in 
order to detect masses in various body districts with a sensibility and specificity of 80% and 
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90% respectively, especially when performed with multiplanar reformations (Gligorievsky, 
2009). Furthermore, 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG)-positron emission 
tomography (PET) has an important role in staging and prognostic evaluation of DLBCL, but 
not in MALT lymphomas and is not recommended in the initial staging of PGL (Yi et al. 2010). 
Endoscopic Ultrasound (EUS) represents with no doubt the golden standard in determine 
the loco-regional staging of PGL, in particular in the era of HP eradication therapy in early 
stage disease.  
 
 
Fig. 6. EUS (radial scanning) demonstrated an irregular circumferential thickening of the 
gastric body with disruption of layers except for serosa (stage: T2 N0).  
Due to the importance of EUS in establishing the most appropriate treatment in PGL, many 
papers has been published during the last decades, together with the number of publication 
about EUS in general (Fusaroli et al., 2010) (fig. 7). 
 
 
Fig. 7. Trend of published papers concerning the usage of EUS in the management of PGL. 
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A bibliographic research in MeSH database, using the key words [Stomach], [Lymphoma, 
Non-Hodgkin] and [Ultrasonography] has revealed a total amount of 117 papers published. 
The majority of them have been published from the second half of ‘90s when has been 
introduced for the first time by Sackmann, in 1997, the concept that early stage PGL 
responds to eradication treatment (Sackmann et al., 1997).  
Particularly, the last decade has viewed an escalating number of published materials, 




Fig. 8. Pie chart describing the typology of published papers concerning EUS in the 
management of PGL in the last decade. 
First publications on the reliability of EUS in staging of PGL raised during the early ’90’s 
(Caletti et al., 1993) reported an accuracy of 80-92% and 77-90% for T and N stage 
respectively. These data were not confirmed by a successive study (Fischbach et al., 2002),  
involving 34 centers that reported an accuracy of 59% in detecting early stages and 71% in 
detecting the nodes involvement. These differences are probably due to the fact that EUS is 
an operator-dependent technique (Janssen, 2009). In general, EUS can define pathologic 
lymph node, defined as size greater than 10mm, sharply demarcated border, echopoor 
structure, rounded contour (Catalano et al., 1994), better than local extension.  
Due to this conflicting data, an inter-observer agreement in diagnosis and staging with EUS 
of gastric lesions has been investigated. Firstly, Gress et al., described how the agreement 
factor, called k factor, in diagnosing sub-epithelial masses is lower (k=0.34) compared to the 
examination of superficial lesions (k=0.53-0.8). Additionally, the rate of disagreement were 
higher between low experienced endosonographers; therefore the lowest the number of EUS 
performed, the higher the discordance (Gress et al., 2001). At the same time, the Italian 
group, in the context of the staging of PGL of MALT type, found a fair agreement for T 
description (k=0.38) and substantial agreement in N definition (k=0.63). The lowest 
agreement was in the definition of intermediate stage (k=0.33-0.35) (Fusaroli et al., 2002).  
Some studies have also indicated that the usage of miniprobe (fig. 9) would have improved 
the accuracy in detecting lesions (Lügering et al., 2001), but additional studies are needed. 
Interestingly, Varas et al. defined, in a subset of 24 patients, an accuracy of EUS in defining 
T factor of 91%, whereas the usage of miniprobes has given an accuracy of 88% and this 
mismatch was higher in evaluating the N factor confirming the high clinical impact of EUS 
(Varas et al., 2006).  
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A bibliographic research in MeSH database, using the key words [Stomach], [Lymphoma, 
Non-Hodgkin] and [Ultrasonography] has revealed a total amount of 117 papers published. 
The majority of them have been published from the second half of ‘90s when has been 
introduced for the first time by Sackmann, in 1997, the concept that early stage PGL 
responds to eradication treatment (Sackmann et al., 1997).  
Particularly, the last decade has viewed an escalating number of published materials, 




Fig. 8. Pie chart describing the typology of published papers concerning EUS in the 
management of PGL in the last decade. 
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detecting the nodes involvement. These differences are probably due to the fact that EUS is 
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examination of superficial lesions (k=0.53-0.8). Additionally, the rate of disagreement were 
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performed, the higher the discordance (Gress et al., 2001). At the same time, the Italian 
group, in the context of the staging of PGL of MALT type, found a fair agreement for T 
description (k=0.38) and substantial agreement in N definition (k=0.63). The lowest 
agreement was in the definition of intermediate stage (k=0.33-0.35) (Fusaroli et al., 2002).  
Some studies have also indicated that the usage of miniprobe (fig. 9) would have improved 
the accuracy in detecting lesions (Lügering et al., 2001), but additional studies are needed. 
Interestingly, Varas et al. defined, in a subset of 24 patients, an accuracy of EUS in defining 
T factor of 91%, whereas the usage of miniprobes has given an accuracy of 88% and this 
mismatch was higher in evaluating the N factor confirming the high clinical impact of EUS 
(Varas et al., 2006).  
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As a general rule, EUS has entered in the clinical practice of staging evaluation (Di 
Raimondo et al., 2007;Pavlović et al. 2005) and has been indicated as an ‘’obligatory part of the 
staging procedure’’ (Fischbach, 2010). Thus, in the 2010 ESMO guidelines (Zucca & Dreayler, 
2010), EUS has been indicated as the most appropriate technique in defining the loco-
regional staging.  
Conversely, EUS staging is not mandatory for DLBCL (Fischbach & Al-Taie, 2010), being  it 
treated as a systemic disease; even though a growing number of reports is showing its 
clinical utility.    
 
 
Fig. 9. Endoscopic view of ulcerated lesion of the gastric body.  Histology revealed a high-
grade gastric lymphoma (left panel); EUS (miniprobe): showing a circumferential 
irregularity of gastric wall limited at the second layer (stage: T2 N0) (right panel).   
5. Prognostic assessment and treatment: how endoscopic ultrasound 
staging can help in tailoring patient management 
Surely, the stage of disease assumes a great prognostic significance, being it related with 
survival either in pre- either post- HP eradication era; above all the bone marrow 
involvement represents a factor of poor outcome, together with the advanced loco-regional 
stage and depth of infiltration (Radaszkiewicz et al., 1992). Before the introduction of HP-
eradication therapy, the presence of an early stage disease represented the major indicator of 
response to surgery, while in HP-eradication era it designates the response to the HP-
therapy itself.   
Nevertheless, the most important factor in risk assessment remains the loco regional staging 
and EUS preserves a great importance due to the fact that it is able to indicate, with accuracy 
superior to other techniques, the precise loco-regional stage of disease and consequently the 
required treatment (Pavlović et al. 2005).  
Indeed, PGL of MALT type, when confined to mucosa and sub-mucosa layers responds to 
HP eradication therapy without any need of chemotherapy, meanwhile DLBCL are usually 
treated as general disease with chemo-immuno-therapy, even if recent case reports 
indicated the regression of locally staged DLBCL after HP eradication (Montalban et al., 
2001, Tari et al., 2009).  
Independently from the stage and dissemination, transformation to DLBCL occurs in about 
10% of the cases (Zucca et al., 2008). Usually, DLBCL shows a prognosis worsen than MALT 
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lymphoma. However, loco-regional stage remains a central prognostic factor also in DLBCL, 
having patients with advanced stage (II2-III according to Lugano classification) an overall 
survival (OS) of 71% at 5 years, whereas patients in early stage (I-II1according to Lugano 
classification) have a greater OS.  
 
Reference n Staging 
procedure 





Wotherspoon et al., 1993; 6 US 83 --- --- 
Savio et al., 1996; 12 CT 84 2-4 0 
Pinotti et al., 1997; 45 CT 67 3-18 2 
Neubauer et al., 1997; 50 CT+EUS 80 1-9 5 
Nobre-Leitão et al., 1998; 17 CT+EUS 100 1-12 1 
Steinbach et al., 1999; 23 CT+EUS 56 3-45 0 
Montalban et al., 2001; 19 CT+EUS 95 2-19 0 
Ruskoné-Fourmestraux et al., 2001; 46 CT+EUS 79 2-18 2 
Stathis et al., 2009 105 CT 76 5-32 16 
Table 4. Response to antibiotics in early-stage gastric MALT lymphoma. US: ultra-
sonography; CT: computed tomography; EUS: endoscopic ultrasonography; n: number of 
patients enrolled in the study; CR: Complete remission; No. of relapses: number of relapses  
The GIT NHL 02/96 study, confirming the results of the previous study GIT NHL 01/92, 
revealed that surgery is no longer the better strategy in early-stage low- and high-grade 
gastric lymphomas (Koch et al., 2005), except when perforation, bleeding or obstruction take 
place, proving these findings in a cohort of 363 patients. Firstly, the great impact of the 
stomach-preserving treatment has been suggested by Fischbach in a prospective non-
randomized trial, reporting a survival rate from 89% to 96% at 2 years for low-grade 
lymphomas and from 83% to 88% for high-grade lymphomas (Fischbach et al., 2000). 
Subsequently, randomized trials confirmed the superiority of a stomach-conservative 
approach compared to surgery in early stage DLBCL (Martinelli et al., 2009) and PGL of 
MALT type.  
Interestingly, the Taiwan Cooperative Oncology Group (TCOG) performed two prospective 
studies, the T1296 study in low grade PGL and DLBCL(MALT) study in high grade PGL, 
involving 41 and 24 patients respectively. They obtained 80% of complete remission among 
patients involved in the T1296 study and 64% in patients enrolled in the study 
DLBCL(MALT), both groups being treated with HP eradicating therapy. 
The same could be said about advanced-stage PGL, where the surgical approach is  
no longer the first choice. On the whole, for advanced gastric lymphomas, the golden 
standard of treatment is the antineoplastic chemotherapy with alkylating agents in 
monochemotherapy such as Clorambucil for MALT lymphomas and polichemotherapy 
together with immunotherapy such as R-CHOP for DLBCL (Zucca & Dreyling, 2010).  
With regard to relapsed low-grade early stages PGL MALT lymphomas, independently 
from the HP eradication, radiotherapy represents a very good treatment option, increasing 
the survival rate to 85–100% at 5 years. Additionally, radiotherapy could be an option in HP 
negative MALT lymphomas. In high-grade lymphomas radiotherapy is usually performed 
in presence of partial remission of disease after chemotherapy or in presence of relapse 
(Aleman et al., 2010). 
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lymphoma. However, loco-regional stage remains a central prognostic factor also in DLBCL, 
having patients with advanced stage (II2-III according to Lugano classification) an overall 
survival (OS) of 71% at 5 years, whereas patients in early stage (I-II1according to Lugano 
classification) have a greater OS.  
 
Reference n Staging 
procedure 





Wotherspoon et al., 1993; 6 US 83 --- --- 
Savio et al., 1996; 12 CT 84 2-4 0 
Pinotti et al., 1997; 45 CT 67 3-18 2 
Neubauer et al., 1997; 50 CT+EUS 80 1-9 5 
Nobre-Leitão et al., 1998; 17 CT+EUS 100 1-12 1 
Steinbach et al., 1999; 23 CT+EUS 56 3-45 0 
Montalban et al., 2001; 19 CT+EUS 95 2-19 0 
Ruskoné-Fourmestraux et al., 2001; 46 CT+EUS 79 2-18 2 
Stathis et al., 2009 105 CT 76 5-32 16 
Table 4. Response to antibiotics in early-stage gastric MALT lymphoma. US: ultra-
sonography; CT: computed tomography; EUS: endoscopic ultrasonography; n: number of 
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place, proving these findings in a cohort of 363 patients. Firstly, the great impact of the 
stomach-preserving treatment has been suggested by Fischbach in a prospective non-
randomized trial, reporting a survival rate from 89% to 96% at 2 years for low-grade 
lymphomas and from 83% to 88% for high-grade lymphomas (Fischbach et al., 2000). 
Subsequently, randomized trials confirmed the superiority of a stomach-conservative 
approach compared to surgery in early stage DLBCL (Martinelli et al., 2009) and PGL of 
MALT type.  
Interestingly, the Taiwan Cooperative Oncology Group (TCOG) performed two prospective 
studies, the T1296 study in low grade PGL and DLBCL(MALT) study in high grade PGL, 
involving 41 and 24 patients respectively. They obtained 80% of complete remission among 
patients involved in the T1296 study and 64% in patients enrolled in the study 
DLBCL(MALT), both groups being treated with HP eradicating therapy. 
The same could be said about advanced-stage PGL, where the surgical approach is  
no longer the first choice. On the whole, for advanced gastric lymphomas, the golden 
standard of treatment is the antineoplastic chemotherapy with alkylating agents in 
monochemotherapy such as Clorambucil for MALT lymphomas and polichemotherapy 
together with immunotherapy such as R-CHOP for DLBCL (Zucca & Dreyling, 2010).  
With regard to relapsed low-grade early stages PGL MALT lymphomas, independently 
from the HP eradication, radiotherapy represents a very good treatment option, increasing 
the survival rate to 85–100% at 5 years. Additionally, radiotherapy could be an option in HP 
negative MALT lymphomas. In high-grade lymphomas radiotherapy is usually performed 
in presence of partial remission of disease after chemotherapy or in presence of relapse 
(Aleman et al., 2010). 
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Of particular interest is the fact that early stage MALT PGL respond to the HP eradication in 
about 90% of cases, sparing chemotherapy to these patients (Andriani et al., 2009). Several 
regimens have been proposed, but the best strategy should be based on the expected 
antibiotic resistance. The first-choice regimen is triple therapy, but other regimens are 
effective as well.  
Certainly, after the first 6 cases published in 1993 by Wotherspoon et al in the Lancet, HP 
eradication has become the best studied therapeutic approach with a large number of 
reported studies confirming that histological regression of the lymphoma can be achieved in 
the majority of cases (Wotherspoon et al., 1993) (table 4).  
That notwithstanding, about 10% of patients do not respond to HP eradication and for these 
patients radiotherapy has been proposed as a good option.  
6. Response evaluation: histology vs endoscopic ultrasound  
Response assessment to treatment lacks of standard reproducible criteria. However, 
histological evaluation on mapping biopsies, considering histologic Wotherspoon score 
(table 2), has gained a great role in determining the response evaluation being it strictly 
related with the clinical outcome. Patients with score ≤ 2 achieve a complete remission, 
while patients with score = 3 a partial response and patients with a score ≥ 4 have a 
persistent lymphoma. Recently, the European Gastro-Intestinal Lymphoma Study (EGILS) 
has proposed the new recommendation on the management of PGL, including EUS in 
establishing the response assessment. Basically, complete remission (CR) is characterized 
by the absence of EUS abnormalities with negative E-Bx (Fig. 10) in two subsequent 
evaluations, Partial remission (PR) is defined as restoration of EUS with histological 
persistence of lymphoma but no clinical signs of progression, Stable disease (SD) is 
defined by constant presence of disease at EUS and/or histology, Progressive disease (PD) 
is defined by expansion of endoscopic findings, or transformation into high grade 
lymphoma in case of MALT lymphomas, Relapse (Rel) is defined as recurrence of 
lymphoma documented with histology after a reached complete remission (Ruskoné-
Fourmestraux et al. 2011).   
 
 
Fig. 10. Endoscopy: gastric body after eradication therapy. No histologic signs of MALT 
Lymphoma (left panel); EUS (radial scanning) showing a complete restoration of the gastric 
wall after eradication therapy (right panel).  
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7. Follow-up: is endoscopic ultrasound clinically helpful?  
Several follow-up studies have confirmed that the achievement of complete response 
corresponds with an augmentation of OS and PFS. The TCOG group confirmed this finding 
in two prospective clinical trial, the T1296 study for low-grade lymphomas and the 
DLBCL(MALT) study for high grade, showing an OS of 94% and 87% at 5- and 7- years  of 
follow-up respectively for patients with MALT lymphoma, while DLBCL patients showed a 
OS of 92% and 92% at 5- and 7-years correspondingly. In these trials, patients with DLBCL 
that achieved complete remission have shown no relapse of disease or lymphoma-related 
death, meanwhile patients with MALT lymphoma, without high-grade component, showed 
a relapse rate of 13% in a 70 months follow-up period. 
Similarly, the German group, in a multicentric prospective study involving 417 patients 
(Fischbach et al., 2002), demonstrated that recurrence of disease occurs in 3.9% of MALT 
lymphoma and 4.7% of DLBCL. Additionally, in another multicentric trial on early stage 
MALT lymphoma, patients with histologically proven residual disease, have shown no 
recurrence of disease, except one of them that presented a transformation to DLBCL. Thus a 
postremission ‘’watch and wait’’ strategy without further treatment can be safely adopted. 
Interestingly, it has been prospected that early-stage HP-negative PGL that respond to Hp-
eradication treatment can be securely managed with the same ‘’watch and wait’’ plan 
(Fischbach, 2010).  
However, a general consensus in the management of follow-up does not exist (Zucca & 
Dreyler, 2010). The ESMO group suggest to perform a strict endoscopic follow-up with 
multiple biopsies 2-3 months after treatment and then twice a year for two years. In certain 
cases, histological relapse can occur, but still a ‘’watch and wait’’ approach seems to be not 
dangerous, even if the level of evidence is IV and the grade of recommendation is D.  
Basically, there is a lack of concordance between the histological evaluation and EUS in 
follow-up due to the fact that even if the EUS can detect the disappearance of gastric-wall 
lesion, histology can identify foci of residual disease, defined as a Wotherspoon score >2. On 
the contrary, in some cases endoscopy with mapping biopsies can give negative results for 
residual disease, whereas EUS is positive. That can be due to the real persistence of disease 
that biopsies cannot detect because the depth of the infiltration or the occurrence of fibrotic 
tissue subsequent to the treatment (Fig. 11-12) or the presence of lesions other than 
lymphoma, posing the same problems when diagnosis have to be established. Residual 
thickness of the gastric wall could represent a scar following the chemotherapy, especially in 
patients affected by DLBCL (fig. 12) where it is well documented that fibrosis remains after 
therapy in patients with nodal presentation of disease (Canellos et al., 1988).  
In the last years few studies have taken into consideration the reliability of EUS in the 
follow-up management of PGL (table 5).  
An early report indicated that post-treatment EUS documented an abnormal thickness of the 
wall in three out of 11 patients affected by MALT and two of the three patients had residual 
lymphoma (Pavlick et al., 1997). In one case of MALT lymphoma, persistence of EUS 
changes was able to predict relapse of disease in absence of a “positive” biopsy. Therefore, 
authors concluded that the persistence of wall thickness at EUS is an indication for repeating 
biopsies in order to detect persistence of disease or early relapse (Levy et al, 1997). These 
and other small studies would indicate that EUS is a useful tool for follow-up evaluation 
and indicate that for patients in remission, with a restoration of normal gastric wall, a 
recurrent wall thickening at EUS might be indicative for relapse. However, more recent 
 
Ultrasound Imaging – Medical Applications 
 
246 
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7. Follow-up: is endoscopic ultrasound clinically helpful?  
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cases, histological relapse can occur, but still a ‘’watch and wait’’ approach seems to be not 
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the contrary, in some cases endoscopy with mapping biopsies can give negative results for 
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thickness of the gastric wall could represent a scar following the chemotherapy, especially in 
patients affected by DLBCL (fig. 12) where it is well documented that fibrosis remains after 
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follow-up management of PGL (table 5).  
An early report indicated that post-treatment EUS documented an abnormal thickness of the 
wall in three out of 11 patients affected by MALT and two of the three patients had residual 
lymphoma (Pavlick et al., 1997). In one case of MALT lymphoma, persistence of EUS 
changes was able to predict relapse of disease in absence of a “positive” biopsy. Therefore, 
authors concluded that the persistence of wall thickness at EUS is an indication for repeating 
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and indicate that for patients in remission, with a restoration of normal gastric wall, a 
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studies, conducted in larger series, have reduced the importance of EUS in the setting of 
follow-up. A study indicated that the accuracy of EUS in evaluating remission of disease 
was inferior to histology, with a concordance between histology and EUS present in 64% of 
patients. In addition, the EUS findings returned to normal in a much more prolonged time 
in respect to gastroscopy with biopsy. After a prolonged follow-up, however, an EUS 
complete remission occurred in almost every patient (Püspök et al., 2002). On the contrary, 
another study confirmed that EUS is reliable in determining tumor regression or relapse 
with a concordance between EUS and endoscopic biopsies of about 80% (Lügering et al., 
2001). During 2003, two other reports stated that EUS is a reliable tool in determining the 
response evaluation and the early detection of disease reappearance, thus avoiding the 
performance of invasive procedures (Hoepffner et al., 2003; Yeh et al., 2003). In addition, the 
Serbian group found a stringent correlation between EUS and histology in patients treated 
both with HP-eradicating therapy and/or chemotherapy ± radiotherapy (Pavlović et al. 2005). 
 
 
Fig. 11. Post-eradication therapy: The fourth layer persists thickened.  
 
 
Fig. 12. EUS (radial scanning): left panel showing an high-grade gastric lymphoma 
infiltrating all layers of the gastric wall and the left lobe of the liver (stage: T4 N0); right 
panel indicates the persistence of residual abnormalities after 6 months post- chemotherapy 
(stage: T3 N0), even if the histology confirmed the complete response to the chemotherapy.   
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Pavlick 1997 11 2 90.9% /// /// 
Lévy 1997 15 17 (4-48) 50% /// /// 
Lügering 2001 24 22 (17-28) 79.16% /// /// 
Püspök 2002 33 15 (3-48) 64% 21.9 41.7 
Yeh 2003 20 24 (3-51) 82.4% /// /// 
Hoepffner 2003 22 21 (4-51) /// /// /// 
Pavlović 2005 26 /// 100% ; 78% * /// /// 
Di Raimondo 2007 23 44 (25-71) 33% 8 20 
*patients treated with HP-eradication therapy and chemotherapy ± radiotherapy 
respectively 
Table 5. studies concerning the reliability of EUS in the follow-up of PGL. 
8. Follow-up evaluation: experience of our group 
Our experience is not confirmatory of the aforementioned studies. In fact, in order to 
evaluate the role of EUS in follow-up management, our group carried out a retrospective 
study in gastric lymphoma patients with the aim to compare EUS with conventional 
endoscopy and biopsy. In our series, after a complete remission, two patients experienced a 
relapse and this event was not predicted by EUS nor by E-Bx. More important, we found 
that EUS was concordant with biopsies in only one third of patients. In addition, the EUS 
findings returned to normal with a considerable delayed time in respect to gastroscopy with 
biopsy, even after a prolonged follow-up (fig.13).  
 
 
Fig. 13. Time required for achieving a complete remission by endoscopy with biopsy (E-Bx) 
and endoscopic ultrasound (EUS) (Di Raimondo et al. 2007) 
Our series was composed by 23 patients, 11 female and 12 male, afferent at Division of 
Hematology, University of Catania, Italy, from January 1994 to December 2003, treated with 
a stomach conserving approach and with at least two EUS evaluation in the follow-up. The 
median age at diagnosis was 60 years ranged between 26 and 79. Sixteen patients had a low 
grade gastric lymphoma; while seven had a high-grade lymphoma, of whom one with a 
MALT lymphoma component. 
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Fig. 11. Post-eradication therapy: The fourth layer persists thickened.  
 
 
Fig. 12. EUS (radial scanning): left panel showing an high-grade gastric lymphoma 
infiltrating all layers of the gastric wall and the left lobe of the liver (stage: T4 N0); right 
panel indicates the persistence of residual abnormalities after 6 months post- chemotherapy 
(stage: T3 N0), even if the histology confirmed the complete response to the chemotherapy.   
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Pavlick 1997 11 2 90.9% /// /// 
Lévy 1997 15 17 (4-48) 50% /// /// 
Lügering 2001 24 22 (17-28) 79.16% /// /// 
Püspök 2002 33 15 (3-48) 64% 21.9 41.7 
Yeh 2003 20 24 (3-51) 82.4% /// /// 
Hoepffner 2003 22 21 (4-51) /// /// /// 
Pavlović 2005 26 /// 100% ; 78% * /// /// 
Di Raimondo 2007 23 44 (25-71) 33% 8 20 
*patients treated with HP-eradication therapy and chemotherapy ± radiotherapy 
respectively 
Table 5. studies concerning the reliability of EUS in the follow-up of PGL. 
8. Follow-up evaluation: experience of our group 
Our experience is not confirmatory of the aforementioned studies. In fact, in order to 
evaluate the role of EUS in follow-up management, our group carried out a retrospective 
study in gastric lymphoma patients with the aim to compare EUS with conventional 
endoscopy and biopsy. In our series, after a complete remission, two patients experienced a 
relapse and this event was not predicted by EUS nor by E-Bx. More important, we found 
that EUS was concordant with biopsies in only one third of patients. In addition, the EUS 
findings returned to normal with a considerable delayed time in respect to gastroscopy with 
biopsy, even after a prolonged follow-up (fig.13).  
 
 
Fig. 13. Time required for achieving a complete remission by endoscopy with biopsy (E-Bx) 
and endoscopic ultrasound (EUS) (Di Raimondo et al. 2007) 
Our series was composed by 23 patients, 11 female and 12 male, afferent at Division of 
Hematology, University of Catania, Italy, from January 1994 to December 2003, treated with 
a stomach conserving approach and with at least two EUS evaluation in the follow-up. The 
median age at diagnosis was 60 years ranged between 26 and 79. Sixteen patients had a low 
grade gastric lymphoma; while seven had a high-grade lymphoma, of whom one with a 
MALT lymphoma component. 
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Diagnosis was based on morphological and immunophenotypic analysis, according to 
WHO classification, from gastric biopsies performed with endoscopy with biopsy (E-Bx). 
HP infection has been assessed by using histochemistry or urea breath test and/or the 
antigen stool test and has resulted as positive in the total amount of patients with low grade 
lymphoma (12/12) and in only 1 patient with high grade lymphoma.  
At diagnosis a total of 6 patients presented alarm symptoms, 4 with low grade lymphoma 
and 2 with high grade lymphoma. The ulcerative pattern was the mainly represented at 
gastroscopy, being present in 12 patients out of 23.  
Patients have been staged at baseline with computed tomography (CT) scan of neck, thorax 
and abdomen, EUS and bone marrow biopsy. EUS staging was carried out according to 
TNM (tumour–node–metastasis) classification and the Lugano staging system (Table 6).   
Response evaluation was based on the Wotherspoon score on bioptic samples. 
Endosonographic remission was defined as wall thickness ≤ 4 mm with a restoration of a 
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Table 6. Extension of disease according to TNM and Lugano classification. 
HP eradication with triple therapy regimen was employed in 6 patients with localized 
MALT lymphoma. Oral alkylating agents (either clorambucil or cyclophosphamide) or 
purine analogues (fludarabina, cladribine) were given, as second line treatment, in 3 out of 6 
patients that failed to achieve the complete remission after AT and, as first line therapy, in 7 
patients with extended MALT lymphoma. Patients with DLBCL were treated with R-CHOP 
(Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) or CHOP-like 
regimens with or without radiotherapy.   
One patient died for hepatic failure and four more patients had a secondary neoplasia, on 
average 4 years after the achieved complete remission (1 colon carcinoma, 1 gastric 
carcinoma, 1 anaplastic NHL and 1 MALT lymphoma of small intestine).  
Follow-up was conducted with endoscopic biopsies (E-Bx) in any abnormal area, or 
randomly if none, with EUS at variable intervals according to clinical judgment.  
The echoendoscopists were unaware of the results of histology and the pathologists were 
unaware of the results of EUS. 
At the end of initial treatment a CR was documented by biopsy in 15 (65%) patients. At the 
same time only two patients showed a normalization of EUS (P = 0.0002). Patients were then 
evaluated with EBs and EUS every 3/6 months and with a more prolonged follow-up (four 
patients) or the addition of further chemotherapy (two patients) a total of six patients in PR 
turned to CR so that the final number of patients in CR by E-Bx has increased to 21 (91%). At 
the same time, although EUS showed a reduction of median value of thickness of gastric 
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wall from 1 to 0.6 cm (P = 0.0031), only seven patients (30%) had a normal EUS (P < 0.0001). 
Complete remission, documented with E-Bx, was achieved in 18 patients with EUS 
restoration significantly delayed respect to E-Bx findings (26 vs 6 moths) (table 7).  
 
TIME TO REACH  CR E-Bx EUS 
TOTAL MEDIAN 6 26 
RANGE 2 19 6 56 
MALT MEDIAN 5 21 
RANGE 2 19 6 56 
HIGH GRADE MEDIAN 6 N.A. RANGE 2 10 
Table 7. Time required for achieving a complete remission by endoscopy with biopsy (E-Bx) 
and endoscopic ultrasound (EUS). CR: Complete Remission, N.A.: Not Available. 
All the patients with MALT lymphoma, which responded to the treatment and maintained 
the response, eventually reached the EUS complete remission at the end of a prolonged 
follow-up, except for one of them that presented EUS abnormalities also after a follow-up of 
114 months. On the contrary, only one patient with high grade lymphoma reached the EUS 
complete remission, after 30 months of follow-up.  
Thus, it is possible that disappearance of lymphoma cells is a very slow process that takes 
several years to extinguish once the initiating factors have been eliminated. In any case, 
persistence of EUS abnormalities, irrespective of the fact that it indicates fibrosis or minimal 
residual disease, did not seem to have a clinical relevance being not predictive of relapse 
and should not be used as a guidance for further treatment. 
A total of 120 EUS were performed, the majority of them (97/120) within the first five years 
of follow-up, with a discordance rate of 61.6%. Particularly, the discordance rate was 68% 
during the first five years of follow-up but it was reduced to 34.7%, in the subsequent 
period; on the contrary, the concordance rate shows an upward trend at 10-years follow-up, 
from 32% to 65%. However, taking into account the histotype, this trend seems to be 
confirmed for MALT lymphomas but not for DLBCL where the discordance rate, after 10 
years of follow-up, remains higher than the concordance rate (Fig. 14). 
On the whole, the prolonged follow-up confirmed our previous findings. In fact, EUS can 
detect the complete remission with a significant delay compared to E-Bx in both types of 
lymphoma. Additionally, EUS restoration of normal stomach layers occurs after many years 
from the achieved complete remission in patients with MALT lymphoma; while in patients 
with DLBCL EUS continues to show an abnormal pattern, despite the obtained complete 
remission. 
9. Conclusion 
The introduction of EUS in the management of PGL has radically changed the approach to 
these patients. Nowadays, EUS keeps a pivotal role in defining the sub-mucosal lesions and 
large gastric folds, also determining the differential diagnosis prior to the histological 
evaluation. The precise staging delineated by EUS assumes a critical importance in defining 
the prognosis and in turn tailors the therapy; nevertheless, EUS seems to be not very useful 
to define the response assessment, since it can show the restoration of gastric layers with a 
great delay compared to the histological evaluation. 
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Table 6. Extension of disease according to TNM and Lugano classification. 
HP eradication with triple therapy regimen was employed in 6 patients with localized 
MALT lymphoma. Oral alkylating agents (either clorambucil or cyclophosphamide) or 
purine analogues (fludarabina, cladribine) were given, as second line treatment, in 3 out of 6 
patients that failed to achieve the complete remission after AT and, as first line therapy, in 7 
patients with extended MALT lymphoma. Patients with DLBCL were treated with R-CHOP 
(Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) or CHOP-like 
regimens with or without radiotherapy.   
One patient died for hepatic failure and four more patients had a secondary neoplasia, on 
average 4 years after the achieved complete remission (1 colon carcinoma, 1 gastric 
carcinoma, 1 anaplastic NHL and 1 MALT lymphoma of small intestine).  
Follow-up was conducted with endoscopic biopsies (E-Bx) in any abnormal area, or 
randomly if none, with EUS at variable intervals according to clinical judgment.  
The echoendoscopists were unaware of the results of histology and the pathologists were 
unaware of the results of EUS. 
At the end of initial treatment a CR was documented by biopsy in 15 (65%) patients. At the 
same time only two patients showed a normalization of EUS (P = 0.0002). Patients were then 
evaluated with EBs and EUS every 3/6 months and with a more prolonged follow-up (four 
patients) or the addition of further chemotherapy (two patients) a total of six patients in PR 
turned to CR so that the final number of patients in CR by E-Bx has increased to 21 (91%). At 
the same time, although EUS showed a reduction of median value of thickness of gastric 
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wall from 1 to 0.6 cm (P = 0.0031), only seven patients (30%) had a normal EUS (P < 0.0001). 
Complete remission, documented with E-Bx, was achieved in 18 patients with EUS 
restoration significantly delayed respect to E-Bx findings (26 vs 6 moths) (table 7).  
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Table 7. Time required for achieving a complete remission by endoscopy with biopsy (E-Bx) 
and endoscopic ultrasound (EUS). CR: Complete Remission, N.A.: Not Available. 
All the patients with MALT lymphoma, which responded to the treatment and maintained 
the response, eventually reached the EUS complete remission at the end of a prolonged 
follow-up, except for one of them that presented EUS abnormalities also after a follow-up of 
114 months. On the contrary, only one patient with high grade lymphoma reached the EUS 
complete remission, after 30 months of follow-up.  
Thus, it is possible that disappearance of lymphoma cells is a very slow process that takes 
several years to extinguish once the initiating factors have been eliminated. In any case, 
persistence of EUS abnormalities, irrespective of the fact that it indicates fibrosis or minimal 
residual disease, did not seem to have a clinical relevance being not predictive of relapse 
and should not be used as a guidance for further treatment. 
A total of 120 EUS were performed, the majority of them (97/120) within the first five years 
of follow-up, with a discordance rate of 61.6%. Particularly, the discordance rate was 68% 
during the first five years of follow-up but it was reduced to 34.7%, in the subsequent 
period; on the contrary, the concordance rate shows an upward trend at 10-years follow-up, 
from 32% to 65%. However, taking into account the histotype, this trend seems to be 
confirmed for MALT lymphomas but not for DLBCL where the discordance rate, after 10 
years of follow-up, remains higher than the concordance rate (Fig. 14). 
On the whole, the prolonged follow-up confirmed our previous findings. In fact, EUS can 
detect the complete remission with a significant delay compared to E-Bx in both types of 
lymphoma. Additionally, EUS restoration of normal stomach layers occurs after many years 
from the achieved complete remission in patients with MALT lymphoma; while in patients 
with DLBCL EUS continues to show an abnormal pattern, despite the obtained complete 
remission. 
9. Conclusion 
The introduction of EUS in the management of PGL has radically changed the approach to 
these patients. Nowadays, EUS keeps a pivotal role in defining the sub-mucosal lesions and 
large gastric folds, also determining the differential diagnosis prior to the histological 
evaluation. The precise staging delineated by EUS assumes a critical importance in defining 
the prognosis and in turn tailors the therapy; nevertheless, EUS seems to be not very useful 
to define the response assessment, since it can show the restoration of gastric layers with a 
great delay compared to the histological evaluation. 
 




Fig. 14. Trend, at 5- and 10- years follow-up, of Discordance (red line) and Concordance 
(blue line) rate between E-Bx and EUS fining in the total set of patients (top panel), in 
patients with MALT lymphoma (left panel on the bottom) and in patients with DLBCL 
(right panel on the bottom). 
Finally, the trustworthiness of EUS in follow-up is questionable. The latest ESMO guidelines 
do not recommend the performance of EUS in the follow-up. We have shown that it is not 
reliable in DLBCL, where most patients maintained a complete remission even with 
persistent EUS abnormality. In MALT patients, the role of EUS during the follow up period 
could be more important since we have noticed several changes in the EUS findings with a 
more prolonged follow up. Our study is, however, retrospective and also lies in a small 
number of cases. A prospective study should be carried out with an adequate number of 
patients so as to distinguish between DLBCL and MALT since the two diseases have 
different therapeutic approaches. We think that until now patients with gastric lymphoma 
should be treated with a conservative approach and they should be followed with both EUS 
and E-Bx in order to have a longer follow-up and more information on the role of EUS in 
detecting early relapse..  
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1. Introduction 
The diagnosis of inflammatory bowel disease (IBD) is based on clinical, endoscopic, 
radiologic and histologic criteria1. There are two main IBD phenotypes – Crohn's disease 
(CD) and ulcerative colitis (UC). In some circumstances, especially when disease extension is 
restricted to the colon or in cases of acute severe pancolitis, recognition of specific IBD 
phenotype is very difficult. Recognition of the exact IBD phenotype is essential for guiding 
therapeutic decisions and detection of complications that warrant treatment.  
Endoscopic examination is the mainstay in the diagnosis of IBD. Endoscopic appearance 
(distribution and shape of lesions) helps to differentiate CD from UC in most cases. 
Pathohistologic analysis confirms the elements of chronic inflammation but it is frequently 
not diagnostic. Patients with UC may have atypical histological features such as microscopic 
inflammation of the ileum, patchiness of inflammation and rectal sparing at the time of 
diagnosis prompting physicians to make the diagnosis of CD in UC cases. Other endoscopic 
findings such as cobble stoning, segmental colitis, ileal stenosis and ulceration, perianal 
disease and pathologically confirmed multiple granulomas in the small bowel or colon 
strongly suggest a diagnosis of CD. 
The progress in genetics, serological markers and imaging studies will lead to more reliable 
determination of exact IBD phenotype in the future2. In the meantime, it is reasonable to 
explore other diagnostic options for better differentiation between different IBD phenotypes. 
We think that endoscopic ultrasound (EUS) elastography is a promising method to achieve 
this goal, picture 1 and 2. It is a new endoscopic procedure which can differentiate the 
stiffness of normal and pathological tissue by ultrasound. This finding is based on B-mode 
scanning during compressions3. There are some data on elastography applied on the GI 
tract, biliary tract, kidney, muscle, breast and the heart3-5.  
Primary sclerosing cholangitis (PSC) is a chronic liver disease of unknown etiology, 
characterized by cholestasis, inflammation, fibrosis and stricture formation of the biliary 
ducts. The pathophysiology of PSC is a complex multistep process included unclear 
immunological mechanisms, genetic susceptibility and various defects of the biliary 
epithelial cells.  
The disease is rare in the general population but is strongly associated with inflammatory 
bowel disease. The prevalence of IBD, predominantly ulcerative colitis, among PSC patients 
is approximately 70-90% while only 5% of patients with UC develop PSC. The percentage of  
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Picture 1. TRUS elastography in a UC patient 
 
 
Picure 2. TRUS elastography in a CD patient 
Crohn’s disease patients affected by PSC is much smaller. Recently, it was recognized that 
PSC-IBD is a distinct IBD phenotype. Ulcerative colitis associated with PSC is usually mild, 
quiet, is associated with rectal sparing, more intensive right sided disease, and backwash 
ileitis and has a significant risk of developing pouchitis after colectomy.  
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In advanced cases symptoms include icterus, itch and lethargy but almost 45% of patients 
have no symptoms and increasing numbers of asymptomatic patients are being identified.  
Primary sclerosing cholangitis is generally aggressive disorder and can progress in cirrhosis. In 
that setting, liver transplantation is the only therapeutic option with cure potential because 
median survival without liver transplantation after diagnosis is approximately 12 years. 
PSC is associated with a 10%-15% lifetime risk of developing cholangiocellular carcinoma 
which often presents in advanced stage with a poor prognosis. Primary sclerosing cholangitis 
also has a risk of developing colorectal dysplasia and neoplasia in IBD. Treatment with high 
dose ursodeoxycholic acid has chemoprotective effects against potential neoplasia. 
Magnetic resonance cholangiography (MRC) and endoscopic retrograde cholangiography 
(ERC) are diagnostic procedures which confirm multifocal strictures and dilatation of biliary 
ducts, characteristic for PSC. Both procedures, ERC and MRC are comparable for diagnosing 
PSC but there are conflicting data regarding the role of ERCP in patients with PSC. It seems 
that elective ERCP has a modest risk of ERCP-related complications in patients with PSC. 
However, ERCP in severe ill IBD patients increases the probability of post procedure 
complications. Because of its noninvasive nature, MRCP may have advantages over invasive 
cholangiography when diagnosis is the main goal of the procedure. 
According to evident well-documented risk of malignant disease during the life course, early 
identification of PSC patients is very important for establishing adequate surveillance strategy.  
Elastography is a method which can differentiate the stiffness of normal and pathological 
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Picture 3. Normal bile duct.  
 




Picture 4. PSC patient.  
Regarding to the fact that imaging of ultrasound tissue elasticity is a way to distinct normal 
from abnormal tissue we analyzed the role of EUS elastography in assessing ductus 
choledochus properties in patients with and without PSC. EUS elastography has a potential 
to define tissue characteristics but specificity has to be improved4. 
Based on the idea that imaging of ultrasound tissue elasticity is a way to differentiate tissue 
characteristics, we hypothesized that EUS elastography has the role in assessing the 
thickness of bowel wall in patients with IBD and in differentiation between types of colonic 
inflammation in Crohn’s colitis and ulcerative colitis6,7 based on the fact that CD is a 
transmural disease and UC is limited to the mucosa and submucosa of the bowel wall.  
2. Discussion 
There are numerous papers in the current literature on the issue of EUS elastography. The 
method was initially inaugurated to distinguish benign from malignant pancreatic 
lesions6,9,10. Although it cannot replace biopsy and histological confirmation of cancer, 
„virtual biopsy“ done by EUS elastography could provide good information of the 
consistency of the tissue of interest11. 
We hypothesized that „virtual biopsy“ technique might be implemented in differentiating 
colonic tissue between CD and UC4,12. IBD phenotyping is clinically very important because 
of three specific reasons. Firstly, Crohn's colitis and UC have different risk of complications 
(fistulas, strictures, extraintestinal manifestations) that require specific therapeutic approach. 
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Secondly, regarding the drugs, there is a clear difference in the efficacy of mesalazine in 
active Crohn's colitis and ulcerative colitis15,16. Delay of introduction of immunosuppressive 
agents in misdiagnosed patients with Crohn's colitis can be deleterious. Thirdly, accurate 
determination of disease phenotype is important in cases were surgical intervention 
becomes necessary, since continent proctocolectomy is inappropriate method in Crohn's 
colitis where pelvic reservoir in case of unrecognized CD gets complicated by fistulas, 
stenosis and pelvic sepsis17. To conclude, present serologic and genetic markers cannot 
always confirm the phenotypic diagnosis and predict the clinical course in IBD patients 18, 19, 
20. EUS elastography could be, therefore, a new diagnostic option with the potential to 
recognize differences in the UC tissue and Crohn's colitis tissue. 
In order to clearly define the differences between the colonic wall in CD and UC, our 
investigation was focused on the characteristics of the rectal wall and perirectal tissue, 
observed by the EUS elastography with SR calculation. Perirectal tissue in UC patients is 
supposed to be soft, without inflammation. In CD patients, „hard tissue“ reflects the 
transmural nature of inflammation. These qualitative and quantitative elastography data 
could lead to accurate differentiation of IBD phenotypes.  
Our pilot study revealed a significant difference in rectal wall thickness between IBD group 
as a whole and controls which is in agreement with other reports from the literature21,22. 
Interestingly, we also found a significant difference in rectal wall thickness between CD 
patients without rectal involvement and controls. The significance of this finding in our pilot 
study is unclear but it could suggest a possible predictive role of TRUS elastography in  
CD. Bearing in mind the fact that CD can involve any part of the GI tract, it would be 
interesting to identify such patients early in the course of the disease and follow them 
prospectively to see whether rectal involvement or perianal disease will develop. In UC 
patients, a significant difference in rectal wall thickness but not strain ratio was found 
between active UC patients and controls. This finding reflects the fact that inflammatory 
process in UC is confined to the mucosa and submucosa leading to the thickening of the 
rectal wall in acute inflammation but without changes in perirectal tissue as measured by 
strain ratio. A significant difference was detected in rectal wall thickness and strain ratio 
between CD and UC patient group reflecting the difference in pathogenetic mechanisms 
driving these diseases with CD being characterized by transmural inflammation  
as opposed to UC. Finally, we detected a significant difference in both rectal wall 
thickness and strain ratio between CD patients with rectal involvement and UC patients 
with active disease.  
There was unfortunately significant difference in age between control group and IBD group. 
The results of TRUS elastography show that control group and UC group had comparable 
strain ratios, while CD group had statistically higher strain ratio. Based on the available 
literature, there are no significant changes in the rectal wall thickness with aging23,24.  
We believe that the results of our study confirm the potential usefulness of TRUS 
elastography in determining the exact phenotype of IBD.  Currently, about 10% of patients 
with inflammation restricted to the colon can not be accurately classified using standard 
diagnostic techniques25,26. More importantly, 4-6 % of patients with presumably UC 
undergoing proctocolectomy with ileoanal anastomosi and pelvic pouch formation turned 
out to have CD resulting in significant morbidity and high rate of pouch failure27,28. 
Although we found a significant difference in rectal wall thickness and significant difference 
in strain ratio between CD patients with rectal involvement and active UC patients, our 
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study has a limitation due to a small number of patients included. There is a need for a 
prospective study with inclusion of a greater number of patients and for the construction of 
receiver operating characteristics (ROC) curve to definitely assess the value of TRUS 
elastography in IBD. 
3. Conclusion  
TRUS elastography with strain ratio calculation provides valuable information regarding 
the stiffness of the rectal and perirectal tissue and can help to differentiate CD from UC. Our 
study indicates that TRUS elastography could be one of the perspective and promising 
diagnostic tools in IBD. A prospective study on a large cohort of patient is necessary to 
consolidate and confirm the results and establish the role of TRUS in distinguishing Crohn's 
colitis and UC. In addition, one of the important benefits of EUS elastography in the long 
run could be the possibility of identifying individuals at risk of developing a transmural 
disease, thereby facilitating appropriate action for prevention of disease complications. 
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1. Introduction 
Since the Doppler effect was firstly described by Christian Doppler in 1842, it has been 
applied in many different fields. In human medicine has been extremely helpful in 
monitoring the fetal viability or assessing the carotid flow, and it is currently being used in 
most of the disciplines. 
In veterinary medicine, the Doppler effect is a helpful tool in abdominal ultrasound, and 
essential in the echocardiography exam. Its principle can be defined as the apparent shift in 
transmitted frequency, reflected back to the source off a target, which occurs as a result of 
the movement of this target. When this effect is applied in ultrasonography, the red blood 
cells (RBC’s) are the moving targets, and the apparent shift in the frequency of the sound 
reflected back to the transducer is proportional to their velocity and direction of the 
movement. The software of the ultrasound machine displays this values in a color code 
(Color Doppler) or in a graphic, (spectral trace of the Pulsed wave Doppler (PW) or 
Continuous wave Doppler (CW)). 
In Color Doppler, a given color is usually assigned to the direction of flow; red is flow 
toward, and blue is flow away from the transducer (Figure 1). 
The center of the color bar, displayed in the screen, is black and represents zero flow. In 
addition to simple direction, velocity information is also displayed. Progressively increasing 
velocities are encoded in varying ranges of either red or blue. The more dull the hue, the 
slower the velocity. The brighter the hue, the faster the relative velocity. Color Doppler is 
also used to display turbulent flow (showing a mosaic of many colors) and allows an 
operator to discriminate between normal and abnormal flow states. Color Doppler is useful 
for assessing relatively big areas, whilst PW (Pulsed Wave) and CW (Continous Wave) 
Doppler are used for assessing smaller areas of interest. Since Color Doppler is a type of 
pulsed wave Doppler, it suffers from the same limitations.  
Before explaining the difference between CW and PW, explaining the concept of spectral 
trace is required. This is the graphic representation of velocity flow profile against time. 
Depending of the number of cells crossing the amount of signal increases (Figure 2).  
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applied in many different fields. In human medicine has been extremely helpful in 
monitoring the fetal viability or assessing the carotid flow, and it is currently being used in 
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the movement of this target. When this effect is applied in ultrasonography, the red blood 
cells (RBC’s) are the moving targets, and the apparent shift in the frequency of the sound 
reflected back to the transducer is proportional to their velocity and direction of the 
movement. The software of the ultrasound machine displays this values in a color code 
(Color Doppler) or in a graphic, (spectral trace of the Pulsed wave Doppler (PW) or 
Continuous wave Doppler (CW)). 
In Color Doppler, a given color is usually assigned to the direction of flow; red is flow 
toward, and blue is flow away from the transducer (Figure 1). 
The center of the color bar, displayed in the screen, is black and represents zero flow. In 
addition to simple direction, velocity information is also displayed. Progressively increasing 
velocities are encoded in varying ranges of either red or blue. The more dull the hue, the 
slower the velocity. The brighter the hue, the faster the relative velocity. Color Doppler is 
also used to display turbulent flow (showing a mosaic of many colors) and allows an 
operator to discriminate between normal and abnormal flow states. Color Doppler is useful 
for assessing relatively big areas, whilst PW (Pulsed Wave) and CW (Continous Wave) 
Doppler are used for assessing smaller areas of interest. Since Color Doppler is a type of 
pulsed wave Doppler, it suffers from the same limitations.  
Before explaining the difference between CW and PW, explaining the concept of spectral 
trace is required. This is the graphic representation of velocity flow profile against time. 
Depending of the number of cells crossing the amount of signal increases (Figure 2).  
 




Fig. 1. Color Doppler window depicting the mesenteric veins. 
 
 
Fig. 2. Spectral trace of an interlobar artery in a kidney 
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The CW Doppler, is an older technology in which the ultrasound waves are continuously 
emitted from, and received back by the same transducer so very high velocities can be 
measured (Figure 3). PW Doppler systems uses only one transducer that alternates packed 
transmission and reception of ultrasound. The main advantage of PW Doppler compared 
with CW Doppler, is its ability to provide Doppler shift data selectively from a small 
segment along the ultrasound beam, referred to as the "sample volume”, which it can be 
controlled by the operator (Figure 4). An ultrasound pulse is sent into the tissues travels for 
a given time and reflected back by a moving red cell. This ultrasound pulse returns to the 
transducer over the same time interval but at a shifted frequency. The location of the sample 
volume it is very important because the speed of ultrasound in the tissues does not change 
and the roundtrip travel time will differ. In this dependence on the location of the window 
lies the main disadvantage of PW Doppler, since it will not be possible to accurately 
measure high blood flow velocities, such as may be encountered in certain types of valvular 
and congenital heart diseases. This limitation is technically known as "aliasing" and results 
in an inability to record velocities above 1.5 to 2 m/sec, depending on the depth (Figures 5, 
6). Although this artefact is very important in echocardiography, it will be rarely found in 
abdominal ultrasound, since the velocity of the blood flow in the abdominal vessels is 
usually lower than 1m/s.  
Another main advantage of PW Doppler is the fact that some imaging may be carried on 
alternately with the Doppler and thus the sample volume may be shown on the actual two-
dimensional display for guidance.  
 
 
Fig. 3. Continous wave Doppler in a severe aortic stenosis. A high velocity profile (6m/s) is 
depicted. 
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Fig. 4. Pulsed wave Doppler in a normal portal vein. Using the sample volume the 
sonographer is able to define the studied volume, in this case it has a width of 4 mm. 
 
 
Fig. 5. Aliasing. The velocity overwhelms the máximum limit in the velocity profile (red-
yellow), depicting the botom of the negative velocities (green-blue). However the blood 
dierction does not change. 
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The spectral trace from PW and CW are also different. When there is no turbulence in the 
blood flow analized, PW will generally display a laminar (narrow band) spectral trace. 
However CW rarely displays such a narrow band of flow velocities, because all the various 
velocities encountered by the ultrasound beams are detected by CW. 
PW is usually used when a specific area of abnormal flow is located. Then, If it is important 
to know the accurate measurement of elevated flow velocity, CW Doppler should be used. 
 
 
Fig. 6. Non-optimised spectral trace obtained by means of pulsed Doppler. The PRF (pulsed 
repetition frequency) is to low. 
A relatively easy and systematic way to achieve a good spectral trace of a vessel can be 
summarised as follows:  
1. Location of the vessel or area to scan by B mode. 
2. Obtain a good view from the area.  If the grey scale is not adequate, the Doppler signal 
will not be optimal. 
3. Activate Color Doppler. Unlike in echocardiography, in abdominal ultrasound is 
preffered to use a higher permanence to be able to identify small structures. The PRF 
scale should be the adequate to fill up the vessels, being used a combination of high 
gain and low PRF.  
4. Activate PW  Doppler. Volume sample should be adjusted to the size of the vessel 
(usually between 2 and 4 mm).  
5. Adjust the angle of insonation. It is convenient to remember that the angle of the probe 
related to the direction of the vessel will change the values of  velocity registered. 
Refering the reader to the literature provided at the end of this chapter, physics of the 
Doppler effect will not be explained in depth, but angles between 0 and 60 degrees are 
recommended to register a reliable velocity.  
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6. Optimization of the spectral trace. In most of the ultrasound machines, the size of the 
screen adapts automatically. Changes in the baseline and scale of the velocity will be 
necessary to obtain the best image. 
2. Aplications of Doppler in abdominal ultrasound 
The most straightforward application using Doppler in abdominal ultrasound is assessing, 
by color Doppler the presence or lack of blood flow in a vascularised structures. It is an 
essential imperative to have a profound knowledge of the machine as well as to set up the 
settings properly. With this, it can be relatively easy differenciate for example between an 
haematoma from another lesion, or identify a thrombosis in a vessel wherein can be difficult 
with the bidimensional mode (Figure 7). 
 
 
Fig. 7. Trombus in the medial iliac artery. The blood flow is interrupted. 
It may also be useful when is necessary  localise areas less vascularised to perform 
aspirations or biopsies. However, when the PRF scale is set up too low in order to 
improving the identification of small vessels flowing at less than 10cm/s, movements or the 
breathing can produce artefacts in the window making difficult the interpretation. Other 
tools, like the Power Doppler (Figure 8),  vascular Doppler or B-Flow (currently included in 
most of the machines), can be very helpful due to its high sensitivity, although they are still 
affected by the same artefacts. The study of the spectral display of the great abdominal 
vessels is widely reported in the veterinary literature. Each artery and vein have distinctive 
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trace depending on the vascular beed they supply or areas they connect. As a example, it is 
totally different the trace of the caudal vena cava, influenced by the respiration and the 
pressure in the right atrium, than the portal vein, much more stable, due to the similar 
pressures between the areas connected by this vessel (Figure 9).  
 
 
Fig. 8. Metastasic Abdominal lymph node. The vessels could not be displayed using color 
Doppler, however the Power Doppler used in the image had sensitivity enough 
 
 
Fig. 9. Left side of the image caudal vena cava spectral trace showing the typical bi- or tri 
phasic pattern. In the right side portal vein spectral trace. 
 
Ultrasound Imaging – Medical Applications 
 
272 
6. Optimization of the spectral trace. In most of the ultrasound machines, the size of the 
screen adapts automatically. Changes in the baseline and scale of the velocity will be 
necessary to obtain the best image. 
2. Aplications of Doppler in abdominal ultrasound 
The most straightforward application using Doppler in abdominal ultrasound is assessing, 
by color Doppler the presence or lack of blood flow in a vascularised structures. It is an 
essential imperative to have a profound knowledge of the machine as well as to set up the 
settings properly. With this, it can be relatively easy differenciate for example between an 
haematoma from another lesion, or identify a thrombosis in a vessel wherein can be difficult 
with the bidimensional mode (Figure 7). 
 
 
Fig. 7. Trombus in the medial iliac artery. The blood flow is interrupted. 
It may also be useful when is necessary  localise areas less vascularised to perform 
aspirations or biopsies. However, when the PRF scale is set up too low in order to 
improving the identification of small vessels flowing at less than 10cm/s, movements or the 
breathing can produce artefacts in the window making difficult the interpretation. Other 
tools, like the Power Doppler (Figure 8),  vascular Doppler or B-Flow (currently included in 
most of the machines), can be very helpful due to its high sensitivity, although they are still 
affected by the same artefacts. The study of the spectral display of the great abdominal 
vessels is widely reported in the veterinary literature. Each artery and vein have distinctive 
 
Foundamentals and Applications of Abdominal Doppler 
 
273 
trace depending on the vascular beed they supply or areas they connect. As a example, it is 
totally different the trace of the caudal vena cava, influenced by the respiration and the 
pressure in the right atrium, than the portal vein, much more stable, due to the similar 
pressures between the areas connected by this vessel (Figure 9).  
 
 
Fig. 8. Metastasic Abdominal lymph node. The vessels could not be displayed using color 
Doppler, however the Power Doppler used in the image had sensitivity enough 
 
 
Fig. 9. Left side of the image caudal vena cava spectral trace showing the typical bi- or tri 
phasic pattern. In the right side portal vein spectral trace. 
 
Ultrasound Imaging – Medical Applications 
 
274 
3. Doppler study in portal hypertension 
By means of portal vein Doppler spectral trace it can be easy to diagnose and to monitore 
portal hypertension (PH). PH is a constant increasing of the venous pressure in the portal 
system, and  it is the main cause of ascites in small animals. For the diagnose of this disease 
is necessary a broad clinical approach including biochemistry and electrolyte profiles, 
radiography and the analysis of the free abdominal fluid, although all these diagnostic 
methods will roughly help as a criteria for the monitoring of the disease. It is in this field 
where the ultrasound, specially  the Doppler study will provide a new tool for its study in 
small animals. Development of PH is due to the obstruction of the blood flow, initially 
distending the vascular beed previous to the site of the obstruction. This place will be used 
as a criteria for the classification of the PH, including: Prehepatic PH (when the vascular 
area affected is located previous to the hepatic hilus) (Figure 10), Intrahepatic PH (hepatic 
structures affected) and Posthepatic PH (when the problem is located in the hepatic veins, 
caudal vena cava or right side of the heart). Prehepatic PH is rare in small animals, and 
although in the acute forms –portal thrombosis- is associated to fatal prognosis at short 
term, chronic evolution (pe external compression, neoplasia, etc) is less aggressive and 
allows for the development of  compensatory mechanisms. Intrahepatic PH is the most 
common type of PH in dogs and cats, being less common in the latest. Almost always is due 
to abnormal sinusoidal circulation produced either in fibrosis or nodular regeneration in 
hepatic cirrhosis. Although this is the most frequent mechanism, any diffuse hepatic disease 
(hepatitis, lipidosis, neoplasia, etc…) may induce portal hypertension. Posthepatic PH is less 
frequent, and is usually due to the increasing of the resistence in hepatic veins or caudal 
vena cava, although  it can be also produced secondary to alterations in the right side of the 
heart (constrictive pericarditis, heart worm disease, etc…) . 
The study of the portal system by B mode ultrasound provides information about the 
integrity and shape of the portal vein, and when Doppler is used, we can also obtain 
quantitative and qualitative information of the flow and velocity. However, the result of 
the ultrasonographic study can by frustrating  if  previous factors are not considered, for 
example the inadequate preparation of the animal, being this the main factor for the 
proper viewing of the prehepatic tract of the portal vein. When performing the 
ultrasonographic study, two positions are usually used depending on the window chosen: 
Left lateral recumbency is the most adequate position for dogs and cats, placing the probe 
in the 11th or 12th intercostal space, or caudal to the last rib. When the animal is placed in 
dorsal recumbency, it is easy to access  the ventral window caudal to the xiphoid process. 
The porta hepatis is the best place for aquirying the spectral trace, but the sonographer has 
to consider as a main concern a proper angle correction. Remaining below 60º is 
acceptable for a reliable velocity profile (Figure 11). The normal trace is quite stable with 
little or no waves, and we can consider a normal mean velocity for dogs betweeen 12 to 
17cm/s and between 10 to 12cm/s in cats. The Doppler evaluation should investigates as 
well the direction of this flow.  
Although the findings in the PH obviously depends on the type (Figure 12), there is a 
common and reliable one, the decrease in the mean velocity. The flow should be decreased 
in aproximately a 50% (below 17 ml/min/kg) and the velocity under 10 cm/s. Another 
consecuence that can be found in a prolonged PH is the development of collateral vessels, 
known as adquired portosystemic shunts (Figure 13). 
 








Fig. 11. Different velocity profile retrieved from the same patient using the right angle 
correction (left) and the wrong one (right) 
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Fig. 12. Portal hypertension in a caval syndrome. The image shows the congestive liver, 
huge hepatic veins related to portal vessels. 
 
 
Fig. 13. Tortuous vessels corresponding to nephro-splenic shunts in a dog with chirrosis 
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4. Doppler assessment of affected lymph nodes 
Lymphadenopathy is a common finding in a wide range of diseases. Benign conditions are 
those related to inflammation induced by infection, trauma, etc. In malignant conditions it is 
possible to distinguish between primary tumour (lymphoma) and tumour dissemination 
(metastases).  Therefore, lymphadenopathy is a non-specific lesion that merely indicates the 
presence of a pathologic process. For this reason and taking into account that both 
conditions can be found in the same patient (e.g. mammary carcinoma in a bitch with 
cystitis) the real pathologic status of the lymph node must be ascertained. Diagnosis mainly 
consists of physical examination, which is very subjective and non-specific, needle 
aspirations and biopsies. These are feasible techniques when dealing with superficial lymph 
nodes; however they have some inconveniences for abdominal lymph nodes. Sonography 
plays an important role in this field, being able to explore size, shape and internal 
appearance. Nevertheless, ultrasonographic changes such as echotexture or size are often 
inconclusive, the same as guided cytological aspiration (Figure 14).  
 
 
Fig. 14. Fine needle aspiration in a mesenteric lymph node. The 22G needle is clearly 
visualizad from the right side entering the jejunal lymph node 
From a clinical point of view, taking a biopsy of every single lymph node that looks bigger 
or shows an altered echo pattern would be unpractical. To circumvent these difficulties 
another diagnostic tool could be used, the Doppler pulse wave analysis of lymph node 
vessels. This has proved its efficacy in canine superficial lymph nodes, in abdominal ones 
and in many human medical studies. The first step in the protocol is to look for an internal 
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lymph node vessel using color Doppler, turning to Power Doppler when necessary. The 
vessel is later insonated using pulsed wave Doppler to obtain the spectral trace, measuring 
two semiquantitative indices: Resistive (RI) and Pulsatility (PI). These indices show the 
relation between arterial flow and the vascular bed. The RI or Pourcelot Index is calculated 
as follows: (Systolic Peak Velocity – Minimum Diastolic Velocity)/ Systolic Peak Velocity, 
and the PI or Gosling-King Index is calculated applying this formula: (Systolic Peak Velocity 
– Minimum Diastolic Velocity)/ Mean Velocity. The final number is obtained using the 
mean of three arterial insonations in the same lymph node. Two groups of lymph nodes are 
proposed, benign (healthy plus reactive) and malignant (tumoral or metastasic) a proposed 
cut-off using the ROC curves had been demonstrated.  
The values under which an iliac lymph node is considered benign are 0.6750 for RI and 1.025 
for PI. The mean PIs obtained for mesenteric lymph nodes (jejunal) were 0.81, 0.87 and 1.32 
for healthy, reactive and tumoral or metastasic ones respectively. The mean RI for the same 
ones were 0.58, 0.60 and 0.79 respectively. Tumoral or metastasic ones were singnificantly 
different for PI and RI. The proposed cut-off obtained from the ROC curves with a 
sensitivity of 100% was 1.23 for the PI and 0.76 for the RI, upper values in a mesenteric 
lymph node pinpoint to a malignant cause (Figures 15,16). 
 
 
Fig. 15. Spectral trace from a reactive mesenteric lymph node, showing a RI of 0.55 
5. Doppler study in renal arteries 
The study of the arcuates arteries is the last importat aplication discussed in this chapter. 
Like the arteries of the lymph nodes, its study reflects the vascular bed. It is essential to 
obtain a clear spectral trace where three waves are displayed and reliable results can be 
 





Fig. 16. Spectral trace from a metastasic mesenteric lymph node from a ovaric carcinoma, 
showing a RI of 0.79 
achieved. The resistive index is obtained as the same way as for the lymph nodes and 
usually indicating the maximal systolic and the minimal diastolic velocities is enough in 
most of the ultrasound machines to calculate it automatically (Figure 17). Results over 
0.75-0.8 are considered abnormal in both dogs and cats. There are processes other than 
renal diseases that can affect the resistivity index like anaemia, hypovolemic status or 
hypertension. Thus, further investigation in small animals is necessary to achieve more 
reliable conclusions, due to most of the published literature proceed from human beings. 
Since the resistive index is harmless, quick, simple and repeatable, and there are no many 
available tools for monitoring renal disease, this index should be used as a routine tool in 
chronic renal failure, diabetes and hyperadrenocorticism. In cats, a raise in this index 
seems to be linked to tubular damage (Figure 17), although further investigation is 
necessary in both dogs and cats to relate the type of pathologic lesions with the alteration 
of this index and clinical signs. As a clinical example, data of a recent study in dogs with 
Leishmaniosis and different stages of renal damage, showed that the resistive index could 
be used as an indicator of the progression, with high sensibility but low specificity. In this 
study all the animals with raised indexes showed advanced renal damage and 
proteinuria. However, many other dogs with renal damage appeared with a normal 
resisitve index. 
The introduction of the Doppler within the routinary abdominal protocol is necessary, 
and provides a higher diagnostic accuracy. In coming years new applications of its use 
will appear as a powerful tool for the diagnosis and monitoring of the diseases in small 
animals. 
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Fig. 17. Normal arquate artery, the spectral trace depicted a low resistence artery, 
meanwhile in the right there is arquate artery from a cat with advance chronic renal faliure. 
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1. Introduction  
1.1 Imaging in drug development  
The development of novel therapeutics follows a typical path from chemical and biological 
activities in the laboratory through extensive clinical testing and if successful, to the 
commercialization of a drug for a given labeled indication. The attrition, the failure of a new 
product to successfully complete all stages of drug testing, is a key metric for defining 
productivity in the pharmaceutical industry. The lack of therapeutic efficacy and poor safety 
profiles are the leading causes of attrition. Several solutions to better address attrition have 
been proposed in order to enhance our knowledge regarding efficacy, safety and 
mechanism of action in pre-clinical and early clinical setups, all in order to minimize late-
stage attrition and make informed decisions regarding the likelihood of the novel 
compounds to successfully complete all stages of drug development and become a product. 
Clinical imaging has the potential to provide key biomarkers and to enable decision-making 
in drug development. Although, imaging is a complementary technology to biofluid-
derived biomarkers, its non-invasive nature provides unique information regarding 
quantitative measurement of function at particular anatomical localization and is highly 
desirable in order to strengthen our confidence in positive clinical outcome.  Imaging, 
therefore, has considerable potential to build upon well-established serum and urine 
biomarkers in order to better validate predictive values of biofluid-derived biomarkers in 
both the pre-clinical and clinical environments. In oncology, imaging techniques are 
complementary to methods that use biomarker techniques to detect presence of tumor 
tissue, tumor progression and response to therapy because imaging modalities provide 
precise anatomical localization of the tumor tissue(s) that generates biomarkers measured in 
fluids. Ultrasonography (US) is one of the emerging technologies that possess several key 
advantages over other molecular imaging modalities.  These include frequency-dependent 
high spatial resolution, real-time imaging, both anatomical and molecular information in the 
single imaging session, freedom from ionizing radiation, inexpensive implementation, 
affordability worldwide, and finally, well-published preclinical and clinical use of US 
technology.  Therefore, research teams can easily access information regarding adequate use 
and predictive value of ultrasound technology to address the specific project needs [1,2].  
1.2 HCC and tumor models  
Hepatocelluar carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-
related death globally that resists conventional chemotherapy and radiotherapy [3-5]. Also, the 
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liver is, in addition to lungs and bones, one of the most common sites of metastases of other 
tumors, in particular colorectal, pancreatic and ovarian cancers. Conventional cytotoxic 
chemotherapy does not significantly prolong survival of patients with primary liver tumors or 
liver metastases, therefore new therapeutic approaches are needed in order to curb the local 
growth of solid tumors as well as micrometastases of HCC.  Given the complexity of the 
interactions between tumor cells and surrounding stroma and uniqueness of 
microvascularization of the liver, there is a strong rationale to combine agents with different 
mechanisms of action when treating HCC, but also to simultaneously target tumor cells and 
surrounding stroma in order to make the tumor microenvironment less friendly (fertile) for 
growth of solid tumors or development of micro-metastases.  In this chapter we describe the 
difference in vascularization between xenograft and orthotopic preclinical models of HCC and 
use of ultrasonogrophy to assess tumor and organ vasculature. Additionally, we emphasize 
the unique value of contrast enhanced ultrasonography to monitor tumor growth and change 
in tumor vasculature over time in order to assess effect of applied therapies.  
1.3 Angiogenesis in tumors   
Angiogenesis is a critical process in local tumor growth and in the invasion and 
development of distant metastases [6,7]. Research investigating molecular pathways of 
tumor angiogenesis has led to the identification of a number of key molecules involved in 
the stimulation of new vessel growth from existing host vasculature. Several of these 
molecules, such as vascular endothelial growth factor and its main receptor 2 (VEGFR2) 
have become targets for antiangiogenic drugs [8,9]. However, successful application of 
novel therapies that target tumor vasculature will require accurate selection of susceptible 
tumors and precise evaluation of early treatment response using adequate preclinical 
models. Previous work has shown that angiogenesis can be successfully characterized in 
vivo by using ultrasonography with microbubble contrast agents bearing anti-integrin 
antibodies adhered to fibroblast growth factor-stimulated vessels [10-12].  
2. Preclinical models of hepatocellular carcinoma  
Preclinical experimentation allows for simultaneous longitudinal implementation of various 
technologies and biomarkers to monitor the tumor take rate, growth and response to treatment 
as well as to confirm and correlate histological and histochemical results at various time points 
with serum or imaging biomarkers, which cannot always be determined in HCC patients. 
2.1 Tumor vasculature in xenograft HCC model 
The vast majority of in vivo oncology studies are performed in xenograft models, 
subcutaneously placed tumor cells in immunodeficient mice or rats. Xenograft models are 
relatively easy to perform since tumor cells are injected in subcutaneous tissue of mice or 
rats and simple caliper measurement of tumor size provides insight regarding tumor take 
rate, growth and the compound efficacy (Figure 1). Since human malignancies never start or 
metastasize to subcutaneous regions of the body, the xenograft models lack many critical 
characteristics of human cancers including lack of preexisting organ vasculature and 
interaction between the tumor cells and cells of the organ where tumor initiated or 
metastasized. Therefore, the main goal of studies using xenograft models is to confirm that 
the “targeted” therapy under investigation hits the intended target that should be present in 
the tumor cell line used in the particular study. In this model there are no pre-existing blood 
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vessels and the newly formed tumor vasculature is fairly simple and consists of nutritional 
arteries designed to provide oxygen and nutrients to the tumor (Figure 1). Consequently, 
antiangiogenic therapy in the HCC xenograft models seems to be very effective against the 
tumor growth [13].  In general, the xenograft models are very informative and allow for 
several types of measurements to be performed simultaneously including caliper 
measurements, IVIS imaging, ultrasonography with and without the contrast agents, PET 
and MRI imaging, measurements of serum or urine biomarkers and finally deployment of 
many histological and histochemical methods. Recently, several groups have demonstrated 
that quantification of intra-tumoral flow of an ultrasound contrast agent with gray-scale 
imaging can be used for monitoring tumor vascular response to anti-angiogenic therapy in 
animal models, a technique that can also be used in the clinic [13-16]. In those studies data 
obtained with ultrasonography paralleled tumor volume data obtained by caliper 
measurement and showed good correlation with tumor histology, allowing assessment of 
necrotic and perfused tumor areas in vivo. 
 
 
Fig. 1. Image of a xenograft of HCC tumor (A), histological appearance of the tumor (B) with 
arrows indicating a blood vessel, and schematic representation of the nutritional blood 
supply to the tumor (C). 
2.2 Tumor vasculature and liver vasculature in orthotopic HCC model 
Orthotopic HCC models of liver tumors are labor-intensive to perform as they require 
surgical inoculation of tumor cells into the liver (or spleen) and the use of sophisticated 
imaging technologies and/or biofluid based biomarkers to monitor the tumor take rate, 
tumor growth and effects of therapy on tumor progression [17]. Because in orthotopic HCC 
models the tumor is placed in the organ of origin, studies performed in those models 
provide more realistic and clinically relevant data regarding compound systemic and tumor 
exposure, efficacy and safety.   
The local vasculature of the liver is extremely complex and is composed of nutritional and 
functional blood supplies that in addition to neo-vasculature created by the tumor itself, 
collectively support tumor growth within the liver (Figure 2). The hepatic artery accounts 
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for only about 65% of the oxygen supply to the liver [18,19]. Slow circulation in the liver and 
an intense nutritional (hepatic artery) and functional (portal vein) vascular network allows 
the tumor to establish, survive and eventually metastasize [20,21]. The blood flow to the 
liver tumor is carried almost exclusively by systemic arterial vessels [22,23]. However, 
oxygen and nutrient supply through the portal vein is respectable, and it has been 
hypothesized that outside edges of the tumor use this alternate route to survive and spread 
to surrounding tissues [24] causing these tumors to be very resistant to antiangiogenic 
therapies. Finally, vascularization in the liver of cancer patients can be further complicated 
by liver cirrhosis [25-27]. Due to technical and other difficulties to reliably describe the exact 
anatomical location of the tumor within the liver, tumor size and growth propensity, 
presence or lack of secondary tumors, as well as tumor response to therapy, scientists that 
utilize orthotopic HCC models in their research as well as clinicians almost entirely depend 
on imaging modalities, including various ultrasound methods.  
 
 
Fig. 2. Overview of a rat liver (A) with orthotopic HCC tumor (arrow head), histological 
appearance of intrahepatic tumor (B) depicting borderline area (arrow) between the tumor 
(T) and normal liver tissue (L) and schematic representation (C) of the nutritional (hepatic 
artery) and functional (portal vein) blood supply in the liver and the intrahepatic tumor, 
emphasizing differences in blood pressure between the two blood systems. 
2.3 Delivery of contrast and/or drug in orthotopic HCC model 
One of the most clinically effective ways to deliver drugs to the liver is through the hepatic 
artery because it allows continuous infusion directly into the arterial bed from which the 
tumor derives nearly all of its blood supply [27,28]. The use of orthotopic animal models 
allows for cannulation of the hepatic artery and portal vein to deliver drugs directly to the 
liver, thus mimicking the clinical arrangement. Due to technical difficulties associated with 
intra-arterial drug delivery, the most common way of dosing animals in preclinical studies is 
via tail-vein injections. Even though tail-vein injections have little similarity with the clinical 
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setup, this method is acceptable as long as the frequency of repeated dosing does not cause 
local tissue damage and necrosis. However, a single bolus injection of a drug or contrast agent 
through the hepatic artery or portal vain is more desirable since it mimics human setup and 
delivers much better results. The differences in the microbubble concentrations in the liver 
following tail-vain, portal vein and hepatic artery delivery are shown in Figures 3.  
 
 
Fig. 3. Ultrasound images of normal rat livers and tumor bearing livers following bolus 
injection of microbubbles (50 µL) into the tail vein, portal vein, or hepatic artery. Take of the 
microbubble contrast (green) by the liver is very high if the injection is made through 
hepatic artery or portal vein, but poor if injection is made through the tail vein. 
Microbubble contrast technology is known to be an extremely useful tool for non-invasive 
assessment of liver vascular structure [29]. Contrast Enhanced Ultrasound Imaging (CEUS) 
is used in both preclinical and clinical studies to diagnose liver tumors and/or liver 
metastases, to monitor disease progression, to deliver drugs and to assess the efficacy of 
antitumor therapies [16,30,31].  
3. Tumor assessment using ultrasound imaging    
Through both structural and functional imaging, ultrasound can provide an integrated suite 
of tools to characterize and monitor tumor changes.  For pre-clinical use, the low-cost and 
real-time capabilities allow for high throughput of analyzed animals. In addition, developed 
imaging biomarkers are often translatable into humans for use in clinical trials. 
3.1 Assessment of tumor volume 
The resolution of an ultrasound B-scan image increases with frequency, though depth 
penetration is diminished due to attenuation. For small-animal imaging, frequencies in the 
range of 20 to 50 MHz can provide sharp images of anatomical structure for depths down to 
1cm.  At 40 MHz, the resolution is on the order of 50 m [32].  In both xenograft and 
orthotopic rodent models, tumors can be viewed with well defined boundaries, allowing for 
quantitative measurement of volume size. 
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penetration is diminished due to attenuation. For small-animal imaging, frequencies in the 
range of 20 to 50 MHz can provide sharp images of anatomical structure for depths down to 
1cm.  At 40 MHz, the resolution is on the order of 50 m [32].  In both xenograft and 
orthotopic rodent models, tumors can be viewed with well defined boundaries, allowing for 
quantitative measurement of volume size. 
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Though 3D matrix array probes are slowly becoming more available, accurate volume 
measurements can be obtained with a mechanical sweep of a 2D array. With the tumor bearing 
rodent fixed on a platform, a stepping motor translates the transducer across the region of 
interest. Post-processing of the 2D image sets includes manual outlining of the tumor on 
individual slices to estimate the volume. For small tumors (less than 2 mm3), the coefficient of 
variation for tumor volume measurements has been shown to be on the order of 10% [33]. 
Delineation of tumor boundaries can be further improved with use of the contrast (Figure 4). 
 
 
Fig. 4. Contrast enhanced ultrasound improves tumor identification and measurement.  The 
left image (A) was taken without contrast, and although a shadow is visible (arrow), the 
tumor is difficult to identify.  After contrast administration (B) a tumor mass (arrow) is 
clearly defined and can be readily quantified.   
3.2 Assessment of tumor vascularity using Doppler 
Since angiogenesis is a major enabling factor of tumor growth, the ability to image and 
monitor tumor vascularity is of primary interest in oncology applications of US technology. 
Doppler ultrasound is the standard modality for measuring blood flow. As a transducer 
emits an acoustic pulse, the echoes from moving scatters are shifted in frequency. In brief, 
the pulsed-wave Doppler sends short pulse bursts and gates the return signal 
corresponding to a specific depth. The display of tumor vasculature shows the velocity 
spectrum as a function of time. This technique is most useful for looking at velocity profiles 
of flow in macrovessels such as hepatic veins and arteries (Figure 5).  
Power Doppler, which uses the integrated power of the Doppler signal, does not provide 
directional flow information, but is angle independent and more sensitive to slow flow than 
frequency-shift-based color Doppler. By using the clinical scanners, vessels as small as 100 
m diameter can be clearly visualized. Quantification is typically based on calculating the 
percentage of colorized-pixels in a region of interest. Power Doppler has been shown to 
have a strong correlation (r=0.98) with tumor blood vessels as determined by histological 
staining [34]. Regional variations, rim versus tumor core, can also be evaluated as well as 
heterogeneity of tumor vasculature. 
3.3 Assessment of tumor perfusion using contrast imaging 
Within the past decade, ultrasound contrast agents have been increasingly used to characterize 
vascular dynamics. The current generation of contrast agents is composed of 1-10 m 
sizedmicrobubbles with a perfluorocarbon or hexafluoride gas core surrounded by a lipid 
shell. Injected into the blood stream, microbubbles are stable in the circulatory system for over 10  
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Fig. 5. Example of color Doppler imaging of the normal rat liver.  Color Doppler shows 
directional flow allowing for visualization of the hepatic artery tree and portal vein.  A pulse 
wave Doppler range gate is placed over the colorized vessel to measure flow velocity.   
minutes, and unlike MRI contrast agents, the microbubbles remain in intravascular 
compartment until excreted from the system. Two methods are available when using the 
contrast agent to assess tumor perfusion; power Doppler and dynamic contrast imaging: 
Use of power Doppler. When insonified by a high power ultrasound pulse, microbubbles 
disintegrate emitting a non-linear signal detectable with Doppler.  Power Doppler imaging 
using contrast agents and a high mechanical index allows detection of vessels down to 
capillary size and is independent of flow velocities [35]. Total vessel fraction within a tumor 
can thus be computed from a 3D sweep and the ratio of colorized pixels to the total number 
of pixels within the tumor can be calculated. 
Use of dynamic contrast imaging. The injection of a bolus of contrast can be monitored with 
low power (less than 0.1) mechanical index.  Simultaneous recording of the intensity 
changes of the contrast agent as a function of time will provide information on blood flow in 
a region of interest during the entire time of imaging. In brief, the uptake curve can be fitted 
to an exponential function using the formula y=A(1-e-t) where A is proportional to the 
microvascular cross-sectional area, and  corresponds to velocity [36]. The product of these 
two parameters can then be used to quantify perfusion. Additional parameters that have 
been used in tumor assessment include peak enhancement, area under the curve, and wash-
in-time [37]. The values obtained can be averaged across the tumor or evaluated on a pixel-
by-pixel case to create parametric maps that demonstrate tumor heterogeneity. 
The separation of fast flow (from larger functional vessels) and slow flow (from the 
microvasculature) can provide further insight to vasculature changes from treatment. In a 
study of an anti-angiogenic drug in a human/mouse chimera model, the quantification of 
CE-US imaging wash-in parameters revealed that the prevalence of fast blood flow, but not 
slow flow (associated with small, leaky vessels), was suppressed in treated tumors 
compared with control tumors [38]. 
4. Ultrasound imaging of tumor growth kinetics  
4.1 Changes in tumor volume and tumor composition 
In both the xenograft and orthotopic models B-mode imaging using high-frequency 
ultrasound can provide valuable data on the volume of the tumor.  Traditional tumor 
volume measurement in xenograft models uses caliper measurement of the tumor width 
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(W) and tumor length (L). An ellipsoid shape is assumed, and the volume computed as 
V=1/2 (L x W2). Using this technique, inter-observer variation is 15% [39]. Measurement of 
tumor volume using calipers is not possible in orthotopic animal models known to much 
closer resemble local and tumor vascular events seen in HCC patients relative to xenograft 
models [17]. Volume size estimates from a 3D ultrasound image set are more accurate due to 
the ability to account for non-ellipsoidal shapes. Currently, there are commercially available 
software that can view individual slices and manually outline the tumor on individual slices 
in both xenograft and orthotopic tumors in rats and mice. By interpolating between slices, 
an accurate representation of the 3D tumor shape is provided along with the volume 
estimation. For fine sweeps, not every slice needs to be evaluated.  We have found that with 
a slice separation in the range of 100 to 300 m, manual tumor delineation on every 10th slice 
provides accurate volume estimation (unpublished data).   
Along with tumor delineation, ultrasound grayscale images can also allow for detection of 
change in tumor composition including tumor necrosis.  Necrotic regions in tumor 
xenograft appear as fluid filled pockets within the tumor (Figure 6). By using the same 
techniques utilized to assess the tumor volume, the necrotic volume can also be estimated. 
 
 
Fig. 6. Example-scan of a xenograft tumor composed of human Huh7.5 cell line outlined in 
red with necrotic core outlined in yellow.   
4.2 Change of tumor vasculature following drug treatment 
Dynamic contrast methods may present some difficulties in the rodent liver due to 
breathing motion.  The high frequency ultrasound systems allow for respiratory gating, but 
the tumor bearing liver in rodents can still be difficult to image with sufficient accuracy. 
Early testing of anti-angiogenic compounds in both xenograft and orthotopic models have 
utilized US imaging in order to provide the proof of mechanism and facilitate design of 
follow-up clinical trials [40,41]. 
Ultrasound has been shown to help in quantifying changes in tumor perfusion in response to 
combination therapy [14]. In this study both, an anti-angiogenic mono-therapy and an anti-
angiogenic plus a tyrosine kinase inhibitor combination were tested. Under approval of the 
IACUC, male nude rats (Taconic) were implanted with Huh7.5 human hepatocarcinoma cells 
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suspended in Matrigel.  During the first phase of the study (days 5 - 21 after cell inoculation) 
rats were treated with either vehicle, sunitinib (Sutent®, Pfizer Inc.) or sunitinib plus a 
FAK/Pyk2 tyrosine kinase inhibitor (PF-562,271).  In the second phase of the study the rats 
switched treatments so that half of vehicle treated rats remained on vehicle,  the other half of 
vehicle treated rats switched to sunitinib + FAK/Pyk2 compound, rats receiving sunitinib 
alone switched to vehicle while rats receiving sunitinib + FAK/Pyk2 switched to vehicle. 
 
 
Fig. 7. Examples of parametric maps and uptake curves generated on HCC xenografts using 
contrast enhanced ultrasound imaging (CEUS). 
Using the high-frequency Vevo770 (VisualSonics, Toronto, ON), 3D grayscale volumes 
were collected along with B-scan cineloops of the center slice of the tumor.  These 
cineloops were collected at 50% power and 100 µl of contrast (MicroMarker, VisualSonics) 
was given as a slow bolus.  Ultrasound imaging, blood and tumor measurements by 
caliper were collected on day 10, 14, 21, and 28 post cell injection, under isoflurane 
anesthesia.  At the end of the study, day 36, the rats were euthanized and the livers were 
collected and processed for histology.  Ultrasound images were analyzed using in house 
developed methods based in Matlab (Mathworks).  Post processing involved both motion 
correction and filtering. 
Temporal uptake curves were obtained for each pixel, and pseudo-colored parametric maps 
were created to reflect spatial variation. Regions where the peak signal was less than a 
predefined threshold were labeled non-perfused. Region averages were then computed to 
provide data on total peak signal and peak signal without necrosis/non-perfused (Figure 8). 
Therefore, early testing of anti-angiogenic compounds for proof of mechanism using 
xenograft model provide valuable data that can be used to improve the design of the studies 
using orthotopic models as well as to devise a better plan human trials. Non-imaging 
assessment in the study published by Bagi et al. [13] showed there was a good correlation 
between results obtained by CEUS and tumor size measured by caliper as well as with 
serum alpha-fetoprotein levels (tumor cell biomarker). 
5. Summary  
Preclinical experimentation allows for simultaneous longitudinal implementation of 
imaging techniques along with use of serum biomarkers to monitor the growth and  
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Fig. 8. Representative images obtained by CEUS depicting HCC xenograft treated with 
vehicle (A) or sunitinib (B) at 2 different time-points. There is a clear difference in tumor size 
and vascularity between control and treated tumor. 
response to treatment of HCC tumors. Although, xenograft and orthotopic models are 
complementary, and both models have a place in the screening strategy of novel therapies 
based on the complex vascular events and microenvironment of the liver that plays a role in 
tumor growth and spreading, only orthotopic liver tumor models can provide the level of 
complexity that is needed to reliably evaluate the antitumor effects of compounds under 
investigation in preclinical studies.  
The first step to establish the clinical diagnosis of HCC in patients consists of a blood test for 
elevated AFP concentrations followed by structural imaging utilizing one of several imaging 
modalities that are currently available including ultrasonography. Ultrasonography has been 
validated for preclinical and clinical use and it has been one of the most valuable translational 
tools to assess the efficacy of novel therapies in animal models of HCC as well as in the 
patients. Additional technological advances toward developing safe contrast agents continue 
to add value to current ultrasonography methods. Therefore, the thorough preclinical research 
of HCC should include both, predictive animal models and reliable technologies. 
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1. Introduction 
Ultrasound imaging has been utilized for the non-invasive and real-time observation of 
pathophysiological conditions in clinical settings. To enhance blood flow signals, 
microbubbles that are quite different in acoustic impedance from blood have been utilized 
as the contrast agent for ultrasound imaging. Unfortunately, the initial performance of 
intravenous contrast-enhanced ultrasound imaging was hampered by the pulmonary 
circulation due to the size of the microbubbles. Additionally, the detection of microbubbles 
was not easy because of the weak signals derived from the bubbles. However, recent 
improvements in the bubble physics and ultrasound imaging technologies have enabled 
non-invasive assessment of organ perfusion by intravenous administration of microbubbles 
(Chahal & Senior, 2010; Porter & Xie, 2010; Wilson & Burns, 2010). Of note, the fate of 
intravenously administrated microbubbles is similar to that of red blood cells (Keller et al., 
1989; Jayaweera et al., 1994). Many contrast agents for contrast-enhanced ultrasound 
imaging are now clinically available all over the world (Table 1). 
On the other hand, ultrasound molecular imaging, which visualizes molecular dynamics in 
situ by detecting the signals derived from retained microbubbles in the target regions, has 
been recently developed. As microbubbles are the intravascular blood flow tracer, 
ultrasound molecular imaging predominantly targets activated leukocytes and molecules 
expressed on endothelial cells. Many papers have been published regarding the diagnostic 
utility of ultrasound molecular imaging for the detection of inflammation, atherosclerosis 
and tumor angiogenesis (Villanueva & Wagner, 2008; Leong-Poi, 2009; Lindner, 2009; 
Chadderdon & Kaul, 2010; Deshpande et al., 2010). 
The utility of molecular imaging has been demonstrated using several modalities, including 
positron emission tomography (PET), magnetic resonance imaging (MRI) and near-infrared 
fluorescence (NIRF) (Jaffer & Weissleder, 2005). Although PET and MRI provide accurate 
diagnostic information, the versatility of these two modalities is limited. On the other hand, 
ultrasound examination is cost effective and is able to be performed at the bedside. 
Therefore, the adaptation of ultrasound molecular imaging for clinical settings is desired. 
For the clinical translation of ultrasound molecular imaging, however, some bottlenecks 
need to be overcome at the same time, including the development of clinically translatable 
targeted bubbles and the improvement of ultrasound imaging techniques. This chapter 
summarizes the recent advances in the preparation of targeted bubbles and ultrasound 
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imaging technologies for realizing the clinical translation of ultrasound molecular imaging 
in the near future. 
 
 Core gas Shell composition Mean diameter 
Levovist 
Bayer Yakuhin, Ltd. 
Osaka, Japan 




C3F8 Human serum albumin 3.0—4.5 μm 
Definity 
Lantheus Medical Imaging, Inc. 
N. Billerica, MA 
C3F8 Phospholipid 1.1-3.3 μm 
Sonovue 
Bracco Imaging SpA 
Milan, Italy 
SF6 Phospholipid 2.5 μm 
Sonazoid 




phosphatidylserine 2.0-3.0 μm 
Table 1. Commercially available ultrasound contrast agents 
2. Recent progress in development of targeted bubbles 
In the previously reported animal studies with ultrasound molecular imaging, various 
intravital molecules have served as target molecules (Chadderdon & Kaul, 2010; Hwang et 
al., 2010). In ultrasound molecular imaging, the methodology for accumulating bubbles at a 
specific target is a principal issue. Until now, two types of bubbles have been developed to 
achieve this purpose, including non-targeted and targeted bubbles (Dayton & Rychak, 2007; 
Deshpande et al., 2010) (Table 2). 
 
 Method to modify bubbles Application 
Non-targeted bubbles Incorporate phospholipids/lipids into bubble shell by sonication 
Inflammation imaging, 
Kupffer imaging 
Targeted bubbles Attach ligands onto bubble surface via covalent/non-covalent coupling Overall 
Table 2. Two types of bubbles for ultrasound molecular imaging 
Non-targeted bubbles contain phosphatidylserine (PS) or other lipids in their shell 
components, and have been utilized as the contrast agent for inflammation and Kupffer cell 
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imaging (Lindner et al., 2000; Christiansen et al., 2002; Watanabe et al., 2007; Yanagisawa et 
al., 2007). On the other hand, targeted bubbles bear antibodies or peptides on the surface of 
the shell via chemical conjugation, including covalent or non-covalent coupling methods 
(Hernot & Klibanov, 2008; Deshpande et al., 2010). Several kinds of potential covalent 
coupling reaction have been considered for the attachment of ligands onto the surface of 
bubbles (Klibanov, 2005; Kiessling et al., 2009) (Table 3). However, the major method for 
ligand attachment in recent ultrasound molecular imaging studies was non-covalent avidin-
biotin complex formation because of its versatility. 
 
 Primary coupling reaction 
Covalent coupling 
Carboxylic Acid (-COOH) / Amine (-NH2) 
Maleimide / Thiol (-SH) 
Aldehyde (-CHO) / Amine (-NH2)  etc. 
Non-covalent coupling Biotin / Avidin or Streptavidin 
Table 3. Coupling strategies for attachment of ligands onto bubble shell 
It is well known that the binding between biotin and streptavidin exhibits extremely high 
affinity (dissociation constant ~10-15); however, at the same time, streptavidin is a major 
barrier for clinical translation of targeted bubbles. Because of the immunogenicity of 
streptavidin, repeated injection of streptavidin-containing bubbles is difficult in humans 
(Marshall et al., 1996; Carter, 2001). Therefore, the development of targeted bubbles that do 
not contain streptavidin is necessary for the clinical translation of ultrasound molecular 
imaging. 
2.1 Commercially available targeted bubbles for basic research 
Because of its difficulty, the preparation of targeted bubbles has been a principal issue in 
ultrasound molecular imaging. Fortunately, several targeted bubbles only for use in basic 
research have been developed recently; MicroMarker® (VisualSonics Inc., Toronto, Canada) 
and Targestar™/Visistar™ (Targeson Inc., San Diego, CA, USA). Because of their versatility, 
these bubbles have been well utilized in in vivo studies (Rychak et al., 2007; Willmann et al., 
2008a, 2008b, 2010; Barreiro et al., 2009). However, the clinical application of these bubbles is 
difficult in the present condition because of the use of streptavidin as a mediator between 
bubbles and ligands. 
2.2 Chemical modification to improve targetability of bubbles 
For ultrasound molecular imaging, improvement of the targetability of ligand-bearing 
bubbles to the disease-related intravital molecule is a principal issue. To this end, several 
chemical modifications have been recently applied to targeted bubbles (Klibanov, 2009; 
Gessner & Dayton, 2010). Firstly, Klibanov et al. conjugated clustered polymeric forms of 
ligands onto the surface of the bubble shell to increase the surface density of ligands 
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imaging (Lindner et al., 2000; Christiansen et al., 2002; Watanabe et al., 2007; Yanagisawa et 
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coupling reaction have been considered for the attachment of ligands onto the surface of 
bubbles (Klibanov, 2005; Kiessling et al., 2009) (Table 3). However, the major method for 
ligand attachment in recent ultrasound molecular imaging studies was non-covalent avidin-
biotin complex formation because of its versatility. 
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2008a, 2008b, 2010; Barreiro et al., 2009). However, the clinical application of these bubbles is 
difficult in the present condition because of the use of streptavidin as a mediator between 
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2.2 Chemical modification to improve targetability of bubbles 
For ultrasound molecular imaging, improvement of the targetability of ligand-bearing 
bubbles to the disease-related intravital molecule is a principal issue. To this end, several 
chemical modifications have been recently applied to targeted bubbles (Klibanov, 2009; 
Gessner & Dayton, 2010). Firstly, Klibanov et al. conjugated clustered polymeric forms of 
ligands onto the surface of the bubble shell to increase the surface density of ligands 
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(Klibanov et al., 2006b). Secondly, targeted bubbles for two intravital molecules have been 
developed by simultaneous conjugation of two kinds of ligands onto the bubble shell 
(Weller et al., 2005; Willmann et al., 2008b; Ferrante et al., 2009). However, dense ligands, 
especially antibodies on the bubble surface would increase the risk of non-specific binding 
and immunogenic responses at the same time. To overcome this issue, Borden et al. 
developed “stealth bubbles” those ligands were buried in a forest of long polyethylene 
glycol (PEG)-brushes (Borden et al., 2008). In this stealth bubble, a radiation force was 
required to induce emergence and activation of the buried ligands. Therefore, the utilization 
of buried ligands might enable the development of targeted bubbles with both low non-
specific binding and low immunogenic response. 
2.3 Streptavidin-free targeted ultrasound contrast agents 
Recently, several approaches for the preparation of targeted bubbles without streptavidin 
have been demonstrated. Anderson et al. utilized covalent maleimide-thiol coupling for 
conjugating the targeting ligands onto the bubble shell (Anderson et al., 2010). As well as 
avidin-biotin binding, this covalent coupling approach would be applicable to a wide 
variety of ligands in the near future. Meanwhile, novel vascular endothelial growth factor 2 
(VEGFR2)-specific bubbles; BR55, which contains a lipopeptide construct in the bubble shell, 
was recently developed (Pysz et al., 2010; Pochon et al., 2010; Tardy et al., 2010). Since BR55 
contains neither antibodies nor biotin/streptavidin complex, the clinical translation of 
targeted bubbles for angiogenesis without an immunogenic response might be feasible by 
using BR55. 
2.4 Preparation of targeted bubbles based on clinically available bubbles 
To achieve easy translation of ultrasound molecular imaging in clinical settings, we 
considered that the easiest approach would be the preparation of targeted bubbles based on 
a clinically available ultrasound contrast agent. However, there have been no reports 
regarding the preparation of targeted bubbles based on a clinically available contrast agent. 
Sonazoid, a clinically available ultrasound contrast agent in Japan, consists of 
perfluorobutane gas microbubbles stabilized by a membrane of hydrogenated egg PS 
(Sontum, 2008). Generally, PS is well known as an important molecule in the cellular 
apoptotic process, especially in the clearance of apoptotic cells (Wu et al., 2006; Nagata et al., 
2010). Under normal physiological conditions, PS is sequestered from the cell surface by 
phospholipid translocators, known as flippases. However, this process is interrupted during 
apoptosis and PS translocates to the cell surface. This translocation of PS triggers the 
recognition and removal of apoptotic cells by phagocytes. In the field of apoptotic 
research, annexin V has been well utilized for detecting PS-expressing apoptotic cells 
(Vermes et al., 1995). Recently, the clinical availability of annexin V for the detection of 
apoptosis or plaque instability was demonstrated (Hofstra et al., 2000; Narula et al., 2001; 
Kietselaer et al., 2004). 
In ultrasound molecular imaging, PS-containing bubbles have been utilized as targeted 
bubbles for activated leukocytes (Lindner et al., 2000; Christiansen et al., 2002). Interestingly, 
PS-containing bubbles were labeled with annexin V as well as apoptotic cells (Lindner et al., 
2000). Based on this result, we hypothesized that preparation of antibody-carrying bubbles 
based on Sonazoid could be feasible by detecting PS in Sonazoid with annexin V and 
utilizing avidin-biotin complex formation (Figure 1). 
 




Fig. 1. Theoretical schema of IgG antibody-carrying bubbles based on Sonazoid through use 
of annexin V and avidin-biotin complex formation. 
As annexin V is a well-known protein that detects PS in a Ca2+-dependent manner, we firstly 
examined the effect of Ca2+ addition on Sonazoid bubbles. By adding a higher concentration 
of CaCl2, obvious and significant aggregation of bubbles was observed (Figure 2A). The size 
distribution histogram was markedly smaller after the addition of 0.25 mmol/L CaCl2 than 
that of naked Sonazoid bubbles (Figure 2B). Additionally, the bubble concentration was 
markedly reduced after the addition of 0.25 mmol/L CaCl2 (naked Sonazoid: 5.3x108 
bubbles/mL vs. 0.25 mmol/L CaCl2: 7.0x107 bubbles/mL). This phenomenon was 
considered to result from neutralization of the surface charge of Sonazoid bubbles (Otani & 
Yamahara, 2011). However, bubble number was not decreased after the addition of 0.05 
mmol/L CaCl2 (5.8x108 bubbles/mL) (Figure 2B). Therefore, the following experiments were 
performed in the presence of 0.05 mmol/L CaCl2, which did not induce obvious aggregation 
of Sonazoid bubbles. 
Secondly, the attachment of annexin V to the PS in Sonazoid bubbles was examined using 
fluorescein isothiocianate (FITC)-conjugated annexin V. The fluorescent signal was 
determined by FACSCalibur (BD Bioscience, San Jose, CA, USA). Even in the condition with 
low Ca2+, FITC-positive bubbles were observed after the conjugation of Sonazoid bubbles 
with FITC-annexin V (Figure 3). In contrast, the fluorescent signal derived from bubbles 
after conjugation in the absence of Ca2+ was significantly reduced. These results imply that 
the PS in Sonazoid could be detected by using annexin V even in the condition of 0.05 
mmol/L CaCl2 (Otani & Yamahara, 2011). 
 
Ultrasound Imaging – Medical Applications 
 
298 
(Klibanov et al., 2006b). Secondly, targeted bubbles for two intravital molecules have been 
developed by simultaneous conjugation of two kinds of ligands onto the bubble shell 
(Weller et al., 2005; Willmann et al., 2008b; Ferrante et al., 2009). However, dense ligands, 
especially antibodies on the bubble surface would increase the risk of non-specific binding 
and immunogenic responses at the same time. To overcome this issue, Borden et al. 
developed “stealth bubbles” those ligands were buried in a forest of long polyethylene 
glycol (PEG)-brushes (Borden et al., 2008). In this stealth bubble, a radiation force was 
required to induce emergence and activation of the buried ligands. Therefore, the utilization 
of buried ligands might enable the development of targeted bubbles with both low non-
specific binding and low immunogenic response. 
2.3 Streptavidin-free targeted ultrasound contrast agents 
Recently, several approaches for the preparation of targeted bubbles without streptavidin 
have been demonstrated. Anderson et al. utilized covalent maleimide-thiol coupling for 
conjugating the targeting ligands onto the bubble shell (Anderson et al., 2010). As well as 
avidin-biotin binding, this covalent coupling approach would be applicable to a wide 
variety of ligands in the near future. Meanwhile, novel vascular endothelial growth factor 2 
(VEGFR2)-specific bubbles; BR55, which contains a lipopeptide construct in the bubble shell, 
was recently developed (Pysz et al., 2010; Pochon et al., 2010; Tardy et al., 2010). Since BR55 
contains neither antibodies nor biotin/streptavidin complex, the clinical translation of 
targeted bubbles for angiogenesis without an immunogenic response might be feasible by 
using BR55. 
2.4 Preparation of targeted bubbles based on clinically available bubbles 
To achieve easy translation of ultrasound molecular imaging in clinical settings, we 
considered that the easiest approach would be the preparation of targeted bubbles based on 
a clinically available ultrasound contrast agent. However, there have been no reports 
regarding the preparation of targeted bubbles based on a clinically available contrast agent. 
Sonazoid, a clinically available ultrasound contrast agent in Japan, consists of 
perfluorobutane gas microbubbles stabilized by a membrane of hydrogenated egg PS 
(Sontum, 2008). Generally, PS is well known as an important molecule in the cellular 
apoptotic process, especially in the clearance of apoptotic cells (Wu et al., 2006; Nagata et al., 
2010). Under normal physiological conditions, PS is sequestered from the cell surface by 
phospholipid translocators, known as flippases. However, this process is interrupted during 
apoptosis and PS translocates to the cell surface. This translocation of PS triggers the 
recognition and removal of apoptotic cells by phagocytes. In the field of apoptotic 
research, annexin V has been well utilized for detecting PS-expressing apoptotic cells 
(Vermes et al., 1995). Recently, the clinical availability of annexin V for the detection of 
apoptosis or plaque instability was demonstrated (Hofstra et al., 2000; Narula et al., 2001; 
Kietselaer et al., 2004). 
In ultrasound molecular imaging, PS-containing bubbles have been utilized as targeted 
bubbles for activated leukocytes (Lindner et al., 2000; Christiansen et al., 2002). Interestingly, 
PS-containing bubbles were labeled with annexin V as well as apoptotic cells (Lindner et al., 
2000). Based on this result, we hypothesized that preparation of antibody-carrying bubbles 
based on Sonazoid could be feasible by detecting PS in Sonazoid with annexin V and 
utilizing avidin-biotin complex formation (Figure 1). 
 




Fig. 1. Theoretical schema of IgG antibody-carrying bubbles based on Sonazoid through use 
of annexin V and avidin-biotin complex formation. 
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determined by FACSCalibur (BD Bioscience, San Jose, CA, USA). Even in the condition with 
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the PS in Sonazoid could be detected by using annexin V even in the condition of 0.05 
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Fig. 2. Changes of Sonazoid bubbles after addition of CaCl2. A) At 30 minutes after addition 
of CaCl2, obvious bubble aggregation was observed when the concentration of CaCl2 was 
0.25 mmol/L or higher. B) The size distribution of Sonazoid bubbles was markedly altered 
at 45 minutes after 0.25 mmol/L CaCl2 addition. (Reproduced from Otani et al. with 
permission) 
Thirdly, we examined whether streptavidin could detect biotinylated-Sonazoid bubbles 
with annexin V. Sonazoid bubbles were conjugated with biotinylated-annexin V followed by 
R-phycoerythrin (PE)-conjugated streptavidin. A strong PE signal was detected from 
Sonazoid bubbles in the presence of biotinylated-annexin V (Figure 4). However, the PE 
signal was obviously weaker in the absence of biotinylated-annexin V. These results imply 
that streptavidn could attach to the surface of Sonazoid via avidin-biotin binding. 
Finally, we examined whether the attachment of IgG antibodies onto the surface of Sonazoid 
bubbles is feasible via annexin V and avidin-biotin complex formation. Sonazoid bubbles 
were conjugated with biotinylated-annexin V followed by streptavidin and biotinylated-
Alexa488-IgG. As shown in Figure 5A, Alexa488-positive bubbles were confirmed by FACS 
analysis (Otani & Yamahara, 2011). However, the suspension of targeted-Sonazoid bubbles 
was obviously thinner than that of naked Sonazoid bubbles (Figure 5B). 
 




Fig. 3. Attachment of annexin V to PS on surface of Sonazoid bubble. In the presence of 
CaCl2, FITC-positive bubbles were detected after the conjugation of Sonazoid bubbles with 
FITC-annexin V. In contrast, the FITC signal derived from Sonazoid bubbles was markedly 
reduced in the absence of CaCl2. (Reproduced from Otani et al. with permission) 
 
 
Fig. 4. Attachment of streptavidin to surface of Sonazoid bubble via avidin-biotin binding. 
PE-positive bubbles were detected after conjugation of Sonazoid bubbles with biotinylated-
annexin V followed by PE-conjugated streptavidin. However, the PE signal was markedly 
reduced in the absence of biotinylated-annexin V. (Reproduced from Otani et al. with 
permission) 
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Fig. 5. IgG-carrying bubbles based on Sonazoid. A) Alexa488-positive Sonazoid bubbles 
were confirmed after conjugation with biotinylated-annexin V followed by streptavidin and 
biotinylated-Alexa488-IgG. B) The concentration of targeted bubbles based on Sonazoid was 
obviously lower than that of naked Sonazoid bubbles. (Reproduced from Otani et al. with 
permission) 
Although our preliminary results demonstrated the feasibility of preparation of targeted 
bubbles based on clinically available microbubbles Sonazoid, the translation of targeted 
Sonazoid bubbles to in vivo settings would be difficult in the present circumstances because 
of the decrease of bubble number and the use of streptavidin. However, our results imply 
that PS in Sonazoid bubbles has the potential to be a mediator of targeted bubbles based on 
Sonazoid. 
2.5 Improvement of targeted sonazoid by using lactadherin 
PS is well known as an important molecule for the clearance of apoptotic cells, and several 
kinds of proteins that bind with PS have been discovered (Wu et al., 2006; Nagata et al., 
2010). Milk fat globule epithelial growth factor 8 (MFG-E8)/lactadherin is a glycoprotein 
which was originally identified as a component of milk fat globules (Stubbs et al., 1990). 
Lactadherin contains a PS-binding C-domain and an RGD (arginine-glycine-aspartate)-motif 
present in the epidermal growth factor domain, which binds to integrins αvβ3 and αvβ5 
(Andersen et al., 2000; Hanayama et al., 2002; Yamaguchi et al., 2008). It is well known that 
the recognition of PS by lactadherin is Ca2+-independent (Shi et al., 2003; Dasgupta et al., 
2006). Therefore, we examined whether PS in Sonazoid could be detected using PE-
conjugated lactadherin instead of annexin V (Figure 6A). By conjugating Sonazoid bubbles 
with PE-labeled lactadherin, PE-positive bubbles were detected by FACS analysis (Figure 
6B, unpublished data). 
 




Fig. 6. Detection of PS in Sonazoid using lactadherin. A) Schema of expected binding 
between Sonazoid bubbles and PE-conjugated lactadherin. B) After conjugation with PE-
lactadherin, the presence of PE-positive Sonazoid bubbles was confirmed. 
Because of the unnecessity of Ca2+ addition in the case of lactadherin, no obvious 
aggregation or decrease in number of bubbles was observed during the preparation of 
lactadherin-bearing bubbles (data not shown). Although the binding between Sonazoid 
bubbles and annexin V was fragile, robust binding with PS in Sonazoid was achieved using 
lactadherin (Figure 7). These results imply that lactadherin is superior to annexin V in 
regard to the detection of PS in Sonazoid bubbles. As lactadherin has a RGD motif in its 
epidermal growth factor domain, lactadherin-bearing Sonazoid bubbles might have the 
potential to attach to integrin αvβ3-expressing cells. Furthermore, lactadherin-bearing 
Sonazoid bubbles might be a novel targeted bubble for angiogenesis, because the integrin 
αvβ3 is well known to play a key role in angiogenesis (Friedlander et al., 1995). Therefore, 
further study to examine the potential of lactadherin-bearing Sonazoid bubbles both in vitro 
and in vivo would be of benefit. 
Although the feasibility of preparation of targeted bubbles based on a clinically available 
ultrasound contrast agent was demonstrated in our present study, there are some concerns 
with lactadherin-bearing Sonazoid bubbles at the present time. The most important issue is 
the direct conjugation of lactadherin onto the bubble shell. This might influence: 1) the 
efficiency of attachment to the target molecule (integrin αvβ3) both in vitro and in vivo 
studies, and 2) the surface density of ligands. The majority of recent targeted bubbles 
contain long PEG spacer arms on the bubble surface to project ligands away from the 
surface of the bubble shell (Klibanov, 2006a; Lindner, 2010). This projection of ligands 
resulted in improvement of flexibility and targetability of bubbles. Furthermore, the surface 
density of ligands would be lower in the case of direct conjugation of ligands to the bubble 
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shell. In these regards, the efficiency of attachment of lactadherin-bearing Sonazoid bubbles 




Fig. 7. Stability of annexin V- and lactadherin-bearing Sonazoid bubbles. Compared to 
annexin V-bearing Sonazoid bubbles, lactadherin-conjugated bubbles were more resistant to 
violent shaking. (Reproduced from Otani et al. with permission) 
3. Improvement of ultrasound technology 
In conjunction with the development of targeted bubbles, improvement of ultrasound 
technology is also an essential issue in ultrasound molecular imaging. Unlike conventional 
contrast-enhanced ultrasound imaging, the number of retained bubbles to the target region 
is quite small. Therefore, a more sensitive ultrasound detection technique would be required 
for the clinical translation of ultrasound molecular imaging. Additionally, a bubble-specific 
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imaging method that suppresses signals from surrounding tissues, to emphasize the 
ultrasound signals derived from bubbles, would be a help for accurate observation of 
molecular dynamics. 
3.1 Evolution of ultrasound detection techniques 
Contrast-enhanced ultrasound imaging visualizes the signals derived from microbubbles. 
Under high mechanical index (MI) ultrasound exposure, bubbles exhibit unique scattering 
behavior. By utilizing this characteristic, harmonic imaging, especially second harmonic 
imaging, has been developed at an early stage of contrast-enhanced ultrasound imaging 
(Porter et al., 1996). In addition, the Doppler technique has been applied for sensitive 
detection of bubbles (harmonic power Doppler imaging). Until now, several harmonic 
imaging techniques including subharmonic, 1.5 harmonic and ultraharmonic imaging have 
been developed (Table 4). However, high MI ultrasound exposure resulted in the 
destruction of bubbles - the source of acoustic signals. Therefore, intermittent exposure is 
inevitable for acquiring contrast-enhanced images in high MI imaging. As a result, real-time 
observation of contrast enhancement has not been achieved in high MI imaging. To 
overcome this issue, real-time imaging which utilizes low power ultrasound has been 
developed in conjunction with high MI imaging techniques. Until now, several techniques 
that detect the bubble signal efficiently with multiple ultrasound pulses have been 
developed, including pulse inversion, power pulse inversion, power modulation, coherent 
contrast imaging and cadence pulse sequencing (Table 4). 
 
 Imaging mode References 
High MI imaging techniques 
(for intermittent observation) 
Subharmonic imaging Forsberg et al., 2000 
1.5 harmonic imaging Toshida et al., 2005 
Ultraharmonic imaging Kuersten et al., 2001 
Harmonic power Doppler Heinle et al., 2000 
Low MI imaging techniques 
(for real-time observation) 
Pulse inversion Burns et al., 2000 
Power pulse inversion Tiemann et al., 1999 
Power modulation Caiani et al., 2005 
Coherent contrast imaging Otani et al., 2004 
Cadence pulse sequencing Phillips, 2001 
Table 4. Imaging technologies for contrast-enhanced ultrasound imaging 
 
Ultrasound Imaging – Medical Applications 
 
304 
shell. In these regards, the efficiency of attachment of lactadherin-bearing Sonazoid bubbles 




Fig. 7. Stability of annexin V- and lactadherin-bearing Sonazoid bubbles. Compared to 
annexin V-bearing Sonazoid bubbles, lactadherin-conjugated bubbles were more resistant to 
violent shaking. (Reproduced from Otani et al. with permission) 
3. Improvement of ultrasound technology 
In conjunction with the development of targeted bubbles, improvement of ultrasound 
technology is also an essential issue in ultrasound molecular imaging. Unlike conventional 
contrast-enhanced ultrasound imaging, the number of retained bubbles to the target region 
is quite small. Therefore, a more sensitive ultrasound detection technique would be required 
for the clinical translation of ultrasound molecular imaging. Additionally, a bubble-specific 
 
Feasibility of Clinical Application of Ultrasound Molecular Imaging 
 
305 
imaging method that suppresses signals from surrounding tissues, to emphasize the 
ultrasound signals derived from bubbles, would be a help for accurate observation of 
molecular dynamics. 
3.1 Evolution of ultrasound detection techniques 
Contrast-enhanced ultrasound imaging visualizes the signals derived from microbubbles. 
Under high mechanical index (MI) ultrasound exposure, bubbles exhibit unique scattering 
behavior. By utilizing this characteristic, harmonic imaging, especially second harmonic 
imaging, has been developed at an early stage of contrast-enhanced ultrasound imaging 
(Porter et al., 1996). In addition, the Doppler technique has been applied for sensitive 
detection of bubbles (harmonic power Doppler imaging). Until now, several harmonic 
imaging techniques including subharmonic, 1.5 harmonic and ultraharmonic imaging have 
been developed (Table 4). However, high MI ultrasound exposure resulted in the 
destruction of bubbles - the source of acoustic signals. Therefore, intermittent exposure is 
inevitable for acquiring contrast-enhanced images in high MI imaging. As a result, real-time 
observation of contrast enhancement has not been achieved in high MI imaging. To 
overcome this issue, real-time imaging which utilizes low power ultrasound has been 
developed in conjunction with high MI imaging techniques. Until now, several techniques 
that detect the bubble signal efficiently with multiple ultrasound pulses have been 
developed, including pulse inversion, power pulse inversion, power modulation, coherent 
contrast imaging and cadence pulse sequencing (Table 4). 
 
 Imaging mode References 
High MI imaging techniques 
(for intermittent observation) 
Subharmonic imaging Forsberg et al., 2000 
1.5 harmonic imaging Toshida et al., 2005 
Ultraharmonic imaging Kuersten et al., 2001 
Harmonic power Doppler Heinle et al., 2000 
Low MI imaging techniques 
(for real-time observation) 
Pulse inversion Burns et al., 2000 
Power pulse inversion Tiemann et al., 1999 
Power modulation Caiani et al., 2005 
Coherent contrast imaging Otani et al., 2004 
Cadence pulse sequencing Phillips, 2001 
Table 4. Imaging technologies for contrast-enhanced ultrasound imaging 
 
Ultrasound Imaging – Medical Applications 
 
306 
Compared to conventional contrast-enhanced ultrasound imaging, the number of retained 
or attached bubbles to the target region in ultrasound molecular imaging is quite small. 
Additionally, the sensitivity for bubble detection in high MI imaging is higher than that in 
low MI real-time imaging. Therefore, early examination of ultrasound molecular imaging 
had been performed using high MI, intermittent imaging (Lindner et al., 2001; Leong-Poi et 
al., 2003). However, high MI imaging interferes with the continuous imaging of molecular 
dynamics, due to the destruction of retained or attached bubbles. Recently, low MI, real-
time imaging has been applied in ultrasound molecular imaging (Kaufmann et al., 2007; 
Stieger et al., 2008). Although the acoustic signal derived from targeted bubbles in low MI 
real-time imaging was weaker than that in high MI imaging, real-time ultrasound molecular 
imaging would enable temporal and spatial recognition of molecular dynamics (Kaufmann 
et al., 2010). Additionally, Klibanov et al. reported the feasibility of individual bubble 
detection using low MI ultrasound imaging (Klibanov et al., 2004). This result implied that 
the sensitivity of low MI ultrasound techniques would be sufficient for application to 
ultrasound molecular imaging. 
3.2 Specialized ultrasound machine for small animal research 
In previous small animal studies on ultrasound perfusion and molecular imaging, the 
detection of bubbles has been performed using clinically available ultrasound imaging 
systems (Weller et al., 2003; Otani et al., 2008). Recently, high resolution ultrasound imaging 
systems specialized for small animal experiments have been developed (Vevo770 and 
Vevo2100; VisualSonics Inc., Toronto, Canada). Several recent basic research studies on 
ultrasound molecular imaging have utilized these machines (Rychak et al., 2007; Willmann 
et al., 2008a, 2008b, 2010). Because of the usage of too high frequency ultrasound (center 
frequency; ~ 55 MHz), this machine would not be suitable for clinical use. However, the 
accumulated results from genetically-modified animal studies using these instruments will 
be of much help for the clinical translation of ultrasound molecular imaging. 
4. Conclusion and future direction 
Contrast-enhanced ultrasound imaging has been applied in clinical settings, and its usability 
has also been demonstrated all over the world. On the other hand, the utility of ultrasound 
molecular imaging has been proved by many animal studies. Therefore, the development of 
clinically translatable targeted bubbles has potential for spreading ultrasound molecular 
imaging into clinical settings rapidly. In parallel with perfusion or molecular imaging, the 
potential of microbubbles as a carrier for drug or gene delivery into cells has been 
demonstrated recently in both in vitro and in vivo studies (Liu et al., 2006; Otani et al., 2009; 
Tinkov et al., 2009). The combination of these features might lead to the localized delivery of 
drugs or genes into target cells in vivo. Although further study is required, progress in 
targeted bubbles physics and ultrasound imaging technologies might realize the clinical 
application of ultrasound molecular imaging and the development of non-invasive localized 
drug/gene delivery systems in the near future. 
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1. Introduction  
Radiation therapy plays an important role in cancer treatment. It is well known that good 
local control is achieved when planned dose of radiation is delivered to the target. 
Recent advances in technology, in particular in image guided radiation therapy (IGRT), has 
significantly improved the accuracy of target localization for daily radiation treatment. 
Daily localization of the target is critical to the delivery of the prescription dose to the target. 
Thus, to achieve accurate targeting and reduce the irradiation of normal tissues and to 
potentially escalate dose to target volumes, IGRT needs to be implemented for daily use 
in the clinic.  
Various IGRT techniques are currently available. One of the techniques integrates an On 
Board low kilovoltage imaging capability into the linear accelerator that produces diagnostic 
quality images. However, this imaging technique requires that extra radiation dose be 
delivered to the patient. Another IGRT imaging system that has been integrated recently 
with the linear accelerator is 3D ultrasound imaging. This technique is non invasive, 
requires no extra radiation to a patient and provides capabilities for daily target localization 
and verification prior to the delivery of radiation treatment. 
Currently, 3D ultrasound imaging is used for target localization and verification of prostate, 
gynecological and breast cancers.  Since the late nineties, 2D ultrasound imaging has been 
used for prostate localization only, but only recently has 3D ultrasound localization been 
available. This has also led to the use of 3D ultrasound for localizing other treatment sites as 
well; although, each site requires unique methods. 
For the prostate cancer treatment, the prostate can move daily compared to the reference 
planning CT (radiation therapy planning and dose calculation for all disease sites is done 
with CT image based)due to bladder and rectal filling. Ultrasound imaging can be used to 
image and localize the prostate target daily. The prostate and bladder can all typically be 
well visualized and compared to the reference ultrasound image or CT image. Shifts are 
then identified and made to reposition the patient to the point that the treatment volumes 
identified each day are aligned with where they were on the planning CT images relative to 
the linear accelerator’s isocenter. This isocenter is the point in space about which the linear 
accelerator rotates and all planning and radiation beam delivery for a daily treatment is 
performed relative to it. 
For gynecological cancer treatment, the ultrasound image does not show the entire target 
because target definition is complex and composed of multiple structures. The purpose of 
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used for prostate localization only, but only recently has 3D ultrasound localization been 
available. This has also led to the use of 3D ultrasound for localizing other treatment sites as 
well; although, each site requires unique methods. 
For the prostate cancer treatment, the prostate can move daily compared to the reference 
planning CT (radiation therapy planning and dose calculation for all disease sites is done 
with CT image based)due to bladder and rectal filling. Ultrasound imaging can be used to 
image and localize the prostate target daily. The prostate and bladder can all typically be 
well visualized and compared to the reference ultrasound image or CT image. Shifts are 
then identified and made to reposition the patient to the point that the treatment volumes 
identified each day are aligned with where they were on the planning CT images relative to 
the linear accelerator’s isocenter. This isocenter is the point in space about which the linear 
accelerator rotates and all planning and radiation beam delivery for a daily treatment is 
performed relative to it. 
For gynecological cancer treatment, the ultrasound image does not show the entire target 
because target definition is complex and composed of multiple structures. The purpose of 
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ultrasound is to visualize the vaginal canal (for hysterectomy patients) or uterus and cervix 
motion with respect to change in bladder filling volume and rectal motion. Daily changes of 
these organs relative to their planned locations can be found by ultrasound localization and 
treatment margins for organ motions can be adjusted accordingly to avoid geographical 
miss especially when patients are being treated with Intensity Modulated Radiation 
Therapy (IMRT). 
For breast cancer treatment, ultrasound is used to image the lumpectomy cavity daily with 
each radiation treatment. This provides an actual visual image and location of the tumor 
cavity. The standard way to treat lumpectomy cavities is based on a reference CT scan 
before the radiation treatment course starts. Using 3D ultrasound, daily tumor bed is 
visualized with the excellent soft tissue imaging and shifts can be made to align the planned 
and treatment locations relative to the isocenter for the boost or partial breast treatments. 
Ultrasound image use is user dependent and requires special skills to acquire good quality 
images compared to other imaging systems used in radiation therapy. This includes 
techniques for acquiring good images and evaluation of the images acquired. 
In this chapter, we will review the application of 3D ultrasound imaging as a tool for daily 
image guidance in radiation therapy. Application of this imaging technique will be 
discussed for various tumor sites such as prostate, gynecological and breast cancers. We will 
also report on the findings of our clinical investigations for these disease sites. Quality 
assurance of the equipment and process, detailed scan acquisition techniques and steps for 
the use of ultrasound for the visualization of various tumors will also be provided based on 
our clinical experiences with the Resonant/Clarity system. Other ultrasound systems are 
commercially available, and they use similar techniques to visualize and localize targets. 
Finally, we will also provide a brief review of other imaging modalities that are used for 
target localization in radiation therapy and a comparison of each of these modalities as well. 
2. Basic concepts for treatment planning and delivery in external beam 
radiation therapy 
2.1 Linear accelerator 
In radiation therapy, a beam (typically photons and/or electrons) is delivered from the 
linear accelerator toward a single point in space—the isocenter. The linear accelerator is a 
device that uses high-frequency electromagnetic waves to accelerate charged particles such 
as electrons to high energies (Mega voltage level) through a linear tube. High –energy 
electron beam or photon beam (electrons can be made to strike a target to produce X-rays) 
can be used for treating cancers. The linear accelerator rotates around the isocenter so that at 
every angle the central axis of the beam is directed through the isocenter. Therefore, within 
the patient, the target to be treated must be precisely placed relative to isocenter.  
2.2 Target definition and prescription for treatment planning 
The treatment target volume is initially identified and outlined by a radiation oncologist on 
a computed tomographic (CT) image. CT scan is the standard method for creating image 
based plans in radiation oncology. The visualized tumor is outlined as the gross tumor 
volume (GTV). A margin or shell is added to this GTV to include volumes that may be 
expected to contain cancerous cells that are too small to be visualized. This larger volume is 
the clinical target volume (CTV). An additional margin is added to the CTV to account for 
uncertainties due to day to day variations such as internal organ motions and setup of a 
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patient. This larger volume is the planning target volume (PTV) and is planned to receive 
the prescribed dose of radiation. The radiation oncologist’s prescription defines the target, 
the type of radiation to be used, the total dose to be delivered to the target, the daily 
radiation dose per fraction to the target, the total number of fractions to deliver that dose, 
and any special instructions regarding how the dose is to be delivered. Typical radiation 
treatments are delivered daily for five to six weeks. 
If imaging is to be used to localize the target, the special instructions will include the type 
and frequency of imaging to be done for this purpose. 
2.3 Process of generating treatment plan 
Once the target has been outlined and a prescription is written, a plan for delivering the 
prescription dose is developed by physicists/dosimetrists with treatment planning 
software. Planning software needs CT scan images for dose calculations and simulation. The 
plan determines the angles from which the linear accelerator will deliver a radiation beam 
for selected beam energy (within the parameters of the prescription), the shape of treatment 
fields (or portals) for each beam angle, and any special devices in the path of the beams to 
further tailor them. The portals are shaped using blocks or a series of thin leaves collectively 
referred to as a multi-leaf collimator (MLC). The blocks or MLCs must be sufficiently thick 
(parallel to the beam direction) to block nearly all of the radiation outside of the block or 
MLC opening so that it can attenuate the beam to an intensity of less than 5.0 percent, and 
each leaf of the MLC must be thin enough, typically 5.0mm or 10.0mm at the level of 
isocenter, and perpendicular to the beam direction to conform to the PTV shape. 
In addition to covering the PTV with the prescription dose, the treatment plan must limit 
dose to nearby critical structures. All tissues within the human body have tolerances of 
radiation dose that they can receive before the risk of radiation damage becomes significant. 
Conventionally generous margins are applied around the target to incorporate uncertainties 
due to organ motion and setup error. This ensures that the PTV receives the prescription 
dose. However, this can result in an increased dose to the normal tissues thus increasing 
risks of normal tissue complications. Maximizing setup accuracy is one of the most 
important ways to reduce the margin added to the CTV and thus reduce risks of normal 
tissues complications.  
Daily imaging of the target on the linear accelerator is an accurate way to localize it relative 
to the isocenter and a key factor in aligning the patient so that the planned dose is delivered 
to the target and critical structures are spared. 
2.4 Verification and confirmation of daily patient setup  
Once the plan is completed, the radiation oncologist will review it and subsequently 
approve the final plan. The patient will then be scheduled for a confirmation simulation by 
radiation therapists. During confirmatory simulation, the patient is setup on a special table 
that is used to move the patient so that the target is aligned to the isocenter as planned. 
Images are taken to confirm isocenter location and shape of beam portals if necessary. Once 
in the final position, the patient’s skin is marked at the points where the central axis of the 
beam enters the skin directly from above and from both sides (these are orthogonal angles). 
The radiation oncologist reviews and approves these images before the patient is treated.  
Each day the patient is setup using the skin marks placed during the confirmatory 
simulation to align the target to the isocenter. Room lasers, sagittal, vertical and lateral are 
used for this setup. The margins in the PTV must account for the uncertainties of where the 
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ultrasound is to visualize the vaginal canal (for hysterectomy patients) or uterus and cervix 
motion with respect to change in bladder filling volume and rectal motion. Daily changes of 
these organs relative to their planned locations can be found by ultrasound localization and 
treatment margins for organ motions can be adjusted accordingly to avoid geographical 
miss especially when patients are being treated with Intensity Modulated Radiation 
Therapy (IMRT). 
For breast cancer treatment, ultrasound is used to image the lumpectomy cavity daily with 
each radiation treatment. This provides an actual visual image and location of the tumor 
cavity. The standard way to treat lumpectomy cavities is based on a reference CT scan 
before the radiation treatment course starts. Using 3D ultrasound, daily tumor bed is 
visualized with the excellent soft tissue imaging and shifts can be made to align the planned 
and treatment locations relative to the isocenter for the boost or partial breast treatments. 
Ultrasound image use is user dependent and requires special skills to acquire good quality 
images compared to other imaging systems used in radiation therapy. This includes 
techniques for acquiring good images and evaluation of the images acquired. 
In this chapter, we will review the application of 3D ultrasound imaging as a tool for daily 
image guidance in radiation therapy. Application of this imaging technique will be 
discussed for various tumor sites such as prostate, gynecological and breast cancers. We will 
also report on the findings of our clinical investigations for these disease sites. Quality 
assurance of the equipment and process, detailed scan acquisition techniques and steps for 
the use of ultrasound for the visualization of various tumors will also be provided based on 
our clinical experiences with the Resonant/Clarity system. Other ultrasound systems are 
commercially available, and they use similar techniques to visualize and localize targets. 
Finally, we will also provide a brief review of other imaging modalities that are used for 
target localization in radiation therapy and a comparison of each of these modalities as well. 
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In radiation therapy, a beam (typically photons and/or electrons) is delivered from the 
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device that uses high-frequency electromagnetic waves to accelerate charged particles such 
as electrons to high energies (Mega voltage level) through a linear tube. High –energy 
electron beam or photon beam (electrons can be made to strike a target to produce X-rays) 
can be used for treating cancers. The linear accelerator rotates around the isocenter so that at 
every angle the central axis of the beam is directed through the isocenter. Therefore, within 
the patient, the target to be treated must be precisely placed relative to isocenter.  
2.2 Target definition and prescription for treatment planning 
The treatment target volume is initially identified and outlined by a radiation oncologist on 
a computed tomographic (CT) image. CT scan is the standard method for creating image 
based plans in radiation oncology. The visualized tumor is outlined as the gross tumor 
volume (GTV). A margin or shell is added to this GTV to include volumes that may be 
expected to contain cancerous cells that are too small to be visualized. This larger volume is 
the clinical target volume (CTV). An additional margin is added to the CTV to account for 
uncertainties due to day to day variations such as internal organ motions and setup of a 
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patient. This larger volume is the planning target volume (PTV) and is planned to receive 
the prescribed dose of radiation. The radiation oncologist’s prescription defines the target, 
the type of radiation to be used, the total dose to be delivered to the target, the daily 
radiation dose per fraction to the target, the total number of fractions to deliver that dose, 
and any special instructions regarding how the dose is to be delivered. Typical radiation 
treatments are delivered daily for five to six weeks. 
If imaging is to be used to localize the target, the special instructions will include the type 
and frequency of imaging to be done for this purpose. 
2.3 Process of generating treatment plan 
Once the target has been outlined and a prescription is written, a plan for delivering the 
prescription dose is developed by physicists/dosimetrists with treatment planning 
software. Planning software needs CT scan images for dose calculations and simulation. The 
plan determines the angles from which the linear accelerator will deliver a radiation beam 
for selected beam energy (within the parameters of the prescription), the shape of treatment 
fields (or portals) for each beam angle, and any special devices in the path of the beams to 
further tailor them. The portals are shaped using blocks or a series of thin leaves collectively 
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In addition to covering the PTV with the prescription dose, the treatment plan must limit 
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radiation dose that they can receive before the risk of radiation damage becomes significant. 
Conventionally generous margins are applied around the target to incorporate uncertainties 
due to organ motion and setup error. This ensures that the PTV receives the prescription 
dose. However, this can result in an increased dose to the normal tissues thus increasing 
risks of normal tissue complications. Maximizing setup accuracy is one of the most 
important ways to reduce the margin added to the CTV and thus reduce risks of normal 
tissues complications.  
Daily imaging of the target on the linear accelerator is an accurate way to localize it relative 
to the isocenter and a key factor in aligning the patient so that the planned dose is delivered 
to the target and critical structures are spared. 
2.4 Verification and confirmation of daily patient setup  
Once the plan is completed, the radiation oncologist will review it and subsequently 
approve the final plan. The patient will then be scheduled for a confirmation simulation by 
radiation therapists. During confirmatory simulation, the patient is setup on a special table 
that is used to move the patient so that the target is aligned to the isocenter as planned. 
Images are taken to confirm isocenter location and shape of beam portals if necessary. Once 
in the final position, the patient’s skin is marked at the points where the central axis of the 
beam enters the skin directly from above and from both sides (these are orthogonal angles). 
The radiation oncologist reviews and approves these images before the patient is treated.  
Each day the patient is setup using the skin marks placed during the confirmatory 
simulation to align the target to the isocenter. Room lasers, sagittal, vertical and lateral are 
used for this setup. The margins in the PTV must account for the uncertainties of where the 
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target is relative to the skin marks. Daily imaging reduces much of this uncertainty by 
directly viewing internal soft tissues or fiducial markers placed inside the tumor. Small (e.g. 
1 mm diameter and 5 mm long) fiducial markers are radio-opaque to kilovoltage radiation 
and are therefore well visualized in kilovoltage images. They can be implanted into soft 
tissues to assist with comparing daily images to reference images. These images can be 
reviewed daily by the radiation oncologist before treatment is delivered.  
Several types of daily imaging are now used in radiation oncology to aid in Image Guided 
Radiation Therapy (IGRT). These new innovative technologies include megavoltage (MV) 
and kilovoltage (KV) X-ray energies to acquire individual radiographs or cone beam CT 
(CBCT). Also, ultrasound images—either planar or volume images—can be used for daily 
localization of certain targets such as gynaecological, prostate, or breast. 
In next couple of sections, 3D ultrasound application as an IGRT in radiation oncology will 
be reviewed.  
3. Applications of ultrasound imaging in prostate cancer  
The prostate location is particularly conducive to ultrasound imaging in that it is located 
beneath the bladder which when full creates a favourable ultrasound path from the skin 
surface of the lower abdomen to the prostate. The bladder-prostate interface is well 
visualized.  
In addition, the prostate is displaced by rectal and bladder filling. This displacement is 
unpredictable and can approach 2 cm (Scarborough et al., 2006). Such a large displacement 
is rare (typically less than 7 % of the time). A few millimetres are more typical on a daily 
basis, and it is less than 1 cm (0.8 – 0.9 mm) with a 95 % confidence interval (Scarborough et 
al., 2006; Serago et al., 2006). Therefore, 1 cm is a typical expansion around the prostate CTV 
to create the PTV without imaging (Hanks et al., 2000; Boersma et al., 1998). With daily 
ultrasound imaging, we have found that the 95 % confidence interval is reduced to 0.7 cm 
which agrees with Serago et al (Serago et al., 2006). Boda-Heggemann et al and Langen et al 
also demonstrated that ultrasound imaging improves prostate localization (Boda-
Heggemann et al., 2008; Langen et al., 2003). Serago et al and Langen et al identified a 
significant improvement in localization in the anterior-posterior direction which is the 
direction of largest prostate displacement because of rectal filling (Serago et al., 2006; 
Langen et al., 2003). Further, the rectum and bladder are adjacent to the prostate, but are 
critical structures that should be spared as much dose as is possible without compromising 
the delivery of the prescribed dose to the prostate. 
Prescribed total doses of 70 to 78 Gy to the entire prostate at 1.8 Gy per daily fraction are 
common for treating prostate cancer (Pollack et al., 2002). Because of the proximity of the 
bladder and rectum to the prostate, a portion of each of these organs typically receives the 
entire dose. In order to avoid serious toxicities to these organs, their volumes receiving such 
large doses of radiation must be limited. A recent review of the literature evaluating bladder 
and rectal tolerances to radiation has suggested the following dose constraints (Michalski et 
al., 2010; Viswanathan et al., 2010): (Table 1) 
Toxic effects are graded using one a few standardized criteria including the Common 
Terminology Criteria for Adverse Events version 3.0 (CTCAE 3.0) and Radiation Therapy 
Oncology Group (RTOG) scoring criteria. Long term toxic effects can include rectal stricture, 
rectal bleeding, diminished rectal compliance, decreased storage capacity with resultant 
small and frequent bowel movements, urgency to empty the bladder frequently, 
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incontinence, reduced flow, bladder spasms, hematuria, fistula, obstruction, ulceration, and 
necrosis (Michalski et al., 2010; Viswanathan et al., 2010). The tabulated limits are expected 
to avoid these serious long term toxic effects in 90% or more of patients (Michalski et al., 
2010; Viswanathan et al., 2010). These criteria were developed over many years without the 
benefits of daily localization; however, daily localization can be expected to help reduce the 
doses to these critical structures (Michalski et al., 2010; Viswanathan et al., 2010) by helping 
us treat with smaller margins thereby reducing toxic effects of radiation. 
 
Specified Dose Percentage of Organ Volume Receiving Greater than Specified Dose (%) 
(Gy) Bladder Rectum 
50  50 
60  35 
65 50 25 
70 35 20 
75 25 15 
80 15  
Table 1. Summary of critical organ and dose volume limits in prostate cancer treatment 
Each day the new ultrasound image is aligned to the reference image right before a 
treatment starts. Our technique included acquiring a reference ultrasound image at the time 
of initial CT scan for the planning. 
At this time, positioning reference volume (PRV) of prostate from ultrasound scan (US) is 
created and this PRV is compared to daily US image during radiation treatment. The 
reference ultrasound image is aligned to the planning CT image with the co-registration of 
the planning CT and PRV to confirm that the prostate, bladder, and rectum are well 
localized and readily visible on both images near the prostate. It is not necessary to visualize 
the entire bladder or rectum in order to localize the prostate in US image. However, patient 
positioning is critical. Ultrasound image is acquired by pressing the ultrasound probe 
against the patient’s lower abdomen and rolling it in the sagittal plane while continuously 
acquiring ultrasound image slices. These slices are then reconstructed based on the position 
and tilt of the ultrasound probe relative to the reference point to create a 3D image of the 
patient.  
The images are acquired through the bladder which serves as a high transmission interface 
between the skin and the prostate. It is therefore necessary that the bladder be relatively full. 
In order to accomplish this, patients are asked to drink 16 ounces of fluid 30 minutes before 
the simulation and every day of treatment. Each day the patient’s skin marks are used to 
align the patient to isocenter. An ultrasound is acquired in the same way that it was 
acquired at the time of the planning CT. The newly acquired image is then compared to the 
PRV and the images of the prostates are aligned Fig 1. This alignment requires a directional 
couch shift which is then made. The treatment is then delivered.  
Other localization techniques exist such as kilovoltage and megavoltage imaging, and 
fiducial markers implanted into the prostate can be used. Studies have demonstrated that 
ultrasound localization is not as precise as these other localization techniques particularly 
when implanted fiducial markers are used where it is possible to align the prostate to within 
4mm at the 95% confidence interval (Moseley et al, 2007). However, kilovoltage and 
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target is relative to the skin marks. Daily imaging reduces much of this uncertainty by 
directly viewing internal soft tissues or fiducial markers placed inside the tumor. Small (e.g. 
1 mm diameter and 5 mm long) fiducial markers are radio-opaque to kilovoltage radiation 
and are therefore well visualized in kilovoltage images. They can be implanted into soft 
tissues to assist with comparing daily images to reference images. These images can be 
reviewed daily by the radiation oncologist before treatment is delivered.  
Several types of daily imaging are now used in radiation oncology to aid in Image Guided 
Radiation Therapy (IGRT). These new innovative technologies include megavoltage (MV) 
and kilovoltage (KV) X-ray energies to acquire individual radiographs or cone beam CT 
(CBCT). Also, ultrasound images—either planar or volume images—can be used for daily 
localization of certain targets such as gynaecological, prostate, or breast. 
In next couple of sections, 3D ultrasound application as an IGRT in radiation oncology will 
be reviewed.  
3. Applications of ultrasound imaging in prostate cancer  
The prostate location is particularly conducive to ultrasound imaging in that it is located 
beneath the bladder which when full creates a favourable ultrasound path from the skin 
surface of the lower abdomen to the prostate. The bladder-prostate interface is well 
visualized.  
In addition, the prostate is displaced by rectal and bladder filling. This displacement is 
unpredictable and can approach 2 cm (Scarborough et al., 2006). Such a large displacement 
is rare (typically less than 7 % of the time). A few millimetres are more typical on a daily 
basis, and it is less than 1 cm (0.8 – 0.9 mm) with a 95 % confidence interval (Scarborough et 
al., 2006; Serago et al., 2006). Therefore, 1 cm is a typical expansion around the prostate CTV 
to create the PTV without imaging (Hanks et al., 2000; Boersma et al., 1998). With daily 
ultrasound imaging, we have found that the 95 % confidence interval is reduced to 0.7 cm 
which agrees with Serago et al (Serago et al., 2006). Boda-Heggemann et al and Langen et al 
also demonstrated that ultrasound imaging improves prostate localization (Boda-
Heggemann et al., 2008; Langen et al., 2003). Serago et al and Langen et al identified a 
significant improvement in localization in the anterior-posterior direction which is the 
direction of largest prostate displacement because of rectal filling (Serago et al., 2006; 
Langen et al., 2003). Further, the rectum and bladder are adjacent to the prostate, but are 
critical structures that should be spared as much dose as is possible without compromising 
the delivery of the prescribed dose to the prostate. 
Prescribed total doses of 70 to 78 Gy to the entire prostate at 1.8 Gy per daily fraction are 
common for treating prostate cancer (Pollack et al., 2002). Because of the proximity of the 
bladder and rectum to the prostate, a portion of each of these organs typically receives the 
entire dose. In order to avoid serious toxicities to these organs, their volumes receiving such 
large doses of radiation must be limited. A recent review of the literature evaluating bladder 
and rectal tolerances to radiation has suggested the following dose constraints (Michalski et 
al., 2010; Viswanathan et al., 2010): (Table 1) 
Toxic effects are graded using one a few standardized criteria including the Common 
Terminology Criteria for Adverse Events version 3.0 (CTCAE 3.0) and Radiation Therapy 
Oncology Group (RTOG) scoring criteria. Long term toxic effects can include rectal stricture, 
rectal bleeding, diminished rectal compliance, decreased storage capacity with resultant 
small and frequent bowel movements, urgency to empty the bladder frequently, 
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incontinence, reduced flow, bladder spasms, hematuria, fistula, obstruction, ulceration, and 
necrosis (Michalski et al., 2010; Viswanathan et al., 2010). The tabulated limits are expected 
to avoid these serious long term toxic effects in 90% or more of patients (Michalski et al., 
2010; Viswanathan et al., 2010). These criteria were developed over many years without the 
benefits of daily localization; however, daily localization can be expected to help reduce the 
doses to these critical structures (Michalski et al., 2010; Viswanathan et al., 2010) by helping 
us treat with smaller margins thereby reducing toxic effects of radiation. 
 
Specified Dose Percentage of Organ Volume Receiving Greater than Specified Dose (%) 
(Gy) Bladder Rectum 
50  50 
60  35 
65 50 25 
70 35 20 
75 25 15 
80 15  
Table 1. Summary of critical organ and dose volume limits in prostate cancer treatment 
Each day the new ultrasound image is aligned to the reference image right before a 
treatment starts. Our technique included acquiring a reference ultrasound image at the time 
of initial CT scan for the planning. 
At this time, positioning reference volume (PRV) of prostate from ultrasound scan (US) is 
created and this PRV is compared to daily US image during radiation treatment. The 
reference ultrasound image is aligned to the planning CT image with the co-registration of 
the planning CT and PRV to confirm that the prostate, bladder, and rectum are well 
localized and readily visible on both images near the prostate. It is not necessary to visualize 
the entire bladder or rectum in order to localize the prostate in US image. However, patient 
positioning is critical. Ultrasound image is acquired by pressing the ultrasound probe 
against the patient’s lower abdomen and rolling it in the sagittal plane while continuously 
acquiring ultrasound image slices. These slices are then reconstructed based on the position 
and tilt of the ultrasound probe relative to the reference point to create a 3D image of the 
patient.  
The images are acquired through the bladder which serves as a high transmission interface 
between the skin and the prostate. It is therefore necessary that the bladder be relatively full. 
In order to accomplish this, patients are asked to drink 16 ounces of fluid 30 minutes before 
the simulation and every day of treatment. Each day the patient’s skin marks are used to 
align the patient to isocenter. An ultrasound is acquired in the same way that it was 
acquired at the time of the planning CT. The newly acquired image is then compared to the 
PRV and the images of the prostates are aligned Fig 1. This alignment requires a directional 
couch shift which is then made. The treatment is then delivered.  
Other localization techniques exist such as kilovoltage and megavoltage imaging, and 
fiducial markers implanted into the prostate can be used. Studies have demonstrated that 
ultrasound localization is not as precise as these other localization techniques particularly 
when implanted fiducial markers are used where it is possible to align the prostate to within 
4mm at the 95% confidence interval (Moseley et al, 2007). However, kilovoltage and 
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megavoltage imaging use ionizing radiation which may have long term radiation effects, 
and implanting fiducial markers is an invasive procedure. Ultrasound can therefore be 
considered an alternative localization method. 
 
 
Fig. 1. Contour of the PRV and inferior bladder wall aligned on a daily ultrasound in the 
sagittal view. 
4. Applications in gynaecological cancers  
For gynaecological cancers (endometrial cancer or cervical cancer), clinical target volume 
(CTV) definition for external beam radiation therapy is more complex compared to other 
cancer sites. It has been challenging to create accurate PTV margins because the CTV is 
composed of multiple structures and they move relative to each other as well as deform 
during the radiation therapy course. Also adjacent normal tissues move randomly daily. In 
order to reproduce a daily consistent setup, patients are instructed to empty their rectum 
and have a full bladder before the acquisition of planning CT and radiation treatment.  
4.1 Anatomy and organ motions 
Pelvic anatomy consists of movable organs such as small bowel, sigmoid, bladder, rectum, 
and cervix/uterus. With radiation therapy for gynaecological cancer treatment, there are 
risks of small bowel and bladder complications due to anatomical close relationship. A full 
bladder can push away small bowel out of the radiation field and reduce target motion 
(cervix/uterus) variability. Therefore, it is important to have a full bladder prior to the 
acquisition of planning CT and the daily radiation treatments. This also ensures consistency 
and reproducibility of target positioning daily during radiation treatment. All patients who 
undergo radiation treatments are given guidelines for bladder filling. 
4.2 Ultrasound images with full bladder for daily treatment  
Patients are instructed to drink 24-32oz of water or fluids 30 minutes prior to scanning for 
daily treatment. Bladder is an easy structure to identify in ultrasound image and full 
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bladder impacts the ultrasound image quality by enhancing the image and sharpening the 
edge between bladder and uterus/cervix/vaginal canal. (Fig.2) For cervical cancer 
patients with an intact uterus, the vaginal canal, cervix and uterus are posterior to the 
bladder (Fig.3). For patients who had a hysterectomy, only the vaginal canal is seen 
posterior to the bladder.  
 
  
            (a)                 (b) 
 
(c) 
Fig. 2. a. Empty bladder, b. Partially filled and c. Full bladder in ultrasound images. Used 
with permission of the Resonant/Clarity. 
Before radiation therapy is started for each patient, a treatment planning CT scan is done 
with a full bladder followed by acquisition of an ultrasound scan. The reference ultrasound 
image is aligned to the CT image. At this time, a positioning reference volume (PRV) of the 
bladder from the ultrasound scan (US) are created and this PRV are compared to the daily 
US images taken during radiation treatment course.  
The US image is acquired as follows. The US probe is placed with firm pressure on the pubic 
symphysis and slowly rotated. The probe is then swept across the abdomen toward the 
patient’s head. Since a full bladder provides good propagation of the sound waves, the 
uterus/cervix/vagina images are acquired by scanning through the bladder. As seen from 
Fig. 4, the outline of bladder and other organs such as the uterus, cervix and vaginal canal 
can be drawn on the US image directly, and their volumes can be measured too. After 
acquisition of the daily US image, 3D reconstructions of the images are made. These 3D 
images are then used for the calculation of any directional shift that are necessary for target 
alignment prior to radiation treatment (Fig.5) Also, with the co-registration of the planning 
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megavoltage imaging use ionizing radiation which may have long term radiation effects, 
and implanting fiducial markers is an invasive procedure. Ultrasound can therefore be 
considered an alternative localization method. 
 
 
Fig. 1. Contour of the PRV and inferior bladder wall aligned on a daily ultrasound in the 
sagittal view. 
4. Applications in gynaecological cancers  
For gynaecological cancers (endometrial cancer or cervical cancer), clinical target volume 
(CTV) definition for external beam radiation therapy is more complex compared to other 
cancer sites. It has been challenging to create accurate PTV margins because the CTV is 
composed of multiple structures and they move relative to each other as well as deform 
during the radiation therapy course. Also adjacent normal tissues move randomly daily. In 
order to reproduce a daily consistent setup, patients are instructed to empty their rectum 
and have a full bladder before the acquisition of planning CT and radiation treatment.  
4.1 Anatomy and organ motions 
Pelvic anatomy consists of movable organs such as small bowel, sigmoid, bladder, rectum, 
and cervix/uterus. With radiation therapy for gynaecological cancer treatment, there are 
risks of small bowel and bladder complications due to anatomical close relationship. A full 
bladder can push away small bowel out of the radiation field and reduce target motion 
(cervix/uterus) variability. Therefore, it is important to have a full bladder prior to the 
acquisition of planning CT and the daily radiation treatments. This also ensures consistency 
and reproducibility of target positioning daily during radiation treatment. All patients who 
undergo radiation treatments are given guidelines for bladder filling. 
4.2 Ultrasound images with full bladder for daily treatment  
Patients are instructed to drink 24-32oz of water or fluids 30 minutes prior to scanning for 
daily treatment. Bladder is an easy structure to identify in ultrasound image and full 
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bladder impacts the ultrasound image quality by enhancing the image and sharpening the 
edge between bladder and uterus/cervix/vaginal canal. (Fig.2) For cervical cancer 
patients with an intact uterus, the vaginal canal, cervix and uterus are posterior to the 
bladder (Fig.3). For patients who had a hysterectomy, only the vaginal canal is seen 
posterior to the bladder.  
 
  
            (a)                 (b) 
 
(c) 
Fig. 2. a. Empty bladder, b. Partially filled and c. Full bladder in ultrasound images. Used 
with permission of the Resonant/Clarity. 
Before radiation therapy is started for each patient, a treatment planning CT scan is done 
with a full bladder followed by acquisition of an ultrasound scan. The reference ultrasound 
image is aligned to the CT image. At this time, a positioning reference volume (PRV) of the 
bladder from the ultrasound scan (US) are created and this PRV are compared to the daily 
US images taken during radiation treatment course.  
The US image is acquired as follows. The US probe is placed with firm pressure on the pubic 
symphysis and slowly rotated. The probe is then swept across the abdomen toward the 
patient’s head. Since a full bladder provides good propagation of the sound waves, the 
uterus/cervix/vagina images are acquired by scanning through the bladder. As seen from 
Fig. 4, the outline of bladder and other organs such as the uterus, cervix and vaginal canal 
can be drawn on the US image directly, and their volumes can be measured too. After 
acquisition of the daily US image, 3D reconstructions of the images are made. These 3D 
images are then used for the calculation of any directional shift that are necessary for target 
alignment prior to radiation treatment (Fig.5) Also, with the co-registration of the planning 
 
 




Fig. 3. Anatomy location of bladder, vaginal canal, cervix and uterus.  
CT and the reference US image, the radiation treatment fields (each portal) and target 
contours can be overlaid on the daily US images as a verification of the setup of the patient 
prior to daily treatment (Fig. 6). However, patient repositioning solely by daily US imaging 
for gynaecological cancers is questionable because the target is of complicated shape and is 
composed of multiple other structures such as the common iliac, external iliac, and internal 
iliac with inguinofemoral and periaortic nodes as well as the uterus, cervix, parametrium 
and vagina. As mentioned before, ultrasound can only image the vaginal canal and uterus in 
the target. In our clinic, as shown in Fig 6, daily US image is compared to the PTV contour 
from the planning CT and verified if the uterus/cervix or vaginal canal is still within the 
PTV. This is a major difference in using US images as an IGRT method between 
gynecological use and other disease sites use such as prostate and breast.    
 
 
Fig. 4. Daily US image. Used with permission of the Resonant/Clarity. 
 




Fig. 5. Daily US image and PRV comparison and calculated positional shift. Used with 
permission of the Resonant/Clarity. 
 
 
Fig. 6. Image co-registration of planning CT and US PRV with PTV contours from CT 
overlaid to daily US. Orange colored shape is PTV defined in CT image. Pink shows bladder 
on reference CT and green for bladder with daily US.  
4.3 Clinical data for bladder and target motion during radiation treatment course 
Data quantifying  bladder motion during radiation therapy have been published in the 
literature (Ahmad et al., 2008; Jhingran et al., 2010; Jurgenliemk-Schulz et al., 2011; Lim et 
al., 2009; McBain et al., 2009; Thawani et al, 2008; Yee et al., 2010). From the experiences 
gained with US imaging at our institution we found that inter-fraction bladder volume 
variations are prominent for gynaecological cancer treatments. Mean bladder volume was 
254.2 cc with a standard deviation of 138.5 cc for 202 fractions with 11 patients. 
 




Fig. 3. Anatomy location of bladder, vaginal canal, cervix and uterus.  
CT and the reference US image, the radiation treatment fields (each portal) and target 
contours can be overlaid on the daily US images as a verification of the setup of the patient 
prior to daily treatment (Fig. 6). However, patient repositioning solely by daily US imaging 
for gynaecological cancers is questionable because the target is of complicated shape and is 
composed of multiple other structures such as the common iliac, external iliac, and internal 
iliac with inguinofemoral and periaortic nodes as well as the uterus, cervix, parametrium 
and vagina. As mentioned before, ultrasound can only image the vaginal canal and uterus in 
the target. In our clinic, as shown in Fig 6, daily US image is compared to the PTV contour 
from the planning CT and verified if the uterus/cervix or vaginal canal is still within the 
PTV. This is a major difference in using US images as an IGRT method between 
gynecological use and other disease sites use such as prostate and breast.    
 
 
Fig. 4. Daily US image. Used with permission of the Resonant/Clarity. 
 




Fig. 5. Daily US image and PRV comparison and calculated positional shift. Used with 
permission of the Resonant/Clarity. 
 
 
Fig. 6. Image co-registration of planning CT and US PRV with PTV contours from CT 
overlaid to daily US. Orange colored shape is PTV defined in CT image. Pink shows bladder 
on reference CT and green for bladder with daily US.  
4.3 Clinical data for bladder and target motion during radiation treatment course 
Data quantifying  bladder motion during radiation therapy have been published in the 
literature (Ahmad et al., 2008; Jhingran et al., 2010; Jurgenliemk-Schulz et al., 2011; Lim et 
al., 2009; McBain et al., 2009; Thawani et al, 2008; Yee et al., 2010). From the experiences 
gained with US imaging at our institution we found that inter-fraction bladder volume 
variations are prominent for gynaecological cancer treatments. Mean bladder volume was 
254.2 cc with a standard deviation of 138.5 cc for 202 fractions with 11 patients. 
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From these patients, it was found to be a bladder volume change more than 30% compared 
to their PRV in 40%-94% of total treatment fractions. 
A US study of 24 cervical patients by Ahmad et al. (2008) found that bladder volume 
decreases dramatically during the treatment course compared to the planning CT scan 
(mean total reduction of 71%). Using US imaging, McBain et al. (2009) investigated bladder 
volume change during the treatment course. Of the 24 patients studied, they found that 
seven patients had more than a 50 % volume change during the treatment course. Lim et al. 
(2009) assessed bladder volume change using weekly MRI scan for twenty cervical patients. 
They found bladder volume change of 7- 450% relative to baseline volumes.  
 Studies have shown that inter-fraction changes in bladder volume are unpredictable and it 
is very difficult to reproduce the daily bladder filling even though written and verbal 
instructions are given to patients. Because target location depends on the fullness of the 
bladder, the reproducibility of the target location daily cannot be guaranteed. Daily 
ultrasound imaging can help ensure that the change in target volume with respect to 
bladder filling is accounted for by PTV margin and if not then the margins should be 
adjusted for individual patient to avoid geographical miss. 
Although many published data show that uterus/cervix positions can be at different 
locations depending on bladder filling (Ahmad et al., 2011; Buchali et al., 1999; Chan et al., 
2004; Han et al., 2006; Huh et al., 2004; Jhingran et al., 2010; Kerkhof et al., 2009; Taylor & 
Powell, 2008; Van de Bunt et al., 2008),  one study reported recently that motion of the 
vagina after the  hysterectomy   varies in a random manner daily and found no correlation 
with changes in bladder and rectum volumes (Jurgenliemk- Schulz et al. ,2011). Also some 
studies claimed that uterus and cervix motion are weakly correlated with bladder and 
rectum filling status because change in target motion not only depends on adjacent bladder 
and rectal filling but also depends on tumor regression and deformation with a patient-
specific correlation (Huh et al., 2004; Van de Bunt et al., 2008). 
On the contrary, consistent clinical investigations with prostate demonstrate that the 
prostate motion strongly depends on bladder and rectum filling (Pinkawa et al., 2006; 
Schild et al.,1993; Stam et al, 2006;  Ten Haken et al., 1991; Thawani et al, 2008; Van Herk 
et al., 1995) 
5. Image guidance to minimize dosimetric impact on target and organs at risk  
IMRT1 has been proven to be beneficial and superior to conform the dose distribution to 
targets and spare critical organs reducing morbidity and toxicity by using sharp dose 
gradient compared to other conventional radiation therapy techniques. Thus IMRT is more 
attractive for the treatment of gynaecological and prostate cancer because of better tumor 
control and sparing critical organs thereby reducing the organ toxicity (Beriwal et al., 2006; 
Cahlon et al., 2008). As dose distribution has sharp gradient with IMRT, it is important to 
localize the target daily in order to reproduce the dose to critical organs and target as 
                                                 
1 Intensity-modulated radiation therapy (IMRT) is an advanced mode of high-precision radiotherapy 
that utilizes computer-controlled linear accelerators to deliver precise radiation doses to a malignant 
tumor or specific areas within the tumor. IMRT allows for the radiation dose to conform more precisely 
to the three-dimensional (3-D) shape of the tumor by modulating the intensity of the radiation beam . 
IMRT also allows higher radiation doses to be focused to regions within the tumor while minimizing 
the dose to surrounding normal critical structures.  
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planned from the initial planning CT. The use of IGRT is critical to accomplish this goal 
because it enables localization of the target prior to treatment and thus account for inter-
fraction motion. 
6. Applications in partial breast irradiation or electron boost treatment 
Standard of care for early stage breast cancer is to deliver photon radiation to the whole 
breast after segmental mastectomy (lumpectomy) as a breast conserving surgery. The 
photon radiation is followed by the electron radiation as a boost to the tumor bed (surgical 
cavity). The total treatment period is about 6-7 weeks of which whole breast radiation takes 
5-6 weeks in 25-28 fractions and the boost is delivered in 4-8 fractions. This approach is well 
tolerated and has good cosmetic result with local control rates comparable to a mastectomy 
(Fisher et al., 1994, 2002; Holland et al., 1985; Veronesi et al., 2002). 
 An alternative technique to this standard approach is the APBI (accelerated partial breast 
irradiation) technique. In this technique radiation targeting is to the tumor bed area only 
instead of the whole breast. The reason is that high local recurrence of the tumor occurs at 
the primary tumor sites after the lumpectomy (Clark et al., 1987; Liljegren et al., 1999; 
Veronesi et al., 2002). APBI helps to avoid radiating normal tissue unnecessarily which will 
reduce the morbidity. Also, APBI offers a shorter treatment course (one week with twice 
daily treatments in contrast to 6-8 weeks for whole breast radiation therapy) which may be 
favourable over the conventional whole breast treatment technique. 
6.1 Ultrasound imaging for tumor bed delineation  
Historically, the palpable tumor bed predicted from the scar position on the skin with a 
clinical margin was the clinical description of the boost volume. This method has shown to 
inaccurately define the tumor bed and dosimetry is poor (Benda et al., 2003;  Landis et al., 
2007; Ringash et al. 2004) .An ideal method for the delineation of the surgical cavity for the 
boost volume has not been established (Landis et al., 2007; Ringash et al., 2004). Ultrasound, 
MRI and CT scans with or without surgical clips are the currently available techniques for 
identifying the boost volume. Various studies reported difficulties in contouring the boost 
volume in CT images because of poor seroma clarity from the surrounding tissue 
specifically in patients with dense breast parenchyma (Berrang et al. , 2009; Landis et al., 
2007; Petersen et al., 2007) . This can lead to high inter-observer variability. 3D US for 
defining the breast boost volume has been introduced recently. Unlike CT images, US can 
differentiate fluid–filled cavity (which is the lumpectomy cavity) from the surrounding 
tissue with high specificity because of excellent soft tissue imaging characteristics (Smitt et 
al., 2001; Yang & Dempsey, 2007 ; Weinstein et al., 2006). This helps to identify the tumor 
bed volume more accurately and has an improved inter-observer consistency. 
6.2 Tumor bed volume localization between US and CT  
Before daily treatment, the US probe is swept over the area near the surgical scar in one 
direction until the lumpectomy cavity is located. After the cavity is identified, it is compared 
to the PRV which is created at the time of the planning CT and directional shifts are made 
based on the comparison. Procedures for the CT and US scans at the time of planning CT are 
explained in previous sections. 
Fig 7. shows a comparison of US to CT for tumor bed volume. 
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From these patients, it was found to be a bladder volume change more than 30% compared 
to their PRV in 40%-94% of total treatment fractions. 
A US study of 24 cervical patients by Ahmad et al. (2008) found that bladder volume 
decreases dramatically during the treatment course compared to the planning CT scan 
(mean total reduction of 71%). Using US imaging, McBain et al. (2009) investigated bladder 
volume change during the treatment course. Of the 24 patients studied, they found that 
seven patients had more than a 50 % volume change during the treatment course. Lim et al. 
(2009) assessed bladder volume change using weekly MRI scan for twenty cervical patients. 
They found bladder volume change of 7- 450% relative to baseline volumes.  
 Studies have shown that inter-fraction changes in bladder volume are unpredictable and it 
is very difficult to reproduce the daily bladder filling even though written and verbal 
instructions are given to patients. Because target location depends on the fullness of the 
bladder, the reproducibility of the target location daily cannot be guaranteed. Daily 
ultrasound imaging can help ensure that the change in target volume with respect to 
bladder filling is accounted for by PTV margin and if not then the margins should be 
adjusted for individual patient to avoid geographical miss. 
Although many published data show that uterus/cervix positions can be at different 
locations depending on bladder filling (Ahmad et al., 2011; Buchali et al., 1999; Chan et al., 
2004; Han et al., 2006; Huh et al., 2004; Jhingran et al., 2010; Kerkhof et al., 2009; Taylor & 
Powell, 2008; Van de Bunt et al., 2008),  one study reported recently that motion of the 
vagina after the  hysterectomy   varies in a random manner daily and found no correlation 
with changes in bladder and rectum volumes (Jurgenliemk- Schulz et al. ,2011). Also some 
studies claimed that uterus and cervix motion are weakly correlated with bladder and 
rectum filling status because change in target motion not only depends on adjacent bladder 
and rectal filling but also depends on tumor regression and deformation with a patient-
specific correlation (Huh et al., 2004; Van de Bunt et al., 2008). 
On the contrary, consistent clinical investigations with prostate demonstrate that the 
prostate motion strongly depends on bladder and rectum filling (Pinkawa et al., 2006; 
Schild et al.,1993; Stam et al, 2006;  Ten Haken et al., 1991; Thawani et al, 2008; Van Herk 
et al., 1995) 
5. Image guidance to minimize dosimetric impact on target and organs at risk  
IMRT1 has been proven to be beneficial and superior to conform the dose distribution to 
targets and spare critical organs reducing morbidity and toxicity by using sharp dose 
gradient compared to other conventional radiation therapy techniques. Thus IMRT is more 
attractive for the treatment of gynaecological and prostate cancer because of better tumor 
control and sparing critical organs thereby reducing the organ toxicity (Beriwal et al., 2006; 
Cahlon et al., 2008). As dose distribution has sharp gradient with IMRT, it is important to 
localize the target daily in order to reproduce the dose to critical organs and target as 
                                                 
1 Intensity-modulated radiation therapy (IMRT) is an advanced mode of high-precision radiotherapy 
that utilizes computer-controlled linear accelerators to deliver precise radiation doses to a malignant 
tumor or specific areas within the tumor. IMRT allows for the radiation dose to conform more precisely 
to the three-dimensional (3-D) shape of the tumor by modulating the intensity of the radiation beam . 
IMRT also allows higher radiation doses to be focused to regions within the tumor while minimizing 
the dose to surrounding normal critical structures.  
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planned from the initial planning CT. The use of IGRT is critical to accomplish this goal 
because it enables localization of the target prior to treatment and thus account for inter-
fraction motion. 
6. Applications in partial breast irradiation or electron boost treatment 
Standard of care for early stage breast cancer is to deliver photon radiation to the whole 
breast after segmental mastectomy (lumpectomy) as a breast conserving surgery. The 
photon radiation is followed by the electron radiation as a boost to the tumor bed (surgical 
cavity). The total treatment period is about 6-7 weeks of which whole breast radiation takes 
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based on the comparison. Procedures for the CT and US scans at the time of planning CT are 
explained in previous sections. 
Fig 7. shows a comparison of US to CT for tumor bed volume. 
 




Fig. 7. Co-registered images of US and CT for a tumor bed. Used with permission of the 
Elsevier (International Journal of Radiation Oncology, Biology, Physics., vol. 73, No.2, pp 
375-383,2009) 
CT overestimates the true tumor bed volume compared to US images. One study (Wong et 
al., 2011) reported that the average difference of the tumor bed volume between US and CT 
is 55% because the seroma or fluid cavity is well visualized in US, but not as well in CT. On 
a CT scan, the fluid cavity plus the fibrotic tissue surrounding the cavity are drawn as the 
cavity/seroma. Fig.8 is one example. 
 
 
Fig. 8. Poor correlation between US and CT for the low seroma clarity from the CT. Upper: 
On CT image there are three different tumor bed drawn (low interobserver corformity 
index). Lower: improved interobserver conformity index with US guidance. Used with 
permission of the Elsevier  (International Journal of Radiation Oncology, Biology, Physics., 
vol. 73, No.2, pp 375-383,2009) 
 
Clinical Application of Ultrasound Imaging in Radiation Therapy 
 
325 
6.3 Inter-fractional changes in tumor bed volume and position with US study 
By the use of 3D US, daily localization of the tumor bed becomes viable. Few studies have 
quantified tumor bed volume changes during the course of treatment (Prendergast et al., 
2009). Redefining the tumor bed right before the boost treatment will give a better 
assessment for the boost volume, and the ultrasound image provides a convenient method 
for this without giving extra dose to the patient. Wong et al., (2011) reported that the 
average tumor bed displacement in the radial direction was 10.8 mm with a standard 
deviation of 6.3 mm, and 50% of the time the fractions had displacements. Other study 
(Weed et al., 2004) using surgical clips or CT images identified average displacements of 
3mm in the radial direction. This suggests that tumor bed localization is important and 3D 
US scans can play an important role in an assessment of surgical bed and localization before 
treatment. This is particularly important for 3D conformal or IMRT for accelerated partial 
breast radiation (APBI techniques) where better daily targeting becomes critical.  
7. Technical issues 
Acquiring ultrasound images requires special skill in the radiation oncology department 
because technicians, physicists, and physicians are not typically trained to scan and review 
ultrasound images. Traditionally ultrasound images have been reviewed by 
radiologists/radiology technicians. Technical skills for acquiring US images for different body 
sites by the radiation oncology staff can be highly user dependent thus affecting acquired 
image quality. In the absence of proper training,  the interpretation of US images by the 
radiation staff can also be highly user dependent. Special consultation by a radiologist is thus 
needed until the radiation oncology staff is properly trained with this imaging modality.  
The Resonant/Clarity ultrasound system for IGRT requires establishment of correspondence 
between the planning CT, acquired ultrasound images in the CT room and the treatment 
images acquired at the treatment vault. This is done by establishing an appropriate calibration 
procedure. In this way, the US workstations can create and save the PRV as a reference image 
by the image co-registration process, sharing the same coordinates with the treatment machine 
from the fusion of CT and the US images. MR and CT images are fused by mathematical 
methods such as pixel data or bony anatomy matching, and PET and CT images are fused by 
the automatic dicom match method. However, fusion of US and CT images is more 
challenging if it is done with manual registration, and it needs more careful consideration to 
achieve an accurate image co-registration if the images do not share a common reference point.   
8. Quality assurance  
As explained in previous sections, the US system is used for daily verification of the patient 
position as well as creating a reference volume for the target localization when fused with 
the CT images for a treatment plan. A calibration phantom is used to check the performance 
of the system which is referred to as a Quality Assurance (QA). QA for the Ultrasound 
system consists of the system integrity check (mechanical function), isocenter verification, 
directional shift calculation, imaging quality check and software performance check. Daily 
QA and monthly QA are routine check-ups for the system. 
8.1 Daily QA  
As a daily check, isocenter accuracy verification and directional shift calculations are 
performed by a therapist. The linear accelerator beam is calibrated at the isocenter and 
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directional shift calculation, imaging quality check and software performance check. Daily 
QA and monthly QA are routine check-ups for the system. 
8.1 Daily QA  
As a daily check, isocenter accuracy verification and directional shift calculations are 
performed by a therapist. The linear accelerator beam is calibrated at the isocenter and 
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intersections of the CT room lasers and treatment room lasers are referenced to the 
isocenter. The calibration phantom that contains a positional guidance volume (PGV) is 
used for QA. The phantom is calibrated at the isocenter by using the optical tracking camera 
in the system. The PGV has a known 3D coordinate position shared with the treatment room 
and CT unit lasers, and it can be verified with daily US scans. The calibration phantom is set 
up with the room lasers (at the isocenter) and scanned with the US probe. After the PGV is 
reconstructed, a 3D view of the US shows the isocenter coordinate. It is then compared to 
the known coordinates (reference value) by image co-registration between the reference 
PGV of the phantom and the daily PGV. Directional shifts and offsets are calculated (Fig 9). 
Tolerance level in isocenter position is 2.0mm in radiation therapy. Isonceter verification is 
done at CT room and treatment room both. 
As for directional shifts calculations, it is performed at the treatment room after the isocenter 
accuracy is checked. The couch is moved from isocenter by a known amount of offset in all 
three directions (anterior-posterior, superior-inferior, medial-lateral), and the phantom is 
scanned. After reconstruction of the PGV is done, 3D coordinates are calculated and checked 
if the offset is correctly calculated. 
 
 
Fig. 9. Daily QA : Green circle is the reference PGV and red one is daily scan image of PGV: 
left image shows 3D coordinates of daily scan, middle image for comparison and directional 
shift between reference and daily PGV, right image is the QA phantom. 
8.2 Monthly QA  
The physicist performs monthly QA. For monthly QA, daily QA is repeated along with 
additional checks such as verification of the phantom PGV image in the US and CT images, 
registration of US and CT images, image reconstruction, and system integrity tests. A CT 
scan of the calibration phantom is performed and an US scan follows. Image co-registration 
is performed by fusing both images, the PGV is contoured, and the size of the PGV is 
measured and compared in both images. After that, the phantom is placed in the treatment 
room and the daily QA is performed. System functionality is checked for the each part of the 
system.  
9. Other image modalities in radiation therapy  
KV/MV verification imaging systems for patient set up such as kV planar images, kV CBCT, 
MV CBCT and MV portal images have been accepted more widely in radiation oncology 
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community for IGRT than US systems. In contrast to US systems, these other IGRT systems 
are integrated with the linear accelerator (Fig 10.)  making data transfer and connectivity 
between treatment machine and imaging device easier. MV portal images have the oldest 
history for patient setup verification and renders verification only of bony anatomy because 
of the poor image quality from the MV photon beams. In addition, MV portal imaging can’t 
be taken on a daily basis because of the extra dose from the high energy therapeutic MV 
beams. Traditionally portal images are taken once a week. kV x-ray based OBI (2D planner 
images) provides better image quality. It allows verifying the bony anatomy as well as soft 
tissues, and daily imaging can be acceptable because of low extra doses. CBCT can provide 
3D volumetric images and renders visualization of soft tissue targets as well as adjacent 
organs. Although doses from kV imaging are low it still gives extra daily dose to a patient 
and careful consideration for the daily extra dose needs to be investigated.  
 
 
Fig. 10. Linear Accelerator with kV imaging arms attached. VARIAN 23 iX with OBI (On 
Board Imager).  
10. Conclusion  
Ultrasound application as IGRT in radiation therapy has been established. Because it is non-
ionizing, provides excellent soft tissue image quality and non invasive in nature, it can be 
beneficial as an IGRT tool for radiation patients. The drawback of this technique is user 
dependence, challenging learning curve for radiation oncology staff and applicability to few 
disease sites only. Besides, it also doesn’t account for intrafraction motion which is also 
important for daliy target localization. Nevertheless, ultrasound guidance has been useful 
for daily localization in target position such as prostate, breast and gynaecological cancers as 
well as for monitoring inter-fractional bladder filling status and organ motion. 
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